{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "919dc72c",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "from bs4 import BeautifulSoup as BS\n",
    "import pandas as pd\n",
    "import time\n",
    "import re\n",
    "from selenium import webdriver\n",
    "from selenium.webdriver.common.by import By\n",
    "import functions_forcrawl\n",
    "edit = functions_forcrawl.All_func()\n",
    "\n",
    "def clean_semicolon(st):\n",
    "    \n",
    "    if re.search(';$|; $', st, flags=re.S):\n",
    "        return re.sub(';$|; $', '', st, flags=re.S).strip()\n",
    "    \n",
    "    else:\n",
    "        return st\n",
    "    \n",
    "def add_minutes(t, m):\n",
    "    \n",
    "    hours, minutes = map(int, t.split(\":\"))\n",
    "    total_minutes = 60 * hours + minutes + m\n",
    "    new_hours = total_minutes // 60\n",
    "    new_minutes = total_minutes % 60\n",
    "    return \"{:02d}:{:02d}\".format(new_hours % 24, new_minutes)\n",
    "\n",
    "\n",
    "cookies = {\n",
    "    'PHPSESSID': 'lbwww6~2f22d77a3de3da12104acedee740dc52',\n",
    "    'joe-chnlcustid': '0a43eed3-8ddd-4ab1-a6c7-c5256b4d9c49',\n",
    "}\n",
    "\n",
    "headers = {\n",
    "    'Accept': 'text/html, */*; q=0.01',\n",
    "    'Accept-Language': 'en-GB,en-US;q=0.9,en;q=0.8',\n",
    "    'Connection': 'keep-alive',\n",
    "    'Content-Type': 'application/x-www-form-urlencoded; charset=UTF-8',\n",
    "    # 'Cookie': 'PHPSESSID=lbwww6~2f22d77a3de3da12104acedee740dc52; joe-chnlcustid=0a43eed3-8ddd-4ab1-a6c7-c5256b4d9c49',\n",
    "    'Origin': 'https://online.eccmid.org',\n",
    "    'Referer': 'https://online.eccmid.org/programme-live-1?coday=2023-02-16&embed=',\n",
    "    'Sec-Fetch-Dest': 'empty',\n",
    "    'Sec-Fetch-Mode': 'cors',\n",
    "    'Sec-Fetch-Site': 'same-origin',\n",
    "    'User-Agent': 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.0.0 Safari/537.36',\n",
    "    'X-Requested-With': 'XMLHttpRequest',\n",
    "    'sec-ch-ua': '\"Not_A Brand\";v=\"99\", \"Google Chrome\";v=\"109\", \"Chromium\";v=\"109\"',\n",
    "    'sec-ch-ua-mobile': '?0',\n",
    "    'sec-ch-ua-platform': '\"Windows\"',\n",
    "}\n",
    "\n",
    "data = {\n",
    "    'idCat': '1',\n",
    "    'sessionRef': '3379',\n",
    "    'timezone': 'Europe/Paris',\n",
    "    'defaultTimezone': 'Europe/Paris',\n",
    "    'dispCountry': '',\n",
    "    'target': '_self',\n",
    "    'embed': 'false',\n",
    "    'dispCities': '',\n",
    "    'firstnameFull': '',\n",
    "    'page': '',\n",
    "}\n",
    "\n",
    "response = requests.post(\n",
    "    'https://online.eccmid.org/fo-user-display-session-details.php',\n",
    "    cookies=cookies,\n",
    "    headers=headers,\n",
    "    data=data,\n",
    ")\n",
    "\n",
    "dic = {\n",
    "    'source_id':[],\n",
    "    'manual_id':[],\n",
    "    'article_title':[],\n",
    "    'url':[],\n",
    "    'authors':[],\n",
    "    'author_affiliation':[],\n",
    "    'abstract_text':[],\n",
    "    'date':[],\n",
    "    'start_time':[],\n",
    "    'end_time':[],\n",
    "    'location':[],\n",
    "    'session_title':[],\n",
    "    'session_number':[],\n",
    "    'name':[],\n",
    "    'session_type':[],\n",
    "    'category':[],\n",
    "    'sub_category':[],\n",
    "    'disclosure':[]\n",
    "    }\n",
    "\n",
    "dates = ['02-15', '02-16', '03-15', '03-16', '04-15', '04-16', '04-17', '04-18', '05-24', '05-25']\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "47369258",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=====**=====S1=====**======= 0\n",
      "sess date :- 15/02/2023\n",
      "sess time :- 16:00 - 17:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3437 - Multi-country outbreaks: from signal to response\n",
      "abs text :- Co-organised with                    \n",
      "Eurosurveillance, European Centre for Disease Prevention and Control (ECDC) During the first half of 2022, several viral and bacterial multi-country outbreaks have illustrated challenges in the detection and response to such events. In this session, speakers will present two outbreaks in Europe, and cover signal detection, outbreak investigation and response measures and follow up. They will demonstrate the importance of cross-disciplinary collaboration that involves clinicians, epidemiologists, microbiologists as well as international coordinating bodies such as the ECDC, EFSA and WHO to gather sound evidence to guide public health decision making in complex situations with a multitude of different actors and lessons learnt for the future.\n",
      "sess auth :- Jacob MORAN; Ines STEFFENS\n",
      "sess aff :- Israel; Sweden\n",
      "========================================================================================================================\n",
      "3437-1 === \n",
      "abs title :- A dangerous pre-Easter surprise: multi-country Salmonella outbreak linked to chocolate products\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3437-2 === \n",
      "abs title :- Multi-country detections of diphtheria in migrants from endemic counties in Europe\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 2\n",
      "=====**=====S2=====**======= 0\n",
      "sess date :- 15/02/2023\n",
      "sess time :- 17:00 - 18:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3268 - Tick-borne diseases in Europe: new, emerging and common\n",
      "abs text :- Co-organised with                    \n",
      "Danish Infectious Disease Society Lyme borreliosis along with Tick-borne encephalitis (TBE) are the most common tick-borne diseases in Europe. Laboratory diagnosis of Lyme borreliosis is challenging. Diagnosing Lyme borreliosis primarily depends on clinical manifestation and serology, however new advantages in diagnostic have been made. In recent years the geographical range of TBE has change and we see an increase in annual incidence in known epidemic areas, and emergence in new geographical areas not previously known to be endemic. In addition, new tick-borne pathogens giving raise to human disease have been discovered in the last decade. Therefore, vigilance are needed in discovering, diagnosing and describing the clinical manifestations of old, new and emerging tick-borne infections. This session aims to give insight into recent breakthroughs in Lyme borreliosis, as well as new tick-borne pathogens in Europe.\n",
      "sess auth :- Nanna Skaarup ANDERSEN ; Olli VAPALAHTI\n",
      "sess aff :- Denmark; Finland\n",
      "========================================================================================================================\n",
      "3268-1 === \n",
      "abs title :- Lyme borreliosis: recent progress and remaining challenges\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3268-2 === \n",
      "abs title :- Neoehrlichia mikurensis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 3\n",
      "=====**=====S3=====**======= 0\n",
      "sess date :- 15/02/2023\n",
      "sess time :- 18:00 - 19:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3395 - The true story of Mycobacterium africanum\n",
      "abs text :-  Tuberculosis (TB) is still the major infectious diseases in the world for lethality. The agent is now known as Mycobacterium tuberculosis complex (MTBC) composed of up to 9 lineages and other species infecting animals. Within MTBC, M. africanum was known as a species but genomic studies led to new insights and redefinition of this species, now lineages L5 and L6 of MTBC. This MTBC infected only people in West Africa and did not expand nor acted as multidrug-resistant. Recently two groups have shown specific clinical and genetic insights of MAF that are important to know when working in the TB field.\n",
      "sess auth :- Christoph LANGE ; Katharina KRANZER\n",
      "sess aff :- Germany; Zimbabwe\n",
      "========================================================================================================================\n",
      "3395-1 === \n",
      "abs title :- Does M. africanum cause the same tuberculosis disease as others MTBC?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3395-2 === \n",
      "abs title :- How genetics showed that M. africanum is so peculiar among the  complex?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 4\n",
      "=====**=====S4=====**======= 0\n",
      "sess date :- 16/02/2023\n",
      "sess time :- 15:30 - 16:00\n",
      "sess loca :- Industry Track\n",
      "sess type :- Industry SessionIndustry Track\n",
      "sess cate :- 11. Other\n",
      "sess title :- S74 - NMR-based lipoprotein phenotyping reveals severity and recovery subgroups in populations infected by SARS-CoV-2\n",
      "abs text :- Co-organised with                    \n",
      "Bruker Microbiology & Diagnostics \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "S7401 === 15:30 - 16:00\n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 5\n",
      "=====**=====S5=====**======= 1\n",
      "sess date :- 16/02/2023\n",
      "sess time :- 16:00 - 17:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3379 - Advances in novel vaccines development against neglected diseases\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Vaccine Study Group (EVASG) The burden of HIV, vector-borne diseases, tuberculosis, enteric diseases as well as emerging infections are a major global health problem in low and middle-income countries. Increasing antimicrobial resistance can also compound health inequalities. Therefore, current vaccine research priorities must include developing and evaluating vaccines targeting these diseases. The session will go through new vaccine candidates and ongoing clinical trials by experts in the field. The COVID-19 pandemic has highlighted disparities in global vaccine access. We need to be better prepared for future health threats by developimg vaccines targed to those who are at highest risk.\n",
      "sess auth :- Gagandeep KANG ; Zitta Barrella HARBOE\n",
      "sess aff :- India; Denmark\n",
      "========================================================================================================================\n",
      "3379-1 === \n",
      "abs title :- Second generation tuberculosis vaccines\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3379-2 === \n",
      "abs title :- Vaccines for vector-borne diseases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 6\n",
      "=====**=====S6=====**======= 1\n",
      "sess date :- 16/02/2023\n",
      "sess time :- 17:00 - 18:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3189 - Whooping cough: a way forward\n",
      "abs text :- Co-organised with                    \n",
      "European Society of Paediatric Infectious Diseases (ESPID), Eastern Europe Pertussis Awareness Group (CEEPAG) Whooping cough is a vaccine-preventable bacterial respiratory infection leading to high morbidity, especially in young infants. Disease burden of pertussis remains a global challenge despite high vaccination coverage in children in western countries. The key issues that will be covered in the proposed session are future steps in disease prevention and the challenges associated with disease treatment and prevention in the post-pandemic era, both in Europe and on the global level.\n",
      "sess auth :- Norman FRY ; Sophie OCTAVIA\n",
      "sess aff :- United Kingdom; Singapore\n",
      "========================================================================================================================\n",
      "3189-1 === \n",
      "abs title :- Whooping cough in the post-pandemic era\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3189-2 === \n",
      "abs title :- Update on the genomic epidemiology of B. pertussis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 7\n",
      "=====**=====S7=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/02/2023\n",
      "sess time :- 18:00 - 19:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3425 - Emerging and re-emerging haemorrhagic fever viruses\n",
      "abs text :- Co-organised with                    \n",
      "Pan-American Association Infectious Diseases (API), ESCMID Study Group for Veterinary Microbiology (ESGVM), ESCMID Study Group for Infections in Travellers and Migrants (ESGITM) Viral haemorrhagic fever (VHF) is a group of acute zoonotic diseases with high mortality rates caused by seven families of viruses that can infect both humans and animals. Diseases caused by haemorragic fever viruses are endemic in certain parts of the world and can cause major outbreaks. Emerging and re-emerging VHFs remain a great health concern across the world due to poor prognosis and lack of specific vaccines or drugs for effective treatment. This session provides two examples, from different geographical regions.\n",
      "sess auth :- Duilio NUNEZ ; Clevy PEREZ\n",
      "sess aff :- Paraguay; Dominican Republic\n",
      "========================================================================================================================\n",
      "3425-1 === \n",
      "abs title :- South American arenaviruses pre- and post-COVID\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3425-2 === \n",
      "abs title :- Expanding boundaries of CCHF\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 8\n",
      "=====**=====S8=====**======= 0\n",
      "sess date :- 15/03/2023\n",
      "sess time :- 15:30 - 16:00\n",
      "sess loca :- Industry Track\n",
      "sess type :- Industry SessionIndustry Track\n",
      "sess cate :- 11. Other\n",
      "sess title :- S75 - Management of ESBL infections in the post-MERINO era\n",
      "abs text :- Co-organised with                    \n",
      "MSD \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 9\n",
      "=====**=====S9=====**======= 1\n",
      "sess date :- 15/03/2023\n",
      "sess time :- 16:00 - 17:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3232 - Is the antibacterial pipeline sufficient to meet clinical needs?\n",
      "abs text :- Co-organised with                    \n",
      "Global Antibiotic R&D Partnership (GARDP), World Health Organization (WHO) The GRAM report comprehensive analysis of the global impact of antimicrobial resistance (AMR) in 204 countries estimated that bacterial drug-resistance caused 1.27 million deaths in 2019, thus highlighting the need for new treatments and vaccines. The World Health Organization's (WHO) annual review of the clinical and preclinical antibacterial pipelines evaluates the potential of candidates in different stages of development with antibacterial activity against drug-resistant bacteria listed in the WHO Bacterial Priority Pathogens List, Mycobacterium tuberculosis and Clostridioides difficile. The clinical pipeline review includes direct-acting small molecules, biological agents, and non-traditional antibacterial medicines. In a dedicated WHO report, vaccines in clinical and pre-clinical development are also reviewed. This symposium will provide an update on the WHO pipeline reviews and discuss whether the pipeline will be sufficient to meet clinical needs across the globe.\n",
      "sess auth :- Cesar ARIAS ; Till T. BACHMANN\n",
      "sess aff :- United States; United Kingdom\n",
      "========================================================================================================================\n",
      "3232-1 === \n",
      "abs title :- WHO pre-clinical and clinical antibacterial pipeline\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3232-2 === \n",
      "abs title :- Will the pipeline be sufficient to meet the clinical needs of countries with a high burden of drug resistance?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 10\n",
      "=====**=====S10=====**======= 1\n",
      "sess date :- 15/03/2023\n",
      "sess time :- 17:00 - 18:00\n",
      "sess loca :- Science track\n",
      "sess type :- Meet-the-ExpertScience track\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3128 - How to guide antimicrobial stewardship in neonatal and pediatric intensive care\n",
      "abs text :- Co-organised with                    \n",
      "European Society of Paedriatic and Neonatal Intensive Care (ESPNIC) Aim of the session is to focus on novel diagnostic methods to help clinicians in PICU to follow an antimicrobial stewardship approach. An overview on evidence of the novel biomarkers in PICU and NICU will be provided. Through this Meet-the-Expert, attendees will gain more knowledge on these novel methods to implement an antimicrobial stewardship strategy in PICUs and NICUs.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3128-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3128-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 11\n",
      "=====**=====S11=====**======= 1\n",
      "sess date :- 15/03/2023\n",
      "sess time :- 18:00 - 19:00\n",
      "sess loca :- Science track\n",
      "sess type :- Meet-the-ExpertScience track\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3303 - Stewardship for acute and chronic suppressive therapy of joint infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Implant-associated Infections (ESGIAI) Diagnosis and treatment of device associated infections require expertise and interdisciplinary collaboration. Future room for improvements in the field is possible Stewardship activities will gain great importance in this field. This session will identify strategies to improve diagnostic approaches and procedures as well as identifying alternative antimicrobial treatment strategies, reducing collateral damage. Overidentification and interpretation of contaminants frequently occur and cause extensive medical and surgical interventions. Improved sampling strategies and careful interpretation could improve care.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3303-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3303-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 12\n",
      "=====**=====S12=====**======= 0\n",
      "sess date :- 16/03/2023\n",
      "sess time :- 15:00 - 15:30\n",
      "sess loca :- Industry Track\n",
      "sess type :- Industry SessionIndustry Track\n",
      "sess cate :- 11. Other\n",
      "sess title :- S76 - SeluxDX\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 13\n",
      "=====**=====S13=====**======= 1\n",
      "sess date :- 16/03/2023\n",
      "sess time :- 16:00 - 17:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3229 - The forgotten story of eliminating MRSA from hospitals: what can we learn from it?\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Epidemiological Markers (ESGEM), ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) Methicillin-resistant Staphylococcus aureus (MRSA) is a continued threat to human health in both community and healthcare settings. However, the nosocomial MRSA incidence density has decreased significantly in many countries across the globe. Differences in the occurrence of AMR pathogens, including MRSA, between countries are most likely caused by differences in healthcare utilisation, patient transfer, antimicrobial use and infection prevention control practices. Pathogen evolution may also play a role in the prevalence of certain MRSA lineages that have declined precipitously in many regions of the world. In this session, we intend to understand how these differences impacted the success of decreasing MRSA trends in several countries. This will improve our understanding of how we can implement successful practices against AMR.\n",
      "sess auth :- Jan A.J.W. KLUYTMANS ; Adrian John BRINK\n",
      "sess aff :- Netherlands; South Africa\n",
      "========================================================================================================================\n",
      "3229-1 === \n",
      "abs title :- The effectiveness of hand hygiene in health care against MRSA\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3229-2 === \n",
      "abs title :- Large-scale decolonization strategies to reduce the burden of MRSA in healthcare settings\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 14\n",
      "=====**=====S14=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/03/2023\n",
      "sess time :- 17:00 - 18:00\n",
      "sess loca :- Science track\n",
      "sess type :- Meet-the-ExpertScience track\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3180 - Harmonisation of phage susceptibility testing\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA) Phages are currently being used in compassionate cases to treat persistent and resistant bacterial infections throughout the world. Additionally, many clinical studies are currently emerging to scientifically test the value and role of phages in clinical use. As phages have a narrow spectrum of activity, sensitivity testing of the patient strain is a prerequisite to treatment. While conventional laboratory methods exist to this end, no standardized and validated methods for phage sensitivity currently exist. In this session we will explore the current knowledge and future directions of phage susceptibility testing that will direct our interpretation in both individual cases and clinical trials.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3180-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3180-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 15\n",
      "=====**=====S15=====**======= 1\n",
      "sess date :- 16/03/2023\n",
      "sess time :- 18:00 - 19:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3212 - Emerging resistance mechanisms spreading across sectors\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Epidemiological Markers (ESGEM), ESCMID Study Group for Veterinary Microbiology (ESGVM) The use of critical last-resort antimicrobials is being threatened by evidence of the distribution of particular resistance determinants in humans, livestock and the environment. \n",
      "The global and intersectoral dissemination of these emerging resistance determinants is raising concerns at the diagnostics, epidemiological and therapeutic levels. The session aims at summarising and distributing most recent knowledge on the detection of corresponding mechanisms, their potential sources and ecological niches of various last resort resistances, both in Gram-positive and Gram-negative pathogens with a clear focus on evaluating the risk and burden for human medicine. The target audience are ID/CM specialists dealing with MDRO infections and last resort antimicrobials for patient treatment. Interested scientists may come from regional and national reference laboratories from either veterinary, food safety and human public health sectors.\n",
      "sess auth :- Alessandra CARATTOLI ; Orjan SAMUELSEN\n",
      "sess aff :- Italy; Norway\n",
      "========================================================================================================================\n",
      "3212-1 === \n",
      "abs title :- Rapidly spreading OXA-48-like carbapenemases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3212-2 === \n",
      "abs title :- Transferable linezolid resistance in staphylococci and enterococci\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 16\n",
      "=====**=====S16=====**======= 1\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour Educational WorkshopHall B\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3420 - Enterovirus and parechovirus infections\n",
      "abs text :-  This educational workshop will explore the significance of enterovirus infections in clinical practice, reminding that this genus of viruses is very diverse and contain over 150 different virus types. These viruses are responsible for various infections, and broad symptoms range from neurological infections to paralysis, sepsis-like disease in young children to hand-foot-and-mouth disease. The burden of these infections is largely unknown, and diagnosis can be challenging. We will discuss the current stage of surveillance and diagnostic in Europe and beyond.\n",
      "sess auth :- Heli HARVALA ; Eeva BROBERG\n",
      "sess aff :- United Kingdom; Sweden\n",
      "========================================================================================================================\n",
      "3420-1 === \n",
      "abs title :- Estimating the clinical burden of enterovirus and parechovirus infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3420-2 === \n",
      "abs title :- Emergence of EV-D68 infections in Europe\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3420-3 === \n",
      "abs title :- EV-A71\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 17\n",
      "=====**=====S17=====**======= 2\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour Oral SessionHall C\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP16 - Hot topics in sepsis\n",
      "abs text :-  \n",
      "sess auth :- Thierry CALANDRA ; Pontus NAUCLER\n",
      "sess aff :- Switzerland; Sweden\n",
      "========================================================================================================================\n",
      "CSP1601 === 08:30 - 10:30\n",
      "abs title :- Sepsis phenotypes: a function of local data?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1602 === 08:30 - 10:30\n",
      "abs title :- Long-term mortality and re-admission of community-acquired severe sepsis in Sweden\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1603 === 08:30 - 10:30\n",
      "abs title :- Cloxacillin plus fosfomycin vs cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteraemia (SAFO): a randomised clinical trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1604 === 08:30 - 10:30\n",
      "abs title :- Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: a Mendelian randomisation study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1605 === 08:30 - 10:30\n",
      "abs title :- Association of Pseudomonas aeruginosa virulence genotype with patient characteristics, septic shock and mortality in bloodstream infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1606 === 08:30 - 10:30\n",
      "abs title :- Prospective evaluation of septic shock patients with bacteraemia in a tertiary care educational university hospital: a series of 232 culture-confirmed cases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1607 === 08:30 - 10:30\n",
      "abs title :- Risk factors for persistent bacteraemia in patients with Gram-negative bloodstream infection: a systematic review with meta-analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1608 === 08:30 - 10:30\n",
      "abs title :- Impact of antimicrobial resistance on risk of recurrence after community-onset bacteraemia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1609 === 08:30 - 10:30\n",
      "abs title :- Risk factors for 30-day mortality in nosocomial enterococcal bloodstream infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1610 === 08:30 - 10:30\n",
      "abs title :- Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) bloodstream infections and mortality in Queensland, Australia: a population-based cohort study from 2000 to 2019\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 18\n",
      "=====**=====S18=====**======= 3\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall D\n",
      "sess type :- 2-hour SymposiumHall D\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3289 - Syndromic testing for infectious disease in LMICs settings: challenges and opportunities\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID International Affairs Subcommittee (EIAS), ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD) In the COVID-19 pandemic era, low- middle-income countries (LMICs) made a great effort to implement molecular diagnostic laboratories to support test-trace-isolate (TTI) strategies. The increased diagnostic capabilities have facilitated a new horizon for using molecular diagnostic techniques for infectious diseases in these countries, thereby improving diagnostic capabilities. Indeed, syndromic diagnostic techniques for respiratory and gastrointestinal infections are commonly used in developed countries. These techniques offer many advantages for the clinical management of patients. Still, several pros and cons need to be addressed, especially in LMICs settings, considering their high cost and the clinical impact. During this symposium the syndromic molecular diagnosis experience will be presented and speakers will discuss its advantages, disadvantages, and guidance for its use in LMICs.\n",
      "sess auth :- Mauricio FARFAN ; Monica SLAVIN\n",
      "sess aff :- Chile; Australia\n",
      "========================================================================================================================\n",
      "3289-1 === \n",
      "abs title :- Syndromic testing for the diagnosis of respiratory infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3289-2 === \n",
      "abs title :- Syndromic testing in patients hospitalised with severe respiratory illness\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3289-3 === \n",
      "abs title :- Use and interpretation of syndromic testing for public health surveillance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3289-4 === \n",
      "abs title :- Performance of a rapid diagnostic test for the detection of enteric pathogens in children admitted to hospital with diarrhoea\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 19\n",
      "=====**=====S19=====**======= 4\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall E\n",
      "sess type :- 2-hour Oral SessionHall E\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW12 - Long COVID: a threat for the future\n",
      "abs text :-  \n",
      "sess auth :- Yousra KHERABI\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "EW1201 === 08:30 - 10:30\n",
      "abs title :- Two-year trajectories of long-term COVID-19 symptoms in a prospective cohort in Amsterdam, Netherlands\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1202 === 08:30 - 10:30\n",
      "abs title :- Long COVID in Brazil: a multi-centre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1203 === 08:30 - 10:30\n",
      "abs title :- Clinical phenotypes of mild acute disease and their association to long-term sequelae: the COVID HOME study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1204 === 08:30 - 10:30\n",
      "abs title :- Pulmonary outcome abnormalities and reversibility of changes after 6 months post-acute SARS-CoV-2 infection among symptomatic patients stratified by severity of infection in Lima, Peru:  prospective FUNCTION study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1205 === 08:30 - 10:30\n",
      "abs title :- Persistent fatigue and concentration problems after COVID-19 are associated with specific cognitive deficits\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1206 === 08:30 - 10:30\n",
      "abs title :- Impact of long COVID on quality of life: a functional assessment of post-COVID long-term sequelae in the ORCHESTRA European cohort\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1207 === 08:30 - 10:30\n",
      "abs title :- Evaluation of SARS-CoV-2 viraemia as a predisposing factor to develop long COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1208 === 08:30 - 10:30\n",
      "abs title :- Long COVID characterisation in a cohort of patients from Campania: prospective cohort study results\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1209 === 08:30 - 10:30\n",
      "abs title :- Long COVID in children, still a long way to go\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1210 === 08:30 - 10:30\n",
      "abs title :- Unraveling the pathophysiology of post-exertional malaise in patients with long COVID\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 20\n",
      "=====**=====S20=====**======= 6\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall G\n",
      "sess type :- 2-hour Educational WorkshopHall G\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3360 - What really matters in antifungal resistance\n",
      "abs text :- Co-organised with                    \n",
      "Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) This session aims to raise awareness of fungal strategies to overcome the antifungal activity beyond the well-known mechanisms of in vitro resistance and highlight the importance of biofilms and tolerance phenomena as contributors to therapy failure in fungal infections. From the fungal perspective, response to antifungals is negatively impacted by phenomena such as the biofilm way of life or tolerance, well known in bacteria but only recently discovered in fungi. As we advance on their knowledge, situations where unexpected antifungal therapy failure may happen (despite MICs in the \"susceptible range\") will be better understood, recognised, prevented, and managed.\n",
      "sess auth :- Mahmoud A. GHANNOUM ; Rita MURRI\n",
      "sess aff :- United States; Italy\n",
      "========================================================================================================================\n",
      "3360-1 === \n",
      "abs title :- What do we know about antifungal non-susceptibility: intrinsic and acquired mechanisms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3360-2 === \n",
      "abs title :- Impact of the biofilm way of life on antifungal response\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3360-3 === \n",
      "abs title :- The antifungal tolerance phenomenon in yeasts and moulds\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 21\n",
      "=====**=====S21=====**======= 7\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall H\n",
      "sess type :- 2-hour Educational WorkshopHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3402 - Training for an outbreak response: interactive simulation with tabletop exercises\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study group Public Health Microbiology (ESGPHM), Trainee Association of ESCMID (TAE) Steering Committee, EFISG, EPIET alumni network (EAN), ESCMID Emerging Infections Task Force (EITaF) COVID-19 pandemic proved relevant our preparedness and response to infectious disease outbreaks. Different transmission routes require different outbreak responses, including specific laboratory techniques, network partners, clinical management, etc. Clinicians in hospital settings encountering patients with a serious unknown disease or laboratories detecting big clusters with the same infection might be challenged in the management and decision making. The line between individual care and public health might be blurred, and guidelines are missing. Tabletop exercises offer a user-friendly solution that can be carried out as informal meetings while challenging the players with simulated emergencies, among different options for training preparedness in simulations. Participants will be expected to engage in the conversation in this Educational Workshop.\n",
      "sess auth :- Eskild PETERSEN ; Kamelia STANOEVA\n",
      "sess aff :- Denmark; Netherlands\n",
      "========================================================================================================================\n",
      "3402-1 === \n",
      "abs title :- The importance of simulation exercises for emergency preparedness\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3402-2 === \n",
      "abs title :- Tabletop exercise in laboratory diagnostics: nosocomial infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3402-3 === \n",
      "abs title :- Tabletop exercise in clinical settings: respiratory infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 22\n",
      "=====**=====S22=====**======= 9\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour SymposiumHall J\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3369 - Antibiotic stewardship for urinary tract infections: challenges and opportunities\n",
      "abs text :- Co-organised with                    \n",
      "CMI Board of Editors Urinary tract infections are among the most common indications for antibiotic treatment across all care settings (community and facility). Improved antimicrobial stewardship for urinary tract infections would, therefore, potentially substantially impact better antibiotic use. The symposium will allow the audience to understand in-depth the challenges and opportunities to adopt antibiotic stewardship approaches in managing urinary tract infections.\n",
      "sess auth :- Candice BONACONSA ; Scott HULTGREN\n",
      "sess aff :- South Africa; United States\n",
      "========================================================================================================================\n",
      "3369-1 === \n",
      "abs title :- Do we all mean the same when we say \"complicated urinary tract infection\"?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3369-2 === \n",
      "abs title :- New and emerging diagnostic technologies and approaches in UTI management\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3369-3 === \n",
      "abs title :- Recurrent urinary tract infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3369-4 === \n",
      "abs title :- Urinary tract infections after urological procedures and interventions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 23\n",
      "=====**=====S23=====**======= 10\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 11:30\n",
      "sess loca :- Hall K\n",
      "sess type :- 3-hour Educational WorkshopHall K\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3118 - EUCAST educational workshop\n",
      "abs text :- Co-organised with                    \n",
      "EUCAST Steering Committee In the annual EUCAST Educational Workshop, the main changes implemented during last year will be described and some of the rationale for the decisions that were made will be shared. Issues to be addressed include breakpoints for oral and intravenous fosfomycin, how laboratories should be interpreting and reporting using breakpoints containing brackets, and how to interpret genotype vs. phenotype for carbapenemases. New developments in antimycobacterial susceptibility testing will also be covered.\n",
      "sess auth :- Barbara Juliane HOLZKNECHT ; Alasdair P. MACGOWAN\n",
      "sess aff :- Denmark; United Kingdom\n",
      "========================================================================================================================\n",
      "3118-1 === \n",
      "abs title :- EUCAST Update\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3118-2 === \n",
      "abs title :- Update on antimycobacterial susceptibility testing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3118-3 === \n",
      "abs title :- Fosfomycin oral and iv breakpoints\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3118-4 === \n",
      "abs title :- Breakpoints in brackets: how to deal with them\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3118-5 === \n",
      "abs title :- Carbapenemases: does genotype trump phenotype?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 24\n",
      "=====**=====S24=====**======= 11\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall L\n",
      "sess type :- 2-hour Oral SessionHall L\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK10 - All about whole genome sequencing in diagnostic microbiology\n",
      "abs text :-  \n",
      "sess auth :- Paul HIGGINS ; Natacha COUTO\n",
      "sess aff :- Germany; United Kingdom\n",
      "========================================================================================================================\n",
      "PAK1001 === 08:30 - 10:30\n",
      "abs title :- Establishing decentralised routine bacterial whole genome sequencing at a clinical microbiology department\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1002 === 08:30 - 10:30\n",
      "abs title :- Within-host and household genomic evolution of methicillin-resistant Staphylococcus aureus in long-term carriers\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1003 === 08:30 - 10:30\n",
      "abs title :- Utilising large and diverse bacterial genome datasets to improve the identification of Streptococcus pneumoniae via PCR-based diagnostics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1004 === 08:30 - 10:30\n",
      "abs title :- Comparison of long-read vs short-read sequencing data for rapid sample-to-genotype MRSA in clinical diagnostics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1005 === 08:30 - 10:30\n",
      "abs title :- Acinetobacter baumannii ST158 (Pasteur): designation of a new international clone, IC10, predominantly found in the Middle East\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1006 === 08:30 - 10:30\n",
      "abs title :- Long-read WGS for rapid typing of Listeria monocytogenes during outbreaks of listeriosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1007 === 08:30 - 10:30\n",
      "abs title :- From MIRU to whole genome sequencing: advancing a Mycobacterium tuberculosis genotyping programme\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1008 === 08:30 - 10:30\n",
      "abs title :- Quantification of the probability of a clonal spread of multidrug-resistant bacteria depending on core genome multi locus sequence typing (cgMLST) data\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1009 === 08:30 - 10:30\n",
      "abs title :- Accuracy of Fourier infrared spectroscopy to identify multidrug-resistant clonal Enterobacteriaceae in the hospital setting: identification and validation of distance thresholds using 401 isolates from four different hospitals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1010 === 08:30 - 10:30\n",
      "abs title :- Development of core genome multilocus sequence typing and taxonomic barcoding schemes to delineate global pneumococcal population structure\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 25\n",
      "=====**=====S25=====**======= 12\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall M\n",
      "sess type :- 2-hour SymposiumHall M\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3195 - How to deal with antibiotic allergy?\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Antibiotic Policies (ESGAP) Allergic reactions to antimicrobials, especially beta-lactam antibiotics, are frequently reported by patients and noted in patient records. However, in most cases, it remains unclear whether this report is relevant and how to deal with it. Frequently, this leads to alternative treatment choices, often with several disadvantages concerning effectiveness, potential toxicity, selective pressure, and cost. Recent guidelines have summarised the current knowledge. This symposium will present the current state-of-the-art findings and guide appropriately dealing with this issue.\n",
      "sess auth :- Paul Christoffer LINDEMANN\n",
      "sess aff :- Norway\n",
      "========================================================================================================================\n",
      "3195-1 === \n",
      "abs title :- Penicillin allergy management after the PEN-FAST study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3195-2 === \n",
      "abs title :- Suspected allergy to non-beta lactam antibiotics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3195-3 === \n",
      "abs title :- Prescribing cephalosporins to penicillin allergic patients: as easy as it seems?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3195-4 === \n",
      "abs title :- The clinical approach to suspected antibiotic allergy: from knowledge to a guideline\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 26\n",
      "=====**=====S26=====**======= 14\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour SymposiumHall O\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3283 - Difficult-to-treat infections: the role of bacterial biofilm and persisters\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS), Sociedad Española de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC) Biofilm and persisters contribute to recurrent and recalcitrant infections. Recent studies provided insight into underlying mechanisms of biofilm formation, persisters, and how these phenotypes are linked to antibiotic tolerance and antimicrobial resistance development. These advances and clinical aspects of these difficult-to-treat infections will be presented at the symposium. Also, the association of persisters and within-patient bacterial phenotypic heterogeneity linked to difficult-to-treat infections will be covered.\n",
      "sess auth :- Frederic LAURENT ; Anna NORRBY\n",
      "sess aff :- France; Sweden\n",
      "========================================================================================================================\n",
      "3283-1 === \n",
      "abs title :- Dynamics of biofilm formation from founder cell to dispersal\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3283-2 === \n",
      "abs title :- The microenvironment, host immune response and bacterial biofilms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3283-3 === \n",
      "abs title :- Persisters in Gram-positive bacterial infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3283-4 === \n",
      "abs title :- S. aureus internalisation and induction of antimicrobial tolerance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 27\n",
      "=====**=====S27=====**======= 15\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall P\n",
      "sess type :- 2-hour SymposiumHall P\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3309 - Human animal interface: chasing Echinococcus\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Clinical Parasitology (ESGCP) Cystic and alveolar echinococcosis are neglected zoonoses of major medical importance and prioritized by the WHO 2021-2030 roadmap of neglected infectious diseases. Their diagnosis may be extremely challenging in both endemic areas and countries receiving patients from endemic areas. Misdiagnosis may result in fatal complications for the patient. Imaging techniques are required for diagnosis and follow-up, but technological and expertise availability are often scant. The development of accurate, robust, and easy-to-use tests which may support diagnosis and follow-up of patients in areas where imaging is not easily available are highly needed. This symposium, of interest to clinicians and laboratory professionals, aims to give an overview of recent research developments with practical importance in diagnosing these infections.\n",
      "sess auth :- Francesca TAMAROZZI ; Cristian ALVAREZ ROJAS\n",
      "sess aff :- Italy; Chile\n",
      "========================================================================================================================\n",
      "3309-1 === \n",
      "abs title :- The changing ecology and burden of Echinococcus spp.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3309-2 === \n",
      "abs title :- What's new in the diagnosis of echinococcal infections?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3309-3 === \n",
      "abs title :- How not to miss and mismanage echinococcal infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3309-4 === \n",
      "abs title :- Optimising tools for the sustainable control of cestode infections in East Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 28\n",
      "=====**=====S28=====**======= 16\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP07 - Bacteria in the soft tissue and bone\n",
      "abs text :-  \n",
      "sess auth :- Marjan WOUTHUYZEN\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "CSP0701 === 08:30 - 09:30\n",
      "abs title :- Preclinical evaluation of a novel antibiotic drug candidate, BWC0977, for activity against multidrug-resistant bacteria implicated in U.S. military combat wound infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0702 === 08:30 - 09:30\n",
      "abs title :- Testing criteria for Fusobacterium necrophorum-pharyngotonsillitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0703 === 08:30 - 09:30\n",
      "abs title :- A magnetic resonance imaging (MRI)-based objective scoring system to differentiate tubercular and pyogenic spondylitis in low-resource settings\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0704 === 08:30 - 09:30\n",
      "abs title :- Streptococcus pyogenes carriage and infection incidence, risk factors and seasonality within households in a longitudinal cohort study in The Gambia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0705 === 08:30 - 09:30\n",
      "abs title :- Evaluation of the efficacy of ceftazidime/avibactam alone or in combinations in OXA-48/ESBL-producing E. coli experimental osteomyelitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0706 === 08:30 - 09:30\n",
      "abs title :- Psychiatric aspect of diabetic foot ulcers\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0707 === 08:30 - 09:30\n",
      "abs title :- Risk factors, management and outcome of early (<6 months) open fracture-related infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0708 === 08:30 - 09:30\n",
      "abs title :- Improved outcomes and fewer re-admissions with S-OPAT compared to H-OPAT: a 6-year retrospective evaluation in a tertiary teaching hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0709 === 08:30 - 09:30\n",
      "abs title :- Corynebacterium striatum isolation in acute bacterial skin and skin structure infections and osteomyelitis: to treat or not to treat? Retrospective observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 29\n",
      "=====**=====S29=====**======= 18\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK07 - Down the drain: infection control and the environment\n",
      "abs text :-  \n",
      "sess auth :- Teresa M. COQUE\n",
      "sess aff :- Spain\n",
      "========================================================================================================================\n",
      "PJK0701 === 08:30 - 09:30\n",
      "abs title :- Improved methodology for detection of antibiotic resistance mechanisms from wastewater for population surveillance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0702 === 08:30 - 09:30\n",
      "abs title :- The hospital aqueous environment may be more important in nosocomial transmission of carbapenemase-producing (CP)-Pseudomonas than in Enterobacterales in an endemic setting: interim analysis of a multicentre prospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0703 === 08:30 - 09:30\n",
      "abs title :- Up the drain? Bromination of toilets and patient education keep transmission rates of multidrug-resistant Pseudomonas aeruginosa low\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0704 === 08:30 - 09:30\n",
      "abs title :- Carbapenamase-producing Enterobacterales in hospital wastewater: consistent detection with diverse epidemiology compared to patient cohort\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0705 === 08:30 - 09:30\n",
      "abs title :- Hospital wastewater: a reservoir and dissemination route for ESBL- and carbapenemase-producing enterobacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0706 === 08:30 - 09:30\n",
      "abs title :- Impact of a simple cleaning intervention to prevent transmission of carbapenemase-producing Enterobacterales from hospital sinks\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0707 === 08:30 - 09:30\n",
      "abs title :- Source and contact investigations among patients and the hospital environment after detection of carbapenemase-producing Pseudomonas aeruginosa: a retrospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0708 === 08:30 - 09:30\n",
      "abs title :- The effect of antibiotic exposures on colonisation resistance to bacteria resident in the healthcare environment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0709 === 08:30 - 09:30\n",
      "abs title :- Disposal of enteral feed and nutritional drink products via handwashing sinks: real-world practices and potential impacts on populations of carbapenemase-producing Enterobacterales\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 30\n",
      "=====**=====S30=====**======= 21\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET19 - Infections in the Elderly Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGIE The official open business meeting for the ESCMID Study Group for Infections in the Elderly (ESGIE). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Virginie PRENDKI ; Dafna YAHAV ; Marco FALCONE ; Claire ROUBAUD\n",
      "sess aff :- Switzerland; Israel; Italy; France\n",
      "========================================================================================================================\n",
      "inr 31\n",
      "=====**=====S31=====**======= 17\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW07 - Critical issues of COVID-19 in immunodeficient patients\n",
      "abs text :-  \n",
      "sess auth :- Anna PAPA\n",
      "sess aff :- Greece\n",
      "========================================================================================================================\n",
      "EW0701 === 09:30 - 10:30\n",
      "abs title :- Effects of kidney transplantation on the prognosis and clinical course of COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0702 === 09:30 - 10:30\n",
      "abs title :- Breakthrough infection is mild in vaccinated patients with haematological malignancy receiving tixagevimab/cilgavimab as pre-exposure prophylaxis to COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0703 === 09:30 - 10:30\n",
      "abs title :- Improved clinical outcome of COVID-19 in haematologic malignancy patients receiving a fourth dose of anti-SARS-CoV-2 vaccine: an EPICOVIDEHA report\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0704 === 09:30 - 10:30\n",
      "abs title :- Immunogenicity and safety of mRNA-based SARS-CoV-2 vaccination in haematopoietic stem cell transplant recipients: a systematic review\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0705 === 09:30 - 10:30\n",
      "abs title :- Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the Haemato-COV 2.0 study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0706 === 09:30 - 10:30\n",
      "abs title :- Comparative efficacy of combination therapy versus monotherapy for high-risk immunocompromised patients with early mild-moderate SARS-CoV-2 infection: a prospective cohort\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0707 === 09:30 - 10:30\n",
      "abs title :- Mortality of cancer patients following hospitalisation with COVID-19 during the Omicron variant wave: a retrospective matched cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0708 === 09:30 - 10:30\n",
      "abs title :- Complications and outcomes of COVID-19 in paediatric haemato-oncology and haematopoietic stem cell transplant patients: a retrospective study from India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0709 === 09:30 - 10:30\n",
      "abs title :- Implementation of AZD7442 (tixagevimab/cilgavimab) COVID-19 pre-exposure prophylaxis (PrEP) in the largest HMO in Israel: real-world uptake and sociodemographic and clinical characteristics across immunocompromised patient groups\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 32\n",
      "=====**=====S32=====**======= 19\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD13 - How to improve therapeutic options: insight into mechanisms and development of novel antimicrobial compounds\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MYD1301 === 09:30 - 10:30\n",
      "abs title :- Monoclonal antibodies against BauA and OmpW2 disrupt growth, prevent sepsis, and promote survival of mice infected with Acinetobacter baumannii\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1302 === 09:30 - 10:30\n",
      "abs title :- Antimicrobial peptides against drug resistant Klebsiella: a multimodal evaluation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1303 === 09:30 - 10:30\n",
      "abs title :- Advancing antimicrobial photodynamic therapy (aPDT): porphyrin conjugated polymers against Staphylococcus aureus biofilms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1304 === 09:30 - 10:30\n",
      "abs title :- Development of a simple-to-use and cost-effective tool to indicate the mechanism of action of a novel antimicrobial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1305 === 09:30 - 10:30\n",
      "abs title :- Building towards a FAIR clinical trial: leveraging multi-source preclinical data through a model-informed workflow\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1306 === 09:30 - 10:30\n",
      "abs title :- Whole-cell penicillin-binding protein (PBP) binding of ceftazidime, avibactam, and aztreonam and elicited morphological changes in Klebsiella pneumoniae (KP)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1307 === 09:30 - 10:30\n",
      "abs title :- Lead optimisation of thiopeptide antibiotics and pre-clinical development of AJ-024 against Clostridioides difficile\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1308 === 09:30 - 10:30\n",
      "abs title :- Synergistic killing of Acinetobacter baumannii (AB) elicited by simultaneous inactivation of three or all four penicillin-binding proteins (PBPs) among PBP1a, 1b, 2 and 3\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1309 === 09:30 - 10:30\n",
      "abs title :- Efficacy of lysin CF-370 in addition to amikacin in a neutropenic rabbit lung infection model caused by an extensively drug-resistant (XDR) P. aeruginosa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 33\n",
      "=====**=====S33=====**======= 22\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- 179 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting179 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET02 - Food- and Water-borne Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "EFWISG The official open business meeting for the ESCMID Food- and Water-borne Infections Study Group (EFWISG). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Ana FREITAS ; Stefan ZIMMERMANN ; Ana TEDIM ; Merica CAREV ; John W. A. ROSSEN\n",
      "sess aff :- Portugal; Germany; Spain; Croatia; Netherlands\n",
      "========================================================================================================================\n",
      "inr 34\n",
      "=====**=====S34=====**======= 0\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3472 - Frontiers in the diagnosis and management of infections in the immunocompromised\n",
      "abs text :-  Professor Monica Slavin leads a National Centre of Research Excellence in Infections in Cancer at University of Melbourne, Australia. She is Director of the Department of Infectious Diseases at Peter MacCallum Cancer Centre and of the Immunocompromised Host Infection Service at Royal Melbourne Hospital in Melbourne, Australia. She is a distinguished infectious diseases clinician researcher whose research focuses on diagnosis and management of infections in immunocompromised patient with a particular interest in fungal infection. She is recognised to have made many innovative contributions to research teaching, mentoring and clinical medicine, resulting in new management guidelines, definitions of fungal infections for clinical trials and translation of new diagnostic tests into practice.\n",
      "sess auth :- Murat AKOVA ; Maurizio SANGUINETTI\n",
      "sess aff :- Turkey; Italy\n",
      "========================================================================================================================\n",
      "3472-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 35\n",
      "=====**=====S35=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall B\n",
      "sess type :- 1-hour SymposiumHall B\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3418 - How to tackle HTLV elimination\n",
      "abs text :-  This session aims to raise clinical awareness of HTLV infection and give participants an overview of the epidemiology of HTLV infection while discussing when to suspect it and how to diagnose it. Disease complications and possible antenatal screening will also be covered. HTLV is an important infection that can lead to cancer. Antenatal screening would help to prevent maternal transmission occurring via breastfeeding. As HTLV is a largely undiagnosed infection, it is important to raise awareness within the ID/CM community. This session will cover the previous work done by and for WHO, where these issues are discussed.\n",
      "sess auth :- Angelica ESPINOSA; Anu KANTELE\n",
      "sess aff :- Brazil; Finland\n",
      "========================================================================================================================\n",
      "3418-1 === \n",
      "abs title :- Global epidemiology of HTLV-1 infection: is elimination possible?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3418-2 === \n",
      "abs title :- Clinical insights into HTLV: diagnosis, prognosis and treatment. What is needed for elimination?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 36\n",
      "=====**=====S36=====**======= 2\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour SymposiumHall C\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3295 - Sexually transmitted infections on the rise: know your enemies\n",
      "abs text :-  This symposium aims to discuss new screening and treatment approaches in the area of increasing macrolide- and quinolone-resistant Mycoplasma genitalium infections incl. monocyline, prostinamycine and lefamulin. It will emphasise rising STI epidemic among HIV pre-exposure prophylaxis users and how PrEP programs can be a gateway to strengthening test/treat strategies globally. Furthermore, it will link to the role of the microbiome in acquisition/prevention as well as clinical manifestation of STDs including Chlamydia trachomatis and Ureaplasma species. And finally elaborate on the development of antibiotic-resistant gonorrhea globally and current treatment approaches including pipeline of new drugs to combat multidrug-resistant gonorrhoea.\n",
      "sess auth :- Michael BEETON ; Lina NERLANDER\n",
      "sess aff :- United Kingdom; Sweden\n",
      "========================================================================================================================\n",
      "3295-1 === \n",
      "abs title :- Multi-resistant Mycoplasma genitalium infection: small bug, big problem\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3295-2 === \n",
      "abs title :- Multi-resistant Neisseria gonorrhea infection: how far are they away from us?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 37\n",
      "=====**=====S37=====**======= 3\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall D\n",
      "sess type :- Meet-the-ExpertHall D\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3133 - Rapid and concise communication: the backbone of epidemic and infection prevention and control\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Nosocomial Infections (ESGNI) To fight the spread of infections, immediate action must hinder transmission while communicating interventions to the stakeholders, the working force, and all persons concerned. Yet, how to do it? Transmission pathways are rarely clear when a new or an altered infectious agent enters the world. Preparedness is a key issue. In this session the experts will share their experience, lessons learned and future aspects to control the spread of human pathogens and disease and re-enforce the defenses of modern medicine in the future.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3133-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3133-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 38\n",
      "=====**=====S38=====**======= 4\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall E\n",
      "sess type :- Meet-the-ExpertHall E\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3266 - What's new in diagnosis and treatment of chronic pulmonary aspergillosis\n",
      "abs text :-  Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary disease that complicates many other respiratory disorders and is associated with high morbidity and mortality. Physicians' unawareness or negligence of CPA in a patient is an important risk factor for the diagnostic and therapeutic delay, partly explaining the increased mortality and the observed low single-site prevalence. This session aims to update the audience on diagnostics and treatment, with specific attention to new treatments and how to handle co-infections with non-tuberculous mycobacteria.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3266-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3266-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 39\n",
      "=====**=====S39=====**======= 5\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall F\n",
      "sess type :- 1-hour Case SessionHall F\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES08 - Highly unusual causes of septic arthiritis\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "BES0801 === 11:00 - 12:00\n",
      "abs title :- A case of septic arthritis and hyperammonaemia syndrome caused by disseminated Ureaplasma urealyticum following B-cell maturation CD3-directed bispecific antibody\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0802 === 11:00 - 12:00\n",
      "abs title :- Symmetrical polyarthritis in a young woman, an unusual autoimmune mimicker.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0803 === 11:00 - 12:00\n",
      "abs title :- Septic arthritis of the hip caused by Fusobacterium necrophorum: a case report and a literature review\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0804 === 11:00 - 12:00\n",
      "abs title :- Francisella tularensis arthritis in native joints: a report of two cases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0805 === 11:00 - 12:00\n",
      "abs title :- Pseudopithomyces sacchari: an exceedingly rare opportunistic infection causing fungal septic arthritis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 40\n",
      "=====**=====S40=====**======= 6\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall G\n",
      "sess type :- 1-hour Oral SessionHall G\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP04 - Impact of the COVID-19 pandemic on AMR\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "ALP0401 === 11:00 - 12:00\n",
      "abs title :- Impact of the COVID-19 pandemic responses on the community transmission of antibiotic-resistance: insight from mathematical modelling of SARS-CoV-2 and Streptococcus pneumoniae transmission\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0402 === 11:00 - 12:00\n",
      "abs title :- Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0403 === 11:00 - 12:00\n",
      "abs title :- Impact of the COVID-19 pandemic on antimicrobial consumption in health care settings: an observational multinational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0404 === 11:00 - 12:00\n",
      "abs title :- Treating urethritis in the PrEP era: dealing with a new monster\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0405 === 11:00 - 12:00\n",
      "abs title :- Quantifying changes in antibiotic prescribing, microbiological testing and Escherichia coli resistance during COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 41\n",
      "=====**=====S41=====**======= 7\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall H\n",
      "sess type :- Meet-the-ExpertHall H\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3320 - Anaerobic bacteria in the frontline laboratory\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Anaerobic Infections (ESGAI) Anaerobic bacteria still present a challenge for many clinical laboratories, despite being a common finding in daily clinical samples. This session will deliver updated information on isolation (how to transport samples, manage the anaerobic atmosphere, separate anaerobes from other bacteria), identification (phenotypic and through MALDI-TOF or sequencing), AST, and characterisation of anaerobic bacteria, as well as insights into the treatment of difficult to treat anaerobic infections. This session is oriented toward clinical microbiologists, but clinical practitioners that frequently encounter anaerobic bacteria will also benefit from it.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3320-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3320-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 42\n",
      "=====**=====S42=====**======= 8\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour SymposiumHall I\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- 3112 - Real-world experience with antivirals for SARS-CoV-2\n",
      "abs text :- Co-organised with                    \n",
      "Polish Society of Epidemiology and Infectious Diseases The antiviral drugs used to treat COVID-19 have been studied in clinical trials, but knowledge about their effectiveness and safety in clinical practice is still limited. The symposium aims to fill this gap, covering both remdesivir, used almost from the beginning of the pandemic, and drugs such as molnupiravir or paxlovid, which practically became available only in 2022. The availability of these drugs increased the sense of security, but the question remains whether their effectiveness is satisfactory?\n",
      "sess auth :- Dorota ZAREBSKA; Adriana VINCE\n",
      "sess aff :- Poland; Croatia\n",
      "========================================================================================================================\n",
      "3112-1 === \n",
      "abs title :- Real-world experience with antivirals administered during the Omicron wave in Poland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3112-2 === \n",
      "abs title :- Lessons learnt from the Italian COVID-19 studies\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 43\n",
      "=====**=====S43=====**======= 9\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour Oral SessionHall J\n",
      "sess cate :- 11. Other\n",
      "sess title :- BES11 - Digital solutions for infectious diseases\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "BES1101 === 11:00 - 12:00\n",
      "abs title :- Machine learning based white blood count estimation for individualised antimicrobial cessation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1102 === 11:00 - 12:00\n",
      "abs title :- Trustworthy machine learning system prototype for blood culture outcome prediction\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1103 === 11:00 - 12:00\n",
      "abs title :- Diagnostic performance of pneumonia on CXR by artificial intelligence varies according to the gold standard used\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1104 === 11:00 - 12:00\n",
      "abs title :- Digitally targeted testing for blood-borne viruses: a systematic review\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1105 === 11:00 - 12:00\n",
      "abs title :- Infodemiology of respiratory syncytial virus (France, Germany, Netherland; 2017-2022): useful, but handle with care\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 44\n",
      "=====**=====S44=====**======= 11\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour SymposiumHall L\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3165 - Protecting long term care facilities residents from infection\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Infections in the Elderly (ESGIE), ESCMID Study Group for Nosocomial Infections (ESGNI) Long-term care facilities (LTCF) and rehabilitation centres are home to fragile patients with multiple comorbidities. These patients are frequently colonised with multidrug-resistant pathogens following heavy healthcare system exposure. These colonised patients may be super-spreaders of MDR bacteria inside LTCF and cause an influx of MDR bacteria into acute care hospitals when hospitalised for various conditions. Admission restrictions of colonised patients needing contact isolation may negatively impact patient prognosis and limit their quality of care. Respiratory infections may also spread through droplet or aerosol pathways in LTCF. The requirement to keep sterile physiotherapy and hydrotherapy equipment in rehabilitation facilities complicates infection control. Therefore, infection control measures and procedures may negatively impact the rehabilitation of colonised patients. This symposium will discuss all these aspects of the double-edged sword of infection control in LTCF.\n",
      "sess auth :- Khetam HUSSEIN ; Nicholas POWER\n",
      "sess aff :- Israel; Ireland\n",
      "========================================================================================================================\n",
      "3165-1 === \n",
      "abs title :- Infection prevention in nursing homes: scope of the problem\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3165-2 === \n",
      "abs title :- Antimicrobial stewardship in long-term care facilities\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 45\n",
      "=====**=====S45=====**======= 12\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour Oral SessionHall M\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK05 - Diagnostic, therapeutic and prophylactic strategies in herpesviruses infections\n",
      "abs text :-  \n",
      "sess auth :- Hans H. HIRSCH\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "MAK0501 === 11:00 - 12:00\n",
      "abs title :- HCMV-specific T-cell response measured at the end of letermovir prophylaxis is predictive for HCMV clinically relevant infection after prophylaxis in HSCTRs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0502 === 11:00 - 12:00\n",
      "abs title :- CMV-RNAemia as accurate marker of active viral replication in transplant recipient\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0503 === 11:00 - 12:00\n",
      "abs title :- Differences among patients with positive intrathecal antibody index test compared with patients with positive PCR in herpes simplex virus or varicella-zoster virus CNS infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0504 === 11:00 - 12:00\n",
      "abs title :- High prevalence of inherited chromosomally integrated human herpes virus type 6 (ici-HHV6) detected in cerebral spinal fluid from children with HHV6 detection by a meningitis/encephalitis multiplex panel\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0505 === 11:00 - 12:00\n",
      "abs title :- Use of an interferon-gamma release assay (QuantiFERON) to manage preventive and curative CMV antiviral therapy in solid organ transplant recipients: a retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 46\n",
      "=====**=====S46=====**======= 13\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall N\n",
      "sess type :- Meet-the-ExpertHall N\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3339 - Antifungal dose optimisation: from theory to clinical practice\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID PK/PD of Anti-Infectives Study Group (EPASG) This session will engage the audience in the interactive debate on PK/PD and dose optimisation. An introduction and background on the topic will be provided for the case-based discussions. Real-life cases will be presented in which typical clinical questions concerning dose optimisation, and TDM will be addressed. Also, 'uncommon' special patient populations (geriatric patients, cirrhotic patients, patients with underweight) will be included.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3339-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3339-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 47\n",
      "=====**=====S47=====**======= 14\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall O\n",
      "sess type :- 1-hour Case SessionHall O\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES03 - The expanding use of phages as therapeutics\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "BES0301 === 11:00 - 12:00\n",
      "abs title :- Treating the untreatable: individualised bacteriophage cocktail preparation for the treatment of 3MRGN-E. coli infection of an aortic-implant\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0302 === 11:00 - 12:00\n",
      "abs title :- Phage therapy against rifampicin-resistant S. epidermidis and ciprofloxacin-resistant E. coli prosthetic joint infections: proof of a multidisciplinary strategy at the Charité, Berlin\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0303 === 11:00 - 12:00\n",
      "abs title :- Exclusive medical treatment combining intraarticular injections of active bacteriophages as adjuvant therapy to antibiotics in patients with S. aureus complex prosthetic joint infections (PJI) contraindicated for, or refusing, surgery: the PHAGEinLYON experience at the CRIOAc Lyon referral centre\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0304 === 11:00 - 12:00\n",
      "abs title :- Successful treatment of two severe, complicated, diabetic foot infections using locally applied novel bacteriophage cocktail TP-102 into the wound\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0305 === 11:00 - 12:00\n",
      "abs title :- Successful treatment with bacteriophages for left ventricular assistant device infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 48\n",
      "=====**=====S48=====**======= 15\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour Oral SessionHall P\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- PJK03 - Intracellular bacterial infections and persistence\n",
      "abs text :-  \n",
      "sess auth :- Ronni DA SILVA ; Suzana SALCEDO\n",
      "sess aff :- Singapore; France\n",
      "========================================================================================================================\n",
      "PJK0301 === 11:00 - 12:00\n",
      "abs title :- Metagenomic and transcriptomic analysis of the virulence-related pathways in tolerant and persister cells of Klebsiella pneumoniae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0302 === 11:00 - 12:00\n",
      "abs title :- Assessing bactericidal dynamics of persisters-manifested Escherichia coli clinical isolates in the presence of immune cells and antibiotics in-vitro\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0303 === 11:00 - 12:00\n",
      "abs title :- Setting up a bi-fluorescent model to follow intracellular replication of Pseudomonas aeruginosa in the presence of antibiotics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0304 === 11:00 - 12:00\n",
      "abs title :- The role of macrophages and intracellular survival of Staphylococcus aureus: new insights from direct evaluation of human tissue samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0305 === 11:00 - 12:00\n",
      "abs title :- Assessing the impact of antimicrobial persisters on relapse of bacterial infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 49\n",
      "=====**=====S49=====**======= 16\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP13 - Resistance to novel antibiotics and beta-lactamase inhibitors\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "ALP1301 === 11:00 - 12:00\n",
      "abs title :- Nationwide genomic surveillance of Klebsiella pneumoniae in the United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1302 === 11:00 - 12:00\n",
      "abs title :- AMR register: creation of a new, freely accessible platform for antimicrobial susceptibility data sharing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1303 === 11:00 - 12:00\n",
      "abs title :- Antimicrobial resistance in invasive Streptococcus pyogenes: England, 2016-2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1304 === 11:00 - 12:00\n",
      "abs title :- Activity of imipenem/relebactam and comparators against clinical MDR and DTR Pseudomonas aeruginosa isolates: SMART, United States, 2019-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1305 === 11:00 - 12:00\n",
      "abs title :- Impact of minor carbapenemases on susceptibility to newly developed β-lactam/β-lactamase inhibitor combinations in Enterobacterales\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1306 === 11:00 - 12:00\n",
      "abs title :- In vitro activity of ceftibuten-avibactam against Enterobacterales from urinary tract infections collected in the 2022 ATLAS Surveillance Program: a regional analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1307 === 11:00 - 12:00\n",
      "abs title :- Antibiotic regimens including vs not including cefiderocol for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia in intensive care unit: a propensity-weighted retrospective observational cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1308 === 11:00 - 12:00\n",
      "abs title :- Preliminary results of an AMR surveillance tool in hospitals in a low-income country: the TSARA project in Madagascar, 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1309 === 11:00 - 12:00\n",
      "abs title :- Clostridioides difficile resistance to primary treatment antibiotics: molecular and phenotypic epidemiology\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 50\n",
      "=====**=====S50=====**======= 18\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK01 - Improving bloodstream infection diagnostics\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PAK0101 === 11:00 - 12:00\n",
      "abs title :- Evaluation of the performance of ASTar system for direct antimicrobial susceptibility testing on Gram-negative blood culture samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0102 === 11:00 - 12:00\n",
      "abs title :- Blood culture transport delays rather than culture volume have a greater impact on reporting times and are associated with a prolonged length of stay\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0103 === 11:00 - 12:00\n",
      "abs title :- A new protocol for bacterial identification by MALDI-TOF directly from positive blood cultures\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0104 === 11:00 - 12:00\n",
      "abs title :- Elaboration and validation of a protocol for rapid identification of Streptococcus pneumoniae from blood culture bottles using the modified bile solubility test: Gram staining is still standing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0105 === 11:00 - 12:00\n",
      "abs title :- Direct identification of Streptococcus pneumoniae serotypes in culture negative paediatric clinical samples by a PCR reverse-hybridisation strip-based commercial assay\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0106 === 11:00 - 12:00\n",
      "abs title :- Rapid proteomic method for characterisation of Staphylococcus aureus antimicrobial resistance in blood cultures\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0107 === 11:00 - 12:00\n",
      "abs title :- Clinical evaluation of a commercial phenotypic test to detect cephalosporinases from positive blood cultures\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0108 === 11:00 - 12:00\n",
      "abs title :- Early assessment of blood culture negativity as a potential support tool for antimicrobial stewardship\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0109 === 11:00 - 12:00\n",
      "abs title :- Enabling rapid (supra)national cross-sectoral cluster detection through integrated molecular surveillance of pathogens: introducing the miGenomeSurv network\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 51\n",
      "=====**=====S51=====**======= 24\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET05 - Antimicrobial Stewardship Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGAP The official open business meeting for the ESCMID Study Group for Antimicrobial Stewardship (ESGAP). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Esmita CHARANI ; Jeroen SCHOUTEN ; Karin THURSKY ; Katja DE WITH ; Paul Otieno YONGA\n",
      "sess aff :- United Kingdom; Netherlands; Australia; Germany; Kenya\n",
      "========================================================================================================================\n",
      "inr 52\n",
      "=====**=====S52=====**======= 3\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S4 - MDx portfolio expansion: a new paradigm\n",
      "abs text :- Organized by                    \n",
      "Seegene Inc. The pandemic was a springboard to see how effective molecular diagnostics (MDx) are in controlling and diagnosing infectious diseases. Though PCR has already become the standard for diagnosis in many fields, such as respiratory, and sexually transmitted infections, there are still many areas that can improve the efficiency through molecular diagnosis. The expansion of the MDx portfolio can shorten the turnaround time and increase accuracy of diagnosis in different patient group, and leverage existing laboratory resources.\n",
      "sess auth :- Makeda SEMRET\n",
      "sess aff :- Canada\n",
      "========================================================================================================================\n",
      "inr 53\n",
      "=====**=====S53=====**======= 4\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S55 - Managing hospitalised COVID-19 patients: leading the way through data and experience\n",
      "abs text :- Organized by                    \n",
      "Gilead Sciences This session aims to provide an overview of the current COVID-19 disease landscape in Europe, including the continued risks and burden to health as we move from a post-vaccination to an endemic era. We will discuss the mechanism of action for therapeutic options for patients with COVID-19, and data from RCTs and the real-world that support their use in the hospital setting.  Use of individualised patient cases will highlight the value of a multifaceted inpatient approach, particularly in cases where patients are difficult to treat.\n",
      "sess auth :- Bruno MEGARBANE\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "inr 54\n",
      "=====**=====S54=====**======= 5\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S3 - Patients with most critical acute bacterial skin infections: which patients, how to identify and how to best manage?\n",
      "abs text :- Organized by                    \n",
      "Menarini Group The incidence and severity of skin infections and their consequences have increased significantly. They present an ongoing problem regarding access to emergency rooms and primary care physicians, as well as accounting for an increase in the number of hospital admissions. This increase is often due to an expansion of frequency of infections caused predominantly by methicillin-resistant Staphylococcus aureus but also other Gram-positive and Gram-negative multi drug resistant bacteria.\n",
      "This symposium aims to highlight the unintended consequences of current treatment approaches for acute bacterial skin infections and how new treatment strategies can enhance the armamentarium. We go on to discuss the value of early discharge, OPAT and IVOST and how a diverse and variable patient group can benefit from these services.\n",
      "sess auth :- Marjan WOUTHUYZEN\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "inr 55\n",
      "=====**=====S55=====**======= 6\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S2 - Passive immunoprophylaxis with long-acting antibodies: the importance of continued protection against severe COVID-19 outcomes\n",
      "abs text :- Organized by                    \n",
      "AstraZeneca This session will focus on passive immunoprophylaxis with long-acting monoclonal antibodies for COVID-19 and will include the following key points:\n",
      ".\tCertain populations, including those who are immunocompromised, remain vulnerable to COVID-19 despite vaccination strategies \n",
      ".\tLong-acting monoclonal antibodies as a strategy for the prevention of severe COVID-19 outcomes in vulnerable populations, particularly hospitalisations and deaths\n",
      ".\tClinical trial, real-world evidence, and case studies on the implementation of tixagevimab/cilgavimab as pre-exposure prophylaxis of COVID-19 in vulnerable populations\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 56\n",
      "=====**=====S56=====**======= 7\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S1 - Tick-borne diseases and prevention\n",
      "abs text :- Organized by                    \n",
      "Pfizer This symposium will provide a summary of temporal and geographic trends in tick-borne disease, with an emphasis on Lyme disease and tick-borne encephalitis (TBE). It will provide an overview of the clinical differentiation and treatment of TBE and Lyme disease, including key clinical similarities and differences seen in patients, before discussing and evaluating TBE vaccine effectiveness, focusing on recent findings and data.\n",
      "sess auth :- Ram B. DESSAU\n",
      "sess aff :- Denmark\n",
      "========================================================================================================================\n",
      "inr 57\n",
      "=====**=====S57=====**======= 16\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 1\n",
      "sess type :- Pipeline CornerArena 1\n",
      "sess cate :- 11. Other\n",
      "sess title :- S56 - Therapeutics\n",
      "abs text :-  The Therapeutics Pipeline Corner offers small, innovative pharmaceutical companies a platform to present their early-stage therapies in development to a wider audience.\n",
      "sess auth :- Ursula THEURETZBACHER\n",
      "sess aff :- Austria\n",
      "========================================================================================================================\n",
      "inr 58\n",
      "=====**=====S58=====**======= 18\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 3\n",
      "sess type :- Open ForumArena 3\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3312 - There is no planet B: sustainability in ID/CM\n",
      "abs text :- Co-organised with                    \n",
      "Trainee Association of ESCMID (TAE) Steering Committee, ESCMID Professional Affairs Subcommittee In recent years, climate change has become one of the most prominent topics in all sectors of society and health care. Unfortunately, conferences, hospitals, and laboratories have their unintended shares in CO2 emissions. The new generation of CM/ID scientists know this pressing matter and have a growing appetite for sustainable approaches in academia. How can we act now to reduce our CO2 footprint in the microbiology lab? How can we make systemic changes towards sustainable research and sustainable health care? Are virtual conferences the green future, or should we look at alternative transportation options? This Open Forum aims to provide an overview of the impact that conferences, healthcare, and laboratories have on climate change and CO2 emission and may serve as a starting point for further discussions.\n",
      "sess auth :- Suzanne Aura Victoria VAN ASTEN\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "3312-1 === \n",
      "abs title :- Decarbonising the ECCMID congress\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3312-2 === \n",
      "abs title :- Reducing the environmental footprint of research laboratories\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3312-3 === \n",
      "abs title :- Sustainability initiatives in CM; environmental protection and hazard waste\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3312-4 === \n",
      "abs title :- Towards systemic change for sustainable research and healthcare\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 59\n",
      "=====**=====S59=====**======= 20\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 12:00 - 13:30\n",
      "sess loca :- Poster Area\n",
      "sess type :- Poster SessionPoster Area\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- PS018 - 3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PS01801 === 12:00 - 13:30\n",
      "abs title :- Study of fusidic acid resistance among Staphylococcus aureus skin and soft tissue isolates, eastern India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01802 === 12:00 - 13:30\n",
      "abs title :- Ecological changes in Gram-positive cocci bloodstream infections in critical areas after ceftaroline introduction: not everything is so predictable\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01803 === 12:00 - 13:30\n",
      "abs title :- Phenotypic and genomic insights into biofilm formation in antibiotic-resistant clinical coagulase-negative Staphylococcus species from South Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01804 === 12:00 - 13:30\n",
      "abs title :- Comparison of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in emerging community lineage ST72 from South Korea: a single centre experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01805 === 12:00 - 13:30\n",
      "abs title :- Molecular characterisation and genetic relatedness of bloodstream_associated Staphylococcus epidermidis isolates obtained from private and public hospitals in South Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01806 === 12:00 - 13:30\n",
      "abs title :- Resistance and molecular characterisation of invasive Staphylococcus aureus isolates obtained from private and public clinical settings in South Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01807 === 12:00 - 13:30\n",
      "abs title :- Reasons for hope? The epidemiology of resistant bacteria among Norwegian cancer patients 2008-2018\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01808 === 12:00 - 13:30\n",
      "abs title :- Detection of MRSA and MSSA CC398 isolates in osteoarticular infections in patients of a Spanish Hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01809 === 12:00 - 13:30\n",
      "abs title :- Epidemiology and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium isolated from blood in 2022 in Poland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01810 === 12:00 - 13:30\n",
      "abs title :- Time for a new CoNSensus? Species specificity of coagulase-negative staphylococci (CoNS) antibiograms in neonatal bloodstream isolate across Europe\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01811 === 12:00 - 13:30\n",
      "abs title :- Antimicrobial resistance in Streptococcus pneumoniae: a retrospective analysis of emerging trends in the United Arab Emirates from 2010-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01812 === 12:00 - 13:30\n",
      "abs title :- Antimicrobial resistance gene profiles of group B Streptococcus colonizing pregnant women and causing disease in newborns in the Netherlands\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01813 === 12:00 - 13:30\n",
      "abs title :- Phenotypic and genotypic characterisation of Staphylococcus aureus isolates from cystic fibrosis patients attending private clinics in South Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01814 === 12:00 - 13:30\n",
      "abs title :- Comparative analysis of different antimicrobial susceptibility methods in pneumococci producing invasive disease in a Spanish region\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01815 === 12:00 - 13:30\n",
      "abs title :- Evolution of the prevalence of livestock-associated methicillin-resistant S. aureus in a region with high pig-farming density\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01816 === 12:00 - 13:30\n",
      "abs title :- Effects of subinhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of methicillin-resistant Staphylococcus aureus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01817 === 12:00 - 13:30\n",
      "abs title :- Changing courses in antibiotic resistance and serotype distribution of S. pneumoniae isolates over 12 years in India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01818 === 12:00 - 13:30\n",
      "abs title :- In vitro surveillance of eravacycline against Gram-positive pathogens, including resistant isolates, collected worldwide during 2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01819 === 12:00 - 13:30\n",
      "abs title :- Detection by automated AST system of methicillin-resistant staphylococci strains lacking mec gene undetected by reference methods\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01820 === 12:00 - 13:30\n",
      "abs title :- High prevalence and genotypic diversity of fusidic acid-resistant methicillin-susceptible Staphylococcus aureus in Kuwait hospitals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01821 === 12:00 - 13:30\n",
      "abs title :- Diversity and characterisation of methicillin-resistant staphylococci (MRS) and mammaliicocci (MRM) isolated from camels in Algeria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01822 === 12:00 - 13:30\n",
      "abs title :- Prevalence, antibiogram and molecular characteristics of livestock-associated methicillin-resistant Staphylococcus aureus from pigs in Korea\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01823 === 12:00 - 13:30\n",
      "abs title :- Study of capsular diversity and antimicrobial resistance in invasive disease-producing Streptococcus pneumoniae isolates from a Spanish region\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01824 === 12:00 - 13:30\n",
      "abs title :- Molecular characterisation of Staphylococcus aureus superinfection among COVID-19 patients in a Spanish hospital: predominance of the two evolutionary subclades of CC398\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01825 === 12:00 - 13:30\n",
      "abs title :- Genotypic profiles of emerging multidrug-resistant Staphylococcus capitis isolates from an ongoing outbreak in critically ill patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01826 === 12:00 - 13:30\n",
      "abs title :- Geographical differences in strain diversity and antimicrobial resistance of S. epidermidis isolated from prosthetic joint infections in Sweden and France\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01827 === 12:00 - 13:30\n",
      "abs title :- Time trends and molecular epidemiology of methicillin-resistant Staphylococcus aureus in the capital region of Denmark, 2006-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01828 === 12:00 - 13:30\n",
      "abs title :- Identification of Nocardia species isolated from various clinical specimens by 16S rRNA sequence analysis and determination of antimicrobial susceptibility profile\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01829 === 12:00 - 13:30\n",
      "abs title :- Genomic insights into Staphylococcus aureus collected from 18 Indian hospitals, a retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01830 === 12:00 - 13:30\n",
      "abs title :- Assessment of chlorohexidine activity against Staphylococcus aureus and Staphylococcus pseudintermedius from skin and soft-tissue infections in companion animals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01831 === 12:00 - 13:30\n",
      "abs title :- Comparison of antibacterial activity between electrospun polyacrylonitrite (PAN), copper nanoparticle (CuNP), and silver nanoparticle (AgNP) nanofibers against different Staphylococcus aureus strains\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01832 === 12:00 - 13:30\n",
      "abs title :- Daptomycin activity and occurrence of heteroresistance among diverse methicillin-resistant Staphylococcus aureus genetic lineages in China\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01833 === 12:00 - 13:30\n",
      "abs title :- Antimicrobial susceptibility of Corynebacterium glucuronolyticum from genital samples in male patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01834 === 12:00 - 13:30\n",
      "abs title :- Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus hospital populations from routinely collected data\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01835 === 12:00 - 13:30\n",
      "abs title :- First genomic analysis of cfr-carrying Staphylococcus saprophyticus and optrA/cfrD-carrying Enterococcus casseliflavus from nares of healthy pigs in Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01836 === 12:00 - 13:30\n",
      "abs title :- Methicillin-resistant Staphylococcus aureus among asylum seekers from a national asylum center in Basel, Switzerland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01837 === 12:00 - 13:30\n",
      "abs title :- Estimated prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA): big data analysis of the Brazilian Antimicrobial Resistance Surveillance System, 2018-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01838 === 12:00 - 13:30\n",
      "abs title :- Antimicrobial resistance, virulence and genetic lineages of Staphylococcus aureus implicated in skin and soft tissue infections of paediatric patients: a five-year follow-up\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01839 === 12:00 - 13:30\n",
      "abs title :- Detection of MRSA and MSSA CC398 isolates in cystic fibrosis patients of a Spanish hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01840 === 12:00 - 13:30\n",
      "abs title :- Correlation of genotypes with phenotyping results of 515 Staphylococcus aureus isolates from invasive infections in one university-affiliated medical centre (2011-2018)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01841 === 12:00 - 13:30\n",
      "abs title :- Evolution of multidrug resistant blood stream infections among haematological patients: results of a 11-year surveillance study at a single institution\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01842 === 12:00 - 13:30\n",
      "abs title :- Antimicrobial resistance in Germany: results and trends from the German Antimicrobial Resistance Surveillance Network 2017-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01843 === 12:00 - 13:30\n",
      "abs title :- Occurrence and variability of norA and other main multidrug efflux pump determinants across the Staphylococcus genus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01844 === 12:00 - 13:30\n",
      "abs title :- CA-MRSA and LA-MRSA: the story of food and clinic roaming clones\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01845 === 12:00 - 13:30\n",
      "abs title :- Full-length sequencing of a cfr-carrying plasmid in a linezolid, multidrug-resistant clonal complex (CC)1 LA-MRSA\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01846 === 12:00 - 13:30\n",
      "abs title :- Burden of pneumococcal disease in hospitalised US children: a multicentre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01847 === 12:00 - 13:30\n",
      "abs title :- Diversity of linezolid-resistance mechanisms in Staphylococcus epidermidis strains from invasive infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01848 === 12:00 - 13:30\n",
      "abs title :- In vitro activity of ceftaroline and comparator agents against bacterial pathogens frequently isolated from patients with respiratory tract, skin and soft tissue, and bloodstream infections collected during the ATLAS global surveillance programme in 2017-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01849 === 12:00 - 13:30\n",
      "abs title :- Whole genome sequencing of Staphylococcus capitis isolates recovered in neonatal intensive care units in Ireland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01850 === 12:00 - 13:30\n",
      "abs title :- Prevalence of multidrug-resistant microorganisms among residents of nursing homes in Hong Kong\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01851 === 12:00 - 13:30\n",
      "abs title :- Molecular typing and antimicrobial resistance of group B Streptococcus causing human infections in Saudi Arabia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01852 === 12:00 - 13:30\n",
      "abs title :- Low prevalence of invasive livestock-associated methicillin resistant Staphylococcus aureus isolated from blood cultures in Slovenia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01853 === 12:00 - 13:30\n",
      "abs title :- Emergence of teicoplanin non-susceptible Staphylococcus epidermidis strains: a 6-year retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 60\n",
      "=====**=====S60=====**======= 21\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 12:30 - 13:30\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET28 - Respiratory Viruses Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGREV The official open business meeting for the ESCMID Study Group for Respiratory Viruses (ESGREV). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Chrysanthi SKEVAKI ; Barbara RATH ; Sotirios TSIODRAS ; Louis BONT ; Roy CHEMALY\n",
      "sess aff :- Germany; France; Greece; Netherlands; United States\n",
      "========================================================================================================================\n",
      "inr 61\n",
      "=====**=====S61=====**======= 24\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 12:30 - 13:30\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET01 - Fungal Infection Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "EFISG The official open business meeting for the ESCMID Fungal Infection Study Group (EFISG). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Lewis WHITE ; Ana ALASTRUEY; Andreas H. GROLL ; Fanny LANTERNIER ; Anuradha CHOWDHARY\n",
      "sess aff :- United Kingdom; Spain; Germany; France; India\n",
      "========================================================================================================================\n",
      "inr 62\n",
      "=====**=====S62=====**======= 0\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall A\n",
      "sess type :- Special SessionHall A\n",
      "sess cate :- 11. Other\n",
      "sess title :- S61 - Excellence Award lecture\n",
      "abs text :-  The ESCMID Excellence Award award recognises and rewards an outstanding lifetime contribution in the areas of science, education or professional affairs in clinical microbiology and/or infectious diseases. The Excellence Award winner will be giving a lecture on his major achievements and will receive the Award by the ESCMID President.\n",
      "sess auth :- Annelies ZINKERNAGEL ; Maurizio SANGUINETTI\n",
      "sess aff :- Switzerland; Italy\n",
      "========================================================================================================================\n",
      "S6101 === 13:30 - 14:30\n",
      "abs title :- Antimicrobial susceptibility testing: where we came from, what we have and what we need\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 63\n",
      "=====**=====S63=====**======= 1\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall B\n",
      "sess type :- 1-hour SymposiumHall B\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3417 - Oxazolidinones and Gram-positive bacteria\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) Oxazolidinones are used for the treatment of severe infections caused by Gram-positive bacteria. Resistances to this family of antibiotics have become a worldwide concern since this drug is one of the last resort antibiotics to treat MRSA and VRE infections. Various mechanisms have been identified, especially in Enterococcus faecium and coagulase-negative staphylococci. Their emergence is directly related to antimicrobial pressure. Geographical but also interspecies (including MRSA) dissemination of resistance have been reported. The horizontal gene transfer of resistance genes has been explored recently and data are worrisome. Finally, the place of linezolid and tedizolid in the treatment is a source of debate as well as their side effects and the way to prevent/limit/avoid them. This symposium will highlight a complete updated overview of oxazolidinones in terms of use and epidemiology/origins/emergence/dissemination of resistance mechanisms.\n",
      "sess auth :- Guido WERNER ; Anders Rhod LARSEN\n",
      "sess aff :- Germany; Denmark\n",
      "========================================================================================================================\n",
      "3417-1 === \n",
      "abs title :- Geographical dissemination and/or horizontal gene transfer in Gram-positive bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3417-2 === \n",
      "abs title :- Oxazolidinones in the management of Gram-positive infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 64\n",
      "=====**=====S64=====**======= 2\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour Oral SessionHall C\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP21 - Bacterial infections in neonates and children\n",
      "abs text :-  \n",
      "sess auth :- Julie TOUBIANA\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "CSP2101 === 13:30 - 14:30\n",
      "abs title :- Recurrent bacterial meningitis in children in the Netherlands: a 22-year nationwide surveillance study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2102 === 13:30 - 14:30\n",
      "abs title :- Oral and intravenous amoxicillin dosing recommendations in neonates at risk for possible severe bacterial infection: a pooled population pharmacokinetic study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2103 === 13:30 - 14:30\n",
      "abs title :- Prescription rates of Access, Watch and Reserve classified antibiotics for treatment of neonatal sepsis in low- and middle- income countries\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2104 === 13:30 - 14:30\n",
      "abs title :- Evaluating clinical decision rules and rapid diagnostic tests for the diagnosis of Streptococcus pyogenes pharyngitis in Gambian children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2105 === 13:30 - 14:30\n",
      "abs title :- Disparities by age, comorbidity, and insurance type in the burden of invasive pneumococcal disease and respiratory syndromes in children in the United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 65\n",
      "=====**=====S65=====**======= 3\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S5 - Lessons on treatment and diagnosis in the AMR era: pneumonia, cSSTIs and MBL resistance\n",
      "abs text :- Organized by                    \n",
      "Pfizer Antimicrobial resistance (AMR) is a growing threat to modern medicine: in 2019, nearly 5 million deaths were associated with bacterial AMR globally, including over 500,000 deaths in the European region. This integrated symposium investigates how resistance has been combated through drug development - focusing on the fifth-generation cephalosporin, ceftaroline fosamil - as well as uncovering where we stand with metallo-?-lactamases, an emerging resistance problem. By delving into clinical trial data and real-world evidence we plan to address how resistance develops, as well as how to appropriately treat drug-resistant infections with existing and novel antibiotics.\n",
      "sess auth :- Jaroslav HRABAK\n",
      "sess aff :- Czech Republic\n",
      "========================================================================================================================\n",
      "inr 66\n",
      "=====**=====S66=====**======= 4\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S6 - Emerging evidence on the use of cefiderocol in Gram-negative infections caused by non-fermentative bacteria\n",
      "abs text :- Organized by                    \n",
      "Shionogi Over the last few years a range of new antibiotics has become available for the treatment of difficult-to-treat-resistant Gram-negative infections. In this Integrated Symposium we will explore the challenges facing clinicians when managing these infections and discuss the latest emerging evidence on the use of cefiderocol on the treatment of infections caused by non-fermentative Gram-negative bacteria, such as P. aeruginosa and A. baumannii.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 67\n",
      "=====**=====S67=====**======= 5\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 15:00\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S7 - The rise of invasive fungal infections: contemporary approaches to diagnosis, treatment and prophylaxis\n",
      "abs text :- Organized by                    \n",
      "Medscape Education Global (funded by Mundipharma Research Ltd.) Clinicians may underestimate the epidemiology and burden of severe fungal infections such as invasive candidiasis and candideamia. Identification of risk factors particularly among hospitalised and immunocompromised individuals is crucial for successful outcomes. While currently available therapeutics have significant limitations with respect to tissue penetration, pharmacokinetics/pharmacodynamics which can contribute to treatment failure and drug resistance, novel therapeutic approaches for the treatment and prophylaxis of severe fungal infections will enter clinical practice. In this symposium, expert faculty will discuss risk factors for invasive fungal infections (IFIs) and how to prophylaxis or diagnose and treat IFIs in light of current practice guidelines. Novel therapeutics for the treatment and prophylaxis of IFIs will also be discussed.\n",
      "sess auth :- Johan MAERTENS\n",
      "sess aff :- Belgium\n",
      "========================================================================================================================\n",
      "S701 === 13:30 - 15:00\n",
      "abs title :- Welcome and introduction\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S702 === 13:30 - 15:00\n",
      "abs title :- The rise of invasive fungal infections: a cause for alarm?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S703 === 13:30 - 15:00\n",
      "abs title :- Are we detecting IFIs in time to improve outcomes?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S704 === 13:30 - 15:00\n",
      "abs title :- Is our current antifungal \"toolbox\" exhausted\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S705 === 13:30 - 15:00\n",
      "abs title :- Novel therapeutic approaches to treatment/prophylaxis - A case-based discussion\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S706 === 13:30 - 15:00\n",
      "abs title :- Panel discussion and Q&A\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 68\n",
      "=====**=====S68=====**======= 6\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S8 - Surveilling the AMR landscape: utilising surveillance data to help inform appropriate management of outpatient uncomplicated UTIs\n",
      "abs text :- Organized by                    \n",
      "GSK - Appropriate empiric uUTI therapy based on local resistance rates and the current unmet medical need? \n",
      "- Exploring the current clinical challenges in appropriate uUTI management due to a current lack of local outpatient antibiotic surveillance data that could be utilised to inform prescribing\n",
      "- Understanding in vitro surveillance data and how it can be utilised to inform prescribing?\n",
      "- Educating on how surveillance studies are designed and how data is collected, analysed, and interpreted? \n",
      "- Describing goals of surveillance including regulatory guidance and the value that it provides? \n",
      "Utilising surveillance data to help inform decisions on both the micro- and macro- scale? \n",
      "Further exploring of current clinical challenges and how surveillance data can and is utilised for both patient specific treatment decisions as well as macro level decisions (formulary, inclusion in guidelines, etc.)?\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 69\n",
      "=====**=====S69=====**======= 8\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour SymposiumHall I\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3135 - Tricks and tips for the infectious diseases consultant\n",
      "abs text :-  A significant value of infectious diseases physicians is to play horizontally within healthcare institutions. Patients with difficult-to-diagnose and difficult-to-treat infections can be found virtually in any ward or medical/surgical service. Infectious diseases physicians frequently act as consultants providing their diagnostic or therapeutic expertise. This session aims to review the main difficulties that infectious diseases physicians face during their role as consultants. It will also analyse and discuss the struggles in recognition of this specialty in low income countries.\n",
      "sess auth :- Jose Ramon PANO; Jose Ramon PANO; Priscilla RUPALI\n",
      "sess aff :- Spain; Spain; India\n",
      "========================================================================================================================\n",
      "3135-1 === \n",
      "abs title :- Surviving guide for the infectious diseases consultant\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3135-2 === \n",
      "abs title :- Evolution of the CM/ID subspecialties\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 70\n",
      "=====**=====S70=====**======= 9\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour Oral SessionHall J\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK04 - What we learned from the Mpox outbreak\n",
      "abs text :-  \n",
      "sess auth :- Alfonso J. RODRIGUEZ; Cristiana Anca OPREA\n",
      "sess aff :- Colombia; Romania\n",
      "========================================================================================================================\n",
      "MAK0401 === 13:30 - 14:30\n",
      "abs title :- Evaluation of virtual wards for the outpatient management of confirmed human monkeypox virus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0402 === 13:30 - 14:30\n",
      "abs title :- Clinical factors associated with monkeypox hospitalisation, a global research network study, 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0403 === 13:30 - 14:30\n",
      "abs title :- Analogous humoral antigen recognition between monkeypox-infected and smallpox-vaccinated individuals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0404 === 13:30 - 14:30\n",
      "abs title :- Pre-exposure smallpox vaccination against monkeypox: comparison of the characteristics with post-exposure vaccinated patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0405 === 13:30 - 14:30\n",
      "abs title :- Risk assessment of human monkeypox infections for vaccine prioritisation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 71\n",
      "=====**=====S71=====**======= 10\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3476 - Year in infection control\n",
      "abs text :-  \"Year in..\" sessions are very well-attended 1-hour Symposia where speakers review recent literature on the topic. ECCMID 2023 will feature four \"Year in.\" sessions: the traditional \"Year in clinical microbiology\", \"Year in infection control\" and \"Year in infectious diseases\", and the new \"Year in public health\".\n",
      "sess auth :- Önder ERGöNüL ; Sarah TSCHUDIN SUTTER\n",
      "sess aff :- Turkey; Switzerland\n",
      "========================================================================================================================\n",
      "3476-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3476-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 72\n",
      "=====**=====S72=====**======= 11\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour SymposiumHall L\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3471 - Hot topics in prosthetic joint infections\n",
      "abs text :-  Prosthetic joint infections (PJI) are among the most difficult-to-treat bacterial infectious diseases. Its management is complex and requires a multidisciplinary approach, from the diagnosis to the medico-surgical strategy. This session will cover advances in the current epidemiology, microbiological diagnosis, pathogenic mechanisms, and novel therapeutic approaches. The latter involves phage therapy to manage infections and antibiotic-resistant microbes and to target microbial biofilms.\n",
      "sess auth :- Anna NORRBY; Özlem Kurt AZAP\n",
      "sess aff :- Sweden; Turkey\n",
      "========================================================================================================================\n",
      "3471-1 === \n",
      "abs title :- Epidemiology and current challenges of difficult-to-treat PJI\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3471-2 === \n",
      "abs title :- PJI: pathogenesis, diagnosis, and novel treatment approaches\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 73\n",
      "=====**=====S73=====**======= 12\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour Oral SessionHall M\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW09 - Towards improving genomic and environmental surveillance of SARS-Cov-2\n",
      "abs text :-  \n",
      "sess auth :- Kimberley BENSCHOP\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "EW0901 === 13:30 - 14:30\n",
      "abs title :- Mutations in SARS-CoV-2 genomes in COVID-19 patients receiving monoclonal antibody treatments\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0902 === 13:30 - 14:30\n",
      "abs title :- How much should we sequence? An analysis of the Swiss SARS-CoV-2 genomic surveillance effort\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0903 === 13:30 - 14:30\n",
      "abs title :- UKHSA GPHA's modelling of lineage growth rates for early identification of competitive SARS-CoV-2 lineages\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0904 === 13:30 - 14:30\n",
      "abs title :- Presence of SARS-CoV-2 and influenza A viruses in indoor air in the tertiary university hospital during Omicron wave and normalisation period\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0905 === 13:30 - 14:30\n",
      "abs title :- Wastewater based surveillance for SARS-CoV-2: the Danish experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 74\n",
      "=====**=====S74=====**======= 13\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall N\n",
      "sess type :- 1-hour Oral SessionHall N\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK07 - Artificial intelligence becoming natural in infectious disease diagnostics\n",
      "abs text :-  \n",
      "sess auth :- Amel LETAIEF ; Timothy John Jay INGLIS\n",
      "sess aff :- Tunisia; Australia\n",
      "========================================================================================================================\n",
      "PAK0701 === 13:30 - 14:30\n",
      "abs title :- Use of Fourier transform infrared (FT-IR) spectroscopy to create a neural network to real time tracing of Citrobacter koseri clonal strains\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0702 === 13:30 - 14:30\n",
      "abs title :- Artificial intelligence software for use in automatic sorting of cultures in the laboratory\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0703 === 13:30 - 14:30\n",
      "abs title :- Bacterial nanomotions, combined with supervised machine learning, accurately classify antibiotic susceptibility\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0704 === 13:30 - 14:30\n",
      "abs title :- Morphologic identification of clinically encountered moulds using a residual neural network\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0705 === 13:30 - 14:30\n",
      "abs title :- Artificial intelligence and microscopy for the improvement of blood parasites diagnosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 75\n",
      "=====**=====S75=====**======= 14\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall O\n",
      "sess type :- 1-hour Oral SessionHall O\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM07 - Pharmacokinetics, also important for fungal infection treatment\n",
      "abs text :-  \n",
      "sess auth :- Russell Edward LEWIS ; Sandrine MARCHAND\n",
      "sess aff :- Italy; France\n",
      "========================================================================================================================\n",
      "MEM0701 === 13:30 - 14:30\n",
      "abs title :- Suboptimal concentrations of isavuconazole in critically ill patients treated for mould infections: a population pharmacokinetic analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0702 === 13:30 - 14:30\n",
      "abs title :- Model-based dose optimisation of intravenous posaconazole for treating patients with invasive aspergillosis in the intensive care unit\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0703 === 13:30 - 14:30\n",
      "abs title :- Potential drug-drug interactions of antifungal prophylaxis and midostaurin in FLT3-mutated acute myeloid leukemia: clinical implications of therapeutic drug monitoring\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0704 === 13:30 - 14:30\n",
      "abs title :- Tolerability of pulse high dose L-AmB as pre-emptive therapy in patients with high risk for intra-abdominal candidiasis: a phase 2 study LAMBDA study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0705 === 13:30 - 14:30\n",
      "abs title :- Lower blood levels of isavuconazole in critically ill patients compared to other populations: possible need for TDM\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 76\n",
      "=====**=====S76=====**======= 15\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour SymposiumHall P\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3313 - Restoring healthy microbiota\n",
      "abs text :- Co-organised with                    \n",
      "Österreichische Gesellschaft für Hygiene, Mikrobiologie und Präventivmedizin (ÖGHMP), ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI) The human respiratory tract offers a variety of niches for microbial colonisation. Local microbial communities are shaped by the different characteristics of the specific location within the human respiratory tract and interact with external and intrinsic factors. In patients with cystic fibrosis colonisation and infection of the respiratory tract plays a major role and may influence the progress of the disease. Recent research on the cystic fibrosis lung microbiome can be broadly divided into efforts to characterise microbiota composition or attempts to understand the cystic fibrosis lung microbiology as an interactive microbial system. Translating these data into clinically useful measures that accurately predict outcomes and guide treatments remains challenging. The symposium will give an overview of current knowledge and indicate future perspectives.\n",
      "sess auth :- Birgit WILLINGER ; Silvio Daniel BRUGGER\n",
      "sess aff :- Austria; Switzerland\n",
      "========================================================================================================================\n",
      "3313-1 === \n",
      "abs title :- The microbiome of the respiratory tract in health and disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3313-2 === \n",
      "abs title :- Probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 77\n",
      "=====**=====S77=====**======= 17\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD01 - Antibiotic stewardship: anything you always wanted to know\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MYD0101 === 13:30 - 14:30\n",
      "abs title :- Factors affecting antibiotic prescribing for care-home residents: a population-based multi-level cross-classified analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0102 === 13:30 - 14:30\n",
      "abs title :- Quality assessment of the evidence underpinning antimicrobial stewardships interventions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0103 === 13:30 - 14:30\n",
      "abs title :- A living systematic review on antibiotic drug shortages and their impact on infection management\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0104 === 13:30 - 14:30\n",
      "abs title :- Assessment of implementation strategies adopted for antimicrobial stewardship interventions in long-term care facilities: a systematic review\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0105 === 13:30 - 14:30\n",
      "abs title :- Antimicrobial stewardship programmes in patients with negative blood culture (NO-BACT Project)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0106 === 13:30 - 14:30\n",
      "abs title :- The consensus amongst human and animal health experts on the use of high importance-rated antimicrobials in animals: a delphi study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0107 === 13:30 - 14:30\n",
      "abs title :- Exploring barriers to penicillin allergy de-labelling in the hospital setting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0108 === 13:30 - 14:30\n",
      "abs title :- From old to new: using a learning health systems approach to redesign a clinical decision support programme for antimicrobial stewardship\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0109 === 13:30 - 14:30\n",
      "abs title :- Enforcing surveillance to improve appropriateness of antimicrobial prescriptions: results from an antimicrobial stewardship intervention in the paediatric setting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 78\n",
      "=====**=====S78=====**======= 19\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK06 - New insights in Clostridioides difficile: from pigs to poo\n",
      "abs text :-  \n",
      "sess auth :- Carlos PALOS\n",
      "sess aff :- Portugal\n",
      "========================================================================================================================\n",
      "PJK0601 === 13:30 - 14:30\n",
      "abs title :- Epidemiology and economic burden of Clostridioides difficile infection in community and hospital settings in France, 2015-2019\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0602 === 13:30 - 14:30\n",
      "abs title :- Association of outpatient antibiotic prescription data and Clostridioides difficile infections on hospital admission in Germany between 2011 and 2019 – an ecologic analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0603 === 13:30 - 14:30\n",
      "abs title :- An investigation of Clostridioides difficile carriage by Irish pigs and relevance to human disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0604 === 13:30 - 14:30\n",
      "abs title :- What is the active ingredient in stool that prevents relapses in Clostridioides difficile infection?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0605 === 13:30 - 14:30\n",
      "abs title :- The HYPOTHETICAL trial: a HYPOTHEtical TrIal of Clostridioides difficile infection treatment ALgorithms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0606 === 13:30 - 14:30\n",
      "abs title :- Impact of changing from a one-step to a two-step algorithm for Clostridioides difficile infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0607 === 13:30 - 14:30\n",
      "abs title :- Community-acquired Clostridioides difficile infection: time for review of current case definitions?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0608 === 13:30 - 14:30\n",
      "abs title :- Role of faecal calprotectin levels in Clostridioides difficile infection patients treated with faecal microbiome transplant\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0609 === 13:30 - 14:30\n",
      "abs title :- Safety and efficacy of RBX2660 in reducing recurrent Clostridioides difficile infection in immunocompromised participants\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 79\n",
      "=====**=====S79=====**======= 22\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- 179 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting179 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET30 - Viral Hepatitis Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGVH The official open business meeting for the ESCMID Study Group for Viral Hepatitis (ESGVH). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Arjan HARXHI ; Gülsen OZKAYA SAHIN\n",
      "sess aff :- Albania; Sweden\n",
      "========================================================================================================================\n",
      "inr 80\n",
      "=====**=====S80=====**======= 23\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET03 - PK/PD of Anti-Infectives Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "EPASG The official open business meeting for the ESCMID PK/PD of Anti-Infectives Study Group (EPASG). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Birgit KOCH ; Thomas TäNGDéN ; Markus ZEITLINGER ; Sonia LUQUE ; Sebastian WICHA\n",
      "sess aff :- Netherlands; Sweden; Austria; Spain; Germany\n",
      "========================================================================================================================\n",
      "inr 81\n",
      "=====**=====S81=====**======= 0\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3364 - Digitalisation and machine learning in microbiology: addressing promises and challenges\n",
      "abs text :- Co-organised with                    \n",
      "Swiss Society for Microbiology (SSM) Digitalisation and machine learning will have a major impact on the future daily routine of laboratory staff. Along the analytical process, the most important now is to identify where digital technologies can be applied and provide a benefit. The education of all staff involved should be adapted to prepare for the advances in digital microbiology. In this Keynote lecture, Adrian Egli will address the usage of machine learning in diagnostic microbiology for instance, to predict antimicrobial resistance based on MALDI-TOF spectra.\n",
      "sess auth :- Hege Vangstein AAMOT ; Jacob MORAN\n",
      "sess aff :- Norway; Israel\n",
      "========================================================================================================================\n",
      "3364-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 82\n",
      "=====**=====S82=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall B\n",
      "sess type :- 1-hour Oral SessionHall B\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- CSP03 - Response to vaccination in different settings\n",
      "abs text :-  \n",
      "sess auth :- Benjamin COWLING\n",
      "sess aff :- Hong-kong China\n",
      "========================================================================================================================\n",
      "CSP0301 === 14:45 - 15:45\n",
      "abs title :- Neutralising antibody levels and cellular immune response in pregnant women vaccinated with mRNA and inactivated SARS-CoV-2 vaccines\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0302 === 14:45 - 15:45\n",
      "abs title :- The association between BCG vaccine scar size and mycobacterial specific and non-specific stimulated cytokine responses in infants\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0303 === 14:45 - 15:45\n",
      "abs title :- Revaccination of children with acute lymphoblastic leukaemia following completion of chemotherapy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0304 === 14:45 - 15:45\n",
      "abs title :- Humoral responses to influenza vaccine in previously and non-previously vaccinated healthy adults\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0305 === 14:45 - 15:45\n",
      "abs title :- Evaluation of potential coverage of a nine valent O-antigen vaccine for extraintestinal pathogenic Escherichia coli infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 83\n",
      "=====**=====S83=====**======= 2\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour SymposiumHall C\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3134 - Rare yeasts and rare moulds: still bad bugs!\n",
      "abs text :- Co-organised with                    \n",
      "Israel Society for Medical Mycology, French Society for Medical Mycology Given the current increase in infections caused by rare yeast and mold species, such as Trichosporon or Geotrichum, and Scedosporium, Talaromyces, or Fusarium species, respectively, this symposium aims to elucidate such infections and their causative agents. The speakers will focus on the microbial features of these rare fungi and the pathogenesis, diagnosis, and therapy of the infections. Difficulties in diagnosis and therapy will be indicated as well.\n",
      "sess auth :- Jean; Esther SEGAL\n",
      "sess aff :- France; Israel\n",
      "========================================================================================================================\n",
      "3134-1 === \n",
      "abs title :- Diagnostic and treatment approaches to rare yeast\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3134-2 === \n",
      "abs title :- Diagnostic and treatment approaches to rare moulds\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 84\n",
      "=====**=====S84=====**======= 8\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour Oral SessionHall I\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD06 - Innovative preclinical PK/PD studies\n",
      "abs text :-  \n",
      "sess auth :- William COUET ; Annelies VERBON\n",
      "sess aff :- France; Netherlands\n",
      "========================================================================================================================\n",
      "MYD0601 === 14:45 - 15:45\n",
      "abs title :- The AdeIJK efflux pump and AmpC β-lactamase predominantly contribute to the MICs of 42 BL and BLIs in wild-type Acinetobacter baumannii (AB) whereas the blaOXA-51-like β-lactamase and AdeABC pump do not\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0602 === 14:45 - 15:45\n",
      "abs title :- Effect of different resistance mechanisms on bacterial killing and resistance emergence of Pseudomonas aeruginosa in response to meropenem dosing regimens in a hollow fibre model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0603 === 14:45 - 15:45\n",
      "abs title :- Transcriptomic data to support in vitro semi-mechanistic PK/PD modelling of polymyxin B against Acinetobacter baumannii\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0604 === 14:45 - 15:45\n",
      "abs title :- Characterising bacterial growth and killing kinetics of RG6006 using in vitro and in vivo time-kill studies and mechanism-based PK/PD modeling\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0605 === 14:45 - 15:45\n",
      "abs title :- Application of the in vitro hollow fibre infection model (HFIM) to inform personalised CAZ-AVI and ATM dosing against an XDR E. coli in transplant patient\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 85\n",
      "=====**=====S85=====**======= 9\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour SymposiumHall J\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3198 - Clostridioides difficile infection in the paediatric population: just the same as adults?\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Clostridioides difficile(ESGCD) Clostridioides difficile infection (CDI) is usually attributed to an older age patient group; however, the paediatric population can also be affected. Although the causative pathogen is the same in adults and children, laboratory diagnostics and treatment approaches can differ. Laboratory diagnostics of CDI can be tricky because the high proportion of C. difficile colonised infants and young children exhibit the high probability of co-infection with another gastrointestinal pathogen(s). The currently available data supports a change in the treatment strategy of CDI in children and adolescents, similar to the adult population. This symposium aims to address optimal CDI laboratory diagnostics and review the evidence for CDI treatment in this population.\n",
      "sess auth :- Alessia FRANCESCHI ; Fidelma FITZPATRICK\n",
      "sess aff :- Italy; Ireland\n",
      "========================================================================================================================\n",
      "3198-1 === \n",
      "abs title :- Testing for Clostridioides difficile infection in children with diarrhoea\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3198-2 === \n",
      "abs title :- Current experience and future challenges in treatment of paediatric Clostridioides difficile infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 86\n",
      "=====**=====S86=====**======= 10\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall K\n",
      "sess type :- Special SessionHall K\n",
      "sess cate :- 11. Other\n",
      "sess title :- MAK00 - Young Investigator Award for research in CM and ID\n",
      "abs text :-  Every year, ESCMID offers up to three Young Investigator Awards for Research in Clinical Microbiology and Infectious Diseases to recognise outstanding research by younger colleagues in these fields. During this symposium, the 2023 ESCMID Young Investigator Award winners will receive their awards and present their research to the audience of ECCMID.\n",
      "sess auth :- Robert Leo SKOV ; Jon S. FRIEDLAND\n",
      "sess aff :- Denmark; United Kingdom\n",
      "========================================================================================================================\n",
      "MAK0001 === 14:45 - 15:45\n",
      "abs title :- Personalised medicine in infections caused by multidrug-resistant Gram-negative bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0002 === 14:45 - 15:45\n",
      "abs title :- Smooth seas do not make skilful sailors: the challenges and opportunities of antimicrobial stewardship in South African primary healthcare\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0003 === 14:45 - 15:45\n",
      "abs title :- Saliva as a reliable sample type for sustainable surveillance and outbreak response efforts\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0004 === 14:45 - 15:45\n",
      "abs title :- Head over heels: how I fell in love with CNS infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 87\n",
      "=====**=====S87=====**======= 11\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour SymposiumHall L\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3438 - Severe acute hepatitis of unknown aetiology in children\n",
      "abs text :- Co-organised with                    \n",
      "European Association for the study of the liver (EASL),  ESGVH,  Trainee Association of ESCMID (TAE) Steering Committee, European Centre for Disease Prevention and Control (ECDC) Every year, a small percentage of children are diagnosed with acute hepatitis of unknown etiology. Since April 2022, hundreds of cases have been reported worldwide, with many children requiring liver transplantation. The epidemiological, laboratory and clinical information currently available regarding this outbreak remains limited. Up to now, no etiological agent has been identified. Adenovirus has been detected in blood or plasma samples of many cases, but in low viral loads. Adenovirus has not yet been identified in the analysed liver tissue samples and, could be a coincidental rather than a causal factor. This symposium will review the epidemiology, potential etiological factors and the clinical presentation, including liver transplantation in these cases of severe acute hepatitis of unknown origin.\n",
      "sess auth :- Mojca MATICIC ; Gülsen OZKAYA SAHIN\n",
      "sess aff :- Slovenia; Sweden\n",
      "========================================================================================================================\n",
      "3438-1 === \n",
      "abs title :- Epidemiological update\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3438-2 === \n",
      "abs title :- Management of fulminant hepatitis in children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 88\n",
      "=====**=====S88=====**======= 12\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour Oral SessionHall M\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK12 - Epidemiology and management of prosthetic joint infections\n",
      "abs text :-  \n",
      "sess auth :- Tiphaine ROUSSEL\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "PJK1201 === 14:45 - 15:45\n",
      "abs title :- Performance of an algorithm for semi-automated surveillance of surgical site infections after total hip and knee arthroplasties in three hospitals: preliminary results\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1202 === 14:45 - 15:45\n",
      "abs title :- Dalbavancin for the treatment of Gram-positive periprosthetic joint infections: a retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1203 === 14:45 - 15:45\n",
      "abs title :- The pathway to a small colony variant morphology: a differential expression gene analysis from isolates causing prosthetic joint infection.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1204 === 14:45 - 15:45\n",
      "abs title :- Intra articular injection(s) of active bacteriophages as adjuvant therapy in patients with prosthetic joint infections (PJI) qualified for open or arthroscopic “Debridement Antibiotics & Implant Retention” (DAIR) followed by suppressive antimicrobial therapy (SAT): the PHAGEinLYON experience at the CRIOAc Lyon referral centre\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1205 === 14:45 - 15:45\n",
      "abs title :- Burden of hospitalisations due to prosthetic joint infection in Spain during the period 2000-2015\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 89\n",
      "=====**=====S89=====**======= 13\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall N\n",
      "sess type :- Meet-the-ExpertHall N\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3352 - Diphtheria: an ancient scourge with global presence\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Public Health Microbiology (ESGPHM) Due to vaccination success, diphtheria is usually considered an \"old\" disease. However, recent outbreaks in countries afflicted by natural or man-made disasters (e.g. Venezuela, Haiti, Syria, Yemen, Myanmar) and sporadic cases in some European countries (e.g. Spain, Germany, UK) have put diphtheria back on the agenda. Many countries have low diphtheria vaccination coverage, and 25% of countries do not recommend booster vaccination. The refugee crisis, and population movements are key factors for transmission and importation to countries with established vaccine programs. Moreover, C. ulcerans, an emerging zoonotic pathogen affecting a wide range of animals, is responsible for increasing human cases. Three new Corynebacterium spp. have been included in the C. diphtheria group, like C. rouxii, C. belfantii and C. silvaticum. Awareness of the resurgence, diagnostic, and management and control of diphtheria needs attention. This session will provide an update on these challenges and possible solutions.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3352-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3352-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 90\n",
      "=====**=====S90=====**======= 14\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall O\n",
      "sess type :- Meet-the-ExpertHall O\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3247 - Implementation of tuberculosis genomics in clinical practice\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Mycobacterial Infections (ESGMYC) Transmission is still a major obstacle to tuberculosis (TB) elimination worldwide. Therefore, understanding TB transmission is key to developing tailored strategies to control its spread on the path to ending TB by 2035. The session aims to explain how transmission dynamics in TB settings can be quantified, characterised, and compared using comprehensive genomic information obtained by whole genome sequencing (WGS). Furthermore, this information can also impact outbreak investigations including identification of index cases, transmitters, estimation of the transmission timing, or cases missed by conventional contact tracing. The session will emphasise the difficulties of capacity building in high TB burden countries, together with the new approaches to personalised medicine for TB treatment management.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3247-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3247-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 91\n",
      "=====**=====S91=====**======= 15\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall P\n",
      "sess type :- Meet-the-ExpertHall P\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3455 - Doing more with less: Improving laboratory quality for AMR surveillance with limited resources\n",
      "abs text :- Co-organised with                    \n",
      "CAESAR network, World Health Organization (WHO) Good quality clinical bacteriology is crucial for effective surveillance and control of AMR, but low-resource settings face challenges of infrastructure, equipment, logistics, and human resources in implementing of good clinical practices. Still, there are ample possibilities for increasing the quality of laboratory procedures. In this session, two experts will explain how surveillance data validation can guide the improvement of laboratory procedures and how a critical review of antimicrobial susceptibility testing results can contribute to identifying problems and lead to corrective actions to improve laboratory quality in laboratories with limited resources. Through discussion with the experts and the exchange of experiences, the audience will get inspired on how to implement affordable solutions.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3455-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3455-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 92\n",
      "=====**=====S92=====**======= 16\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP12 - Antibiotic resistance in sexually transmitted infections\n",
      "abs text :-  \n",
      "sess auth :- David FISMAN\n",
      "sess aff :- Canada\n",
      "========================================================================================================================\n",
      "ALP1201 === 14:45 - 15:45\n",
      "abs title :- Relation between phenotype and genotype antibiotic resistance of Mycoplasma genitalium using culture and typing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1202 === 14:45 - 15:45\n",
      "abs title :- Surveillance of macrolide and fluoroquinolone resistance in Mycoplasma genitalium in metropolitan and overseas France in 2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1203 === 14:45 - 15:45\n",
      "abs title :- Macrolide and fluoroquinolone resistance of M. genitalium from patients with urethritis or cervicitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1204 === 14:45 - 15:45\n",
      "abs title :- Implementation of genotypic resistance testing for Neisseria gonorrhoeae in a multiplex-PCR\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1205 === 14:45 - 15:45\n",
      "abs title :- Transcriptomic profiling of ceftriaxone-tolerant phenotypes of Neisseria gonorrhoeae WHO P reference strain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1206 === 14:45 - 15:45\n",
      "abs title :- Nationwide surveillance for emerging resistant Neisseria gonorrhoeae in Korea\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1207 === 14:45 - 15:45\n",
      "abs title :- Clinical evaluation of a molecular assay for detection of azithromycin and ciprofloxacin resistance in Neisseria gonorrhoeae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1208 === 14:45 - 15:45\n",
      "abs title :- Antimicrobial resistance of Neisseria gonorrhoeae in southern Spain in the last 11 years\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1209 === 14:45 - 15:45\n",
      "abs title :- Gonococcal resistance to zoliflodacin can be acquired from commensal Neisseria species: an in vitro transformation study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 93\n",
      "=====**=====S93=====**======= 18\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- PAK13 - Tropical pearls\n",
      "abs text :-  \n",
      "sess auth :- Heiman WERTHEIM\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "PAK1301 === 14:45 - 15:45\n",
      "abs title :- Do we think enough about strongyloidiasis, schistosomiasis and Chagas disease among HIV-positive migrant patients? Screening ratio and seroprevalence in a tertiary healthcare centre in Italy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1302 === 14:45 - 15:45\n",
      "abs title :- A crucial look at leishmaniasis pathogenesis: investigation of possible viscerotropism-associated proteins and genes of viscerotropic Leishmania tropica strains\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1303 === 14:45 - 15:45\n",
      "abs title :- Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1304 === 14:45 - 15:45\n",
      "abs title :- Male genital schistosomiasis (MGS) among local fishermen along the south shoreline of lake Malawi in Mangochi district\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1305 === 14:45 - 15:45\n",
      "abs title :- Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field: the ESTRELLA study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1306 === 14:45 - 15:45\n",
      "abs title :- Investigations of schistosomiasis on the Namwera plateau (ISNaP)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1307 === 14:45 - 15:45\n",
      "abs title :- Circulating cell-free DNA in urine as a biomarker for molecular diagnosis of neurocysticercosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1308 === 14:45 - 15:45\n",
      "abs title :- Pulmonary echinococcosis: a four-year, single-centre experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 94\n",
      "=====**=====S94=====**======= 21\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET04 - Anaerobic Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGAI The official open business meeting for the ESCMID Study Group for Anaerobic Infections (ESGAI). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Michael BUHL ; Jozsef SOKI ; Samo JEVERICA ; Yann DUMONT ; Trefor MORRIS\n",
      "sess aff :- Germany; Hungary; Slovenia; France; United Kingdom\n",
      "========================================================================================================================\n",
      "inr 95\n",
      "=====**=====S95=====**======= 1\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour Oral SessionHall B\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD12 - What is going on in the world of AMS: from admission to discharge and beyond\n",
      "abs text :-  \n",
      "sess auth :- Evelina TACCONELLI ; Thomas TäNGDéN\n",
      "sess aff :- Italy; Sweden\n",
      "========================================================================================================================\n",
      "MYD1201 === 16:15 - 18:15\n",
      "abs title :- Factors related to inappropriate antibiotic therapy in the emergency department: results from a prospective observational study in a large university hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1202 === 16:15 - 18:15\n",
      "abs title :- Antimicrobial lead time: a new quality and process indicator\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1203 === 16:15 - 18:15\n",
      "abs title :- Jabs to tabs: a time and motion study investigating medicines administration\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1204 === 16:15 - 18:15\n",
      "abs title :- Nurses' contribution to antimicrobial stewardship: finding integration in daily practice\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1205 === 16:15 - 18:15\n",
      "abs title :- A computer-based algorithm to identify inappropriateness of carbapenem therapy in a large Italian university hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1206 === 16:15 - 18:15\n",
      "abs title :- Antimicrobial therapeutic drug monitoring in critically ill adult patients: an international perspective on access, utilisation, barriers and clinical value\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1207 === 16:15 - 18:15\n",
      "abs title :- The impact on the CO2 footprint when inappropriate intravenous antibiotic therapy is used instead of an earlier, clinically appropriate switch to an oral formulation or stopping the therapy entirely in a UK based tertiary hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1208 === 16:15 - 18:15\n",
      "abs title :- Quality assurance and performance improvement of an outpatient parenteral antimicrobial therapy program in the United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1209 === 16:15 - 18:15\n",
      "abs title :- Is there a difference in antibiotic prescribing between remote and face-to-face consultations for acute respiratory infections in primary care? A patient-level analysis of electronic health records using machine learning\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1210 === 16:15 - 18:15\n",
      "abs title :- Supporting stewardship in Australian aged care homes: results of the 2021 Aged Care National Antimicrobial Prescribing Survey\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 96\n",
      "=====**=====S96=====**======= 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour Oral SessionHall C\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK13 - New insights in diagnosis and prevention of healthcare and community-acquired outbreaks\n",
      "abs text :-  \n",
      "sess auth :- Walter ZINGG\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "PJK1301 === 16:15 - 18:15\n",
      "abs title :- Next-generation outbreak investigation: AFLP and nanopore whole genome sequencing streamlined initial local outbreak investigation during a countrywide Pseudomonas aeruginosa hospital outbreak in Norway\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1302 === 16:15 - 18:15\n",
      "abs title :- High-risk clones of Pseudomonas aeruginosa contaminate the drinking water networks of French cities\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1303 === 16:15 - 18:15\n",
      "abs title :- A one-year genomic investigation of Escherichia coli epidemiology and nosocomial spread at a large US healthcare network\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1304 === 16:15 - 18:15\n",
      "abs title :- Plasmids shift the paradigm of bacterial outbreaks in a German hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1305 === 16:15 - 18:15\n",
      "abs title :- New insights into low abundant extended-spectrum beta-lactamase producing Enterobacterales species in a One-Health context\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1306 === 16:15 - 18:15\n",
      "abs title :- Detection of regional methicillin resistant Staphylococcus aureus (MRSA) outbreak, involving multiple healthcare settings, laboratories, infection control departments (ICD) and the municipal health service (MHS) between 2017 - 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1307 === 16:15 - 18:15\n",
      "abs title :- Hospital-acquired invasive pneumococcal disease in South Central Ontario, Canada, 1995-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1308 === 16:15 - 18:15\n",
      "abs title :- Comparison of multiple definitions for ventilator-associated pneumonia in critically ill patients admitted for non-pulmonary conditions: preliminary data from PULMIVAP, an Italian multicentre cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1309 === 16:15 - 18:15\n",
      "abs title :- Relationship between immunosuppression and intensive care unit-acquired colonisation and infection related to multidrug-resistant bacteria: a prospective multicentre cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1310 === 16:15 - 18:15\n",
      "abs title :- National outbreaks caused by contaminated non-medicinal products, UK 2020-2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 97\n",
      "=====**=====S97=====**======= 3\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S13 - The Million Microbiome from Humans Project: the largest database of sequencing data of the human microbiome\n",
      "abs text :- Organized by                    \n",
      "MGI MGI would like to use the opportunity to inform the ECCMID attendees about the Million Microbiome from Humans Project (MMHP), which was officially launched at the 14th International Conference on Genomics (ICG-14). \n",
      "Scientists from China, Sweden, Denmark, France, and Latvia agreed to collaborate on a large-scale microbial metagenomic project, aiming to sequence and analyse one million samples from the intestine, mouth, skin, reproductive tract, and other organs in the next three to five years to construct a microbiome map of the human body and build the world's largest database of the human microbiome. In this session we would like to provide and update on the project and we welcome contributions from the ECCMID community.\n",
      "sess auth :- Holger ROHDE\n",
      "sess aff :- Germany\n",
      "========================================================================================================================\n",
      "inr 98\n",
      "=====**=====S98=====**======= 4\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S10 - COVID-19...where do we go from here?\n",
      "abs text :- Organized by                    \n",
      "Shionogi Since 2019, the global COVID-19 pandemic has dominated the infectious disease world. This educational symposium will aim to provide HCPs with an informed update on the current global situation as it stands in 2023 in terms of disease burden, treatment landscape and future unmet needs.\n",
      "sess auth :- William HANAGE\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "inr 99\n",
      "=====**=====S99=====**======= 5\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S11 - Changing microbiology: revolutionary technologies enhancing today´s diagnostics\n",
      "abs text :- Organized by                    \n",
      "Bruker Microbiology & Infection Diagnostics This integrated symposium highlights the latest updates and trends across a broad spectrum of technologies, including microbial identification and typing, molecular and rapid AST assays. The use of AI approaches on large MALDI-TOF datasets from microbial identification opens new possibilities in research and future diagnostics, already being explored by MALDI TOF users. IR spectroscopy strain typing technology greatly facilitates hygiene control and epidemiology as the built-in classifiers enable quick decision-making. Infectious disease molecular diagnostic assays provide comprehensive coverage with powerful next-generation multiplexing in a familiar PCR-based workflow.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 100\n",
      "=====**=====S100=====**======= 6\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S12 - Exploring what's new on recent antibiotics with activity against MDR bacteria\n",
      "abs text :- Organized by                    \n",
      "ADVANZ PHARMA The main aim of the symposium is to review the most important novelties published on the most recent antibiotics, and contribute to training and clinical updating of healthcare professionals in the area of infectious disease, in the proper and optimal use of antibiotics.\n",
      "sess auth :- Rafael CANTON ; Mark WILCOX\n",
      "sess aff :- Spain; United Kingdom\n",
      "========================================================================================================================\n",
      "S1201 === 16:15 - 18:15\n",
      "abs title :- Welcome and introduction\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1202 === 16:15 - 18:15\n",
      "abs title :- A review on new antibiotics with pediatric indication\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1203 === 16:15 - 18:15\n",
      "abs title :- Novelties in PK/PD data for long-acting glycopeptides\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1204 === 16:15 - 18:15\n",
      "abs title :- Panel discussion and Q&A\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1205 === 16:15 - 18:15\n",
      "abs title :- Introduction /Part 2\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1206 === 16:15 - 18:15\n",
      "abs title :- Update on the current situation of ESBL infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1207 === 16:15 - 18:15\n",
      "abs title :- New BL/BLIs for the treatment of ESBL infections - what to consider for the selection of the most appropriate combination?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1208 === 16:15 - 18:15\n",
      "abs title :- Panel discussion and Q&A\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 101\n",
      "=====**=====S101=====**======= 7\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S9 - TBC\n",
      "abs text :- Organized by                    \n",
      "Pfizer TBC\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 102\n",
      "=====**=====S102=====**======= 8\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall I\n",
      "sess type :- 2-hour SymposiumHall I\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3291 - Interactions between human, animal, and environmental antibiotic resistomes\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS) The One Health concept has been established in recent years to tackle antibiotic resistance issues. Many epidemiological studies have been conducted worldwide to identify the resistance determinants that may be found in the different compartments (human, environmental, animal) but also their potential routes of transmission. It is time to analyse all the data generated to evaluate which critical problems have been identified.\n",
      "sess auth :- Ana FREITAS ; Els BROENS\n",
      "sess aff :- Portugal; Netherlands\n",
      "========================================================================================================================\n",
      "3291-1 === \n",
      "abs title :- Successful MDR clones as potential drivers of AMR\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3291-2 === \n",
      "abs title :- What is shared (and not shared) between animals and humans?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3291-3 === \n",
      "abs title :- The shared resistome between human and environmental bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3291-4 === \n",
      "abs title :- Plasmids as cross-ecological sources of resistance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 103\n",
      "=====**=====S103=====**======= 9\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour SymposiumHall J\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3386 - Optimising the diagnosis and treatment of difficult-to-treat cardiovascular infection\n",
      "abs text :- Co-organised with                    \n",
      "Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Sociedad Espanola de Infecciones Cardiovasculares (SEICaV), Società italiana di terapia anti-infettiva (SITA) Diagnosis and treatments of patients with cardiovascular infections are frequently challenging. For example, in developing countries lacking diagnostic tests, diagnosis of endocarditis is difficult in patients with an intracardiac prosthetic valve and in patients using antibiotics before the blood culture sampling. Delays in the correct diagnosis are associated with increased mortality and morbidity. Furthermore, infections such as infective endocarditis, and cardiovascular device infections are particularly frequent and difficult to treat. Still, the evidence supporting the decisions in such circumstances may not be solid enough or available. The symposium aims to discuss updated diagnostic criteria of infective endocarditis issued in 2022 by ISCVID and ESC, focusing on alternative blood sampling methods and the challenges in treating patients. Speakers will provide some recommendations for difficult situations based on the available evidence or rationale and define the priority areas for future research.\n",
      "sess auth :- Jacob STRAHILEVITZ\n",
      "sess aff :- Israel\n",
      "========================================================================================================================\n",
      "3386-1 === \n",
      "abs title :- Diagnostic criteria for infective endocarditis 2023\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3386-2 === \n",
      "abs title :- Microbiologic diagnosis of infective endocarditis: beyond blood cultures\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3386-3 === \n",
      "abs title :- Balancing risk/benefit for the timing of urgent cardiac operation in infective endocarditis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3386-4 === \n",
      "abs title :- Antibiotic treatment for infected vascular grafts: selection and duration\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 104\n",
      "=====**=====S104=====**======= 10\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall K\n",
      "sess type :- 2-hour SymposiumHall K\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3131 - The future of infection prevention and control\n",
      "abs text :- Co-organised with                    \n",
      "EUCIC Steering Committee, ESCMID Study Group for Nosocomial Infections (ESGNI), Trainee Association of ESCMID (TAE) Steering Committee, ESCMID Study Group for Biofilms (ESGB) Infection prevention and control (IPC) are fundamental for medicine. Being a cross-sectional medical discipline not only involving patient therapy and care but also the hierarchical functionality and the technical infrastructure of the hospital, plus being a potter's wheel of communication and education IPC demands experience and knowledge from its protagonists. Nevertheless, IPC must demand support and resources from the stakeholders for its full function to protect patients and all individuals in a hospital. This symposium will focus on these infection control functions, indicate future pathways to advance infection control, and highlight how to get resources and appreciate its \"Hercules' labours.\"\n",
      "sess auth :- Nico Tom MUTTERS ; Yousra KHERABI\n",
      "sess aff :- Germany; France\n",
      "========================================================================================================================\n",
      "3131-1 === \n",
      "abs title :- The joy of infection prevention and control: save and protect!\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3131-2 === \n",
      "abs title :- To foster infection prevention and control is the job of the CEO\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3131-3 === \n",
      "abs title :- Infection prevention and control: how to communicate and find allies and friends\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3131-4 === \n",
      "abs title :- MRDO epidemiology 4.0: profiling and control culprits\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 105\n",
      "=====**=====S105=====**======= 12\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall M\n",
      "sess type :- 2-hour Educational WorkshopHall M\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3280 - Host-pathogen interactions and immunotherapies in infectious diseases\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Mycobacterial Infections (ESGMYC), ESCMID Fungal Infection Study Group (EFISG), ESCMID Study Group for Respiratory Viruses (ESGREV) Antimicrobial therapies alone are insufficient to improve patient outcomes, as highlighted by the COVID-19 pandemic, underlining the relevance of host-pathogen interactions and immunotherapy in infectious diseases. The host response to the pathogen often causes collateral damage, and therapies are required to dampen these harmful responses. Recent advances show how new biomarkers or biosignatures can help direct immunotherapy to improve the outcome of sepsis, fungal infections, and mycobacterial disease. Such host-directed therapy is increasingly important in light of increasing antimicrobial resistance. This session presents a state-of-the-art overview of host-pathogen interaction and immunotherapy in infectious diseases, linking laboratory sciences, clinical trials, and individual patients.\n",
      "sess auth :- Chrysanthi SKEVAKI ; Graeme Ayton MEINTJES\n",
      "sess aff :- Germany; South Africa\n",
      "========================================================================================================================\n",
      "3280-1 === \n",
      "abs title :- Host-pathogen interactions and immunotherapy in mycobacterial infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3280-2 === \n",
      "abs title :- A framework for understanding host-pathogen interactions in infectious diseases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3280-3 === \n",
      "abs title :- Immune dysregulation and immunotherapy for fungal infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 106\n",
      "=====**=====S106=====**======= 13\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall N\n",
      "sess type :- Special SessionHall N\n",
      "sess cate :- 11. Other\n",
      "sess title :- MAK - TAE Research Bites\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Trainee Association (TAE) Steering Committee, ESCMID Scientific Affairs Subcommittee The Research Bites session  is co-organised by TAE and SAS members, and aims to increase young scientists' chances, especially from LMICs and economically disadvantaged regions, to give an oral presentation at ECCMID 2023. Six speakers will be selected for this session. The Research Bites session aims to provide less experienced and/or economically disadvantaged early career researchers additional opportunities to gain a foothold in the scientific community and to advance in their research careers by presenting at ECCMID 2023. As a part of the preparation for the session, each selected presenting author will be coached by an experienced TAE or SAS member on how to efficiently present their research.\n",
      "sess auth :- Jon S. FRIEDLAND ; Katharina LAST\n",
      "sess aff :- United Kingdom; Germany\n",
      "========================================================================================================================\n",
      "QC === \n",
      "abs title :- Can AST/ALT predict mortality in Crimean-Congo haemorrhagic fever?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "QC === \n",
      "abs title :- Faecal colonisation with carbapenemase and ESBL/AmpC-producing Enterobacterales in Portugal and the United Kingdom: a One Health perspective on the human-companion animal relationship\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "QC === \n",
      "abs title :- Ertapenem vs class-2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia: a propensity score-matched study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "QC === \n",
      "abs title :- Advanced HIV disease and mortality among children in sub-Saharan Africa: a trend analysis from the Kilombero and Ulanga antiretroviral cohort\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "QC === \n",
      "abs title :- Serotype specific differences in clinical manifestation, laboratory parameters, risk of severe disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "QC === \n",
      "abs title :- Predicting antibacterial efficacy of linezolid on Staphylococcus aureus in cerebral infections using in vitro hollow fiber model and pharmacokinetic/pharmacodynamic modelling\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 107\n",
      "=====**=====S107=====**======= 14\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour SymposiumHall O\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3185 - HIV-associated fungal infections: the state of the field\n",
      "abs text :-  After TB, fungal infections are the leading cause of death and morbidity among people living with HIV worldwide. It ranges from mucormycosis to pneumocystis pneumonia and several disseminated deep fungal infections, some of which are endemic and more prevalent in certain regions of the world. The recent breakthroughs in diagnostic tests for these infections and several treatment trials have informed international guideline updates. Yet challenges remain related to late diagnosis of disease and high mortality despite current treatments. In this session, four leading experts in this field will focus on a specific fungal pathogen, and will provide updates on epidemiology, diagnosis, prevention, and treatment. The infections covered will be mucormycosis, talaromycosis, histoplasmosis, and pneumocystis pneumonia.\n",
      "sess auth :- Cristina MUSSINI ; David DENNING\n",
      "sess aff :- Italy; United Kingdom\n",
      "========================================================================================================================\n",
      "3185-1 === \n",
      "abs title :- Mucormycosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3185-2 === \n",
      "abs title :- Talaromycosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3185-3 === \n",
      "abs title :- Histoplasmosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3185-4 === \n",
      "abs title :- Pneumocystis pneumonia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 108\n",
      "=====**=====S108=====**======= 15\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall P\n",
      "sess type :- 2-hour Oral SessionHall P\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- PJK04 - Pathogenesis and therapeutic targeting of bacterial and biofilm-associated infections\n",
      "abs text :-  \n",
      "sess auth :- Molly INGERSOLL\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "PJK0401 === 16:15 - 18:15\n",
      "abs title :- The spatial distribution of transcriptomics lung immune responses during chronic lung infection by opportunistic pathogens\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0402 === 16:15 - 18:15\n",
      "abs title :- Metabolic rewiring of Pseudomonas aeruginosa during within-patient evolution\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0403 === 16:15 - 18:15\n",
      "abs title :- The sRNA B11 controls virulence-associated phenotypes in Mycobacteroides abscessus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0404 === 16:15 - 18:15\n",
      "abs title :- An emerging Staphylococcus aureus MRSA clone encodes a CRISPR-Cas type III-A system that is excisable and provides immunity against phage attack\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0405 === 16:15 - 18:15\n",
      "abs title :- Evaluation of genomic and transcriptomic changes in the evolution of S. aureus USA300 isolate from wild-type to scv, able to perform phagosomal escape\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0406 === 16:15 - 18:15\n",
      "abs title :- Staphylococcus aureus biofilm-associated compartment PNAG stimulates immunomodulatory chemokine CXCL10 secretion as an immune evasion mechanism\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0407 === 16:15 - 18:15\n",
      "abs title :- Duration and dynamics of Klebsiella pneumoniae gut colonisation in community-based adults\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0408 === 16:15 - 18:15\n",
      "abs title :- Characterisation of persisters in Enterococcus faecium\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0409 === 16:15 - 18:15\n",
      "abs title :- Predating of pathogens: a novel strategy for treatment of burn wounds infection in mouse model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0410 === 16:15 - 18:15\n",
      "abs title :- In vitro activity of fenticonazole against biofilms formed by clinically relevant Candida species\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 109\n",
      "=====**=====S109=====**======= 17\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP05 - Urinary tract infections: diagnostic and treatment issues\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "CSP0501 === 16:15 - 17:15\n",
      "abs title :- Development and validation of a predictive algorithm to assess the risk for antimicrobial resistance among patients with uncomplicated urinary tract infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0502 === 16:15 - 17:15\n",
      "abs title :- Occurrence and prevalent species of recurrent urinary tract infections in 145,800 women\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0503 === 16:15 - 17:15\n",
      "abs title :- Modelling the effects of a novel antibiotic on the prevalence of antimicrobial resistance in uncomplicated urinary tract infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0504 === 16:15 - 17:15\n",
      "abs title :- Recurrence, healthcare resource use, and costs in the treatment of uncomplicated urinary tract infection in female patients in Germany\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0505 === 16:15 - 17:15\n",
      "abs title :- Multi-centre analysis of urinary Escherichia coli isolates from female outpatients before and during the COVID-19 pandemic in the United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0506 === 16:15 - 17:15\n",
      "abs title :- Identification of pathogenicity factors in quinolones and fosfomycin low level resistance isolates from uropathogenic Escherichia coli isolates from kidney transplant patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0507 === 16:15 - 17:15\n",
      "abs title :- Comparison of clinical features and microbiological factors of Escherichia coli from urinary versus non-urinary source in patients with bacteraemia and sepsis/septic shock (PROBAC EC Study)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0508 === 16:15 - 17:15\n",
      "abs title :- Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to multidrug-resistant Escherichia coli: a post-hoc analysis of the FOREST randomised trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0509 === 16:15 - 17:15\n",
      "abs title :- Is the isolation of Staphylococcus aureus from the urinary tract a harbinger for Staphylococcus aureus bacteraemia?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 110\n",
      "=====**=====S110=====**======= 19\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW06 - Critically ill COVID-19 patients: still room to understand vulnerability and improve outcome\n",
      "abs text :-  \n",
      "sess auth :- Bruno MEGARBANE\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "EW0601 === 16:15 - 17:15\n",
      "abs title :- Tixagevimab/cilgavimab pre-exposure prophylaxis in lung transplant recipients during the Omicron wave: a real-world monocentric experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0602 === 16:15 - 17:15\n",
      "abs title :- Mortality per waves of SARS-CoV-2 in critical and non-critical hospitalised COVID-19 patients in a tertiary care hospital in Mexico City\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0603 === 16:15 - 17:15\n",
      "abs title :- Impaired systemic antiviral immune response in critically ill COVID-19 patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0604 === 16:15 - 17:15\n",
      "abs title :- Characterisation of cellular immune patterns of bronchoalveolar lavage fluid and peripheral blood in patients with severe COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0605 === 16:15 - 17:15\n",
      "abs title :- Impact of early diagnosis and treatment of CAPA on survival in critically ill COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0606 === 16:15 - 17:15\n",
      "abs title :- Risk factor nosocomial infection in critically ill patients with COVID-19 infection: new risk factor early use of antibiotic potential increased risk more than corticosteroid administration\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0607 === 16:15 - 17:15\n",
      "abs title :- High-dose anakinra in addition to standard of care including dexamethasone in patients with severe COVID-19 treated with non-invasive ventilation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0608 === 16:15 - 17:15\n",
      "abs title :- Inflammatory clusters associated with organ failure endotypes in patients with COVID-19 pneumonia admitted to intensive care units in Colombia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0609 === 16:15 - 17:15\n",
      "abs title :- Reactivation of herpes simplex virus in critically ill patients with COVID-19 and ARDS receiving dexamethasone\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 111\n",
      "=====**=====S111=====**======= 22\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- 179 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting179 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET27 - Public Health Microbiology Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGPHM The official open business meeting for the ESCMID Study Group for Public Health Microbiology (ESGPHM). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Pikka JOKELAINEN ; Titia M. KORTBEEK ; Marc J. STRUELENS\n",
      "sess aff :- Denmark; Netherlands; Sweden\n",
      "========================================================================================================================\n",
      "inr 112\n",
      "=====**=====S112=====**======= 23\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET13 - Epidemiological Markers Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGEM The official open business meeting for the ESCMID Study Group for Epidemiological Markers (ESGEM). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Guido WERNER ; Angela NOVAIS ; Benjamin Peter HOWDEN ; Natacha COUTO ; Kristin HEGSTAD\n",
      "sess aff :- Germany; Portugal; Australia; United Kingdom; Norway\n",
      "========================================================================================================================\n",
      "inr 113\n",
      "=====**=====S113=====**======= 16\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM01 - Resistance in fungi: a moving field\n",
      "abs text :-  \n",
      "sess auth :- David PERLIN\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "MEM0101 === 17:15 - 18:15\n",
      "abs title :- European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0102 === 17:15 - 18:15\n",
      "abs title :- Recent increase in fluconazole-nonsusceptible Candida parapsilosis in a global surveillance with the expansion of the Erg11 Y132F genotype and a rapid detection method to detect this alteration\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0103 === 17:15 - 18:15\n",
      "abs title :- Fluconazole-resistant C. parapsilosis spreading across Madrid has gained traction in 2022: an update of the CANDIMAD (Candidaemia in Madrid) survey\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0104 === 17:15 - 18:15\n",
      "abs title :- Frequency, mechanisms and clinical outcomes of azole-resistant Candida parapsilosis bloodstream isolates in Israel\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0105 === 17:15 - 18:15\n",
      "abs title :- CpTAC1 mutation leads to increased expression of multiple ABC transporters and triazole resistance in Candida parapsilosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0106 === 17:15 - 18:15\n",
      "abs title :- Decreased echinocandin susceptibility in Candida parapsilosis causing candidaemia and emergence of a pan-echinocandin resistant case in China\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0107 === 17:15 - 18:15\n",
      "abs title :- CandiRes: relationship of antifungal exposure to emergence of Candida resistance in intensive care patients: a multi-site cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0108 === 17:15 - 18:15\n",
      "abs title :- Resistance surveillance of antifungal agents in clinical use: data from the 2021 ARIA surveillance initiative, analysis of resistance in antifungals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0109 === 17:15 - 18:15\n",
      "abs title :- Increased rate of terbinafine resistance among Trichophyton isolates and identification of Trichophyton indotineae in the United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 114\n",
      "=====**=====S114=====**======= 18\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK02 - Viral infections across the globe\n",
      "abs text :-  \n",
      "sess auth :- Joanna Maria ZAJKOWSKA\n",
      "sess aff :- Poland\n",
      "========================================================================================================================\n",
      "MAK0201 === 17:15 - 18:15\n",
      "abs title :- Hepatitis C screening and elimination strategy: implementation of the FOCUS program in Almería, Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0202 === 17:15 - 18:15\n",
      "abs title :- The Azov-Black Sea region is a hot-spot in Europe for early detection of H5 HPAI viruses in clinical healthy wild birds\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0203 === 17:15 - 18:15\n",
      "abs title :- Molecular characterisation of imported dengue cases in Northeastern Spain in 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0204 === 17:15 - 18:15\n",
      "abs title :- Acute flaccid paralysis in patients with West Nile neuroinvasive disease: clinical presentation and the disease outcome\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0205 === 17:15 - 18:15\n",
      "abs title :- Post-COVID neurocognitive function in people living with and without HIV\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0206 === 17:15 - 18:15\n",
      "abs title :- Clinical laboratory validation and implementation of an orthopox qualitative real-time assay for the diagnosis of monkeypox\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0207 === 17:15 - 18:15\n",
      "abs title :- Epidemiological surveillance of monkeypox virus during the outbreak in Barcelona, Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0208 === 17:15 - 18:15\n",
      "abs title :- I-TAC, IP-10, MIP-3A and MIG as potential biomarkers of direct-acting antiviral treatment of chronic hepatitis C infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0209 === 17:15 - 18:15\n",
      "abs title :- First identification of Toscana virus neuroinvasive infections in Algeria: a series of 23 cases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 115\n",
      "=====**=====S115=====**======= 21\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 15/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET14 - Forensic and Postmortem Microbiology Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGFOR The official open business meeting for the ESCMID Study Group for Forensic and Postmortem Microbiology (ESGFOR). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Veroniek SAEGEMAN ; Amparo FERNáNDEZ; Marta COHEN\n",
      "sess aff :- Belgium; Spain; United Kingdom\n",
      "========================================================================================================================\n",
      "inr 116\n",
      "=====**=====S116=====**======= 24\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET10 - Clostridioides difficile Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGCD The official open business meeting for the ESCMID Study Group for Clostridioides difficile (ESGCD). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Marcela KRUTOVA ; Kerrie DAVIES ; Benoit GUERY ; Frédéric BARBUT ; Fidelma FITZPATRICK\n",
      "sess aff :- Czech Republic; United Kingdom; Switzerland; France; Ireland\n",
      "========================================================================================================================\n",
      "inr 117\n",
      "=====**=====S117=====**======= 0\n",
      "sess date :- 15/04/2023\n",
      "sess time :- 18:30 - 20:00\n",
      "sess loca :- Hall A\n",
      "sess type :- Special SessionHall A\n",
      "sess cate :- 11. Other\n",
      "sess title :- S51 - Opening ceremony\n",
      "abs text :-  The ceremony will be followed by a reception open to all delegates.\n",
      "sess auth :- Emmanuelle CAMBAU ; Alexander W. FRIEDRICH ; Annelies ZINKERNAGEL ; Anu KANTELE ; Jose Ramon PANO; Maurizio SANGUINETTI ; Jacob MORAN; Robert Leo SKOV\n",
      "sess aff :- France; Germany; Switzerland; Finland; Spain; Italy; Israel; Denmark\n",
      "========================================================================================================================\n",
      "inr 118\n",
      "=====**=====S118=====**======= 0\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3474 - Infections in low resource countries: from immunity to mitigation\n",
      "abs text :-  Dr. Firdausi Qadri, currently Director at Centre for Vaccine Sciences International Centre for Diarrhoeal Disease and Research in Bangladesh, is an engaged inspiring scientist specialised in basic and applied immunology of infectious diseases but also clinical and large field-based studies on enteric vaccines. She played a key role in developing a more affordable oral cholera vaccine (OCV) and the typhoid conjugate vaccine (Vi-TCV).\n",
      "sess auth :- Florian KRAMMER ; Jon S. FRIEDLAND\n",
      "sess aff :- United States; United Kingdom\n",
      "========================================================================================================================\n",
      "3474-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 119\n",
      "=====**=====S119=====**======= 1\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour Oral SessionHall B\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK07 - (Re-)emerging zoonotic and vector-borne diseases\n",
      "abs text :-  \n",
      "sess auth :- Antonino DI CARO ; Anna PAPA\n",
      "sess aff :- Italy; Greece\n",
      "========================================================================================================================\n",
      "MAK0701 === 08:30 - 10:30\n",
      "abs title :- One Health investigation following a local cluster of rare, but lethal human Borna Disease Virus 1 (BoDV-1) infections in Germany, 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0702 === 08:30 - 10:30\n",
      "abs title :- Zika virus infection in pregnancy and risk of neurological defect on their normal screening newborn; 1-3 years old follow up in Thailand during 2019-2020\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0703 === 08:30 - 10:30\n",
      "abs title :- Novel mutation E1:M407I in Chikungunya virus ECSA-IOL strain from Pakistani outbreak affects replicative fitness in mammalian & mosquitoes cells\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0704 === 08:30 - 10:30\n",
      "abs title :- Chikungunya viral kinetics and the challenge for an antiviral treatment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0705 === 08:30 - 10:30\n",
      "abs title :- Evaluation of viral kinetic change and occurrence of secondary infection according to specific treatments in patients with severe fever with thrombocytopenia syndrome: a prospective multicentre cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0706 === 08:30 - 10:30\n",
      "abs title :- Role of inflammasomes in the modulation of dengue disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0707 === 08:30 - 10:30\n",
      "abs title :- Pitfalls of serologic diagnostics: tick-borne encephalitis and neuroborreliosis co-infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0708 === 08:30 - 10:30\n",
      "abs title :- Clinical and microbiological characterisation of cases observed during a recent outbreak of West Nile Virus infection in Veneto Region, Italy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0709 === 08:30 - 10:30\n",
      "abs title :- Models for identification of endothelial glycocalyx degradation mechanisms during Puumala virus infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 120\n",
      "=====**=====S120=====**======= 2\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour Oral SessionHall C\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- CSP04 - New vaccines in clinical development\n",
      "abs text :-  \n",
      "sess auth :- Leonard LEIBOVICI ; Fausto BALDANTI\n",
      "sess aff :- Israel; Italy\n",
      "========================================================================================================================\n",
      "CSP0401 === 08:30 - 10:30\n",
      "abs title :- High rates of adverse events among placebo recipients in a double-blinded, randomised, placebo-controlled phase 2b trial on an oral vaccine against enterotoxigenic Escherichia coli\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0402 === 08:30 - 10:30\n",
      "abs title :- Efficacy and safety of Clostridioides difficile vaccine in adults ≥50 years old: results from the CLOVER trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0403 === 08:30 - 10:30\n",
      "abs title :- Humoral and cellular responses of mpox vaccination in at-risk individuals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0404 === 08:30 - 10:30\n",
      "abs title :- Immunogenicity and safety of a live-attenuated Chikungunya vaccine candidate from second phase 3 trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0405 === 08:30 - 10:30\n",
      "abs title :- Overview of safety and immunogenicity of an Ad26.ZEBOV booster dose given up to 4.5 years after Ad26.ZEBOV, MVA-BN-Filo primary regimen in phase 2 and 3 trials conducted in various populations in Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0406 === 08:30 - 10:30\n",
      "abs title :- Immunogenicity of a novel COVID-influenza combination (CIC) vaccine assessed with response surface modelling (RSM)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0407 === 08:30 - 10:30\n",
      "abs title :- Safety of quadrivalent recombinant influenza vaccine in pregnant women and their infants\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0408 === 08:30 - 10:30\n",
      "abs title :- Six-month immunogenicity and safety of an mRNA-based seasonal influenza vaccine (mRNA-1010) in adults\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0409 === 08:30 - 10:30\n",
      "abs title :- Initial safety results from the SALVO trial investigating the iNTS-GMMA vaccine\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0410 === 08:30 - 10:30\n",
      "abs title :- Three-season efficacy of Ad26.RSV.preF/RSV preF protein vaccine against respiratory syncytial virus (RSV)-mediated lower respiratory tract disease (LRTD) and associated emergent medical resource utilization (MRU) and relevance of an LRTD case definition in older adults\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 121\n",
      "=====**=====S121=====**======= 3\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S16 - Diagnosis and management of refractory and rare moulds: a case-based approach\n",
      "abs text :- Organized by                    \n",
      "F2G (in partnership with Shionogi) How do you define refractory IFD? Different centres use different approaches, but an expert consensus has produced a guidance document to support clinicians and clinical triallists. One reason why a case may be refractory is that the causative organism is a rare mould and not the typical invasive aspergillosis which most clinicians would expect. This session will provide guidance on how to approach determining if an infection is refractory and also use clinical cases to guide decision-making and provide examples of challenging cases. The panel discussion will address the unmet medical need that still exists in this field and what innovations are in development to help with clinical challenges.\n",
      "sess auth :- Katrien LAGROU\n",
      "sess aff :- Belgium\n",
      "========================================================================================================================\n",
      "inr 122\n",
      "=====**=====S122=====**======= 6\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S18 - Molecular diagnostics for various infectious diseases and their usability through actual test performance\n",
      "abs text :- Organized by                    \n",
      "BIONEER corp. After COVID-19, molecular diagnostics, real-time PCR are more disseminated compared to 2019. Molecular diagnostics require more instruments and reagents. There are new demands for more convenient test methods and less steps to the results. More simple ways to collect specimens, Point-of-Care systems and fully automated systems are examples. COVID-19 has entered endemic phase, so bigger demand arose for more various molecular tests in routine laboratories and physicians' offices to utilize PCR instruments, by applying PCR tests to wider range of infectious diseases.\n",
      "During the session, new approach to diagnosis of various infectious diseases, including identification of antimicrobial resistant genes of infectious bacteria with easier methods, will be presented. More effective methods to test tuberculosis, respiratory viruses, HIV, and hepatitis virus will be discussed. Additionally, the efficiency of COVID-19 test with saliva specimens will be reviewed and will suggest the saliva as a preferred specimen for the era of COVID-19 endemic.\n",
      "sess auth :- Snjezana ZIDOVEC LEPEJ\n",
      "sess aff :- Croatia\n",
      "========================================================================================================================\n",
      "inr 123\n",
      "=====**=====S123=====**======= 7\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S17 - Preventing influenza and its complications: why randomised studies matter\n",
      "abs text :- Organized by                    \n",
      "Sanofi Multiple major organ systems can be impacted by influenza infection. Vaccination may be important in the prevention of such consequences. This symposium will discuss the different ways to generate high-quality data and how they should be evaluated when considering vaccines for prevention of influenza infection and its complications, especially in more vulnerable populations. The Q&A session will allow an interactive discussion on how influenza vaccines can be used effectively in the upcoming seasons.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 124\n",
      "=====**=====S124=====**======= 8\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall I\n",
      "sess type :- 2-hour Educational WorkshopHall I\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3454 - Improving indoor ventilation in healthcare environments\n",
      "abs text :-  Improving indoor air quality in clinical environments represents a hitherto overlooked infection prevention level impacting airborne pathogens such as respiratory viruses including influenza; SARS-2, norovirus; and Clostridioides difficile (since the latter produces airborne spores which can take 48 h to settle). Furthermore, meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and coliforms have also been found in hospital air. Improving indoor ventilation might also benefit infection prevention strategies against these pathogens. The recent pandemic has forced us to examine air quality in all indoor environments and presenting this relatively new paradigm will raise awareness about it.\n",
      "sess auth :- David FISMAN ; Stephanie J. DANCER\n",
      "sess aff :- Canada; United Kingdom\n",
      "========================================================================================================================\n",
      "3454-1 === \n",
      "abs title :- Conventional hospital ventilation systems\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3454-2 === \n",
      "abs title :- Indoor air pollutants and removal strategies\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3454-3 === \n",
      "abs title :- Air purification (UV-C) for healthcare environments:\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 125\n",
      "=====**=====S125=====**======= 9\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour SymposiumHall J\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3259 - AMR and adaptive mechanisms in persistent cystic fibrosis infection\n",
      "abs text :- Co-organised with                    \n",
      "Czech Society for Medical Microbiology (SPLM) Due to the nature of cystic fibrosis (CF), antibiotic resistance is a major problem for this group of patients. This symposium will go beyond the obvious resistance mechanisms discovered in clinical microbiology laboratories. The non-obvious resistance mechanisms comprise accessory and compensatory changes in genotype and phenotype which are important for the long-term evolution of chronic infections in CF and stable resistance development in CF-related pathogens. Among mechanisms of biofilm development, persistence, metabolic redirection and complexity arising from the lung microbiome will be mentioned.\n",
      "sess auth :- Susanne HAEUSSLER ; Tom COENYE\n",
      "sess aff :- Germany; Belgium\n",
      "========================================================================================================================\n",
      "3259-1 === \n",
      "abs title :- Staphylococcus aureus, microbial evolution and AMR\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3259-2 === \n",
      "abs title :- Why is the AMR an issue in cystic fibrosis?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3259-3 === \n",
      "abs title :- P. aeruginosa and AMR: diversity of mechanisms behind antimicrobial therapy failures in cystic fibrosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3259-4 === \n",
      "abs title :- Problems with non-tuberculous mycobacteria in cystic fibrosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 126\n",
      "=====**=====S126=====**======= 11\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall L\n",
      "sess type :- 2-hour SymposiumHall L\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3191 - Fairytales or reality, checking some eminence paradigms for treatment of severe infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID PK/PD of Anti-Infectives Study Group (EPASG), EUCAST Steering Committee In antimicrobial therapy, many paradigms have been established. However, some lack clear scientific or clinical rationale and might be considered eminence instead of evidence based. The symposium is set to review the latest evidence, including preclinical, clinical, and translational data from the most recent literature, for four of the most widely established paradigms and myths in the treatment of severe and/or deep seeded infections.\n",
      "sess auth :- Sophie STOCKER ; Maddalena GIANNELLA\n",
      "sess aff :- Australia; Italy\n",
      "========================================================================================================================\n",
      "3191-1 === \n",
      "abs title :- Kill fast! These infections must be treated with a \"bactericidal\" antibiotic!\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3191-2 === \n",
      "abs title :- Is oral the new IV?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3191-3 === \n",
      "abs title :- Into the deep: can tissue penetration of antibiotics make the difference?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3191-4 === \n",
      "abs title :- Good things take time: minimum duration of treatment for specific infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 127\n",
      "=====**=====S127=====**======= 12\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall M\n",
      "sess type :- Educational WorkshopHall M\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3359 - Software makes the lab go round: laboratory information management software (LIMS) revisited\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Anaerobic Infections (ESGAI), Trainee Association of ESCMID (TAE) Steering Committee Laboratory information management software (LIMS) builds the backbone of CM laboratories not only for generating reports with the results of diagnostic procedures but also for managing data in a broader sense. While LIMS helps laboratories efficiently capture and process data, real-life clinical microbiology is often limited by the constraints of the software setup lacking flexibility and custom-tailored options. This binds the considerable resources of the medical and IT laboratory staff and hampers optimal reporting to the treating physicians and ID specialists. Furthermore, it eventually limits surveillance and data analysis in the research context. This symposium will provide an overview of current LIMS solutions, both commercial and open-source, aiming at empowering clinical microbiologists to make the best choice of software for their laboratory, rounded off by real-life CM experiences of the potentials in LIMS (SARS-CoV-2, resource-limited settings).\n",
      "sess auth :- Adrian EGLI ; Etienne RUPPE\n",
      "sess aff :- Switzerland; France\n",
      "========================================================================================================================\n",
      "3359-1 === \n",
      "abs title :- Choosing wisely: challenges and pitfalls in replacing an old LIMS or implementing a new one\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3359-2 === \n",
      "abs title :- Make a wish: shaping the ideal LIMS by a user-centric approach for resource-limited settings and beyond\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3359-3 === \n",
      "abs title :- How to implements omics test results in the LIMS?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 128\n",
      "=====**=====S128=====**======= 13\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall N\n",
      "sess type :- 2-hour Oral SessionHall N\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP09 - Resistance epidemiology in a One Health perspective\n",
      "abs text :-  \n",
      "sess auth :- Els BROENS\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "ALP0901 === 08:30 - 10:30\n",
      "abs title :- The transmission risk of multidrug-resistant organisms between pets and humans\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0902 === 08:30 - 10:30\n",
      "abs title :- Fine-scale spatial and longitudinal survey of AMR prevalence, antibiotic prescribing and antibiotic residues across Oxfordshire wastewater treatment works (WWTWs)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0903 === 08:30 - 10:30\n",
      "abs title :- Klebsiella pneumoniae ecology and antimicrobial resistance in a One Health perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0904 === 08:30 - 10:30\n",
      "abs title :- Colonisation and contamination of ESBL- and carbapenemase-producing bacteria in hospital surfaces from six low- and middle-income countries\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0905 === 08:30 - 10:30\n",
      "abs title :- Long-term persistence of a highly promiscuous IncL-blaVIM-1 plasmid in ICU hospital sinks\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0906 === 08:30 - 10:30\n",
      "abs title :- One health intercompartmental dissemination of carbapenemase-producing Enterobacterales in the Reunion Island (Indian Ocean)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0907 === 08:30 - 10:30\n",
      "abs title :- Does resistance to 3rd/4th generation cephalosporins and fluoroquinolones change when we stop using them? A longitudinal study of 20 UK dairy farms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0908 === 08:30 - 10:30\n",
      "abs title :- Global phylogeography and genomic surveillance of carbapenem-resistant ST15 blaOXA-232-carrying Klebsiella pneumoniae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0909 === 08:30 - 10:30\n",
      "abs title :- Acquired-carbapenemase-producing high-risk clones and environmental strains through sewers and wastewater treatment plants: results from the Vastum project\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0910 === 08:30 - 10:30\n",
      "abs title :- Evidence of antibiotic-resistant Escherichia coli causing human bloodstream infections from farmed animal origin\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 129\n",
      "=====**=====S129=====**======= 14\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour Educational WorkshopHall O\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3286 - Beyond toxic: immunomodulatory roles of bacterial toxins\n",
      "abs text :-  Bacterial toxins are important virulence factors that promote infection and disease. Many toxins directly target host cells, thereby manipulating host immune responses and infection control. This workshop will cover toxins, including genotoxins, superantigens, and pore-forming toxins. The presentations will illuminate the pleiotropic and complex roles of the toxin, ranging from cytotoxic, immunostimulatory, and immunosuppressive effects.\n",
      "sess auth :- Francois VANDENESCH ; Olivier DENIS\n",
      "sess aff :- France; Belgium\n",
      "========================================================================================================================\n",
      "3286-1 === \n",
      "abs title :- Bacterial genotoxins modulating the host immune microenvironment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3286-2 === \n",
      "abs title :- Superantigens: manipulators of the immune response to S. aureus infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3286-3 === \n",
      "abs title :- Pleiotropic functions of a-toxin in Staphylococcus aureus associated pulmonary infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 130\n",
      "=====**=====S130=====**======= 15\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall P\n",
      "sess type :- 2-hour Oral SessionHall P\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP15 - New trends in staphylococcal infections\n",
      "abs text :-  \n",
      "sess auth :- Nikolai SIEMENS ; Frederic LAURENT\n",
      "sess aff :- Germany; France\n",
      "========================================================================================================================\n",
      "CSP1501 === 08:30 - 10:30\n",
      "abs title :- Temporal waves of genetic variation in Staphylococcus aureus from bloodstream infections, 2010 to 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1502 === 08:30 - 10:30\n",
      "abs title :- Around the world in 20 days: global differences in the management of Staphylococcus aureus bacteraemia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1503 === 08:30 - 10:30\n",
      "abs title :- Why is Panton-Valentine leukocidin-positive Staphylococcus aureus widespread in Africa?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1504 === 08:30 - 10:30\n",
      "abs title :- Increasing numbers and complexity of Staphylococcus aureus bloodstream infection: 14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findings\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1505 === 08:30 - 10:30\n",
      "abs title :- Epidemiology of invasive group A Streptococcus infections in people who inject drugs in South West England between 2016 and 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1506 === 08:30 - 10:30\n",
      "abs title :- Serotype distribution of non-invasive Streptococcus pneumoniae strains in Belgium, 2020-2022: a prospective, observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1507 === 08:30 - 10:30\n",
      "abs title :- High frequency detection of Streptococcus pneumoniae in alveolar macrophages of asymptomatic adults\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1508 === 08:30 - 10:30\n",
      "abs title :- Epidemiology of invasive Streptococcus pyogenes infections in time of COVID pandemic\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1509 === 08:30 - 10:30\n",
      "abs title :- Predictors of mortality of Staphylococcus aureus bacteraemia among patients hospitalised in a Swiss university hospital and the role of early source control: a retrospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1510 === 08:30 - 10:30\n",
      "abs title :- Antimicrobial resistance and molecular epidemiology of group B Streptococcus in pregnant women and neonates in Hong Kong\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 131\n",
      "=====**=====S131=====**======= 16\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP14 - MRSA: still an important pathogen\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "ALP1401 === 08:30 - 09:30\n",
      "abs title :- Source attribution of Staphylococcus aureus through a polyphasic approach based on whole genome sequence data\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1402 === 08:30 - 09:30\n",
      "abs title :- Clonal dynamics of methicillin-resistant Staphylococcus aureus in a Chilean tertiary healthcare centre between 2000-2016\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1403 === 08:30 - 09:30\n",
      "abs title :- Methicillin-resistant Staphylococcus aureus throat carriers: effectiveness of decolonisation treatment and risk factors for chronic carriage\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1404 === 08:30 - 09:30\n",
      "abs title :- Tracing back the spread of methicillin-resistant Staphylococcus aureus spa-type t008, Panton-Valentine leukocidin positive strain among injecting drug users by whole genome sequencing, Finland, 2015-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1405 === 08:30 - 09:30\n",
      "abs title :- Genomic characterisation of methicillin-resistant Staphylococcus aureus isolates causing community infections in children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1406 === 08:30 - 09:30\n",
      "abs title :- Increasing antimicrobial resistance trend among methicillin-resistant Staphylococcus aureus cases in Southwest Finland, 2007 – 2016: changes in strain types and epidemiology\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1407 === 08:30 - 09:30\n",
      "abs title :- Comparative genomic analysis of staphylococcal cassette chromosome mec (SCCmec) type V strains of Staphylococcus aureus: estimation of mecA horizontal gene transfer events of type V\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1408 === 08:30 - 09:30\n",
      "abs title :- Change of genotype distribution in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates in South Korea, 2004-2020\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1409 === 08:30 - 09:30\n",
      "abs title :- Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among livestock in Portugal\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 132\n",
      "=====**=====S132=====**======= 18\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW03 - Around the world in 60 minutes with COVID\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "EW0301 === 08:30 - 09:30\n",
      "abs title :- Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis informing the Priority Public Health Conditions Framework\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0302 === 08:30 - 09:30\n",
      "abs title :- Wastewater-based molecular epidemiology of commercial aircraft lavatory waste testing for SARS-CoV-2 variant at Airports in Thailand, July - October 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0303 === 08:30 - 09:30\n",
      "abs title :- SARS-CoV-2 recombinant variants monitoring in a city in Southern Brazil\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0304 === 08:30 - 09:30\n",
      "abs title :- Quilombola communities in Brazil and the pandemic: a neglected population\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0305 === 08:30 - 09:30\n",
      "abs title :- Influence of general practitioners on vaccination intention during the COVID-19 pandemic in Germany\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0306 === 08:30 - 09:30\n",
      "abs title :- Identifying essential resources for pandemic response: an international Delphi study within the EU-PANDEM-2 project\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0307 === 08:30 - 09:30\n",
      "abs title :- Diversity of SARS-CoV-2 exposure settings and their roles in the propagation of transmission networks during different epidemic waves\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0308 === 08:30 - 09:30\n",
      "abs title :- Stranded abroad during the COVID-19 pandemic: examining the impact of border restrictions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0309 === 08:30 - 09:30\n",
      "abs title :- Using electronic medical records and data science to assess the impact of COVID-19 lockdown restrictions on maternal and neonatal outcomes in Kampala, Uganda.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 133\n",
      "=====**=====S133=====**======= 24\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET24 - Mycobacterial Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGMYC The official open business meeting for the ESCMID Study Group for Mycobacterial Infections (ESGMYC). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Lorenzo GUGLIELMETTI ; Daniela Maria CIRILLO ; Catherine ONG\n",
      "sess aff :- France; Italy; Singapore\n",
      "========================================================================================================================\n",
      "inr 134\n",
      "=====**=====S134=====**======= 25\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 08:00 - 12:00\n",
      "sess loca :- Moche Room\n",
      "sess type :- Special SessionMoche Room\n",
      "sess cate :- 11. Other\n",
      "sess title :- TAE001 - TAE Day\n",
      "abs text :- Co-organised with                    \n",
      "Trainee Association of ESCMID (TAE) Steering Committee This session contains different activities related to trainees, such as a very useful presentation on opportunities for ESCMID Young Scientist Members, the TAE outstanding trainee awards ceremony and the famous TAE quiz. The highlight of the TAE Day is the Round Table Session, an informal setting where trainees/young professionals have the opportunity to get inspiration from renowned experts in the field of CM and ID.\n",
      "sess auth :- Christian GISKE ; Luigia SCUDELLER ; Anu KANTELE ; Robert Leo SKOV ; Jose Ramon PANO; Murat AKOVA ; Evelina TACCONELLI ; Jacob MORAN\n",
      "sess aff :- Sweden; Italy; Finland; Denmark; Spain; Turkey; Italy; Israel\n",
      "========================================================================================================================\n",
      "TAE00101 === 08:00 - 12:00\n",
      "abs title :- Opening of TAE Day, Introduction to TAE and Status of the Network\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "TAE00102 === 08:00 - 12:00\n",
      "abs title :- ESCMID Opportunities\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "TAE00103 === 08:00 - 12:00\n",
      "abs title :- TAE Award Ceremony\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "TAE00104 === 08:00 - 12:00\n",
      "abs title :- TAE Quiz\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "TAE00105 === 08:00 - 12:00\n",
      "abs title :- Round table sessions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "TAE00106 === 08:00 - 12:00\n",
      "abs title :- Closing and invitation to join Young Scientist Lunch afterwards\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 135\n",
      "=====**=====S135=====**======= 17\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD04 - Antibiotic stewardship around the globe\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MYD0401 === 09:30 - 10:30\n",
      "abs title :- Antibacterial drug use in hospitalised patients with COVID-19 during successive epidemic waves in Hong Kong\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0402 === 09:30 - 10:30\n",
      "abs title :- Implementation of an international, semi-automatic online antimicrobial stewardship (AMS) board: taking AMS to the next level\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0403 === 09:30 - 10:30\n",
      "abs title :- Decrease in the duration of antibiotic treatment in surgery with a specific nationwide antibiotic stewardship programme\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0404 === 09:30 - 10:30\n",
      "abs title :- Sustainability of the Australian Surgical National Antimicrobial Prescribing Survey: latest results from 6 years of a national auditing programme\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0405 === 09:30 - 10:30\n",
      "abs title :- Surgical antimicrobial prophylaxis in Japanese hospitals: current status and problems\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0406 === 09:30 - 10:30\n",
      "abs title :- Rapid diagnostic supporting antimicrobial stewardship in patients with pneumonia (RASP-LRTI)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0407 === 09:30 - 10:30\n",
      "abs title :- Impact of a non-restrictive antimicrobial stewardship programme on antibiotic consumption and incidence of bloodstream infections due to MDR bacteria in the emergency department of a secondary-level hospital in Campania region: an interrupted time series analysis (ITSA)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0408 === 09:30 - 10:30\n",
      "abs title :- Assessing the impact of a national social marketing campaign for antimicrobial resistance on public awareness, attitudes, and behaviours\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0409 === 09:30 - 10:30\n",
      "abs title :- Antibiotic sales in rural Vietnam: a medicine dispenser's perspective, from perception to practice\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 136\n",
      "=====**=====S136=====**======= 19\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- PAK12 - Intestinal pathogens: old problems, new challenges\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PAK1201 === 09:30 - 10:30\n",
      "abs title :- Strongyloides stercoralis diagnosis during COVID-19 pandemic in an urban teaching hospital in Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1202 === 09:30 - 10:30\n",
      "abs title :- Post-infectious irritable bowel syndrome after diagnosis of traveller's diarrhea: a comprehensive clinical and laboratory profile characterisation of patients from an international health referral centre\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1203 === 09:30 - 10:30\n",
      "abs title :- Sexually-transmitted and not-tropical strongyloidiasis, severe infections at risk of mis-diagnosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1204 === 09:30 - 10:30\n",
      "abs title :- Chronic schistosomiasis and strongyloidiasis amongst Ethiopian immigrants in Netanya\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1205 === 09:30 - 10:30\n",
      "abs title :- Prediction of helminthiases in travellers and migrants with eosinophilia in Stockholm: a cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1206 === 09:30 - 10:30\n",
      "abs title :- Comparison of treatment efficacy of metronizadole versus paramomycin in Blastocystis spp. infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1207 === 09:30 - 10:30\n",
      "abs title :- Clinical impact of syndromic molecular Point-of-Care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1208 === 09:30 - 10:30\n",
      "abs title :- How well does physician-directed microbiologic testing based on clinical presentation identify causative enteropathogens in gastroenteritis compared to multiplex PCR-based detection?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1209 === 09:30 - 10:30\n",
      "abs title :- Associations between water and sanitation service, risk of intestinal schistosomiasis, infection intensity, and liver fibrosis in selected households living near lake Albert: a descriptive cross-sectional study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 137\n",
      "=====**=====S137=====**======= 21\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET32 - Vaccine Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "EVASG The official open business meeting for the ESCMID Vaccine Study Group (EVASG). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Zitta Barrella HARBOE ; Jose TUELLS ; Olivier EPAULARD\n",
      "sess aff :- Denmark; Spain; France\n",
      "========================================================================================================================\n",
      "inr 138\n",
      "=====**=====S138=====**======= 0\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3448 - A revolution in the management of cryptococcal meningitis\n",
      "abs text :-  Professor Tom Harrison has led a series of clinical trials published in the New England Journal of Medicine, which has led to a complete revolution in the management of cryptococcal meningitis in resource-poor settings. The key trials are ACTA (NEJM 2022) and AMBITION (NEJM 2018), but previous important studies include REMSTART and ASSURED. The type of drugs and the mode of delivery have altered bringing therapy to many who would not previously have survived. His work has had major impact and within days of the publication of the recent ACTA trial, the WHO revised their guidelines as they have with all previous studies. Professor Harrison serves on many national and international panels. Importantly, he is a clear speaker who tells a good story.\n",
      "sess auth :- Sevtap ARIKAN; Graeme Ayton MEINTJES\n",
      "sess aff :- Turkey; South Africa\n",
      "========================================================================================================================\n",
      "3448-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 139\n",
      "=====**=====S139=====**======= 1\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall B\n",
      "sess type :- Meet-the-ExpertHall B\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3434 - Paediatric interactive cases: dilemmas for the microbiologist and infection specialist\n",
      "abs text :- Co-organised with                    \n",
      "European Society of Paedriatic Infectious Diseases (ESPID) Paediatric cases will highlight common pitfalls in diagnosis and management presented by two eminent paediatric infectious diseases specialists. Cases will be interactive, and the audience will be encouraged to participate using an online voting platform. The cases will reflect common pathologies encountered by paediatricians, clinical microbiologists, and adult ID specialists and will highlight recent changes in practice.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3434-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3434-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 140\n",
      "=====**=====S140=====**======= 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour Oral SessionHall C\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK06 - More speed in microbiological testing\n",
      "abs text :-  \n",
      "sess auth :- Joanna Maria ZAJKOWSKA\n",
      "sess aff :- Poland\n",
      "========================================================================================================================\n",
      "PAK0601 === 11:00 - 12:00\n",
      "abs title :- A 29-mRNA host response test to identify bacterial and viral infections and to predict 30-day mortality in emergency department patients with suspected infections: a large prospective observational cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0602 === 11:00 - 12:00\n",
      "abs title :- Siderophore-based non-invasive differentiation of Aspergillus fumigatus colonisation and invasion in pulmonary aspergillosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0603 === 11:00 - 12:00\n",
      "abs title :- Skip the petri dish: analytical performance characteristics of a novel technology for rapid, droplet-based, direct-from-specimen, phenotypic microorganism identification and antimicrobial susceptibly testing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0604 === 11:00 - 12:00\n",
      "abs title :- Urinary pyrosequencing, a novel method to detect genitourinary TB: a retrospective observational study from Mumbai, India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0605 === 11:00 - 12:00\n",
      "abs title :- A fast, accurate antimicrobial susceptibility test (AST) for bacteria from urine samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 141\n",
      "=====**=====S141=====**======= 3\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall D\n",
      "sess type :- 1-hour Case SessionHall D\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES09 - Difficult-to-manage CNS infections\n",
      "abs text :-  \n",
      "sess auth :- Matthijs BROUWER\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "BES0901 === 11:00 - 12:00\n",
      "abs title :- A “tree-in-brain” bringing us back to the roots of diagnosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0902 === 11:00 - 12:00\n",
      "abs title :- Brain abscess in an immunocompetent patient\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0903 === 11:00 - 12:00\n",
      "abs title :- A case of dual fungal brain abscess in an immunocompromised child: an unusual entity\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0904 === 11:00 - 12:00\n",
      "abs title :- Multiple unilateral brain abscesses caused by Fusarium spp. in the absence of disseminated disease: a difficult diagnosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0905 === 11:00 - 12:00\n",
      "abs title :- The first case of Azorhizobium caulinodans CNS infection in a paediatric patient\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 142\n",
      "=====**=====S142=====**======= 4\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall E\n",
      "sess type :- 1-hour SymposiumHall E\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3325 - What can be learned from successful vertical programs to mitigate AMR\n",
      "abs text :-  Public health practices and programmes have long been focused on a single disease (TB, HIV, Malaria) or priority areas (mother and child health, vaccines). Recent studies indicate that antimicrobial resistance led to more than a million deaths in 2019, much more than HIV or TB. This cross-cutting real-world challenge across geography and demography needs an urgent response. The targeted platforms for delivery of health services at the country level are a missed opportunity for leveraging the limited existing resources to address cognate health imperatives such as AMR. Global and national action plans on AMR announced in 2015, remain orphans with limited integration into public health systems. This gap needs to be plugged by repurposing or expanding existing platforms & resources of public health systems.\n",
      "sess auth :- Haileyesus GETAHUN ; Jyoti JOSHI\n",
      "sess aff :- Switzerland; Denmark\n",
      "========================================================================================================================\n",
      "3325-1 === \n",
      "abs title :- How to leverage experiences from TB/HIV to combat AMR\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3325-2 === \n",
      "abs title :- Successful approaches to integrate AMR in existing public health programs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 143\n",
      "=====**=====S143=====**======= 5\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall F\n",
      "sess type :- 1-hour Case SessionHall F\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES05 - Virulent viruses\n",
      "abs text :-  \n",
      "sess auth :- Wilmer VILLAMIL\n",
      "sess aff :- Colombia\n",
      "========================================================================================================================\n",
      "BES0501 === 11:00 - 12:00\n",
      "abs title :- Severe and prolonged monkeypox (mpox) in a person with advanced HIV infection, complicated by HLH and possible IRIS\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0502 === 11:00 - 12:00\n",
      "abs title :- Widespread autonomic dysfunction in rabies encephalitis: a myriad of clinical manifestations\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0503 === 11:00 - 12:00\n",
      "abs title :- A rare case of disseminated human herpesvirus 6 infection in an immunocompetent adult\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0504 === 11:00 - 12:00\n",
      "abs title :- Salvage treatment of refractory HSV-oral lesions with pritelivir in allogeneic haematopoietic cell transplant recipients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0505 === 11:00 - 12:00\n",
      "abs title :- Asymptomatic immunodeficiency-associated vaccine-derived poliovirus (iVDPV) infections in two UK children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 144\n",
      "=====**=====S144=====**======= 6\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall G\n",
      "sess type :- 1-hour SymposiumHall G\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3292 - When a microbe turns the body against itself: enteroviruses and autoimmunity\n",
      "abs text :-  A growing number of reports suggest that viral infections contribute to the development of autoimmune diseases. It is well established that a viral infection can trigger the production of autoantibodies, but how a viral infection triggers a sustained immune \"attack\" on host cells and causes the autoimmune disease is not well understood. This symposium will discuss current knowledge on viral infections as a cause of autoimmune disease. Specifically, speakers will also elaborate on observations that have strengthened the associations between enteroviruses and acute flaccid myelitis (AFM) and recently initiated vaccine efforts to elucidate type 1 diabetes viral etiology.\n",
      "sess auth :- Heli HARVALA ; Randi EIKELAND\n",
      "sess aff :- United Kingdom; Norway\n",
      "========================================================================================================================\n",
      "3292-1 === \n",
      "abs title :- EV-D68 Acute Flaccid Myelitis (AFM): insights into treatment and pathogenesis from animal models\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3292-2 === \n",
      "abs title :- Enteroviral infections in the aetiology and pathogenesis of type 1 diabetes: mechanisms and vaccine efforts\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 145\n",
      "=====**=====S145=====**======= 7\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall H\n",
      "sess type :- 1-hour SymposiumHall H\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- 3192 - Inborn errors of immunity, COVID-19 and beyond: determinants of host immunity to infectious diseases\n",
      "abs text :- Co-organised with                    \n",
      "Danish Infectious Disease Society Novel technologies such as whole genome sequencing and molecular immunological assays have uncovered important principles of host immunity and led to the identification of host genetic determinants of immunity to viral infection and \"inborn errors of immunity\" (IEI) in humans. This session will present recent discoveries in IEI accounting for some of the knowledge gaps on interindividual variability in susceptibility and severity of viral infectious diseases and recent findings on host susceptibility to viral infections, autoimmune conditions, and the state-of-the-art technologies for studying these. The workshop will illustrate how studies on patients with severe infectious diseases can provide fundamental insights into essential innate host-pathogen sensors, signaling pathways, and molecules in human immunology while teaching lessons on the pathogenesis of infectious diseases. Finally, the workshop will include examples of identifying individuals at increased risk of infection to improve prophylaxis and targeted treatment from a personalised medicine perspective.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3192-1 === \n",
      "abs title :- Role of neutralising autoantibodies to type I interferons in the pathogenesis of critical COVID-19 and influenza\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3192-2 === \n",
      "abs title :- Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 146\n",
      "=====**=====S146=====**======= 8\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall I\n",
      "sess type :- Meet-the-ExpertHall I\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3145 - Why is it still so complex? how I treat persistent neutropaenic fever\n",
      "abs text :-  Neutropaenic fever continues to be a major area of consultation in infectious diseases. It entails considering the underlying aetiology, current immunosuppression, and a broad spectrum of pathogens. In addition, it challenges selecting appropriate therapeutics and sometimes convincing care providers to alter immune-suppressing agents. Speakers will discuss new approaches and challenges in treating neutropaenic fever.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3145-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3145-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 147\n",
      "=====**=====S147=====**======= 9\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour SymposiumHall J\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3463 - It's all about the U bend\n",
      "abs text :-  Hospital water distribution systems have long been recognised as a potential source of HAIs and have been implicated in several outbreaks. The best evidence for the role of water in the transmission of pathogens is provided by case-control studies that show an association between exposure of affected patients and a contaminated water source. This has since been confirmed with molecular genotyping studies. This symposium will focus on the location of pathogens within plumbing components, particularly those that are multiply drug resistant, and the mechanisms whereby they reach patients. It will also explore the role of wet surface biofilm in sink traps and drains and a range of methods to reduce or eradicate them.\n",
      "sess auth :- Bhanu SINHA ; Lorena LOPEZ CERERO\n",
      "sess aff :- Netherlands; Spain\n",
      "========================================================================================================================\n",
      "3463-1 === \n",
      "abs title :- Is biofilm the link between MDR bacteria and healthcare plumbing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3463-2 === \n",
      "abs title :- Sinks spread MDRO, but how to decontaminate drains and other components?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 148\n",
      "=====**=====S148=====**======= 10\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3477 - Year in infectious disease\n",
      "abs text :-  \"Year in..\" sessions are very well-attended 1-hour Symposia where speakers review recent literature on the topic. ECCMID 2023 will feature four \"Year in.\" sessions: the traditional \"Year in clinical microbiology\", \"Year in infection control\" and \"Year in infectious diseases\", and the new \"Year in public health\".\n",
      "sess auth :- Carlos DEL RIO ; Simona RUTA\n",
      "sess aff :- United States; Romania\n",
      "========================================================================================================================\n",
      "3477-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3477-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 149\n",
      "=====**=====S149=====**======= 12\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall M\n",
      "sess type :- Meet-the-ExpertHall M\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3164 - New imaging methods in infective endocarditis\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) Infective endocarditis (IE) is a common and treatable condition. However, delays in the diagnosis of endocarditis are associated with increased mortality, and morbidity. As a result, it is very important to diagnose IE in patients who have negative results of either blood cultures or echocardiographic investigation, or both. During this Meet-the-Expert, speakers will discuss some of the new imaging methods that can help in diagnose IE in difficult cases, together with some practical solutions for the diagnosis problems of IE.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3164-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3164-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 150\n",
      "=====**=====S150=====**======= 13\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall N\n",
      "sess type :- 1-hour SymposiumHall N\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3327 - Therapy optimisation of antiviral drugs\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID PK/PD of Anti-Infectives Study Group (EPASG) Recent years have shown the urgent need for rapid development of antiviral agents in light of the COVID-19 pandemic. In addition, the incidence of other viruses, such as cytomegalovirus (CMV) and herpes virus type 6, is continuously increasing due to the growing number of immunocompromised patients worldwide. In vitro methodologies, such as the hollow fiber infection model, have shown to be useful for testing novel antiviral agents without harming patients and laboratory animals. In clinical care therapy, optimisation has shown to be beneficial for different viruses; however, it is complex due to the immune system playing an important role in the clearance of viruses. The current session will focus on the in vitro studies for antiviral drug discovery and the clinical evidence for dosage optimisation of antivirals.\n",
      "sess auth :- Anne; Sebastian WICHA\n",
      "sess aff :- United Kingdom; Germany\n",
      "========================================================================================================================\n",
      "3327-1 === \n",
      "abs title :- In vitro PK/PD of antivirals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3327-2 === \n",
      "abs title :- Antiviral PK/PD in the clinical setting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 151\n",
      "=====**=====S151=====**======= 14\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall O\n",
      "sess type :- Meet-the-ExpertHall O\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3297 - Data analyses of microbiota data: what is state of the art and what can be expected?\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID study group for host and microbiota interaction group (ESGHAMI), American Society of Microbiology (ASM) Research on the microbiota has intensified recently, which resulted in a wide range of tools, packages, and algorithms to analyze microbiota data. In this Meet-the-Expert, speakers will provide an overview of the currently existing tools that can be used to perform visual and statistical analysis on the microbiota, and associate the including methods, visual representations and data features to the research objectives currently of interest in microbiota research.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3297-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3297-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 152\n",
      "=====**=====S152=====**======= 15\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour Oral SessionHall P\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- PAK14 - Management of infections  in low- and middle-income settings\n",
      "abs text :-  \n",
      "sess auth :- Camilla RODRIGUES ; Heiman WERTHEIM\n",
      "sess aff :- India; Netherlands\n",
      "========================================================================================================================\n",
      "PAK1401 === 11:00 - 12:00\n",
      "abs title :- Insufficient coverage provided by empiric antibiotic regimens for serious bacterial infections in neonates and children in south-east Asia and the Pacific\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1402 === 11:00 - 12:00\n",
      "abs title :- Linking sepsis aetiology, antimicrobial use, and antimicrobial resistance in Malawi to inform pragmatic sepsis trials in sub-Saharan Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1403 === 11:00 - 12:00\n",
      "abs title :- Neonatal sepsis in a tertiary care hospital in Sri Lanka: reflection on rising antibiotic resistance over five years\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1404 === 11:00 - 12:00\n",
      "abs title :- The impact of COVID-19 on community and clinical antibiotic use in Nairobi city, Kenya\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1405 === 11:00 - 12:00\n",
      "abs title :- Tuberculosis is a frequent cause of febrile illness among patients receiving chemotherapy for the treatment of solid tumours in Uganda\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 153\n",
      "=====**=====S153=====**======= 18\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK02 - Diagnosis of infections in LMIC including tuberculosis\n",
      "abs text :-  \n",
      "sess auth :- Rogier VAN DOORN\n",
      "sess aff :- Vietnam\n",
      "========================================================================================================================\n",
      "PAK0201 === 11:00 - 12:00\n",
      "abs title :- A comparison of two different blood sample collection sequences in reducing blood culture contamination: the preliminary report of the first randomised controlled study in Thailand\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0202 === 11:00 - 12:00\n",
      "abs title :- Effects of rapid detection of bloodstream infections using molecular method in developing country\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0203 === 11:00 - 12:00\n",
      "abs title :- Contribution in tuberculosis diagnosis at the Kamenge University Teaching Hospital: a cross-sectional study in Burundi\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0204 === 11:00 - 12:00\n",
      "abs title :- Stool Xpert MTB/RIF for the diagnosis of pulmonary tuberculosis in Africa: a systematic review and meta-analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0205 === 11:00 - 12:00\n",
      "abs title :- Gene Xpert for tuberculosis diagnosis in Nepal: opportunities, challenges and way forward\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0206 === 11:00 - 12:00\n",
      "abs title :- Performance of a highly-sensitive commercial M. tuberculosis PCR on non-sputum sample types\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0207 === 11:00 - 12:00\n",
      "abs title :- Improving local production of quality-assured culture media in resource limited settings: design, manufacturing, transport, and installation of a microbiology production facility in a transportable container at Cotonou, Benin\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0208 === 11:00 - 12:00\n",
      "abs title :- Affordable blood culture systems from China: in vitro evaluation for use in low-resource settings\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0209 === 11:00 - 12:00\n",
      "abs title :- A diagnostic stewardship intervention to reduce turnaround time for clinical reporting in Gram-negative sepsis: a primer for clinical bacteriology laboratories in LMICs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 154\n",
      "=====**=====S154=====**======= 24\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET29 - Staphylococci Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGS The official open business meeting for the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Steven TONG ; Frederic LAURENT ; Marc STEGGER ; Alicia LACOMA\n",
      "sess aff :- Australia; France; Denmark; Spain\n",
      "========================================================================================================================\n",
      "inr 155\n",
      "=====**=====S155=====**======= 3\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S23 - Value of diagnostic information for antimicrobial stewardship\n",
      "abs text :- Organized by                    \n",
      "bioMérieux Intensive care units (ICUs) are unique environments where clinicians often make antibiotic decisions under diagnostic uncertainty and with high-stakes consequences. This symposium will discuss the Value Of Diagnostic Information (VODI) in sepsis to understand how rapid diagnostics can have an impact on patient outcomes and healthcare system, and how beliefs, perceptions and contextual factors influenced ICU clinicians' antibiotic prescribing. Two main examples will illustrate the case, with lower respiratory tract infections and blood stream infections.\n",
      "sess auth :- Jeroen SCHOUTEN\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "inr 156\n",
      "=====**=====S156=====**======= 4\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S21 - COVID-19 today: optimising outpatient management\n",
      "abs text :- Organized by                    \n",
      "Merck MSD This symposium is an opportunity to provide scientific education on key topics and emerging data in COVID-19 outpatient managment, including burden of disease, current predominant SARS-CoV-2 variants, emerging data informing clinical decision making, and current standards of care. The desired outcome is to increase awareness the current challenges in outpatient managment of COVID-19, available antiviral therapy options, key data informing clinical decision making, and approaches to optimising care so that all at risk patients are able to benefit from therapy.\n",
      "sess auth :- Mary HORGAN\n",
      "sess aff :- Ireland\n",
      "========================================================================================================================\n",
      "inr 157\n",
      "=====**=====S157=====**======= 5\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S22 - Keeping pace with SARS-CoV-2: ongoing considerations for COVID-19 management\n",
      "abs text :- Organized by                    \n",
      "AstraZeneca This session will focus on long-acting monoclonal antibodies for the treatment of COVID-19 and will include the following key points:\n",
      ".\tCOVID-19 treatments are needed for individuals who remain at risk of severe outcomes; current options include long-acting monoclonal antibodies and antivirals\n",
      ".\tLong-acting monoclonal antibodies reduce the risk of poor outcomes in the COVID-19 treatment setting and have the potential to provide extended protection against subsequent SARS-CoV-2 infections\n",
      ".\tAccurate identification of patients most likely to benefit from the use of long-acting monoclonal antibodies can lead to improved outcomes\n",
      "sess auth :- Gustavo Daniel LOPARDO\n",
      "sess aff :- Argentina\n",
      "========================================================================================================================\n",
      "inr 158\n",
      "=====**=====S158=====**======= 6\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S24 - Sample collection: needs, challenges, and future\n",
      "abs text :- Organized by                    \n",
      "Copan Group Sample collection and preservation, without any doubt, are the most critical prerequisites for accurate test results for a final clinical diagnosis. Unfortunately, this process is dependent on human intervention that cannot be fully standardised or controlled. In fact, 40 to 60% of the total errors in clinical testing are generated during this phase. Sample collection, preservation and preparation represent a real bottleneck to provide proper diagnostics to all society. \n",
      "In this symposium, we discuss the need for correct and innovative sample collection and preservation for the diagnostics laboratories, introducing challenges and opportunities for current and future sample collection, preservation, and management. Finally, we demonstrate how, innovative anatomically designed devices, associated to proper collection techniques and optimal sample preservation and management, can help to improve patients' testing accessibility, laboratories' analysis accuracy and physicians' diagnostics tools for accurate patient treatment.\n",
      "sess auth :- Kate TEMPLETON\n",
      "sess aff :- United Kingdom\n",
      "========================================================================================================================\n",
      "inr 159\n",
      "=====**=====S159=====**======= 7\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S20 - Building a strong defense: addressing the importance of adult vaccination in the evolving pneumococcal disease landscape\n",
      "abs text :- Organized by                    \n",
      "Pfizer While the introduction of pneumococcal conjugate vaccines has resulted in a reduction in pneumococcal disease through both direct and indirect effects, a substantial burden of disease remains in adults. Now more than ever, there is a need to help reduce vaccine preventable respiratory diseases and their impact on healthcare resource use. In this symposium we will discuss pneumococcal conjugate vaccines and how expanded valent vaccines can help protect adults against serotypes that are important causes of pneumococcal disease.\n",
      "sess auth :- Joanne M LANGLEY\n",
      "sess aff :- Canada\n",
      "========================================================================================================================\n",
      "inr 160\n",
      "=====**=====S160=====**======= 16\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 1\n",
      "sess type :- Pipeline CornerArena 1\n",
      "sess cate :- 11. Other\n",
      "sess title :- S60 - Diagnostics\n",
      "abs text :-  The Diagnostics Pipeline Corner offers small, innovative pharmaceutical companies a platform to present their early-stage developments in diagnostics techniques to a wider audience.\n",
      "sess auth :- Till T. BACHMANN\n",
      "sess aff :- United Kingdom\n",
      "========================================================================================================================\n",
      "inr 161\n",
      "=====**=====S161=====**======= 17\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 2\n",
      "sess type :- Open ForumArena 2\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3328 - Equal opportunity in publication and research?\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Ethics Advisory Committee, CMI Board of Editors, Trainee Association of ESCMID (TAE) Steering Committee, ESCMID Parity Commission, ESCMID Professional Affairs Subcommittee Publications and citations are crucial metrics in academic medicine and path the way for progression in one's research career. Moreover, publication output creates visibility within the scientific community and facilitates research collaborations and the acquisition of funding. The peer-review system is the backbone of this publication process but has been criticized for its shortcomings and limitations. During this session, gender and geographical inequalities, power-based imbalances, and other representation gaps will be analysed regarding their general effects on research and the peer-review system in particular.\n",
      "sess auth :- Onya OPOTA\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "3328-1 === \n",
      "abs title :- Identifying and mitigating representation gaps in infectious diseases and antimicrobial stewardship research\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3328-2 === \n",
      "abs title :- Open access vs no access at all: publishing research from LMICs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3328-3 === \n",
      "abs title :- Gender and geographical imbalances in research\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 162\n",
      "=====**=====S162=====**======= 19\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 4\n",
      "sess type :- Open ForumArena 4\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3130 - Developing your funding application: from drug discovery to drug development\n",
      "abs text :- Co-organised with                    \n",
      "Joint Programming Initiative on Antimicrobial Resistance and the Industry Working Group (JPIAMR) The aim of this session is to guide potential applicants through funding applications for AMR research, providing some hints and tips on how to develop a successful translational grant application.\n",
      "sess auth :- Marc LEMONNIER\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "3130-1 === \n",
      "abs title :- JPIAMR funding calls and funding for academic research\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3130-2 === \n",
      "abs title :- Translating your research\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3130-3 === \n",
      "abs title :- Funding your innovation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 163\n",
      "=====**=====S163=====**======= 20\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:00 - 13:30\n",
      "sess loca :- Poster Area\n",
      "sess type :- Poster SessionPoster Area\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- PS010 - 2a. Tuberculosis and other mycobacterial infections (incl. epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PS01001 === 12:00 - 13:30\n",
      "abs title :- Did discordance in genotypic and phenotypic sensitivities impact clinical care in tuberculosis patients at a UK centre?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01002 === 12:00 - 13:30\n",
      "abs title :- Isoniazid mono-resistant tuberculosis: trends in a tertiary hospital in KwaZulu-Natal province, South Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01003 === 12:00 - 13:30\n",
      "abs title :- Subspecies distribution and antimicrobial susceptibility testing of Mycobacterium abscessus clinical isolates in Madrid, Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01004 === 12:00 - 13:30\n",
      "abs title :- Systematic expression profiling analysis reveals key microRNAs in Mycobacterium tuberculosis infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01005 === 12:00 - 13:30\n",
      "abs title :- Non-tuberculous mycobacteria infections during a 13-year period in Lleida (Spain)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01006 === 12:00 - 13:30\n",
      "abs title :- Neutrophil extracellular traps drive lung remodelling in tuberculosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01007 === 12:00 - 13:30\n",
      "abs title :- Impact of the COVID-19 pandemic on tuberculosis public healthcare laboratory diagnostic services, Greece, 2019-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01008 === 12:00 - 13:30\n",
      "abs title :- Plasma host protein signatures correlating with Mycobacterium tuberculosis activity prior to and during antituberculosis treatment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01009 === 12:00 - 13:30\n",
      "abs title :- Challenges of monitoring NTM lung disease in a tertiary referral center.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01010 === 12:00 - 13:30\n",
      "abs title :- Antigen-specific HLA-DR upregulation with intracellular cytokine immunoprofiling to differentiate treated and untreated latent tuberculosis infection: a pilot cohort\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01011 === 12:00 - 13:30\n",
      "abs title :- Genomic and transcriptomic data integration to study diversity across lineages in Mycobacterium tuberculosis complex\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01012 === 12:00 - 13:30\n",
      "abs title :- Platelets are pro-inflammatory but not pro-thrombotic in pulmonary tuberculosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01013 === 12:00 - 13:30\n",
      "abs title :- Variations of QuantiFERON-TB Gold Plus responses and white blood cell counts in tuberculosis patients with poorly controlled type 2 diabetes mellitus: a prospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01014 === 12:00 - 13:30\n",
      "abs title :- Rv0109  protein of Mycobacterium tuberculosis induces macrophage apoptosis by targeting host mitochondria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01015 === 12:00 - 13:30\n",
      "abs title :- Accuracy of upper respiratory tract samples to diagnose Mycobacterium tuberculosis: a systematic review and meta-analysis.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01016 === 12:00 - 13:30\n",
      "abs title :- Economic evaluation of community active case-finding strategies for detection of tuberculosis in Cambodia: a pragmatic cluster randomised trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01017 === 12:00 - 13:30\n",
      "abs title :- Prevalence, incidence, and antibiotic resistance testing frequency of non-tuberculous mycobacteria isolated in German microbiology laboratories from 2016-2020\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01018 === 12:00 - 13:30\n",
      "abs title :- Antimicrobial susceptibilities of non-tuberculous mycobacterial isolates from a single center over a 10-year period\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01019 === 12:00 - 13:30\n",
      "abs title :- Infections associated with Mycobacterium chelonae contaminated cardiovascular bioprostheses: evidence of clinical relevance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01020 === 12:00 - 13:30\n",
      "abs title :- Non-tuberculous mycobacterial infections: bloodstream isolates from immunocompromised patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01021 === 12:00 - 13:30\n",
      "abs title :- Detection of Mycobacterium chimaera in medical device-water samples by customised real-time PCR\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01022 === 12:00 - 13:30\n",
      "abs title :- Prevalence of high level resistance to isoniazid and fluoroquinolones and their implication on empirical shorter DRTB regimen\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01023 === 12:00 - 13:30\n",
      "abs title :- Genomic diversity of Mycobacterium abscessus isolates in Portugal\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01024 === 12:00 - 13:30\n",
      "abs title :- Increasing nontuberculous mycobacteria recovery rate and regional distribution of mycobacterial species over 11 years in a Korean tertiary care hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01025 === 12:00 - 13:30\n",
      "abs title :- Assessment of the magnitude and determinants of isoniazid preventive therapy uptake among under-five children in Addis Ababa, Ethiopia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01026 === 12:00 - 13:30\n",
      "abs title :- Mycobacterium simiae as a cause of pulmonary disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01027 === 12:00 - 13:30\n",
      "abs title :- Metabolism regulates MMP-dependent tissue remodelling during Mycobacterium tuberculosis infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01028 === 12:00 - 13:30\n",
      "abs title :- Preliminary assessment of the standard short all-oral regimen in the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in a national tertiary referral hospital for infectious diseases in Manila\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01029 === 12:00 - 13:30\n",
      "abs title :- Integrating genomics and refined epidemiology to analyse tuberculosis transmission dynamics involving paediatric population\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01030 === 12:00 - 13:30\n",
      "abs title :- Simultaneous detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis clinical isolates: performances of a rapid molecular assay\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01031 === 12:00 - 13:30\n",
      "abs title :- Effect of statins on the outcome of anti-tuberculosis treatment in tuberculosis combined type II diabetes mellitus patients (TB-T2DM) and construction of prognosis models\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01032 === 12:00 - 13:30\n",
      "abs title :- Population-based genomic epidemiology study for tailored strategies for surveillance and control of tuberculosis (TB-SEQ) in Catalonia, Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01033 === 12:00 - 13:30\n",
      "abs title :- Diagnostic accuracy of rapid molecular tests for tuberculous meningitis in Tunisia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01034 === 12:00 - 13:30\n",
      "abs title :- Assessment of anti-tuberculosis chemotherapy response among TB-only and TB-diabetes cases using different microbiological methods\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01035 === 12:00 - 13:30\n",
      "abs title :- Reliability of drug-resistant tuberculosis treatment delivery in primary healthcare in Srinagar, India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01036 === 12:00 - 13:30\n",
      "abs title :- A structured two week follow up visit in the cascade of care for tuberculosis increases case detection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01037 === 12:00 - 13:30\n",
      "abs title :- Utilisation of whole genome sequencing approach for surveillance of Mycobacterium tuberculosis in Lombardy Region in 2017-2019\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01038 === 12:00 - 13:30\n",
      "abs title :- Life expectancy among patients with pulmonary tuberculosis is less than one-third of life expectancy in the background population in Guinea-Bissau: an observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01039 === 12:00 - 13:30\n",
      "abs title :- Rapid screening of contacts of tuberculosis cases by pooled oral swab samples and Xpert Ultra at the household level: a laboratory simulation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01040 === 12:00 - 13:30\n",
      "abs title :- Bedaquiline degradation in the culture medium during drug susceptibility testing is prevented using ascorbic acid-pyruvate as stabiliser\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01041 === 12:00 - 13:30\n",
      "abs title :- Improving the tuberculosis infection screening and treatment cascade among migrants to Canada: a cost-effectiveness analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01042 === 12:00 - 13:30\n",
      "abs title :- The potential of RPS20, KIF13B and UBE2B splicing as biomarkers\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01043 === 12:00 - 13:30\n",
      "abs title :- Is tuberculosis in the elderly always a reactivation of the disease?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01044 === 12:00 - 13:30\n",
      "abs title :- Minimum inhibitory concentrations of 38 antibiotics against ten rarely isolated Mycobacterium species\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01045 === 12:00 - 13:30\n",
      "abs title :- Hit to lead optimisation campaign on thiopeptide antibiotics against NTM-MAC\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01046 === 12:00 - 13:30\n",
      "abs title :- Quantifying antimycobacterial treatment-related harms among patients with non-tuberculosis Mycobacteria infections: an opportunity for novel agents?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01047 === 12:00 - 13:30\n",
      "abs title :- Protective and risk factors for Buruli ulcer in an endemic region: a comprehensive case control study, Victoria Australia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01048 === 12:00 - 13:30\n",
      "abs title :- Evolution of Mycobacterium abscessus resistance to beta-lactams in a cystic fibrosis patient\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01049 === 12:00 - 13:30\n",
      "abs title :- Evaluation of MTBC-NTM real-time PCR kit for detection of Mycobacterium tuberculosis, Mycobacterium tuberculosis complex and nontuberculous mycobacteria in clinical samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01050 === 12:00 - 13:30\n",
      "abs title :- QTc prolongation with BPaL-based regimens in TB-PRACTECAL clinical trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01051 === 12:00 - 13:30\n",
      "abs title :- Altered IL-6 signalling and risk of TB disease: a meta-analysis and Mendelian randomisation analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01052 === 12:00 - 13:30\n",
      "abs title :- Non-tuberculosis mycobacteria in Denmark: characterisation of an emerging disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01053 === 12:00 - 13:30\n",
      "abs title :- Hypervirulent Klebsiella pneumoniae: prevalence, clinical presentation and antibiotic resistance in a French tertiary care hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01054 === 12:00 - 13:30\n",
      "abs title :- The value of TBAg/PHA ratio in diagnosing tuberculosis: a systematic review and meta-analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01055 === 12:00 - 13:30\n",
      "abs title :- The impact of diabetes mellitus on mortality among extrapulmonary tuberculosis patients at a tertiary care hospital in Central India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01056 === 12:00 - 13:30\n",
      "abs title :- MALDI-TOF vs PCR-based microarray and identification of surgical site infections caused by atypical mycobacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01057 === 12:00 - 13:30\n",
      "abs title :- Musculoskeletal tuberculosis in an university-affiliated hospital TB clinic\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01058 === 12:00 - 13:30\n",
      "abs title :- Implementation of urine-LAM testing for tuberculosis in a routine care setting among severely ill inpatients with HIV: a multi-centre stepped wedge cluster-randomised trial from Ghana\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01059 === 12:00 - 13:30\n",
      "abs title :- Tuberculosis in the SARS-CoV-2 pandemic period\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01060 === 12:00 - 13:30\n",
      "abs title :- Epidemiology, resistance pattern and outcomes of extrapulmonary tuberculosis (EPTB): a 30-year observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01061 === 12:00 - 13:30\n",
      "abs title :- Drug interaction potential of optimised-dose rifampicin: results from a phenotyping cocktail study in patients with pulmonary tuberculosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01062 === 12:00 - 13:30\n",
      "abs title :- Assessment of the incidence of active tuberculosis disease among people living with HIV/AIDS who took isoniazid preventive therapy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01063 === 12:00 - 13:30\n",
      "abs title :- Difficult to detect Mycobacterium tuberculosis borderline isoniazid resistance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01064 === 12:00 - 13:30\n",
      "abs title :- Development of multiepitope vaccine from regulatory proteins of Mycobacterium tuberculosis: a step towards end TB strategy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01065 === 12:00 - 13:30\n",
      "abs title :- Outcomes of a household contact tracing program and provision of tuberculosis preventive therapy in Dili, Timor-Leste\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS01066 === 12:00 - 13:30\n",
      "abs title :- Comparing three assays for Mycobacterium tuberculosis drug resistance testing in sputum with long-read sequencing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 164\n",
      "=====**=====S164=====**======= 21\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 12:30 - 13:30\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET12 - Clinical Parasitology Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGCP The official open business meeting for the ESCMID Study Group for Clinical Parasitology (ESGCP). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Francesca TAMAROZZI ; Jaya SHRIVASTAVA ; Hanne BREKKE ; Theo MANK ; Caroline RöNNBERG\n",
      "sess aff :- Italy; United Kingdom; Norway; Netherlands; Sweden\n",
      "========================================================================================================================\n",
      "inr 165\n",
      "=====**=====S165=====**======= 23\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:30 - 13:30\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET06 - Antimicrobial Resistance Surveillance Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGARS The official open business meeting for the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Laurent POIREL ; Cansu CIMEN ; Antonio OLIVER ; Thierry NAAS ; Yesim BESLI\n",
      "sess aff :- Switzerland; Germany; Spain; France; Turkey\n",
      "========================================================================================================================\n",
      "inr 166\n",
      "=====**=====S166=====**======= 25\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 12:00 - 13:00\n",
      "sess loca :- Moche Room\n",
      "sess type :- ESCMID open meetingMoche Room\n",
      "sess cate :- \n",
      "sess title :- Meet 42 - Young Scientist Reception\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID \n",
      "sess auth :- Alexander W. FRIEDRICH ; Jon S. FRIEDLAND\n",
      "sess aff :- Germany; United Kingdom\n",
      "========================================================================================================================\n",
      "inr 167\n",
      "=====**=====S167=====**======= 0\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall A\n",
      "sess type :- Special SessionHall A\n",
      "sess cate :- 11. Other\n",
      "sess title :- S44 - Selective Pressure: Quiz Show - Pre-round\n",
      "abs text :-  The new at ECCMID Selective Pressure will be an interactive session open to all ECCMID participants, where registered groups of four people will compete with each other. This competitive quiz show is divided into 2 parts.\n",
      "During the first hour, all the registered teams will undergo a qualifying rapid fire round of questions. In the second hour, the top four groups will compete in a semi final and then final round which will set off the winner team.\n",
      "sess auth :- Jesús RODRíGUEZ; David VAN DUIN ; Maria VEHRESCHILD ; Jacob MORAN\n",
      "sess aff :- Spain; United States; Germany; Israel\n",
      "========================================================================================================================\n",
      "inr 168\n",
      "=====**=====S168=====**======= 1\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall B\n",
      "sess type :- 1-hour SymposiumHall B\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3240 - Antigen testing vs RT-PCR for viral respiratory tract infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD) This symposium is a pro/con debate on antigen vs PCR testing for viral respiratory infections. It is important to discuss both approaches' advantages and limitations. The low sensitivity of antigen tests is sometimes minimised by the increased access to tests. If antigen assays are acceptable for epidemiology, is it still acceptable for patient care? This is a major question. The session's goal is to educate early career specialists about the limitations and advantages of both options.\n",
      "sess auth :- Eric CLAAS ; Veroniek SAEGEMAN\n",
      "sess aff :- Netherlands; Belgium\n",
      "========================================================================================================================\n",
      "3240-1 === \n",
      "abs title :- PCR should be used given the low sensitivity of antigen tests\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3240-2 === \n",
      "abs title :- The role of antigen tests for viral respiratory diseases in patient and population health\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 169\n",
      "=====**=====S169=====**======= 2\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour SymposiumHall C\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3274 - Effects of viruses on the central nervous system\n",
      "abs text :- Co-organised with                    \n",
      "Federation of European Microbiological Societies (FEMS) The central nervous system (CNS) is targeted by multiple viruses, resulting in severe symptoms and mortality. It is the case for established viruses and emerging or zoonotic viral infections. Recent studies addressed novel aspects of the role of viruses in CNS syndromes. For example, CNS symptoms are described as salient in the COVID-19 patients, both in the acute and in the sequelae forms of the disease. In addition, the endemic Zika virus had devastating effects on the CNS in the infected individuals of Central and South Americas, while viral infections, have been suspected for decades to contribute to the pathogenesis of multiple sclerosis (MS). In this symposium, renowned speakers will discuss hot topics in neurovirology, with an overview of the field and reports on CNS complications of Zika Virus.\n",
      "sess auth :- Alfredo GARZINO DEMO ; Roy CHEMALY\n",
      "sess aff :- Italy; United States\n",
      "========================================================================================================================\n",
      "3274-1 === \n",
      "abs title :- Consequences of Zika virus infection on the brain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3274-2 === \n",
      "abs title :- Consequences of viral Infections on the central nervous system\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 170\n",
      "=====**=====S170=====**======= 3\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S29 - Chasing variants? Future of COVID-19 prevention in the EU\n",
      "abs text :- Organized by                    \n",
      "Novavax The session will focus on the discussion around changing needs for COVID-19 prevention in Europe, focusing on evolution of emerging variants of concern (VoC), patterns of shifting vaccine acceptance among general public, and challenges that EU countries face on their journey to maximise vaccine coverage and minimise the impact of COVID-19. We will also look at the new data on the variant-adopted vaccines and discuss the actual need for chasing SARS-CoV-2 variants or if we can adopt existing vaccines during each wave.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 171\n",
      "=====**=====S171=====**======= 4\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S26 - Best of both worlds: maximising serotype coverage and quality of immune responses for pneumococcal disease prevention\n",
      "abs text :- Organized by                    \n",
      "MSD Pneumococcal disease remains a leading cause of morbidity and mortality in older adults and adults with certain risk conditions. The introduction of new high valency vaccines provides an opportunity to address residual disease in this population. Two new PCVs have been recently introduced and additional vaccine candidates are currently under development and may soon be available. This symposium will focus on implementation of adult immunization programs in the context of an evolving adult pneumococcal vaccine landscape. The symposium will also consider the impact of new expanded valency vaccines for children on adult pneumococcal disease prevention.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 172\n",
      "=====**=====S172=====**======= 5\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S28 - Optimising the treatment of invasive fungal infections: spotlight on evolving epidemiology and the current diagnostic landscape\n",
      "abs text :- Organized by                    \n",
      "Gilead Sciences To explore the future role of liposomal amphotericin B and other available antifungal treatments in the evolving epidemiology of invasive fungal infections and new groups of patients emerging in the ICU and haemato-oncology setting due to increased risk of IFI as a consequence of underlying disease or the introduction of new treatments. \n",
      "The session will review treatment considerations in relation to spectrum of activity, increased rates of rare yeasts and rare mould infections, mixed fungal infections, drug-resistance and the role of resistance surveillance data as a guide to treatment, current guidelines and consensus recommendations and a discussion on de-escalation strategies. \n",
      "To discuss future considerations regarding empirical, pre-emptive/diagnostic driven treatment of unspecified and treatment of proven invasive fungal infection and treatment challenges in the ICU and haemato-oncology setting due to significant drug-drug interactions.\n",
      "sess auth :- Ronen BEN\n",
      "sess aff :- Israel\n",
      "========================================================================================================================\n",
      "inr 173\n",
      "=====**=====S173=====**======= 6\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S27 - Prevention of respiratory diseases with mRNA vaccines\n",
      "abs text :- Organized by                    \n",
      "Moderna Therapeutics We aim to present the details of the pioneering mRNA technology and a peek into the pipeline of mRNA vaccines in the respiratory space. The aim of this symposium is to describe the burden of disease, long term consequences, sequalae and health care resource utilisation associated with COVID, RSV and influenza. The lectures will be followed by a Q&A session.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 174\n",
      "=====**=====S174=====**======= 7\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S25 - TBC\n",
      "abs text :- Organized by                    \n",
      "Pfizer TBC\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 175\n",
      "=====**=====S175=====**======= 8\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour Oral SessionHall I\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD08 - Recently approved antibacterials in real life\n",
      "abs text :-  \n",
      "sess auth :- Ilan SCHWARTZ\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "MYD0801 === 13:30 - 14:30\n",
      "abs title :- Real-world experience of cefiderocol in Europe from the PROVE (Retrospective Cefiderocol Chart Review) study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0802 === 13:30 - 14:30\n",
      "abs title :- Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0803 === 13:30 - 14:30\n",
      "abs title :- Off-label use of ceftazidime-avibactam in neonates: a real-life experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0804 === 13:30 - 14:30\n",
      "abs title :- Real-world experience with meropenem/vaborbactam for the treatment of infections caused by carbapenem- and non-carbapenem resistant Enterobacterales\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0805 === 13:30 - 14:30\n",
      "abs title :- Fosfomycin for non-urinary tract infections: a systematic review\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 176\n",
      "=====**=====S176=====**======= 9\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour Oral SessionHall J\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK01 - Viral hepatitis epidemiology to prevention\n",
      "abs text :-  \n",
      "sess auth :- Massimo PUOTI ; Adriana VINCE\n",
      "sess aff :- Italy; Croatia\n",
      "========================================================================================================================\n",
      "MAK0101 === 13:30 - 14:30\n",
      "abs title :- Adeno-associated virus 2 (AAV2) infection in children with non-A-E hepatitis in Ireland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0102 === 13:30 - 14:30\n",
      "abs title :- Phylogenetic analysis of a novel hepatitis A virus IB strain spreading in Hungary in 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0103 === 13:30 - 14:30\n",
      "abs title :- Hepatitis A in men who have sex with men in a single tertiary care centre in Bucharest due to low vaccination coverage\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0104 === 13:30 - 14:30\n",
      "abs title :- A need for reflex hepatitis delta RNA testing: data from the cascade of HDV diagnosis in Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0105 === 13:30 - 14:30\n",
      "abs title :- Booster vaccination in infancy reduces the incidence of occult HBV infection in maternal HBsAg-positive children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 177\n",
      "=====**=====S177=====**======= 10\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3188 - Innovative trial design and new drugs/regimens for tuberculosis: current update and management impact\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Mycobacterial Infections (ESGMYC) This symposium aims to describe novel clinical trial designs that improved the efficacy of clinical research and the recent results in developing new drugs and regimens in the field of tuberculosis. Presentations will provide a comprehensive overview of the field, including planned and ongoing trials and recent trial results leading to breakthroughs in the standard of care for both drug-susceptible and drug-resistant tuberculosis. In addition, there will be ample space for discussion with the audience on the impact of the latest results on the management of tuberculosis and the expected evolution of tuberculosis clinical development in the future. Participation in the discussion of community representatives will be encouraged.\n",
      "sess auth :- Bouke DE JONG ; Lorenzo GUGLIELMETTI\n",
      "sess aff :- Belgium; France\n",
      "========================================================================================================================\n",
      "3188-1 === \n",
      "abs title :- Innovative trials designs for anti-TB drugs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3188-2 === \n",
      "abs title :- New drugs/regimens for TB: impact on clinical management\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 178\n",
      "=====**=====S178=====**======= 11\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour Oral SessionHall L\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP05 - Using omics approaches to study AMR\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "ALP0501 === 13:30 - 14:30\n",
      "abs title :- The metagenomic and transcriptomic changes during colistin susceptible-tolerant-resistant switch in Pseudomonas aeruginosa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0502 === 13:30 - 14:30\n",
      "abs title :- Global surveillance of hypervirulent and convergent Klebsiella pneumoniae lineages\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0503 === 13:30 - 14:30\n",
      "abs title :- Intra- and intersectoral circulation of extended spectrum beta-lactamase (ESBL) gene-carrying plasmids in Escherichia coli in Madagascar\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0504 === 13:30 - 14:30\n",
      "abs title :- ABRomics: an open access online platform on antimicrobial resistance to store, integrate, analyse and share multi-omics data\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0505 === 13:30 - 14:30\n",
      "abs title :- Rapid prediction of antibiotic susceptibility in uropathogens using direct sequencing from urine cultures coupled with neighbour-typing prediction algorithms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 179\n",
      "=====**=====S179=====**======= 12\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall M\n",
      "sess type :- Meet-the-ExpertHall M\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3282 - Tropical and travel medicine: a case-based approach\n",
      "abs text :-  Tropical and travel medicine are two sides of a coin. Diseases experienced in an endemic setting are often a syndrome in returning travellers e.g., fever, eosinophilia, dermatological and neurological syndromes. This session attempts to highlight the variety of pathology seen in the tropics along with the attendant challenges in diagnosis and access and treatment options in the endemic regions as seen among the returned travellers, migrants, and expatriates. It will also provide a case-based explanation of tropical and travel medicine emphasising preventive aspects.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3282-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3282-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 180\n",
      "=====**=====S180=====**======= 13\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall N\n",
      "sess type :- 1-hour Case SessionHall N\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES10 - Management of endocarditis caused by unusual microorganisms\n",
      "abs text :-  \n",
      "sess auth :- Serap SIMSEK\n",
      "sess aff :- Turkey\n",
      "========================================================================================================================\n",
      "BES1001 === 13:30 - 14:30\n",
      "abs title :- Kytoccocus schroeteri: suspected contamination in a blood culture leading to a severe recurrence of infectious endocarditis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1002 === 13:30 - 14:30\n",
      "abs title :- A rare case of endocarditis caused by Gemella spp.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1003 === 13:30 - 14:30\n",
      "abs title :- A rare but probably increasing entity: small colony variant Staphylococcus epidermidis causing endocarditis and spondylodiscitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1004 === 13:30 - 14:30\n",
      "abs title :- Lactococcus garvieae as causitive pathogen of native valve endocarditis and spondylodiscitis: a case report and review of the literature\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1005 === 13:30 - 14:30\n",
      "abs title :- Infective endocarditis post-transcatheter aortic valve implantation with Cardiobacterium valvarum\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 181\n",
      "=====**=====S181=====**======= 14\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall O\n",
      "sess type :- 1-hour Oral SessionHall O\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK08 - Diagnosis of bloodstream infections and sepsis\n",
      "abs text :-  \n",
      "sess auth :- Maria Eugenia GUTIERREZ PIMENTEL ; Andreas Friedrich WENDEL\n",
      "sess aff :- Panama; Germany\n",
      "========================================================================================================================\n",
      "PAK0801 === 13:30 - 14:30\n",
      "abs title :- A dedicated mycosis flask increases the likelihood of identifying candidaemia sepsis.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0802 === 13:30 - 14:30\n",
      "abs title :- T2 magnetic resonance for selected adult patients: experience in a tertiary hospital with sepsis code\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0803 === 13:30 - 14:30\n",
      "abs title :- Reported time to blood culture results in hospitals with 24/7 microbiological service compared to hospitals with limited microbiological service: results from an international survey in 870 hospitals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0804 === 13:30 - 14:30\n",
      "abs title :- An observatory of the diagnosis of bloodstream infection to better tailor sepsis diagnostic policies\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0805 === 13:30 - 14:30\n",
      "abs title :- Rapid nanopore metagenomic sequencing and predictive susceptibility testing from positive blood cultures in patients admitted to intensive care with sepsis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 182\n",
      "=====**=====S182=====**======= 15\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall P\n",
      "sess type :- Meet-the-ExpertHall P\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3166 - How to set up a phage therapy centre\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA) The potential of phages as an adjunctive treatment measure to eradicate persistent and resistant infections has been reported extensively in the last few years. However, most phage therapies are limited to highly specialised centres that can overcome logistic obstacles and hurdles. The major hurdles may include but are not limited to reliable phage sensitivity testing, the ability to produce human-grade phages, create regulatory approvals, and promptly allow for effective patient treatment. In this session, we will provide \"how-to\" guidance from two leading experts on what is needed to create a thriving phage treatment centre and how to build a centre from \"scratch\" to provide cutting-edge therapy.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3166-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3166-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 183\n",
      "=====**=====S183=====**======= 16\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP09 - Update on TB basic and clinical research, 2023\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "CSP0901 === 13:30 - 14:30\n",
      "abs title :- Pilot application of targeted next-generation sequencing for detection of drug-resistant tuberculosis directly from clinical samples in Bangladesh\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0902 === 13:30 - 14:30\n",
      "abs title :- MIC distributions and variability over time for bedaquiline, clofazimine, delamanid, linezolid and pretomanid in multidrug-resistant and extensively drug-resistant tuberculosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0903 === 13:30 - 14:30\n",
      "abs title :- Risk factors and clinical outcomes of tuberculosis after solid organ transplant in highly endemic region\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0904 === 13:30 - 14:30\n",
      "abs title :- Role of smallRNAs in rifampicin tolerance in M. tuberculosis complex\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0905 === 13:30 - 14:30\n",
      "abs title :- Molecular and genomic analysis coupled to refined epidemiology to optimise tuberculosis transmission surveillance in complex populations\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0906 === 13:30 - 14:30\n",
      "abs title :- Hallmarks of tuberculosis reactivation assessed by serum metabolite profiling in a Swedish retrospective cohort: work in progress towards stratification of risk groups\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0907 === 13:30 - 14:30\n",
      "abs title :- A description of phenotypic drug susceptibility testing results for second line anti-tuberculous drugs within a programmatic setting: KwaZulu-Natal, South Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0908 === 13:30 - 14:30\n",
      "abs title :- First values of delamanid and pretomanid MICs measured using the new EUCAST reference method\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0909 === 13:30 - 14:30\n",
      "abs title :- Clinical management of QT prolongation in the STREAM stage 1 trial and its effect on patient outcome\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 184\n",
      "=====**=====S184=====**======= 18\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM04 - Fungal infection treatment around the world\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MEM0401 === 13:30 - 14:30\n",
      "abs title :- Use of antifungals in acute hospital trusts in England, 2017-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0402 === 13:30 - 14:30\n",
      "abs title :- Outcomes in a clinical trial cohort of patients with invasive Scopulariopsis infections treated with olorofim\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0403 === 13:30 - 14:30\n",
      "abs title :- Safety and effectiveness of isavuconazole in real-life non-neutropaenic patients in Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0404 === 13:30 - 14:30\n",
      "abs title :- Outcomes of oral ibrexafungerp in subjects with urinary tract infections from two phase 3 open-label Studies: difficult-to-treat invasive fungal infections (FURI) and infections with Candida auris (CARES)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0405 === 13:30 - 14:30\n",
      "abs title :- Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0406 === 13:30 - 14:30\n",
      "abs title :- In vitro activity of olorofim against clinically relevant filamentous fungi from French reference center for invasive mycosis and antifungals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0407 === 13:30 - 14:30\n",
      "abs title :- Effectiveness, safety, and patterns of real-world isavuconazole use: a retrospective medical record review study of patients with invasive aspergillosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0408 === 13:30 - 14:30\n",
      "abs title :- Breakthrough invasive fungal infection in patients with haematologic malignancy receiving posaconazole tablet prophylaxis: clinical features, risk factors, and posaconazole profiles\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0409 === 13:30 - 14:30\n",
      "abs title :- Shorter intravenous amphotericin B followed by oral posaconazole for diabetes-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study using a simple, stratified treatment approach\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 185\n",
      "=====**=====S185=====**======= 24\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET16 - Implant-associated Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGIAI The official open business meeting for the ESCMID Study Group for Implant-associated Infections (ESGIAI). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Marjan WOUTHUYZEN; Tobias KRAMER ; Yvonne ACHERMANN ; Jaime ESTEBAN MORENO ; Efthymia GIANNITSIOTI\n",
      "sess aff :- Netherlands; Germany; Switzerland; Spain; Greece\n",
      "========================================================================================================================\n",
      "inr 186\n",
      "=====**=====S186=====**======= 0\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall A\n",
      "sess type :- Special SessionHall A\n",
      "sess cate :- 11. Other\n",
      "sess title :- S45 - Selective Pressure: Quiz Show - Semi-final and final\n",
      "abs text :-  The new at ECCMID Selective Pressure will be an interactive session open to all ECCMID participants, where registered groups of four people will compete with each other. This competitive quiz show is divided into 2 parts.\n",
      "During the first hour, all the registered teams will undergo a qualifying rapid fire round of questions. In the second hour, the top four groups will compete in a semi final and then final round which will set off the winner team.\n",
      "sess auth :- Jesús RODRíGUEZ; David VAN DUIN ; Maria VEHRESCHILD ; Jacob MORAN\n",
      "sess aff :- Spain; United States; Germany; Israel\n",
      "========================================================================================================================\n",
      "inr 187\n",
      "=====**=====S187=====**======= 1\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall B\n",
      "sess type :- Meet-the-ExpertHall B\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3464 - How to make sure my MALDI is doing a good job?\n",
      "abs text :-  MALDI-TOF MS has become the routine method for identifying isolates in laboratories, and most labs perform dozens and even hundreds of identifications daily. MALDI also has newer applications, such as the determination of AMR and typing. The quality of MALDI instruments differs between labs and is influenced by many factors related to the instrument, its maintenance, and the workflow. Therefore, assessing the performance of MALDI may not be easy. In this session, two experts in MALDI-TOF will provide tips and tricks on what influences the readings of MALDI, how QC can be done, and how high performance can be assured.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3464-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3464-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 188\n",
      "=====**=====S188=====**======= 2\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour SymposiumHall C\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3181 - ESCMID guidelines on diagnosis and treatment of brain abscess\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Infectious Diseases of the Brain (ESGIB), ESCMID Guidelines Subcommittee During this symposium the results of the ESCMID guidelines development project on diagnosis and treatment of brain abscess will be presented. Speakers will elaborate on epidemiology, clinical presentation, and diagnostic investigations advised to confirm the diagnosis and search for underlying conditions. In addition, the consensus of the guidelines committee on antibiotic, neurosurgical and adjunctive treatments will be presented with potential complications during treatment.\n",
      "sess auth :- Inmaculada LóPEZ MONTESINOS ; Emma Cecilia WALL\n",
      "sess aff :- Spain; United Kingdom\n",
      "========================================================================================================================\n",
      "3181-1 === \n",
      "abs title :- Epidemiology and clinical presentation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3181-2 === \n",
      "abs title :- Management of brain abscesses and their complications\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 189\n",
      "=====**=====S189=====**======= 8\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour Oral SessionHall I\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP20 - Challenges and advances in skin, soft tissue, bone and joint infections\n",
      "abs text :-  \n",
      "sess auth :- Robin PATEL ; Andrej TRAMPUZ\n",
      "sess aff :- United States; Germany\n",
      "========================================================================================================================\n",
      "CSP2001 === 14:45 - 15:45\n",
      "abs title :- Clinical features and outcome of vertebral osteomyelitis after spinal injection: is it worth the price?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2002 === 14:45 - 15:45\n",
      "abs title :- Evolution towards small colony variants of pandemic multidrug resistant ST131 Escherichia coli isolates from a 10-year bone infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2003 === 14:45 - 15:45\n",
      "abs title :- Staphylococcus epidermidis implant-associated infections: high rate of multi-resistance associated with treatment failure: a retrospective analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2004 === 14:45 - 15:45\n",
      "abs title :- Broad-spectrum antibiofilm activity of novel agents in a wound infection in vitro model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP2005 === 14:45 - 15:45\n",
      "abs title :- A prospective, multi-centre cohort study assessing the use, effectiveness and safety of dalbavancin in France\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 190\n",
      "=====**=====S190=====**======= 9\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour Oral SessionHall J\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW10 - Particularities of paediatric COVID: from molecular diagnosis to therapeutic response\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "EW1001 === 14:45 - 15:45\n",
      "abs title :- Use of remdesivir in children with COVID-19: report of an Italian multi-centre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1002 === 14:45 - 15:45\n",
      "abs title :- Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents in comparison to RT-qPCR, November 2020 to September 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1003 === 14:45 - 15:45\n",
      "abs title :- Molecular characterisation of SARS-CoV-2 Omicron clade and clinical presentation in children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1004 === 14:45 - 15:45\n",
      "abs title :- Ancestral SARS-CoV-2 reactive T cells cross-recognise variants of concern in children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1005 === 14:45 - 15:45\n",
      "abs title :- Alteration of serum cytokine profile in children with long COVID\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 191\n",
      "=====**=====S191=====**======= 10\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3154 - New antibiotics: from early discovery to bedside\n",
      "abs text :-  After years of drought, there is revitalisation in the antibiotic drug development pipeline. This symposium will review and evaluate new antibiotics from early discovery to those that entered the market in the last years or are in the licensing phase, both against Gram-positive and Gram-negative bacteria.\n",
      "sess auth :- Markus ZEITLINGER ; Sandrine MARCHAND\n",
      "sess aff :- Austria; France\n",
      "========================================================================================================================\n",
      "3154-1 === \n",
      "abs title :- New drugs against Gram-positive bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3154-2 === \n",
      "abs title :- New drugs against Gram-negative bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 192\n",
      "=====**=====S192=====**======= 11\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour Oral SessionHall L\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP02 - Novel resistance mechanisms\n",
      "abs text :-  \n",
      "sess auth :- Sören G. GATERMANN\n",
      "sess aff :- Germany\n",
      "========================================================================================================================\n",
      "ALP0201 === 14:45 - 15:45\n",
      "abs title :- Novel ramR point mutations lead to eravacycline resistance and increased virulence in clinical isolates of Klebsiella pneumoniae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0202 === 14:45 - 15:45\n",
      "abs title :- Occurrence of cefiderocol (CFDC) hetero-resistance in carbapenem-resistant Acinetobacter baumannii (CRAB) cells after exposure to human fluids\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0203 === 14:45 - 15:45\n",
      "abs title :- Mechanism behind antibiotic-enhanced plasmid transfer and identification of compounds which inhibit this mechanism\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0204 === 14:45 - 15:45\n",
      "abs title :- Collateral fitness and pathogenicity effects on Pseudomonas aeruginosa after antibiotic exposure\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0205 === 14:45 - 15:45\n",
      "abs title :- Metallo-beta-lactamase folds in candidate phyla radiation: quasi-ubiquitous proteins and highly divergent sequences from bacterial ones\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 193\n",
      "=====**=====S193=====**======= 12\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour SymposiumHall M\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3273 - Learning from the past: paleomicrobiology\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Forensic and Postmortem Microbiology (ESGFOR), Spanish Society of Forensic Pathology (SEPAF) The history of pandemics can draw lessons from previous ones, such as those from influenza or the recent COVID-19. Current and future environmental changes are a source of the resurgence of ancient epidemic diseases and can determine the appearance of emerging pathogens. The genomics revolution over the past decade, made possible through the development of high-throughput sequencing, has triggered considerable progress in studying ancient DNA, enabling complete genomes of extinct organisms to be reconstructed. In this symposium the history of influenza will be revisited in the light of new discoveries, and the development of DNA-based ancient pathogen research, including the specialised methods and tools implemented to authenticate infectious diseases of the past, will be explored.\n",
      "sess auth :- Nihan ZIYADE ; Amparo FERNáNDEZ\n",
      "sess aff :- Turkey; Spain\n",
      "========================================================================================================================\n",
      "3273-1 === \n",
      "abs title :- Was Spanish flu Spanish?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3273-2 === \n",
      "abs title :- How to analyse a sample that is 1'000 years old\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 194\n",
      "=====**=====S194=====**======= 13\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall N\n",
      "sess type :- Meet-the-ExpertHall N\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3252 - How do I deal with patients having suspected BSL-3/BSL-4 micro-organism?\n",
      "abs text :- Co-organised with                    \n",
      "UEMS-ID Nowadays, infections with BSL-3 or BSL-4 microorganisms occur worldwide, sometimes as sporadic cases (a traveler with yellow fever), outbreaks (Ebola), and sometimes even bioterrorism. As a result, microbiologists and infectious disease physicians may encounter such microorganisms with or without personal protective measurements. In addition, protocols in laboratories or clinics are not always followed \"in the heat of the moment.\" During this session, participants will learn how to handle expected and unexpected (patients with) BSL-3/BSL-4 microorganisms.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3252-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3252-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 195\n",
      "=====**=====S195=====**======= 14\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall O\n",
      "sess type :- 1-hour Oral SessionHall O\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM06 - Innovative diagnostic approaches for fungal infections\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MEM0601 === 14:45 - 15:45\n",
      "abs title :- Metagenomic next generation sequencing of plasma for the diagnosis of COVID-19 associated pulmonary aspergillosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0602 === 14:45 - 15:45\n",
      "abs title :- Diagnostic value of microbial cell-free DNA sequencing in blood from patients with haematological malignancies suspected for invasive fungal disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0603 === 14:45 - 15:45\n",
      "abs title :- Invasive mould infection in immunocompromised children: pulmonary computed tomography findings in 99 cases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0604 === 14:45 - 15:45\n",
      "abs title :- A new machine learning-based approach to classifying patients with invasive fungal disease (IFD)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0605 === 14:45 - 15:45\n",
      "abs title :- Non-invasive diagnosis of invasive aspergillosis infection: utility of plasma cell-free DNA PCR vs serum galactomannan\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 196\n",
      "=====**=====S196=====**======= 15\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour Oral SessionHall P\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- PJK02 - Anti-virulence targets at the bacterial surface\n",
      "abs text :-  \n",
      "sess auth :- Francoise VAN BAMBEKE ; Joseph ZACKULAR\n",
      "sess aff :- Belgium; United States\n",
      "========================================================================================================================\n",
      "PJK0201 === 14:45 - 15:45\n",
      "abs title :- Pseudomonas aeruginosa UDP-glucose pyrophosphorylase: an antivirulence drug target\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0202 === 14:45 - 15:45\n",
      "abs title :- Multi-omics investigation of Escherichia coli reveals unique pathogenic markers such as the L-sorbose phosphotransferase system (PTS)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0203 === 14:45 - 15:45\n",
      "abs title :- The Listeria monocytogenes rhamnosyltransferase: structure and mechanism\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0204 === 14:45 - 15:45\n",
      "abs title :- Functional membrane microdomains and FhuC govern Isd-dependent haem acquisition in Staphylococcus aureus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0205 === 14:45 - 15:45\n",
      "abs title :- Iron starvation induces functional type II toxin-antitoxin modules in Waddlia chondrophila\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 197\n",
      "=====**=====S197=====**======= 17\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP11 - Gastrointestinal and abdominal infections: epidemiology to management\n",
      "abs text :-  \n",
      "sess auth :- Benoit GUERY\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "CSP1101 === 14:45 - 15:45\n",
      "abs title :- The largest outbreak of enterohemorrhagic Escherichia coli in South Korea: the epidemiological and clinical characteristics of EHEC O157:H7 outbreak in preschool\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1102 === 14:45 - 15:45\n",
      "abs title :- Putative genes associated with development of haemolytic uraemic syndrome among verotoxigenic Escherichia coli notifications in Ireland 2017-2020: a case control study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1103 === 14:45 - 15:45\n",
      "abs title :- Detection of blaKPC-2-producing E. coli in pet food packages\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1104 === 14:45 - 15:45\n",
      "abs title :- Clinical and epidemiological characteristics of human salmonellosis cases admitted between 2015 and 2021 in a rural-set hospital in the metropolitan area of Milan (Italy): a retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1105 === 14:45 - 15:45\n",
      "abs title :- Large outbreak of typhoid fever on a river cruise ship used as a shelter location for asylum seekers in the Netherlands\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1106 === 14:45 - 15:45\n",
      "abs title :- Oral administration of defined microbial communities and their metabolites protects against Clostridioides difficile infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1107 === 14:45 - 15:45\n",
      "abs title :- Impact of COVID-19 restrictions on incidence of enteropathogenic bacteria, viruses and parasites in Denmark: a register based study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1108 === 14:45 - 15:45\n",
      "abs title :- Clinical and genomic specificities of 135 Escherichia coli bloodstream infections from a biliary port of entry in France\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1109 === 14:45 - 15:45\n",
      "abs title :- Antimicrobial drugs penetration in human abdominal abscesses\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 198\n",
      "=====**=====S198=====**======= 19\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK09 - Seasonal respiratory virus: a continued challenge\n",
      "abs text :-  \n",
      "sess auth :- Magrit Jarlsdatter HOVIND\n",
      "sess aff :- Norway\n",
      "========================================================================================================================\n",
      "MAK0901 === 14:45 - 15:45\n",
      "abs title :- A retrospective study on impact of antibiotic therapy on mortality in viral respiratory infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0902 === 14:45 - 15:45\n",
      "abs title :- Small molecule cyclophilin inhibitor (SMCyPI) screening against respiratory syncytial virus reveals their potential as inhibitors of hRSV RNA transcription/replication\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0903 === 14:45 - 15:45\n",
      "abs title :- Viral co-detections as a risk factor for severe respiratory syncytial virus infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0904 === 14:45 - 15:45\n",
      "abs title :- RSV-associated adult hospitalisations in a Belgian university hospital during seven years: epidemiological and clinical considerations considering flu surveillance schemes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0905 === 14:45 - 15:45\n",
      "abs title :- Exploring the potential of a saliva-based, RNA-extraction-free PCR test for the multiplexed detection of key respiratory pathogens\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0906 === 14:45 - 15:45\n",
      "abs title :- Descriptive analysis of respiratory adenoviruses circulating in children, Ile-de-France, 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0907 === 14:45 - 15:45\n",
      "abs title :- Three years later… Back to normal circulation of viral and bacterial respiratory pathogens?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0908 === 14:45 - 15:45\n",
      "abs title :- Measuring influenza and respiratory syncytial virus alongside SARS-CoV-2 nested within a large national cohort study: protocol for a pragmatic sub-study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0909 === 14:45 - 15:45\n",
      "abs title :- Full re-emergence of invasive pneumococcal disease among adults in Germany after strong reduction throughout SARS-CoV-2 pandemic lockdown\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 199\n",
      "=====**=====S199=====**======= 22\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- 179 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting179 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET22 - Mycoplasma and Chlamydia Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGMAC The official open business meeting for the ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Michael BEETON ; Sabine PEREYRE ; Tomislav MESTROVIC ; Jorgen Skov JENSEN\n",
      "sess aff :- United Kingdom; France; Croatia; Denmark\n",
      "========================================================================================================================\n",
      "inr 200\n",
      "=====**=====S200=====**======= 23\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET15 - Host and Microbiota Interaction Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGHAMI The official open business meeting for the ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Christophe VAN DIJCK ; Lesley HOYLES ; Ed J. KUIJPER\n",
      "sess aff :- Belgium; United Kingdom; Netherlands\n",
      "========================================================================================================================\n",
      "inr 201\n",
      "=====**=====S201=====**======= 0\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3377 - Urinary tract infections: from fundamental bench science to translatable therapeutics\n",
      "abs text :-  The Keynote Lecture of Scott Hultgreb will demonstrate how a blend of multiple scientific disciplines enables the elucidation of bacterial and host mechanisms that determine the onset, course, and outcome of interactions between a host mucosal surface and bacterial pathogens. It will further demonstrate how this fundamental approach and its translation has changed the way UTIs are evaluated, has re-shaped models of bacterial infections in general, and has spawned new technologies to design novel vaccines and anti-microbial therapeutics to diagnose, treat and/or prevent UTIs and their sequelae.\n",
      "sess auth :- Kimberly KLINE ; Maria VEHRESCHILD\n",
      "sess aff :- Switzerland; Germany\n",
      "========================================================================================================================\n",
      "3377-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 202\n",
      "=====**=====S202=====**======= 1\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour Oral SessionHall B\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP07 - A genomics view of the evolution and spread of carbapenem-resistant Enterobacterales\n",
      "abs text :-  \n",
      "sess auth :- Martin ANTONIO\n",
      "sess aff :- Gambia\n",
      "========================================================================================================================\n",
      "ALP0701 === 16:15 - 18:15\n",
      "abs title :- Molecular epidemiology of carbapenemase-producing hospital-acquired Klebsiella pneumoniae in Ukraine\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0702 === 16:15 - 18:15\n",
      "abs title :- A prolonged multispecies outbreak of VIM-1-producing Enterobacterales driven by bacterial clones and plasmids in a tertiary care centre in Germany\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0703 === 16:15 - 18:15\n",
      "abs title :- Multiclonl dissemination of multidrug-resistant high-risk clone ST147 Klebsiella pneumoniae  carrying hybrid plasmids in India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0704 === 16:15 - 18:15\n",
      "abs title :- Genomic dissection of endemic carbapenem resistance: metallo-beta-lactamase gene dissemination through clonal, plasmid and integron transfer pathways\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0705 === 16:15 - 18:15\n",
      "abs title :- Simultaneous outbreaks of blaOXA-23 + blaNDM-producing Acinetobacter baumannii among northern Parisian hospitals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0706 === 16:15 - 18:15\n",
      "abs title :- Entry and early spread of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital of Valencia (Spain)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0707 === 16:15 - 18:15\n",
      "abs title :- WGS analysis of CP-K. pneumoniae isolates resistant to ceftazidime-avibactam from intestinal carriage of hospitalised elderly patients, in Italy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0708 === 16:15 - 18:15\n",
      "abs title :- Genotypic characterisation of carbapenem-resistant Enterobacterales clinical isolate along with their colistin susceptibility\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0709 === 16:15 - 18:15\n",
      "abs title :- Enterobacterales co-harbouring two carbapenemases in a tertiary hospital in Madrid, Spain: a new epidemiological scenario?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0710 === 16:15 - 18:15\n",
      "abs title :- Ten-year longitudinal epidemiology study on genotypic and phenotypic characterisation of carbapenem-resistant Enterobacterales in China (2011–2020)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 203\n",
      "=====**=====S203=====**======= 2\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour SymposiumHall C\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3470 - Viral infections in immunosuppressed patients:what is new?\n",
      "abs text :-  This session will focus on new data on viral infections in immunosuppressed patients and cover their clinical features, diagnosis, case management, and outcome. Topics will include up-date treatment of SARS-CoV-2 and CMV infections in immunosuppressed patients and also provide an overview of what every clinician should know about BK, JC, HHV-6, and adenovirus infections. When should we be concerned, and if we are concerned, what should we do?\n",
      "sess auth :- Priscilla RUPALI ; Hans H. HIRSCH\n",
      "sess aff :- India; Switzerland\n",
      "========================================================================================================================\n",
      "3470-1 === \n",
      "abs title :- SARS-CoV-2\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3470-2 === \n",
      "abs title :- CMV\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3470-3 === \n",
      "abs title :- BK, JC and HHV-6\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3470-4 === \n",
      "abs title :- Adenovirus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 204\n",
      "=====**=====S204=====**======= 3\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S33 - Integrated approaches to accelerate and improve diagnostics in microbiology\n",
      "abs text :- Organized by                    \n",
      "Becton Dickinson The session aims at presenting real life experiences on how working in a concerted effort amongst different healthcare stakeholders can alleviate some of the pressing pains and gaps in the diagnostic pathway. Improving the diagnostic paths to ultimately achieve better patient care and optimal utilisation of resources should move along two axes: best practice, in the broadest sense of integrated diagnostic stewardship, and innovation.  These 2 axes are not mutually exclusive but on the contrary build on each other.  Innovation on its own, without a coalition behind it and a clear change management effort may not be sufficient to maximise potential impact. The goal of rapid and accurate results is to support clinicians in making appropriate therapeutic choices. Yet there is no impact if these fast and accurate results are not communicated and acted upon in a timely matter.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 205\n",
      "=====**=====S205=====**======= 4\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S31 - Infectious disease rounds: case-based discussion of incorporating new data managing CMV and Gram-negative infections into clinical practice\n",
      "abs text :- Organized by                    \n",
      "MSD This symposium will review the latest evidence on managing CMV and Gram-negative infections, and incorporation of this data into real life scenarios. The 2-hour session will be divided into 2 parts, with the 1st one focused on new antibiotics for Gram-negative infections, highlighting pneumonia in the ICU as well as challenging cases of MDR Gram-negative infections. The 2nd part will focus on CMV Management, including Challenges in renal transplantation CMV prophylaxis (Is help on the horizon?), as well Optimising CMV prophylaxis in HSCT (Is more better?).\n",
      "sess auth :- Giorgia CARUANA\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "inr 206\n",
      "=====**=====S206=====**======= 5\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S32 - AMR, sustainability and efficiency: 'Staying ahead of tomorrow's challenges, today'\n",
      "abs text :- Organized by                    \n",
      "Thermo Fisher Scientific Microbiology laboratories are faced with the consequences of a number of global health crises, including the ongoing spread of antimicrobial resistance (AMR), and newer emerging resistance in the aftermath of the coronavirus pandemic. On top of this, laboratories are often challenged by increasingly higher demands and limited resources, with pressure to streamline workflows and operate more sustainably. So how can microbiology labs stay ahead of tomorrow's challenges, today?\n",
      "\n",
      "In this session, we will explore:\n",
      ".\tHow antimicrobial susceptibility testing (AST) devices featuring new antimicrobials can be a promising tool in the battle against AMR\n",
      ".\tHow artificial intelligence-enabled technology for automating culture plate reading can free up full time employee resources so they can put their time toward more meaningful activities\n",
      ".\tHow we're partnering with microbiology labs to reduce our impact on the environment, together, and build a more sustainable future\n",
      "sess auth :- Karl Gustaf KRISTINSSON\n",
      "sess aff :- Iceland\n",
      "========================================================================================================================\n",
      "inr 207\n",
      "=====**=====S207=====**======= 6\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S34 - Next generation sequencing in routine use for all clinical microbiology laboratories: this is now!\n",
      "abs text :- Organized by                    \n",
      "Illumina Next generation sequencing technology is now part of routine for many clinical microbiology laboratories and is increasingly being used for various applications: genotypic antimicrobial resistance, strain typing for outbreak control, direct detection of pathogens and their resistance mechanisms in specimens, metagenomics, etc.\n",
      "This Integrated Symposium will give opportunity to listen clinical microbiology laboratories sharing their experiences in using NGS for key routine applications.\n",
      "sess auth :- Colin R. MACKENZIE\n",
      "sess aff :- Germany\n",
      "========================================================================================================================\n",
      "inr 208\n",
      "=====**=====S208=====**======= 7\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S30 - Get smart in invasive mould disease (IMD) management\n",
      "abs text :- Organized by                    \n",
      "Pfizer .\tIn this session, our expert multi-disciplinary faculty will explore best practice in the diagnosis and management of invasive mould disease (IMD) in at-risk patients in both haematology and intensive care units\n",
      ".\tThey will highlight the importance of recognising IMD risk factors to improve the early diagnosis of IMD through a patient case discussion\n",
      ".\tThe faculty will also review the considerations for management strategy selection, exploring how to implement a diagnostic-driven approach and its value in antifungal stewardship\n",
      "sess auth :- Lior NESHER\n",
      "sess aff :- Israel\n",
      "========================================================================================================================\n",
      "inr 209\n",
      "=====**=====S209=====**======= 8\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall I\n",
      "sess type :- 2-hour Educational WorkshopHall I\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3413 - Basic microbiology for infectious disease doctors: indications, preanalytics, methods and pitfalls\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Education Subcommittee, Trainee Association of ESCMID (TAE) Steering Committee, CAESAR network The microbiological diagnostic landscape is evolving, and new methods are available to provide faster and better diagnostics. For ID specialists, the value of specific methods might not always be clear, and in the era of AMR, the wish for targeted therapy may lead to excess sampling. But what can you expect from your diagnostics? How can an understanding of specific laboratory methods guide sampling? And under what circumstances do faster diagnostic systems change clinical courses? How can clinicians help to improve microbiological diagnostics: is proper sampling the key to good microbiology results? This Educational Workshop targets ID and CM specialists and trainees as well as other clinicians who frequently use microbiological testing, aiming to improve ward to laboratory understanding and communication.\n",
      "sess auth :- Christian GISKE ; Saskia NAHRGANG\n",
      "sess aff :- Sweden; Denmark\n",
      "========================================================================================================================\n",
      "3413-1 === \n",
      "abs title :- The dos and don'ts in clinical microbiology sampling\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3413-2 === \n",
      "abs title :- Strengths and weaknesses of multiplex testing: take responsibility for the results you were not looking for!\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3413-3 === \n",
      "abs title :- Fungal infections: what do different diagnostics tell us and what not?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 210\n",
      "=====**=====S210=====**======= 9\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour SymposiumHall J\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3423 - Tackling influenza and RSV management in the post-COVID era\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Respiratory viruses (ESGREV), ISIRV (International Society for Influenza and other Respiratory Virus Diseases) Current respiratory viral infections treatment and management guidelines originate predominantly from pre-COVID-19 times. This symposium and follow-up discussion will bring together specialists from Europe and around the World. Experts will discuss how and in which aspects the COVID-19 pandemic may have impacted the prevention, testing, treatment, and management of influenza and RSV infections. These changes influenced clinical guidelines, the surveillance and monitoring of influenza and RSV infections inside and outside the hospital setting.\n",
      "sess auth :- Barbara RATH ; Cornelia ADLHOCH\n",
      "sess aff :- France; Sweden\n",
      "========================================================================================================================\n",
      "3423-1 === \n",
      "abs title :- Differences in the clinical presentation and outcomes of respiratory viral infections at the extremes of age\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3423-2 === \n",
      "abs title :- The impact of diagnostics on the timeliness of antiviral treatment of influenza, RSV and COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3423-3 === \n",
      "abs title :- From clinical trials to clinical practice: evolution of the management of COVID, RSV and influenza in North America\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3423-4 === \n",
      "abs title :- Treatment or prevention? Global and public health perspectives of guideline development for respiratory viruses\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 211\n",
      "=====**=====S211=====**======= 10\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall K\n",
      "sess type :- 2-hour SymposiumHall K\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3225 - Sepsis: present and future considerations in management\n",
      "abs text :- Co-organised with                    \n",
      "International Sepsis Forum (ISF), ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) This session, organised with the International Sepsis Forum (ISF) and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES), will focus on sepsis' most recent clinical aspects and bloodstream infections. After attending the session, participants will be able to identify ways to improve their current and future management of sepsis. This symposium will start with a 5-minute presentation from the ISF Award winner, an early career researcher.\n",
      "sess auth :- Thierry CALANDRA ; Willem Joost WIERSINGA\n",
      "sess aff :- Switzerland; Netherlands\n",
      "========================================================================================================================\n",
      "3225-1 === \n",
      "abs title :- Sepsis pathogenesis: we should embrace its complexity!\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3225-2 === \n",
      "abs title :- Improving diagnosis in sepsis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3225-3 === \n",
      "abs title :- Challenges in sepsis management for LMICs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3225-4 === \n",
      "abs title :- Biomarker-driven immunotherapy: it works\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 212\n",
      "=====**=====S212=====**======= 11\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall L\n",
      "sess type :- 2-hour SymposiumHall L\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3171 - Clostridioidies difficile infection, to bacteria and beyond\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Clostridioides difficile(ESGCD) The pathophysiology of Clostridioides difficile infection remains with many questions, specifically in recurrences. Besides the classical treatments with drugs, several non-antibiotic approaches were recently proposed, the first being faecal microbiota transplantation (FMT). Bacteria and the role of other factors such as phages or active metabolites cannot only explain the success of FMT. This symposium will explore new therapeutic pathways starting with microbiota and phages, and discuss the role of targeted synthetic microbiota and the host response.\n",
      "sess auth :- Benoit GUERY\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "3171-1 === \n",
      "abs title :- Faecal microbiota transplantation, are bacteria the cornerstone?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3171-2 === \n",
      "abs title :- Phages, the elephant in the room?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3171-3 === \n",
      "abs title :- Role of enteric nervous system on Clostridioides difficile infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3171-4 === \n",
      "abs title :- Interactions between CDI and pathogenic bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 213\n",
      "=====**=====S213=====**======= 12\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall M\n",
      "sess type :- 2-hour Oral SessionHall M\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW13 - How good are the COVID-19 vaccines?\n",
      "abs text :-  \n",
      "sess auth :- Oriol MANUEL\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "EW1301 === 16:15 - 18:15\n",
      "abs title :- Interim safety and immunogenicity results of a bivalent SARS-CoV-2 Omicron booster vaccine: a phase 3, randomised, observer-blind, active-controlled trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1302 === 16:15 - 18:15\n",
      "abs title :- Efficacy of monovalent [D614] and bivalent [D614 + B.1.351] SARS-CoV-2 recombinant protein vaccines with AS03 adjuvant (CoV2 preS dTM-AS03) in adults\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1303 === 16:15 - 18:15\n",
      "abs title :- Tolerability, safety and immunogenicity of intradermal delivery of a fractional dose mRNA -1273 SARS-CoV-2 vaccine in healthy adults as a dose sparing strategy: a non-inferiority, randomised controlled trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1304 === 16:15 - 18:15\n",
      "abs title :- Homologous vs heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalised COVID-19 patients in Belgium\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1305 === 16:15 - 18:15\n",
      "abs title :- Investigating immunity from SARS-CoV-2 infection and COVID-19 vaccination through the pandemic within the UK SIREN study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1306 === 16:15 - 18:15\n",
      "abs title :- Vaccine effectiveness against mild and severe disease caused by COVID-19 variants in England\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1307 === 16:15 - 18:15\n",
      "abs title :- Low neutralisation of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by four doses of parental mRNA vaccine or a BA.5-bivalent booster\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1308 === 16:15 - 18:15\n",
      "abs title :- Vaccine effectiveness against COVID-19 death between December 2020–March 2022 in Finland: Register-based cohort analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1309 === 16:15 - 18:15\n",
      "abs title :- Estimated number of deaths directly averted as a result of COVID-19 vaccination programmes in the WHO European region (December 2020 to September 2022)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1310 === 16:15 - 18:15\n",
      "abs title :- COVID-19 vaccination is associated with reduced antibiotic prescribing in older adults with confirmed SARS-CoV-2: a population-wide cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 214\n",
      "=====**=====S214=====**======= 13\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall N\n",
      "sess type :- 2-hour SymposiumHall N\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3255 - Neglected tropical skin diseases\n",
      "abs text :- Co-organised with                    \n",
      "UEMS-ID Leishmania and others are endemic in specific parts of the world and can cause debilitating diseases. Many times, it is the working population suffering from this disease. The WHO has special programs for skin NTD's, and knowledge of epidemiology, diagnostic methods, and treatment is continuously increasing. Therefore, a session with renowned speakers in this field will impact awareness and knowledge of these diseases.\n",
      "sess auth :- Sipho Kenneth DLAMINI ; Hilmir ASGEIRSSON\n",
      "sess aff :- South Africa; Sweden\n",
      "========================================================================================================================\n",
      "3255-1 === \n",
      "abs title :- Mycetoma\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3255-2 === \n",
      "abs title :- Podoconiosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3255-3 === \n",
      "abs title :- Sporotrichosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3255-4 === \n",
      "abs title :- Buruli ulcer\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 215\n",
      "=====**=====S215=====**======= 14\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour Oral SessionHall O\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD11 - Clinical PK/PD studies to improve dosing\n",
      "abs text :-  \n",
      "sess auth :- Isabel SPRIET ; João Paulo TELLES\n",
      "sess aff :- Belgium; Brazil\n",
      "========================================================================================================================\n",
      "MYD1101 === 16:15 - 18:15\n",
      "abs title :- Towards individualised piperacillin therapy: multicentre systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on bayesian forecasting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1102 === 16:15 - 18:15\n",
      "abs title :- Optimisation of piperacillin-tazobactam dosing regimen for critically ill patient with sepsis: the OPT-TAZ population pharmacokinetics study.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1103 === 16:15 - 18:15\n",
      "abs title :- Measuring unbound ceftriaxone concentrations in plasma of critically ill patients: ultrafiltration versus equilibrium dialysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1104 === 16:15 - 18:15\n",
      "abs title :- Population pharmacokinetics of cefuroxime in critically ill patients: a pharmacokinetics guided dose proposal\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1105 === 16:15 - 18:15\n",
      "abs title :- Population pharmacokinetics and clinical outcomes of meropenem-vaborbactam among patients with Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacterales (CRE) infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1106 === 16:15 - 18:15\n",
      "abs title :- PKpopLCR study: pharmacokinetic and pharmacodynamic of linezolid in neurointensive care patients with external ventricular drainage\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1107 === 16:15 - 18:15\n",
      "abs title :- Linezolid toxicity in clinical practice: towards a better detection of at-risk patients? Interim analysis of a prospective multicentric study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1108 === 16:15 - 18:15\n",
      "abs title :- Population pharmacokinetics of multiple dose fosfomycin in critically ill patients without and with intermittent, prolonged-intermittent or continuous renal replacement therapy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1109 === 16:15 - 18:15\n",
      "abs title :- The Monte Carlo simulation on geriatric patients' population treated with different dalbavancin therapeutic protocols and evaluation of intracellular penetration of the drug\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD1110 === 16:15 - 18:15\n",
      "abs title :- Oral antibiotics in patients with short bowel syndrome: worth a try!\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 216\n",
      "=====**=====S216=====**======= 15\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall P\n",
      "sess type :- 2-hour Educational WorkshopHall P\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3263 - Adding a twist to the tail: update on spirochaetes of medical and veterinary importance\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Veterinary Microbiology (ESGVM), ESCMID Food- and Water-borne Infections Study Group (EFWISG) Spirochaetes are often regarded as enigmatic, with a general lack of understanding of their ecology, transmission, pathogenesis and diagnostics. This Educational Workshop will update, de-mystify and guide attendees toward best diagnostic and therapeutic practice. Our presenters will cover risks for infection, pathogenesis and inform the audience on the merits of different diagnostic strategies. Furthermore, we will explore the likely broader evolutionary origins of diseases thought once to be human-specific. This obviously has a huge impact on control or possibilities for eradication. The session will be thought-provoking and some aspects controversial, thus stimulating good discussion.\n",
      "sess auth :- Merica CAREV ; Sally Jane CUTLER\n",
      "sess aff :- Croatia; United Kingdom\n",
      "========================================================================================================================\n",
      "3263-1 === \n",
      "abs title :- Leptospirosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3263-2 === \n",
      "abs title :- Dispelling myths on diagnosis of Lyme borreliosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3263-3 === \n",
      "abs title :- Yaws elimination prospects: are humans the only reservoir?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 217\n",
      "=====**=====S217=====**======= 16\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP10 - AMR in LMICs\n",
      "abs text :-  \n",
      "sess auth :- Irene Andia BIRARO\n",
      "sess aff :- Uganda\n",
      "========================================================================================================================\n",
      "ALP1001 === 16:15 - 17:15\n",
      "abs title :- Supporting low- and middle-income countries to fight multidrug-resistant bacterial infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1002 === 16:15 - 17:15\n",
      "abs title :- Would maintaining a hospital microbiology surveillance system be cost-effective in Timor-Leste?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1003 === 16:15 - 17:15\n",
      "abs title :- Population structure and dynamics of antimicrobial resistance among historical enteropathogenic Escherichia coli\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1004 === 16:15 - 17:15\n",
      "abs title :- Neonatal bacteraemia at secondary hospitals in Kenya (NeoBACs)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1005 === 16:15 - 17:15\n",
      "abs title :- Travellers often become colonised by extended- spectrum beta-lactamase-producing Enterobacterales already during their first daysi n the tropics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1006 === 16:15 - 17:15\n",
      "abs title :- Genetic adaptation of hypermutable Pseudomonas aeruginosa colonising the airways of cystic fibrosis patients attending public clinics in Gauteng\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1007 === 16:15 - 17:15\n",
      "abs title :- AmpC β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southeast Asia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1008 === 16:15 - 17:15\n",
      "abs title :- Plasmid-mediated quinolone resistance (PMQR) genes qnr in Escherichia coli isolated in children, animals, water and households in Rural Andean Peru\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1009 === 16:15 - 17:15\n",
      "abs title :- Antimicrobial resistance pattern in Bangladesh (2017-2021): findings from a nationwide surveillance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 218\n",
      "=====**=====S218=====**======= 18\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK05 - Infection control and COVID-19\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PJK0501 === 16:15 - 17:15\n",
      "abs title :- Spatio-temporal analysis of the detection of the SARS-CoV-2 virus in the air of dialysis unit welcoming uninfected and SARS-CoV-2-infected patients during successive sessions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0502 === 16:15 - 17:15\n",
      "abs title :- Epidemiology, time course and risk factors of hospital-acquired bloodstream infections in a cohort of 14884 patients before and during COVID-19 pandemic\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0503 === 16:15 - 17:15\n",
      "abs title :- Automated antimicrobial resistance profile comparison for the detection of bacterial outbreaks during COVID-19 waves\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0504 === 16:15 - 17:15\n",
      "abs title :- Healthcare-associated infections in COVID-19 and non-COVID-19 intensive care unit patients during the pandemic: a prospective surveillance study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0505 === 16:15 - 17:15\n",
      "abs title :- Third-generation cephalosporin overuse during the COVID-19 pandemic and complete susceptibility report of multidrug-resistant Gram-negative bacilli (MDR-GNB) surveillance in critical areas: a good story to tell\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0506 === 16:15 - 17:15\n",
      "abs title :- The burden of Clostridioides difficile infection during the COVID-19 pandemic: a retrospective case-control study in Italian hospitals (CloVid)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0507 === 16:15 - 17:15\n",
      "abs title :- Hospital-acquired infections on the COVID-19 units at a comprehensive cancer centre\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0508 === 16:15 - 17:15\n",
      "abs title :- SARS-CoV-2 infection surveillance in a cohort of hospital healthcare workers\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0509 === 16:15 - 17:15\n",
      "abs title :- The outbreak of Burkholderia ambifaria bacteraemia in COVID-19 patients related to sink contamination with a common environmental isolate\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 219\n",
      "=====**=====S219=====**======= 24\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 16/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET23 - Genomic and Molecular Diagnostics Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGMD The official open business meeting for the ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Hege Vangstein AAMOT ; Belen RODRIGUEZ; Gilbert GREUB ; Cecile BEBEAR ; Eric CLAAS\n",
      "sess aff :- Norway; Spain; Switzerland; France; Netherlands\n",
      "========================================================================================================================\n",
      "inr 220\n",
      "=====**=====S220=====**======= 17\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW05 - Using sequencing to trace SARS-CoV-2\n",
      "abs text :-  \n",
      "sess auth :- Eeva BROBERG\n",
      "sess aff :- Sweden\n",
      "========================================================================================================================\n",
      "EW0501 === 17:15 - 18:15\n",
      "abs title :- SARS-CoV-2 sequencing in a routine NHS laboratory contributing to national surveillance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0502 === 17:15 - 18:15\n",
      "abs title :- The genomic epidemiology of nosocomial SARS-CoV-2 transmission in Exeter (Oct 2020-Feb 2021): a comparison of transmission models\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0503 === 17:15 - 18:15\n",
      "abs title :- Tracking the spread of Omicron subvariants in Switzerland using SARS-CoV-2 full genome sequencing from wastewater samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0504 === 17:15 - 18:15\n",
      "abs title :- Genomic and mutational profiling of SARS-CoV-2 virus causing infection in liver transplant recipients: a single centre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0505 === 17:15 - 18:15\n",
      "abs title :- Emergence of SARS-CoV-2 P.1.17.1 Gamma cases linked to nightlife in Luxembourg, summer 2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0506 === 17:15 - 18:15\n",
      "abs title :- Genetic instability time intervals lead to the emergence of new SARS-CoV-2 variants\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0507 === 17:15 - 18:15\n",
      "abs title :- Genomic surveillance of SARS-CoV-2 VOC Omicron in the Rio Grande do Sul (RS), Southern Brazil\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0508 === 17:15 - 18:15\n",
      "abs title :- Systematic analysis of SARS-CoV-2 coinfections throughout the whole pandemic and segregation of the involved strains\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0509 === 17:15 - 18:15\n",
      "abs title :- Wastewater-based epidemiology of COVID-19 in Belgium and future application\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 221\n",
      "=====**=====S221=====**======= 19\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- PJK01 - Bacterial virulence from bench to bebside\n",
      "abs text :-  \n",
      "sess auth :- Erlangga YUSUF\n",
      "sess aff :- Belgium\n",
      "========================================================================================================================\n",
      "PJK0101 === 17:15 - 18:15\n",
      "abs title :- Assessing the role of the accessory genome of Pseudomonas aeruginosa through functional genomics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0102 === 17:15 - 18:15\n",
      "abs title :- Correlation of oxygen consumption rates of Pseudomonas aeruginosa patient isolates with clinically relevant phenotypes: a multi-omics approach\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0103 === 17:15 - 18:15\n",
      "abs title :- Modelling the host-pathogen interaction in the lung: infecting human bronchial airway organoids with bacterial pathogens\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0104 === 17:15 - 18:15\n",
      "abs title :- Inter-species bacterial interaction in a humanised 3D-airway tissue model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0105 === 17:15 - 18:15\n",
      "abs title :- Bacteriophage ISP in combination with antibiotics, but not alone, eradicates MRSA biofilms on metal implants in vitro\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0106 === 17:15 - 18:15\n",
      "abs title :- Streptopain (speB) derived from S. pyogenes as novel anti-pancreatic cancer drug candidate\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0107 === 17:15 - 18:15\n",
      "abs title :- Metabolites of the skin commensal bacterium S. hominis modulate tight junction barrier function in primary human keratinocytes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0108 === 17:15 - 18:15\n",
      "abs title :- Identification of haemolysis-related pathogenicity factors of Bartonella bacilliformis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0109 === 17:15 - 18:15\n",
      "abs title :- Genetic conflicts between the SXT-element and multidrug resistance plasmids in Vibrio cholerae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 222\n",
      "=====**=====S222=====**======= 23\n",
      "sess date :- 16/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET17 - Brain Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGIB The official open business meeting for the ESCMID Study Group for Infectious Diseases of the Brain (ESGIB). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Jacob BODILSEN ; Stephen L. LEIB ; Matthias KLEIN ; Emma Cecilia WALL ; Matthijs BROUWER\n",
      "sess aff :- Denmark; Switzerland; Germany; United Kingdom; Netherlands\n",
      "========================================================================================================================\n",
      "inr 223\n",
      "=====**=====S223=====**======= 0\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall A\n",
      "sess type :- 2-hour SymposiumHall A\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- 3163 - Measuring the changing threat of COVID-19: a view from four continents\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Scientific Affairs Subcommittee Three years into the pandemic, we are still far from being able to predict what will happen next. A crucial feature of the COVID-19 pandemic has been the changing landscape in terms of severity (e.g., Omicron) and population immunity (from vaccination and prior infection). This symposium aims to provide a platform for leading infectious disease epidemiologists from four continents to showcase their COVID-19 studies and how they assessed the evolving pandemic in their countries. This will include modeling and forecasting infection, hospitalisation and mortality, the effects of vaccination, new variants, and prior immunity at different time points of the pandemic. Altogether these talks should provide some guidance on what worked well and how we can improve assessing future pandemic threats.\n",
      "sess auth :- Joel MOSSONG ; Jacob MORAN\n",
      "sess aff :- Luxembourg; Israel\n",
      "========================================================================================================================\n",
      "3163-1 === \n",
      "abs title :- Measuring the changing threat of COVID-19: an Asian perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3163-2 === \n",
      "abs title :- Measuring the changing threat of COVID-19: an African perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3163-3 === \n",
      "abs title :- Measuring the changing threat of COVID-19: an American perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3163-4 === \n",
      "abs title :- Measuring the changing threat of COVID-19: a European perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 224\n",
      "=====**=====S224=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour SymposiumHall B\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3374 - Neisseria meningitidis: from worldwide epidemiology to national vaccination policies\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Vaccine Study Group (EVASG) Meningococcal disease is a fast-moving field. Recently introduced vaccine against B serotype is likely to affect the burden of the disease. In contrast, the rise of W serotype in Europe questions the need for immunisation beyond B and C serotypes. At the same time, epidemiology in the African meningitis belt is still challenging. This symposium will provide attendees with data regarding epidemiology in various areas, the performances of the different vaccines, their impact, and the recent adaptation of policies to face these evolutions.\n",
      "sess auth :- Olivier EPAULARD ; Kirsten MAERTENS\n",
      "sess aff :- France; Belgium\n",
      "========================================================================================================================\n",
      "3374-1 === \n",
      "abs title :- Meningococcus epidemiology: a worldwide overview\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3374-2 === \n",
      "abs title :- B and non-B meningococcal vaccines: efficacy and impact\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3374-3 === \n",
      "abs title :- National policies regarding meningococcus vaccines in Europe: a moving field\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3374-4 === \n",
      "abs title :- Meningitis in Sub-Saharan Africa and vaccination: progress and pitfalls\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 225\n",
      "=====**=====S225=====**======= 2\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour SymposiumHall C\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3277 - Responsible publishing in CM/ID\n",
      "abs text :- Co-organised with                    \n",
      "Trainee Association of ESCMID (TAE) Steering Committee, CMI Board of Editors Being alert to fraudulent data and images in publications is becoming increasingly important for every scientist and clinician. A culture of open, critical discussion fosters this, as well as additional ways to facilitate discussion in the scientific community, such as blogs. It was evident more than ever during the COVID-19 pandemic, while faulty studies had a worldwide influence. Hyperbole and hype were common. Articles were retracted from journals because of fake data. Such publications might harm patients. Learning how to detect issues with research integrity needs training both for individuals, as well as for journal editorial offices. The symposium aims to discuss how we can prevent such errors with the audience.\n",
      "sess auth :- Ines STEFFENS ; Ursula HOFER\n",
      "sess aff :- Sweden; United Kingdom\n",
      "========================================================================================================================\n",
      "3277-1 === \n",
      "abs title :- \"Hot\" studies with bad methods: responsibility of editors\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3277-2 === \n",
      "abs title :- Bad behaviour and practice\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3277-3 === \n",
      "abs title :- Identifying fraudulent images and figures\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3277-4 === \n",
      "abs title :- Focus on statistics and epidemiology\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 226\n",
      "=====**=====S226=====**======= 4\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S52 - Easy assessing multiplexed PoC molecular diagnostic platform that can differentiate respiratory infectious diseases and new virus (monkeypox)\n",
      "abs text :- Organized by                    \n",
      "SD Biosensor - Effectiveness of differentiation on PoC RT-PCR assay of respiratory infectious viruses such as influenza, RSV, and SARS-CoV-2 \n",
      "- Diagnostics on diversified co-infection patterns and viral loads \n",
      "- Potentially useful PoC PCR assays compare to sophisticated laboratory equipment \n",
      "- Sharing clinical study results: comparison between commercially available confirmatory tests \n",
      "- Introducing diagnostics of monkeypox virus effectiveness compared to approved real-time PCR assay\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 227\n",
      "=====**=====S227=====**======= 5\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S35 - Democratising genomic applications in clinical microbiology research with nanopore sequencing technology\n",
      "abs text :- Organized by                    \n",
      "Oxford Nanopore Technologies Genomics is playing a pivotal role for applications in clinical microbiology and infectious disease, including whole-genome sequencing of bacteria and fungi from isolates, and detection of pathogens and antimicrobial resistance. However, long turnaround times, high economic costs, large device footprints, and inherent technical limitations associated with legacy sequencing platforms have hindered widespread adoption for many of these applications. Nanopore sequencing allows to overcome these limitations by providing accessible, cost-effective devices that generate accurate sequencing reads of any length, from short to ultra-long, and enable rapid turnaround times from receipt of sample to experimental answer/analysis/reporting of findings/conclusions. In this session, leading clinician researchers and scientists in this field will describe the implementation of nanopore sequencing for: (1) low-cost, flexible-throughput isolate sequencing, that produces reference-quality microbial genome assemblies for applications such as outbreak surveillance; (2) rapid detection of Mycobacterium tuberculosis and drug resistance directly from sputum using a targeted PCR-based approach; and (3) metagenomic detection and characterisation of lower respiratory tract infection pathogens.\n",
      "sess auth :- Monika DOLEJSKA\n",
      "sess aff :- Czech Republic\n",
      "========================================================================================================================\n",
      "inr 228\n",
      "=====**=====S228=====**======= 7\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S36 - Next-generation vaccine in the fight against COVID-19\n",
      "abs text :- Organized by                    \n",
      "Sanofi The aim of this session is to bring healthcare?experts together to explore the latest medical developments in COVID-19 vaccinology, to appreciate the global burden of COVID-19, the impact of COVID-19 vaccines on this burden, and the enduring unmet need for COVID-19 booster vaccines, and to understand the scientific rationale for the use of various antigens and formulations in the current COVID-19 booster armamentarium.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 229\n",
      "=====**=====S229=====**======= 9\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour SymposiumHall J\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3296 - Point-of-Care testing (POCT): impact and challenges\n",
      "abs text :- Co-organised with                    \n",
      "Danish Society for Clinical Microbiology Point-of-care (POC) testing is increasingly introduced at the hospital, primary care, and community level. In addition, the COVID-19 pandemic has resulted in molecular-based POC testing being made available at the community level for citizens in most European countries. However, despite its widespread use, there are still major knowledge gaps on the clinical and organisational impact of POC testing, which need to be addressed. The session aims to educate attendees on the many aspects of the use of POC testing.\n",
      "sess auth :- Theresa J. OCHOA ; Gorm LISBY\n",
      "sess aff :- Peru; Denmark\n",
      "========================================================================================================================\n",
      "3296-1 === \n",
      "abs title :- Future of POCT from an engineering perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3296-2 === \n",
      "abs title :- The real-life pros and cons of POCT\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3296-3 === \n",
      "abs title :- Clinical impact of POCT on antimicrobial stewardship and contact isolation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3296-4 === \n",
      "abs title :- The future of diagnostic stewardship and geography of POCT\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 230\n",
      "=====**=====S230=====**======= 10\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall K\n",
      "sess type :- 2-hour Educational WorkshopHall K\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3209 - All for one and one for all! Prevention, diagnostic, and antibiotic stewardship to reduce the burden of AMR: guidance in real cases\n",
      "abs text :- Co-organised with                    \n",
      "EUCIC Steering Committee This workshop aims at providing real clinical case scenarios in the sense of an infection control grand round. The workshop will show how effectively implement the three pillars of diagnostic, prevention, and antibiotic stewardship to reduce the clinical burden of antibiotic-resistant infections. Each speaker will answer specific questions using real cases. It will be presented as an interactive, evidence-based seminar.\n",
      "sess auth :- Nasia SAFDAR ; Elda RIGHI\n",
      "sess aff :- United States; Italy\n",
      "========================================================================================================================\n",
      "3209-1 === \n",
      "abs title :- The VRE-CVC related BSI\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3209-2 === \n",
      "abs title :- The CRE BSI case\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3209-3 === \n",
      "abs title :- The CRPA cUTI case\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 231\n",
      "=====**=====S231=====**======= 11\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall L\n",
      "sess type :- 2-hour SymposiumHall L\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3468 - Antimicrobial stewardship in special populations\n",
      "abs text :- Co-organised with                    \n",
      "World Association for Infectious Diseases and Immunological Disorders (Waidid), European Society for Paediatric Infectious Diseases (ESPID), ESGCIP, ESGAP Antimicrobial resistance (AMR) is a rapidly growing global public health emergency. The increasing AMR has led to the need to develop measures aimed at the rational and effective use of the available drugs. Continuous training of prescribing physicians, collaboration with highly qualified multidisciplinary staff, creation of local and national guidelines, rapid diagnostic tests, and research activities by testing new broad-spectrum antibiotics are mandatory. However, these measures must be supported by adequate investment. This symposium aims to discuss how only by making AMS daily practice, through financial resources and dedicated staff, AMR can be fought to ensure safe and effective care for special populations, like neonates and children, or in specific practices, like dental medicine, ICU or in the ED.\n",
      "sess auth :- Annelies VERBON ; Piersigilli FIAMMETTA\n",
      "sess aff :- Netherlands; Belgium\n",
      "========================================================================================================================\n",
      "3468-1 === \n",
      "abs title :- AMS in children: what are differences from adults?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3468-2 === \n",
      "abs title :- AMS in the ICU: what is best practice in the era of AMR?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3468-3 === \n",
      "abs title :- AMS in the ER: is there room for watchful waiting?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3468-4 === \n",
      "abs title :- AMS in dental practice: are interventions needed?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 232\n",
      "=====**=====S232=====**======= 12\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall M\n",
      "sess type :- 2-hour SymposiumHall M\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3206 - TB infection screening and preventive therapy in high- and low-endemic settings\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Mycobacterial Infections (ESGMYC) Screening for latent tuberculosis infection and preventive therapies are crucial for better control of global tuberculosis (TB) pandemic. Recent studies have brought breakthroughs in our understanding of TB infection and (subclinical) disease, new tests and biomarkers, better ways to predict individual risks for developing TB, and new preventive regimens. This symposium will present state-of-art progress in TB infection and preventive therapies. It will link discovery science, epidemiology, policy, and clinical practice, with relevance to high- and low-TB-endemic settings.\n",
      "sess auth :- Francesca CONRADIE ; Jon S. FRIEDLAND\n",
      "sess aff :- South Africa; United Kingdom\n",
      "========================================================================================================================\n",
      "3206-1 === \n",
      "abs title :- Reassessing the natural history and global burden of TB infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3206-2 === \n",
      "abs title :- New tests and biomarkers for TB preventive therapy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3206-3 === \n",
      "abs title :- Risk stratification for TB preventive therapy in high- and low-endemic settings\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3206-4 === \n",
      "abs title :- Global policy and new developments with respect to TB preventive therapy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 233\n",
      "=====**=====S233=====**======= 13\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall N\n",
      "sess type :- 2-hour Oral SessionHall N\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP08 - Last line antibiotics against pan-drug resistant Gram-negative bacteria\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "ALP0801 === 08:30 - 10:30\n",
      "abs title :- Development of cefiderocol resistance during treatment in Klebsiella pneumoniae due to the association of fhuA, cirA and fiu mutations\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0802 === 08:30 - 10:30\n",
      "abs title :- Change in Klebsiella pneumoniae susceptibility profile after the arrival of ceftazidime-avibactam in Argentina: an ecological nightmare\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0803 === 08:30 - 10:30\n",
      "abs title :- Evaluation of various antibiotic combinations by in vitro time-kill assays against colistin-heteroresistant Klebsiella pneumoniae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0804 === 08:30 - 10:30\n",
      "abs title :- In vitro dynamics and mechanisms of cefiderocol resistance development in Pseudomonas aeruginosa including XDR high-risk clones\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0805 === 08:30 - 10:30\n",
      "abs title :- blaGES-52, a novel GES-type β-lactamase conferring resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Pseudomonas aeruginosa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0806 === 08:30 - 10:30\n",
      "abs title :- Significance of cefiderocol heteroresistance in patients with severe infections by carbapenem-resistant Acinetobacter baumannii: a retrospective clinical and microbiological study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0807 === 08:30 - 10:30\n",
      "abs title :- Transcriptomic analysis reveals the global regulatory role of PmrAB TCS in the clinical colistin-resistant A. nosocomialis isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0808 === 08:30 - 10:30\n",
      "abs title :- Higher colistin dosing associated with a lower mortality in neonates with carbapenem resistant infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0809 === 08:30 - 10:30\n",
      "abs title :- Facile bacterial encapsulation for digital antimicrobial susceptibility testing of colistin\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0810 === 08:30 - 10:30\n",
      "abs title :- Rapid colistin MIC determination by flow-cytometry directly from positive blood cultures\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 234\n",
      "=====**=====S234=====**======= 14\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour Oral SessionHall O\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP14 - Endocarditis update 2023\n",
      "abs text :-  \n",
      "sess auth :- Serap SIMSEK; Maja WEISSER ROHACEK\n",
      "sess aff :- Turkey; Switzerland\n",
      "========================================================================================================================\n",
      "CSP1401 === 08:30 - 10:30\n",
      "abs title :- Recurrence of bacteraemia and infective endocarditis, differences in microbiological aetiology: a nationwide study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1402 === 08:30 - 10:30\n",
      "abs title :- Role of cerebral imaging on diagnosis and management in patients with suspected infective endocarditis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1403 === 08:30 - 10:30\n",
      "abs title :- Evolution, treatment, and prognosis of initially unruptured mycotic aneurysms in patients with infective endocarditis: analysis of a national prospective cohort\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1404 === 08:30 - 10:30\n",
      "abs title :- New insight in endocarditis: do biofilms impact therapy success?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1405 === 08:30 - 10:30\n",
      "abs title :- Use of teicoplanin in the treatment of enterococcal infective endocarditis: a retrospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1406 === 08:30 - 10:30\n",
      "abs title :- Should “Resolution of symptoms suggesting infective endocarditis with antibiotic therapy for ≤4 days” be used to reject infective endocarditis? A study of 1022 febrile patients with suspected infective endocarditis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1407 === 08:30 - 10:30\n",
      "abs title :- Candida endocarditis in the recent years: experience from a large multicentric national series\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1408 === 08:30 - 10:30\n",
      "abs title :- Infective endocarditis treatment: gap between clinical practice and available guidelines; the LEIOT multi-centre study, preliminary results\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1409 === 08:30 - 10:30\n",
      "abs title :- Cutibacterium species infective endocarditis in Spain: data from the GAMES cohort (2008-2022)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1410 === 08:30 - 10:30\n",
      "abs title :- Mortality of infective endocarditis with and without surgery in patients aged over 80 years (MoISE study)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 235\n",
      "=====**=====S235=====**======= 15\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall P\n",
      "sess type :- 2-hour Educational WorkshopHall P\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3219 - Understanding molecular diagnostics in mycology: from standardisation to guidelines\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Fungal Infection Study Group (EFISG), European Confederation of Medical Mycology (ECMM) Molecular diagnostics in mycology has recently been integrated into the guidelines for diagnosing invasive fungal diseases. However, limited standardisation between centres, the remaining high prevalence of in-house tests, and the difficulties in differentiating colonisation from infection in certain sample types (e.g., respiratory samples) in many invasive fungal diseases (e.g., pneumocystosis, aspergillosis) makes it difficult to properly interpret and use these tools efficiently in the clinical setting. This Educational Workshop targets trainees and non-expert senior clinical microbiologists to better understand, incorporate and utilise these essential tools in a routine diagnostic capacity.\n",
      "sess auth :- Ferry HAGEN ; Ana ALASTRUEY\n",
      "sess aff :- Netherlands; Spain\n",
      "========================================================================================================================\n",
      "3219-1 === \n",
      "abs title :- Towards global standardisation of qPCR for fungal disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3219-2 === \n",
      "abs title :- High sensitivity and the colonisation/infection dilemma: how do we cope?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3219-3 === \n",
      "abs title :- Molecular tools for diagnosing IFI: can we do better?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 236\n",
      "=====**=====S236=====**======= 16\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW04 - Age-related susceptibility to COVID and risks in long-term facilities\n",
      "abs text :-  \n",
      "sess auth :- Simona RUTA\n",
      "sess aff :- Romania\n",
      "========================================================================================================================\n",
      "EW0401 === 08:30 - 09:30\n",
      "abs title :- First study of a self-amplifying mRNA (samRNA) vaccine, GRT-R910, as a COVID-19 boost in healthy volunteers ≥60 years of age: preliminary evidence of sustained immunogenicity\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0402 === 08:30 - 09:30\n",
      "abs title :- Monoclonal antibodies in geriatric patients with mild-moderate COVID-19 at high risk of disease progression: comparison between registration and real-life studies\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0403 === 08:30 - 09:30\n",
      "abs title :- Effect of age on human alveolar macrophage responses to SARS-CoV-2 antigens\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0404 === 08:30 - 09:30\n",
      "abs title :- Severity of COVID-19 among residents in aged care facilities in Victoria, Australia: a retrospective cohort study comparing the Delta and Omicron epidemic periods\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0405 === 08:30 - 09:30\n",
      "abs title :- Molecular and epidemiological investigation of a large SARS-CoV-2 outbreak in a long-term care facility in Luxembourg, 2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0406 === 08:30 - 09:30\n",
      "abs title :- Cumulative incidence of SARS-CoV-2 infection amongst staff and residents of long-term care facilities in England over two years (VIVALDI)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0407 === 08:30 - 09:30\n",
      "abs title :- Dementia and COVID-19 outcomes: findings from a multicentric study by the CoviCamp network in Southern Italy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0408 === 08:30 - 09:30\n",
      "abs title :- Real life experience through different COVID-19 waves in an Italian hospital: the challenge of facing a continuous evolving enemy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0409 === 08:30 - 09:30\n",
      "abs title :- Patterns of humoral response to the COVID-19 vaccine in the elderly who have and have not had suffered the disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 237\n",
      "=====**=====S237=====**======= 18\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK06 - Changing viral epidemiology\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MAK0601 === 08:30 - 09:30\n",
      "abs title :- Non-polio enterovirus surveillance from environmental samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0602 === 08:30 - 09:30\n",
      "abs title :- Utility of non-coding region MF-NCR for the identification of chains of transmission and hidden events of importation of measles cases during post-elimination phase in Spain, 2017-2020\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0603 === 08:30 - 09:30\n",
      "abs title :- Enterovirus D68 upsurge in Europe during 2021: an example of early warning from a voluntary network and evidence to harmonise surveillance practices\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0604 === 08:30 - 09:30\n",
      "abs title :- Characterisation of subacute sclerosing panencephalitis (SSPE): a retrospective study at a tertiary diagnostic laboratory in India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0605 === 08:30 - 09:30\n",
      "abs title :- Early molecular evolution tracking of emerging enterovirus D68 by complete genome sequencing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0606 === 08:30 - 09:30\n",
      "abs title :- Poliovirus vaccination status among adult participants in the VACCELERATE Volunteer Registry\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0607 === 08:30 - 09:30\n",
      "abs title :- Progressive multifocal leukoencephalopathy (PML): changing epidemiology and survival in a large cohort of patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0608 === 08:30 - 09:30\n",
      "abs title :- Whole genome sequencing and comparative genomic analysis of MERS-CoV isolated from patients in Saudi Arabia from 2015 to 2019\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0609 === 08:30 - 09:30\n",
      "abs title :- Evaluation of high-risk human papillomavirus prevalance and genotype disribution and cervical smear results in female patients applied to our hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 238\n",
      "=====**=====S238=====**======= 23\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET07 - Biofilms Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGB The official open business meeting for the ESCMID Study Group for Biofilms (ESGB). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Gordon RAMAGE ; Claus MOSER ; Maria Dolores MACIA ROMERO ; Elisa BORGHI ; Joana AZEREDO\n",
      "sess aff :- United Kingdom; Denmark; Spain; Italy; Portugal\n",
      "========================================================================================================================\n",
      "inr 239\n",
      "=====**=====S239=====**======= 17\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK10 - Vector-borne diseases\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MAK1001 === 09:30 - 10:30\n",
      "abs title :- Identifying novel druggable host targets for Zika virus infection using a quantitative phosphoproteomics approach\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1002 === 09:30 - 10:30\n",
      "abs title :- Hearing loss in dengue fever: a case control study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1003 === 09:30 - 10:30\n",
      "abs title :- Dengue infection in the tertiary care hospital of northern India: cross-sectional latent class cluster analysis in different serotypes of dengue infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1004 === 09:30 - 10:30\n",
      "abs title :- Metagenomic virome screening of potentially invasive mosquito species in Austria reveals WNV circulation in Aedes albopictus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1005 === 09:30 - 10:30\n",
      "abs title :- The west study: a multicentric study on the impact of steroid therapy in West Nile encephalitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1006 === 09:30 - 10:30\n",
      "abs title :- West Nile virus neuroinvasive infection in centre eastern of Tunisia in 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1007 === 09:30 - 10:30\n",
      "abs title :- The association of the intrathecal inflammation with genetic background in tick-borne encephalitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1008 === 09:30 - 10:30\n",
      "abs title :- Management of patients with tick-borne encephalitis by infectious diseases specialists or neurologists\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK1009 === 09:30 - 10:30\n",
      "abs title :- Toscana virus infection clinical characterisation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 240\n",
      "=====**=====S240=====**======= 19\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- PAK03 - Outbreaks: early recognition and diagnosis\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PAK0301 === 09:30 - 10:30\n",
      "abs title :- Diphtheria outbreak among young asylum seekers in a national asylum centre in Basel, Switzerland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0302 === 09:30 - 10:30\n",
      "abs title :- Corynebacterium diphtheriae among asylum seekers in the UK\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0303 === 09:30 - 10:30\n",
      "abs title :- Ongoing European outbreak of Corynebacterium diphtheriae among asylum seekers: situational report illuminated through whole genome sequencing (WGS)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0304 === 09:30 - 10:30\n",
      "abs title :- An outbreak of cutaneous leishmaniasis among returning agricultural students ex Israel, Thailand 2018\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0305 === 09:30 - 10:30\n",
      "abs title :- An unusual outbreak of cryptosporidiosis in a British military population in Kenya\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0306 === 09:30 - 10:30\n",
      "abs title :- Accuracy of Fourier transform infrared spectroscopy to diagnose simultaneous carbapenemase producing Enterobacteriales outbreaks in a tertiary care hospital: a one year retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0307 === 09:30 - 10:30\n",
      "abs title :- Defining a national outbreak surveillance approach for methicillin-resistant Staphylococcus aureus within Genomic Medicine Sweden\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0308 === 09:30 - 10:30\n",
      "abs title :- Refining the outbreak definition: genotyping, resistome analysis and outbreak mapping of an ESBL Klebsiella pneumoniae outbreak on a neonatal intensive care unit at a large north-west England acute trust using short-read whole genome sequencing technology\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0309 === 09:30 - 10:30\n",
      "abs title :- IR Biotyper: a new tool in outbreak detection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 241\n",
      "=====**=====S241=====**======= 24\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET08 - Bloodstream Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGBIES The official open business meeting for the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Brigitte LAMY ; Maddalena GIANNELLA ; Achim KAASCH ; Yehuda CARMELI ; Willem Joost WIERSINGA\n",
      "sess aff :- France; Italy; Germany; Israel; Netherlands\n",
      "========================================================================================================================\n",
      "inr 242\n",
      "=====**=====S242=====**======= 0\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3475 - Mitigation of rotavirus: current and future\n",
      "abs text :-  Professor Kang is a physician scientist, known for her inter-disciplinary research studying the transmission, development and prevention of enteric infections and their sequelae in children in India. To develop practical approaches and to support public health, she developed multi-site rotavirus and typhoid surveillance networks across India and southeast Asia, established laboratories to support vaccine trials and conducted phase I-III clinical trials of vaccines, a successful approach that has supported two Indian WHO pre-qualified vaccines.\n",
      "sess auth :- Snjezana ZIDOVEC LEPEJ ; Joanne M LANGLEY\n",
      "sess aff :- Croatia; Canada\n",
      "========================================================================================================================\n",
      "3475-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 243\n",
      "=====**=====S243=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall B\n",
      "sess type :- Meet-the-ExpertHall B\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- 3344 - When an entire country is a cohort: harnessing epi and micro data\n",
      "abs text :-  This session highlights a particular strength of the ECCMID hosting country in fighting COVID-19 pandemic. Denmark has a unique national infrastructure for healthcare data related to each person's social security number. In this session, speakers will show how these data were used in daily clinical practice, public health, and research.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3344-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3344-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 244\n",
      "=====**=====S244=====**======= 2\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall C\n",
      "sess type :- Meet-the-ExpertHall C\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3220 - Managing multidrug-resistant Candida infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Fungal Infection Study Group (EFISG), European Confederation of Medical Mycology (ECMM) The emergence of Candida species with resistance to more than one antifungal therapy represents a serious global threat, given the significant number of patients at risk from or diagnosed with invasive candidiasis and the limited number of available antifungal drug classes. Successful management of such cases is often dependent on early diagnosis and subsequent identification of resistance. Still, it is complicated by guidelines being based on limited evidence-based data, with recommendations often based on a compilation of anecdotal evidence. This session will ask healthcare experts with significant experience in managing cases/outbreaks with multidrug-resistant Candida species to provide a personal, evidence-based perspective for managing these infections and future perspectives to minimise the impact of these global threats.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3220-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3220-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 245\n",
      "=====**=====S245=====**======= 3\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall D\n",
      "sess type :- 1-hour SymposiumHall D\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3142 - Health problems of the largest wave of war refugees in modern history in Europe\n",
      "abs text :- Co-organised with                    \n",
      "Polish Society of Epidemiology and Infectious Diseases, Slovak Society for Infectious Diseases The current war crisis and the massive influx of refugees increased the likelihood of a new wave of coronavirus infections in refugee host countries because the conditions in which they are housed are conducive to the transmission of the virus. Poor hygienic conditions, malnutrition, and high levels of stress are additional risk factors for exacerbating chronic diseases, as well as the emergence of infectious diseases typical of such conditions, including whooping cough, measles, infectious diarrhoea, viral and bacterial respiratory infections, and meningitis. The most difficult epidemiological situation in Ukraine concerns diseases most easily transmitted, by droplet route, such as tuberculosis, whooping cough, measles, and HIV/AIDS through sexual contact.\n",
      "sess auth :- Robert FLISIAK ; Pavol JARCUSKA\n",
      "sess aff :- Poland; Slovakia\n",
      "========================================================================================================================\n",
      "3142-1 === \n",
      "abs title :- Infectious diseases among Ukrainian refugees in Poland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3142-2 === \n",
      "abs title :- Health problems in Ukrainian refugees in Slovakia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 246\n",
      "=====**=====S246=====**======= 4\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall E\n",
      "sess type :- 1-hour SymposiumHall E\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3239 - Chlamydia: from the epidemiology to the clinics\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD), ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) This symposium aims to share current knowledge on chlamydia, starting from new discoveries about chlamydial biology made during the last two years in term of cell and molecular biology. Presentations will be clinically oriented, highlighting diagnostics issues and treatment/infection management of chlamydia pathogens.\n",
      "sess auth :- Hege Vangstein AAMOT ; Kate TEMPLETON\n",
      "sess aff :- Norway; United Kingdom\n",
      "========================================================================================================================\n",
      "3239-1 === \n",
      "abs title :- Chlamydia pneumoniae: its role in bronchitis, pneumonia and asthma\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3239-2 === \n",
      "abs title :- Chlamydia psittaci: epidemiology, diagnosis and treatment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 247\n",
      "=====**=====S247=====**======= 5\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall F\n",
      "sess type :- 1-hour Oral SessionHall F\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- CSP02 - Immune protection in vulnerable populations\n",
      "abs text :-  \n",
      "sess auth :- Muge CEVIK\n",
      "sess aff :- United Kingdom\n",
      "========================================================================================================================\n",
      "CSP0201 === 11:00 - 12:00\n",
      "abs title :- How to identify common variable immunodeficiency patients earlier: drug consumption\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0202 === 11:00 - 12:00\n",
      "abs title :- Immune suppression is common and becoming more common in patients presenting with community-acquired pneumonia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0203 === 11:00 - 12:00\n",
      "abs title :- Mono vs combined therapy in immunocompromised COVID-19 in-patients: addressing an unmet need\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0204 === 11:00 - 12:00\n",
      "abs title :- ­Human GTF3A deficiency predisposes to neuroinvasive HSV-1 infection by disrupting host-derived antiviral ligands\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0205 === 11:00 - 12:00\n",
      "abs title :- High-dose vs standard dose quadrivalent influenza vaccine influences the degree of early innate immune response and late humoral response in subjects over 65 years old\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 248\n",
      "=====**=====S248=====**======= 6\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall G\n",
      "sess type :- 1-hour SymposiumHall G\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3467 - Strengthening laboratory systems in Africa\n",
      "abs text :- Co-organised with                    \n",
      "American society of Microbiology (ASM) The current COVID-19 pandemic has revealed the importance of local laboratory systems to detect emerging pathogens rapidly and reliably. As a result, the African continent is investing in its infrastructure to address current infectious disease outbreaks and prepare for future pandemics, such as antimicrobial-resistant 'superbugs.' The speakers will share the strategies and approaches of their respective organisations to strengthen laboratory systems, including bolstering reference laboratories, initiatives to enable genomic sequencing, and developing ecosystems to support critical networks. These lessons will inform One Health-driven policy and advocacy efforts to catalyse much needed investments into laboratory systems.\n",
      "sess auth :- Wes KIM\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "3467-1 === \n",
      "abs title :- Strengthening Ghana's laboratory systems to enable effective surveillance of infectious diseases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3467-2 === \n",
      "abs title :- Preparing Africa's lab systems for the next pandemic: lessons learned from COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 249\n",
      "=====**=====S249=====**======= 7\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall H\n",
      "sess type :- 1-hour Oral SessionHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- BES12 - Digital applications for participatory infection surveillance\n",
      "abs text :-  \n",
      "sess auth :- Pontus NAUCLER\n",
      "sess aff :- Sweden\n",
      "========================================================================================================================\n",
      "BES1201 === 11:00 - 12:00\n",
      "abs title :- Community engagement in the design of tuberculosis integrated research platform trials\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1202 === 11:00 - 12:00\n",
      "abs title :- The role of participant engagement: lessons from 24 months of following up SARS-CoV-2 Immunity & Reinfection Evaluation (SIREN) study participants, UK\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1203 === 11:00 - 12:00\n",
      "abs title :- CoronaCheck: rapid development of a self-assessment and triage tool for managing the early stages of the COVID-19 pandemic in Switzerland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1204 === 11:00 - 12:00\n",
      "abs title :- Flåtinfo.dk, a citizen-science project and source of information about ticks: outcomes after one year from launch of the website\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES1205 === 11:00 - 12:00\n",
      "abs title :- The WoundApp: a citizen tool\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 250\n",
      "=====**=====S250=====**======= 8\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour Oral SessionHall I\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP19 - Cutting edge in respiratory bacterial infections\n",
      "abs text :-  \n",
      "sess auth :- Delia GOLETTI\n",
      "sess aff :- Italy\n",
      "========================================================================================================================\n",
      "CSP1901 === 11:00 - 12:00\n",
      "abs title :- Clinical presentation and disease course of clinical pneumonia in primary care according to microbiological aetiology: ancillary study of a randomised controlled trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1902 === 11:00 - 12:00\n",
      "abs title :- Immunomodulatory effect of different antimicrobial combinations with corticosteroids against severe S. pneumoniae pneumonia: an experimental study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1903 === 11:00 - 12:00\n",
      "abs title :- Epidemiology and aetiology of community-acquired pneumonia in adults across Europe during the COVID-19 pandemic\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1904 === 11:00 - 12:00\n",
      "abs title :- Steep decrease in the carriage of pneumococcal serotype 6C in Belgian children attending day-care centres two years after the switch from PCV10 to PCV13\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1905 === 11:00 - 12:00\n",
      "abs title :- The clinical impact of syndromic point-of-care PCR testing on antibiotic treatment of patients admitted with suspected community-acquired pneumonia in emergency departments: a multi-centre randomised controlled trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 251\n",
      "=====**=====S251=====**======= 9\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour SymposiumHall J\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3318 - Personalised prevention and control of HAIs in the ICU\n",
      "abs text :- Co-organised with                    \n",
      "Healthcare Infection Society Current national approaches to infection and AMR prevention are broad multi-modal strategies commonly undertaken at specific points within patients' healthcare journey. Unfortunately, this model is often reactionary and fails to address additional opportunities to enhance prevention. With technological progression in pathogen detection, infection prediction, and therapeutic monitoring, coupled with a national focus on healthcare services harmonisation, this session explores how these advances support the development of proactive and individualised prevention measures and their impact on optimising patient outcomes safety. It will provide the audience with a unique understanding of novel advances in infection prediction and diagnostic techniques, updates in the implementation of personal therapeutic monitoring, and consideration of opportunities to challenge current concepts of public health and IPC.\n",
      "sess auth :- Bruno MEGARBANE ; James PRICE\n",
      "sess aff :- France; United Kingdom\n",
      "========================================================================================================================\n",
      "3318-1 === \n",
      "abs title :- Predicting healthcare-associated infections to allow targeted interventions and response to public health issues\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3318-2 === \n",
      "abs title :- Personalised perioperative antibiotic therapy and control of HAIs in the ICU\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 252\n",
      "=====**=====S252=====**======= 10\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3478 - Year in clinical microbiology\n",
      "abs text :-  \"Year in..\" sessions are very well-attended 1-hour Symposia where speakers review recent literature on the topic. ECCMID 2023 will feature four \"Year in.\" sessions: the traditional \"Year in clinical microbiology\", \"Year in infection control\" and \"Year in infectious diseases\", and the new \"Year in public health\".\n",
      "sess auth :- Colin R. MACKENZIE ; Daniela Maria CIRILLO\n",
      "sess aff :- Germany; Italy\n",
      "========================================================================================================================\n",
      "3478-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3478-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 253\n",
      "=====**=====S253=====**======= 11\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour SymposiumHall L\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3238 - Phage therapy: countering resistance development\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA), Sociedad Española de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC) Genome sequencing enables us to precisely track the evolutionary dynamics of bacterial pathogens under pressure of phages in vitro but also during treatment. Indeed, when samples are collected regularly over the course of a therapy, these approaches can reveal genetic mutations causing resistance to the phage, as well as adaptation of the phage during its amplification and circulation in vivo. In this workshop we will discuss the insights these bioinformatics approaches offer and illustrate their practical applications using examples from recent in vitro studies as well as phage therapy cases.\n",
      "sess auth :- Zuzanna DRULIS; Shawna MCCALLIN\n",
      "sess aff :- Poland; Switzerland\n",
      "========================================================================================================================\n",
      "3238-1 === \n",
      "abs title :- In vitro to in vivo predictions of bacterial evolution in phage therapy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3238-2 === \n",
      "abs title :- Molecular mechanisms of resistance to phage infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 254\n",
      "=====**=====S254=====**======= 12\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour Oral SessionHall M\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK05 - Bone and prosthetic joint infections: addressing diagnostic challenges\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PAK0501 === 11:00 - 12:00\n",
      "abs title :- Improving the diagnosis of bone and joint infections: evaluation of 16S rRNA Nanopore metagenomics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0502 === 11:00 - 12:00\n",
      "abs title :- Comparison of culture, amplicon next-generation sequencing and metagenomic next-generation sequencing of sonication fluid in the diagnosis of orthopaedic implant-associated infections due to Cutibacterium acnes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0503 === 11:00 - 12:00\n",
      "abs title :- Sensitive pathogen detection directly from synovial fluid by metagenomic next-generation sequencing (mNGS)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0504 === 11:00 - 12:00\n",
      "abs title :- Evaluation of a new rapid syndromic multiplex PCR panel for the diagnosis of patients with a suspicion of joint infection in a real world environment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0505 === 11:00 - 12:00\n",
      "abs title :- Patients with post-traumatic Pseudomonas aeruginosa osteomyelitis admitted to the MSF (Medecins Sans Frontieres) orthopaedic centres in the conflict settings of Mosul, Iraq and Gaza, Palestine between 2018 and 2021: a retrospective descriptive cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 255\n",
      "=====**=====S255=====**======= 13\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall N\n",
      "sess type :- 1-hour SymposiumHall N\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3398 - Ethical dilemmas with antimicrobial therapy\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Ethics Advisory Committee (EEAC) Antibiotics are an example of a \"tragedy of the commons\"; if we use them irresponsibly for some patients, we may harm others. Furthermore, we daily face the conflict of prescribing the current patient antibiotics while hoping not to harm future patients with resistance. Hence, the use of antibiotics and antimicrobial resistance are ethical issues. This symposium aims to discuss the ethical significance of antimicrobial use and resistance. We will also discuss issues concerning costs of antibiotics, distribution between high and low-income countries, how guidelines should address the differences between countries, and models for reimbursing hospitals for antibiotic costs. The management of antibiotics in patients at end-of-life will also be presented.\n",
      "sess auth :- Asma NASIM ; Dafna YAHAV\n",
      "sess aff :- Pakistan; Israel\n",
      "========================================================================================================================\n",
      "3398-1 === \n",
      "abs title :- Antibiotics at the end-of-life\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3398-2 === \n",
      "abs title :- Ethical dilemmas on antimicrobial stewardship in LMICs: cost vs antimicrobial use/infection control\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 256\n",
      "=====**=====S256=====**======= 14\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall O\n",
      "sess type :- Meet-the-ExpertHall O\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3218 - How to incorporate gender in AMR\n",
      "abs text :-  Integrating a gender lens?is a prerequisite for quality public health research and the significance of cuts across human, animal, and environmental health.?Gender and its intersections with other socio-behavioral factors shape the emergence of antimicrobial resistance (AMR) and influence who can access, use, and benefit from antimicrobials.?There is,?however,?limited evidence addressing?the impact of gender-related?inequalities on AMR or antimicrobial use nor a compendium of best practices to incorporate a gender lens in AMR research. Available studies focus on physiological differences based on sex rather than socially constructed differences based on gender, and current research designs?are often gender blind.??A gender lens?supports the quality, credibility and relevance of AMR research and ultimately increases the?impact and sustainability of interventions in real-world scenarios.?This session offers guidance?on incorporating a gender lens across the AMR research-intervention continuum.?\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3218-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3218-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 257\n",
      "=====**=====S257=====**======= 15\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour Case SessionHall P\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES02 - Puzzling parasites\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "BES0201 === 11:00 - 12:00\n",
      "abs title :- Identification of toxoplasmosis in hematology patients after allogenic stem cell transplantation by next-generation sequencing (NGS): a case series\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0202 === 11:00 - 12:00\n",
      "abs title :- Case series of human fascioliasis at a tertiary care centre in southern India increasing the index of suspicion\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0203 === 11:00 - 12:00\n",
      "abs title :- Spinal cystic echinococcosis: challenges in clinical management associated with a difficult to treat parasitic infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0204 === 11:00 - 12:00\n",
      "abs title :- Severe toxoplasmosis pneumonia requiring intubation in an immunocompetent patient after consumption of deer meat in the southern United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0205 === 11:00 - 12:00\n",
      "abs title :- Worm globalisation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 258\n",
      "=====**=====S258=====**======= 16\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP11 - Old antibiotics used for MDR Gram-negative infections\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "ALP1101 === 11:00 - 12:00\n",
      "abs title :- Occurrence of plasmid-mediated fosfomycin resistance (fos genes) among Escherichia coli isolates, Portugal\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1102 === 11:00 - 12:00\n",
      "abs title :- In vitro activity of fosfomycin against ceftazidime/avibactam-resistant blaKPC-producing Klebsiella pneumoniae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1103 === 11:00 - 12:00\n",
      "abs title :- Determination of fosfomycin resistance uropathogens isolated from patients attended in 34 primary care units (PCU) and comparison of disk-diffusion and agar dilution methods\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1104 === 11:00 - 12:00\n",
      "abs title :- Efficacy and safety of ceftazidime/avibactam alone or in combination with fosfomycin for the treatment of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP): a multicentric retrospective study from the SUSANA database.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1105 === 11:00 - 12:00\n",
      "abs title :- Comparison of growth rates among clinical Klebsiella pneumoniae (KP) isolates stratified by the production of inner colonies during fosfomycin disk diffusion (DD) testing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1106 === 11:00 - 12:00\n",
      "abs title :- Evaluation of in-house agar dilution for susceptibility to fosfomycin in Enterobacterales and minimal inhibitory concentration distribution\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1107 === 11:00 - 12:00\n",
      "abs title :- Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1108 === 11:00 - 12:00\n",
      "abs title :- Clinical risk factors and survival effect of colistin heteroresistant Pseudomonas aeruginosa: a university hospital experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1109 === 11:00 - 12:00\n",
      "abs title :- Polymyxin-including therapy versus colistin-including therapy in the therapy of carbapenem-resistant Gram-negative infections: a retrospective matched cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 259\n",
      "=====**=====S259=====**======= 18\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD02 - Infection against infections: innovative studies with phages\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MYD0201 === 11:00 - 12:00\n",
      "abs title :- Phage-antibiotic combinations eradicate XDR Pseudomonas aeruginosa in 4-day ex vivo simulated endocardial vegetation models\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0202 === 11:00 - 12:00\n",
      "abs title :- Bacteriophage-antibiotic combinations as an alternative treatment option for carbapenem-resistant Pseudomonas aeruginosa (CRPA)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0203 === 11:00 - 12:00\n",
      "abs title :- Combined antibacterial effect of a bacteriophage with beta-lactams on multidrug-resistant Pseudomonas aeruginosa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0204 === 11:00 - 12:00\n",
      "abs title :- Engineering P. aeruginosa phage genomes with enhanced functionalities\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0205 === 11:00 - 12:00\n",
      "abs title :- Formulating a phage cocktail targeting Klebsiella pneumoniae high-risk clone ST258 using the GENPH (GENeva PHage) collection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0206 === 11:00 - 12:00\n",
      "abs title :- Tackling epidemic/pandemic multidrug-resistant ST131 Escherichia coli strains using therapeutic phages\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0207 === 11:00 - 12:00\n",
      "abs title :- In vitro activity of meropenem in combination with lytic bacteriophages against carbapenemase-producing Klebsiella pneumoniae isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0208 === 11:00 - 12:00\n",
      "abs title :- Randomised double-blind study to determine multiple doses, safety and tolerability of TP-102 bacteriophage cocktail in subjects with non-infected and infected diabetic foot ulcers\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0209 === 11:00 - 12:00\n",
      "abs title :- Understanding the pharmacokinetics/pharmacodynamics of anti-pseudomonal bacteriophage therapy using mathematical models: connecting the dots to advance phage therapy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 260\n",
      "=====**=====S260=====**======= 21\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET09 - Lyme Borreliosis Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGBOR The official open business meeting for the ESCMID Study Group for Lyme Borreliosis (ESGBOR). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Mateusz MARKOWICZ ; Volker FINGERLE ; Anna J HENNINGSSON\n",
      "sess aff :- Austria; Germany; Sweden\n",
      "========================================================================================================================\n",
      "inr 261\n",
      "=====**=====S261=====**======= 3\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S40 - How can we optimise the management of critically ill patients with CRE-KPC infections: from clinical trials to clinical practice\n",
      "abs text :- Organized by                    \n",
      "Menarini Group Carbapenem-resistant Enterobacteriales (CRE) have been listed by the WHO as high-priority pathogens owing to their high association with mortality and morbidity in particular in the intensive care units. They present a public health threat worldwide.  \n",
      "The advent of new treatments provides additional options, but are they being used judiciously? Are changes in the attitude of HCPs and other stakeholders needed to optimise clinical outcomes for the patient? This symposium aims to explore how a personalised resistance mechanism-based approach is key to the successful treatment of MDRGNI specifically CRE-KPC in order to achieve the best outcomes for the patient and for modern medicine in the context of antimicrobial resistance.\n",
      "sess auth :- Alasdair P. MACGOWAN\n",
      "sess aff :- United Kingdom\n",
      "========================================================================================================================\n",
      "inr 262\n",
      "=====**=====S262=====**======= 4\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S39 - BacteriologIA: Artificial Intelligence applied to bacteriology\n",
      "abs text :- Organized by                    \n",
      "Copan Group Technological innovation is growing in the healthcare system. \n",
      "The microbiology laboratory has, like never before, the opportunity to change. The introduction of lab automation, digitalisation, and Artificial Intelligence can aid the microbiologist in managing the multiple challenges that a modern microbiology laboratory faces: staff reduction, inquiry of traceability, improved quality, reduction of turn-around time, and the importance of demonstrating the clinical value brought by the microbiology lab to the patient.  \n",
      "In this symposium, we will present the experiences of clinical laboratories that re-shaped their workflows according to the adoption of new technologies.\n",
      "sess auth :- Derek MACFADDEN\n",
      "sess aff :- Canada\n",
      "========================================================================================================================\n",
      "inr 263\n",
      "=====**=====S263=====**======= 5\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S37 - TBC\n",
      "abs text :- Organized by                    \n",
      "Pfizer TBC\n",
      "sess auth :- Annefleur LANGEDIJK\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "inr 264\n",
      "=====**=====S264=====**======= 6\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S15 - The uUTI paradox: appropriate antibiotics use in empiric setting? Harnessing data to support clinical practice\n",
      "abs text :- Organized by                    \n",
      "GSK Paradox of EMPIRIC uUTI management: Explore the current clinical challenges in the appropriate uUTI management and decision tree, limited time for consultation and needs of patients with seeking rapid symptom resolution (Florian's presentation) \n",
      "Paradox of APPROPRIATE uUTI management: Navigate through the principles of treatment stewardship, exploring the challenges of appropriate antibiotic prescribing to the appropriate uUTI patient and considering clinical solution tools such a resistance predictive risk models and local antibiotic surveillance to overcome the challenge of antimicrobial resistance in the community (Ryan's presentation)\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 265\n",
      "=====**=====S265=====**======= 7\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S38 - Value of the syndromic approach for testing respiratory tract infections at point of care\n",
      "abs text :- Organized by                    \n",
      "bioMérieux Molecular point-of-care testing can directly influence the timely and proper care of patients experiencing symptoms of respiratory tract infections. This symposium will discuss the value of the syndromic approach used in  point-of-care. We will discuss how rapid and actionable results available during a patient visit have the potential to impact patient outcomes and antibiotic stewardship. The challenges of delocalising diagnostic testing away from the controlled diagnostic laboratory environment to the Emergency Department will be debated.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 266\n",
      "=====**=====S266=====**======= 17\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 2\n",
      "sess type :- Open ForumArena 2\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3449 - Adaptive platform trials after the COVID-19 pandemic\n",
      "abs text :- Co-organised with                    \n",
      "European Clinical Research Alliance on Infectious Diseases (ECRAID) Adaptive platforms were crucial for the fast evaluation of new treatments for COVID-19. These methodologically innovative trials also reflected successful international collaborations that will be sustained after the pandemic. In this session, the study designs and contents of four adaptive platform trials will be presented with a focus on post-pandemic interventions. The audience will benefit from knowledge about the study designs and the interventions currently evaluated. REMAP-CAP, EU-SolidAct, and ECRAID-PRIME were active during the pandemic. SNAP was designed to evaluate several aspects of S. aureus bacteraemia treatment.\n",
      "sess auth :- Marlieke DE KRAKER\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "3449-1 === \n",
      "abs title :- REMAP-CAP\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3449-2 === \n",
      "abs title :- ECRAID-PRIME\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3449-3 === \n",
      "abs title :- EU-SolidAct\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3449-4 === \n",
      "abs title :- SNAP (Staphylococcus aureus Network Adaptive Platform)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 267\n",
      "=====**=====S267=====**======= 19\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 4\n",
      "sess type :- Open ForumArena 4\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3332 - Gamification and simulated environments in CM/ID education\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Education Subcommittee, Trainee Association of ESCMID (TAE) Steering Committee, International Federation of Medical Students Associations In recent years, the focus of medical education has shifted to a more learner-centred model with an emphasis on team-based problem solving that is essential to the practice of modern healthcare. Innovative, game-based approaches to medical education can act as a low-cost, high-impact resource for various learners, as they have been shown to increase engagement and participation on an individual and team basis. This Open Forum will discuss practical examples of gamification for infectious diseases education, including simulated environments of escape rooms, competitive infection-based card games, and online quizzes. In addition, the participants will hear from experts with real-world experience of the implementation of gamification in practice and gain knowledge on how to implement these ideas in their practice.\n",
      "sess auth :- Anja STERBENC\n",
      "sess aff :- Slovenia\n",
      "========================================================================================================================\n",
      "3332-1 === \n",
      "abs title :- A tale of survival game\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3332-2 === \n",
      "abs title :- ECCMID experience: escape room dos and don'ts\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3332-3 === \n",
      "abs title :- Playing your cards right: how to design an infection card game\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 268\n",
      "=====**=====S268=====**======= 20\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:00 - 13:30\n",
      "sess loca :- Poster Area\n",
      "sess type :- Poster SessionPoster Area\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- PS069 - 10a. Host genetics: infection susceptibility & primary immunodeficiency\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PS06901 === 12:00 - 13:30\n",
      "abs title :- Polymorphisms in genes regulating innate immunity and risk for RVVC in Nigerian women\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 269\n",
      "=====**=====S269=====**======= 22\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:30 - 13:30\n",
      "sess loca :- 179 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting179 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET31 - Veterinary Microbiology Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGVM The official open business meeting for the ESCMID Study Group for Veterinary Microbiology (ESGVM). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Luca GUARDABASSI ; Sally Jane CUTLER ; Els BROENS\n",
      "sess aff :- Denmark; United Kingdom; Netherlands\n",
      "========================================================================================================================\n",
      "inr 270\n",
      "=====**=====S270=====**======= 24\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 12:30 - 13:30\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET18 - Compromised Host Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGICH The official open business meeting for the ESCMID Study Group for Infections in Compromised Hosts (ESGICH). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Monica SLAVIN ; Christian VAN DELDEN ; Carlos CERVERA ; Jose Maria AGUADO GARCIA ; Paolo Antonio GROSSI\n",
      "sess aff :- Australia; Switzerland; Canada; Spain; Italy\n",
      "========================================================================================================================\n",
      "inr 271\n",
      "=====**=====S271=====**======= 0\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3299 - The role of the archaeome: composition and function in human health and disease\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI) Archaea represent a separate domain of life, distinct from bacteria and eukarya. The archaea constitute a considerable fraction of the Earth's ecosystems and have been identified as a substantial component of complex microbiomes in plants, animals, humans, and the environment. However, the human archaeome remained little studied until recently, due to methodological limitations. New insights indicate that the archaea of the human microbiome (i.e. the archaeome) are diverse and use unique metabolic pathways to produce a variety of metabolites that contribute to host-microbe interactions, potentially influencing human health and disease.\n",
      "sess auth :- Joshua NOSANCHUK\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "3299-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 272\n",
      "=====**=====S272=====**======= 1\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall B\n",
      "sess type :- Meet-the-ExpertHall B\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3465 - How to set up in house qPCR assays for rare pathogens?\n",
      "abs text :-  In-house qPCR has become a routine method for detecting and quantifying pathogens in clinical samples. Many laboratories perform dozens and hundreds of PCR reactions daily in single and multiplex formats. While many assays are commercially available, there is still substantial reliance on in-house assays. This is evident in the case of rare and unusual pathogens for which no readily available solutions exist. In this session, two experts in qPCR will provide tips and tricks on approaching the development of qPCR for rare pathogens, overcoming challenges related to quality control, availability of control materials, and monitoring assay performance.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3465-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 273\n",
      "=====**=====S273=====**======= 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour Oral SessionHall C\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP17 - New developments in bacterial CNS infections\n",
      "abs text :-  \n",
      "sess auth :- Emma Cecilia WALL\n",
      "sess aff :- United Kingdom\n",
      "========================================================================================================================\n",
      "CSP1701 === 13:30 - 14:30\n",
      "abs title :- Dynamics of complement system activation in bacterial meningitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1702 === 13:30 - 14:30\n",
      "abs title :- Role of pericytes in experimental pneumococcal meningitis: investigations in a mouse model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1703 === 13:30 - 14:30\n",
      "abs title :- The challenge of aetiologic diagnosis of subacute or chronic meningitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1704 === 13:30 - 14:30\n",
      "abs title :- Community-acquired Staphylococcus aureus meningitis in adults\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1705 === 13:30 - 14:30\n",
      "abs title :- SARS-CoV-2 pandemic and Neisseria meningitidis serogroup B invasive infections: insights from Italian surveillance data and vaccination rates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 274\n",
      "=====**=====S274=====**======= 3\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S54 - C. difficile infection: targeting an unwelcome and persistent threat\n",
      "abs text :- Organized by                    \n",
      "Tillotts Pharma The aim of the scientific symposium are:\n",
      ".\tTo explore and understand the diagnostic landscape for Clostridioides difficile infection (CDI) including the epidemiology and surveillance of infection and approaches to diagnosis\n",
      ".\tTo present profiles of patients at highest risk for CDI, and the role of dysbiosis and antimicrobial use in disease\n",
      ".\tTo present data exploring extended dosing regimens of antibiotics in managing CDI\n",
      ".\tTo explore a challenging patient case with the audience and Faculty collaborating to consider how to approach assessment and treatment to achieve the best outcome\n",
      "sess auth :- Anne GONZALES\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "inr 275\n",
      "=====**=====S275=====**======= 4\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S42 - Diagnostics in the post-COVID-19 era: variants, superbugs and future pandemics\n",
      "abs text :- Organized by                    \n",
      "Cepheid It is important in the post-COVID-19 era to focus on the future role of diagnostics for infectious diseases. In this Integrated Symposium, hear from leaders in their field presenting contemporary data on current and emerging healthcare threats. They will focus on the detection of microorganisms which might cause future pandemics as well as respiratory threats posed by flu and COVID variants. The topics of healthcare- associated infections, Group B streptococcus infections in new-born babies and antimicrobial resistance will also be covered. Evidence will be presented on how fast molecular tests can innovate patient management, infection control and antimicrobial stewardship.\n",
      "sess auth :- Belen RODRIGUEZ\n",
      "sess aff :- Spain\n",
      "========================================================================================================================\n",
      "inr 276\n",
      "=====**=====S276=====**======= 5\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S46 - Immunising adults: understanding prevention options and gaps for those at risk\n",
      "abs text :- Organized by                    \n",
      "GSK The aims of the symposium are to present the global status of adult immunisation, its value, current gaps and factors increasing the risk and severity of clinical outcomes of communicable diseases in the adult population. This will include populations at risk due to aging as well as immunosuppressive/underlying conditions and will be presented in the context of selected vaccine-preventable diseases and their burden. In the same context of adult immunisation, a separate session will be dedicated to herpes zoster and its prevention through vaccination. Another session will be dedicated to RSV, for which there are currently no immunisation options available, and its burden of disease.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 277\n",
      "=====**=====S277=====**======= 6\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S43 - STI testing in the next decade\n",
      "abs text :- Organized by                    \n",
      "Hologic To provide insight in the trends in STI testing for the years to come. What type of testing will continue over the years, what kind of new assays analytes might come and which might disappear?\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 278\n",
      "=====**=====S278=====**======= 7\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S41 - TBC\n",
      "abs text :- Organized by                    \n",
      "Pfizer TBC\n",
      "sess auth :- Odile LAUNAY\n",
      "sess aff :- France\n",
      "========================================================================================================================\n",
      "inr 279\n",
      "=====**=====S279=====**======= 8\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour SymposiumHall I\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3444 - Viral hepatitis elimination: implications of the new roadmap\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Viral Hepatitis (ESGVH), Lithuanian Society for Infectious Diseases (LID) In 2021 the WHO released important global guidance for countries seeking validation of elimination of HBV or HCV infection as a public health problem. This guidance provides a global framework for confirming the elimination targets of HBV and HCV incidence and mortality. This symposium aims to provide a public health perspective on the granular aspects of the path to elimination for those working at the clinical coalface through to those working in public health and policy making. The session is relevant and timely because it will provide insights into the early implementation of this global guidance. It will also highlight an international perspective from the WHO on the ambitious plan of EMTCT (triple elimination of HBV, HIV and syphilis MTCT) and a European perspective on how the new guidance is impacting the path to viral hepatitis elimination in Europe.\n",
      "sess auth :- Mala MAINI ; Monique ANDERSSON\n",
      "sess aff :- United Kingdom; United Kingdom\n",
      "========================================================================================================================\n",
      "3444-1 === \n",
      "abs title :- Elimination of mother-to-child transmission of HBV, HIV and syphilis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3444-2 === \n",
      "abs title :- HCV/HBV viral hepatitis elimination: reflections and plan ahead in Europe\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 280\n",
      "=====**=====S280=====**======= 9\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour Oral SessionHall J\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK11 - New interventional trials in infection control\n",
      "abs text :-  \n",
      "sess auth :- Pilar RETAMAR; Peter Werner SCHREIBER\n",
      "sess aff :- Spain; Switzerland\n",
      "========================================================================================================================\n",
      "PJK1101 === 13:30 - 14:30\n",
      "abs title :- Ceftriaxone to prevent early ventilator-acquired pneumonia in comatose brain-injured patients: a multicenter, randomised, double-blind, placebo-controlled trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1102 === 13:30 - 14:30\n",
      "abs title :- EFFECT of daily antiseptic body wash with octenidine on ICU-acquired bacteraemia and ICU-acquired multidrug-resistant organisms (MDRO) in intensive care units (ICU): a multicentre, controlled, cluster-randomised, double-blind, crossover study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1103 === 13:30 - 14:30\n",
      "abs title :- A comparison between six- and seven-step hand hygiene technique using alcohol-based hand rub: the first randomised controlled trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1104 === 13:30 - 14:30\n",
      "abs title :- Significant and durable microbiome compositional changes and clonal engraftment in a phase 3 trial of RBX2660 for recurrent Clostridioides difficile infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1105 === 13:30 - 14:30\n",
      "abs title :- Efficacy and safety of whole-body chlorhexidine gluconate (CHG) skin application, with or without emollient, in reducing bacterial skin colonisation of hospitalised low birth weight neonates: the NeoCHG trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 281\n",
      "=====**=====S281=====**======= 10\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3479 - Year in public health\n",
      "abs text :-  \"Year in..\" sessions are very well-attended 1-hour Symposia where speakers review recent literature on the topic. ECCMID 2023 will feature four \"Year in.\" sessions: the traditional \"Year in clinical microbiology\", \"Year in infection control\" and \"Year in infectious diseases\", and the new \"Year in public health\".\n",
      "sess auth :- Vitali SINTCHENKO ; Maria Luisa RICCI\n",
      "sess aff :- Australia; Italy\n",
      "========================================================================================================================\n",
      "3479-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3479-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 282\n",
      "=====**=====S282=====**======= 11\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour SymposiumHall L\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3120 - The use and misuse of MICs in patient management\n",
      "abs text :- Co-organised with                    \n",
      "EUCAST Steering Committee, ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) This session is directed to infectious diseases and microbiology clinicians, clinical pharmacists and dedicated stewardship practitioners who might use the MIC of the invasive pathogen obtained from an individual patient in patient management, especially for dosage adjustment or change of agent. It will focus on the clinical situations where obtaining an MIC will be useful in clinical management but will highlight the pitfalls of attempting to interpret and apply a single MIC measurement in an individual patient.\n",
      "sess auth :- Anouk Edwina MULLER ; Joseph MELETIADIS\n",
      "sess aff :- Netherlands; Greece\n",
      "========================================================================================================================\n",
      "3120-1 === \n",
      "abs title :- When are MICs important?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3120-2 === \n",
      "abs title :- When are MIC values not helpful?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 283\n",
      "=====**=====S283=====**======= 12\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour Case SessionHall M\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES07 - NTMs keep surprising us!\n",
      "abs text :-  \n",
      "sess auth :- Andres FLOTO\n",
      "sess aff :- United Kingdom\n",
      "========================================================================================================================\n",
      "BES0701 === 13:30 - 14:30\n",
      "abs title :- Disseminated Mycobacterium malmoense infection mimicking malignancy: as the first presentation of anti-interferon-gamma autoantibodies-associated immunodeficiency syndrome\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0702 === 13:30 - 14:30\n",
      "abs title :- Mycobacterium abscessus prosthetic valve endocarditis: is surgical intervention must for cure?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0703 === 13:30 - 14:30\n",
      "abs title :- Cutaneous Mycobacterium ulcerans infection in a heart transplant recipient: Challenges in diagnosis and management\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0704 === 13:30 - 14:30\n",
      "abs title :- Mycobacterium smegmatis osteomyelitis after bull horn injury\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0705 === 13:30 - 14:30\n",
      "abs title :- Disseminated Mycobacterium kansasii infection with haemophagocytic lymphohistiocytosis (HLH): a case report\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 284\n",
      "=====**=====S284=====**======= 13\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall N\n",
      "sess type :- Meet-the-ExpertHall N\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3357 - The hopes and hurdles in the prevention and treatment of SSI in orthopaedic surgery and traumatology\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Implant-associated Infections (ESGIAI) Infection prevention and control are key in treating patients cared for in orthopaedic wards. Especially prevention of infections in elective surgeries is of uttermost importance. This session will guide the audience through different stages and components of prevention pre-, during, and after surgery. Long-standing practices will be questioned in the light of new evidence. Innovative strategies will be presented and critically discussed. In addition, a focus will be put on how to implement new measures initially and secure their use during daily routine.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3357-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3357-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 285\n",
      "=====**=====S285=====**======= 14\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall O\n",
      "sess type :- Meet-the-ExpertHall O\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3316 - Easy to miss parasitic diseases in non-endemic settings\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Clinical Parasitology (ESGCP), ESCMID Study Group for Infections in Travellers and Migrants (ESGITM) Europe accounts for 70% of imported malaria globally, mostly settled migrants visiting friends and relatives (VFRs) in countries of malaria origin, especially West Africa. Several studies reported 3-30% parasite prevalence in migrants from endemic areas. VFRs often don't take chemoprophylaxis. Some members of the African diaspora believe European doctors have little experience or competence in managing malaria. In addition, considerable debate surrounds the importance of submicroscopic malaria since it may have significant health and societal consequences. Previous initiatives to improve the protection of VFRs have failed. Submicroscopic malaria may also have clinical consequences in migrant populations, particularly pregnant women and children.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3316-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3316-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 286\n",
      "=====**=====S286=====**======= 15\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour Oral SessionHall P\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM05 - Impact of host and pathogen genetics in fungal infections\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MEM0501 === 13:30 - 14:30\n",
      "abs title :- Galectin-3 (LGALS3) rs4644 polymorphism predisposes to development of aspergillosis in severe influenza patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0502 === 13:30 - 14:30\n",
      "abs title :- Pulmonary transcriptomics reveal immune dysfunction and exhaustion in mice with invasive pulmonary mucormycosis, partially restored by PD-L1 immune checkpoint blockade\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0503 === 13:30 - 14:30\n",
      "abs title :- Aspergillus fumigatus cyp51A mutations altering the glycine-54 residue confer a therapeutically exploitable collateral sensitivity\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0504 === 13:30 - 14:30\n",
      "abs title :- The individual SNPs and combinations thereof impact on the azole phenotype in TR34-mediated resistance genotypes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0505 === 13:30 - 14:30\n",
      "abs title :- Clonal fungemia outbreak of L. elongisporus in neonatal intensive care unit in Delhi and loss of heterozygosity, an adaptive strategy in the environmental L. elongisporus.\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 287\n",
      "=====**=====S287=====**======= 16\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP10 - New insights in sepsis\n",
      "abs text :-  \n",
      "sess auth :- Silvio Daniel BRUGGER\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "CSP1001 === 13:30 - 14:30\n",
      "abs title :- Severe infections as risk factors for acute myocardial infarction: a nationwide, population-based cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1002 === 13:30 - 14:30\n",
      "abs title :- What is a “normal” C-reactive protein response to sepsis? An electronic health records study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1003 === 13:30 - 14:30\n",
      "abs title :- Evaluation of presepsin as an early marker of neonatal sepsis: a single-centre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1004 === 13:30 - 14:30\n",
      "abs title :- Donor-derived CRKP does not increase the risk for 12 months mortality in adult kidney transplantation recipients: a retrospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1005 === 13:30 - 14:30\n",
      "abs title :- Rapid identification of sepsis causative micro-organisms directly from positive blood cultures using a highly multiplexed targeted proteomics assay\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1006 === 13:30 - 14:30\n",
      "abs title :- Pathogenicity islands in the four main clones of Escherichia coli from patients with bacteraemia and sepsis/septic shock in 21 hospitals in Spain: PROBAC-EC Study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1007 === 13:30 - 14:30\n",
      "abs title :- Bloodstream infections are associated with acute cognitive dysfunction and mood disturbance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1008 === 13:30 - 14:30\n",
      "abs title :- Evaluating the optimal duration of antimicrobial therapy for the management of Gram-negative sepsis in immunocompromised hosts with neutropaenia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1009 === 13:30 - 14:30\n",
      "abs title :- Intravenous (i.v.) fosfomycin for treatment of severe infections caused by Gram-negative pathogens: an update from a European, multi-centre, non-interventional and prospective clinical study (FORTRESS)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 288\n",
      "=====**=====S288=====**======= 18\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK04 - New diagnostic tools for respiratory infections\n",
      "abs text :-  \n",
      "sess auth :- Makeda SEMRET\n",
      "sess aff :- Canada\n",
      "========================================================================================================================\n",
      "PAK0401 === 13:30 - 14:30\n",
      "abs title :- Seasonal variation in predominant influenza A subtypes can require modification of diagnostic assays and differentiated visitation of clinical samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0402 === 13:30 - 14:30\n",
      "abs title :- A novel flow cytometry-based surrogate assay (FlowSA) for the detection of infectious SARS-CoV-2 in clinical samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0403 === 13:30 - 14:30\n",
      "abs title :- Clinical impact of a near-patient assay capable of discriminating between viral or bacterial lower respiratory tract infection in ambulatory adult patients: a pilot study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0404 === 13:30 - 14:30\n",
      "abs title :- Development of a point of care device for rapid non-invasive pathogen detection in patients with hospital-acquired pneumonia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0405 === 13:30 - 14:30\n",
      "abs title :- The feasibility of implementing a close to patient molecular test to determine the aetiology of non-ventilator acquired hospital acquired pneumonia (NV-HAP)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0406 === 13:30 - 14:30\n",
      "abs title :- Diagnostic utility of oropharyngeal swabs as an alternative to lower respiratory tract samples for PCR-based syndromic testing in patients with community acquired pneumonia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0407 === 13:30 - 14:30\n",
      "abs title :- Comparative evaluation of the multiplex PCR pneumonia panel with bacterial culture in community-acquired pneumonia patients in conjunction with leukocyte esterase test\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0408 === 13:30 - 14:30\n",
      "abs title :- Microbiology of of hospital-acquired and ventilator-associated pneumonia as detected by multiplex PCR in intensive care unit patients from the UK: an INHALE sub-study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0409 === 13:30 - 14:30\n",
      "abs title :- Whole genome sequencing for characterisation of consecutive respiratory Pseudomonas aeruginosa isolates in the intensive care unit\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 289\n",
      "=====**=====S289=====**======= 23\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET11 - Critically Ill Patients Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGCIP The official open business meeting for the ESCMID Study Group for Critically Ill Patients (ESGCIP). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Christian ECKMANN ; Matteo BASSETTI ; Claire ROGER ; Emine ALP MESE\n",
      "sess aff :- Germany; Italy; France; Turkey\n",
      "========================================================================================================================\n",
      "inr 290\n",
      "=====**=====S290=====**======= 0\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote Scientific InterviewHall A\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3143 - Structural determinants of health: how scientific societies can influence change\n",
      "abs text :- Co-organised with                    \n",
      "Infectious Diseases Society of America (IDSA) The Keynote Scientific Interview will focus on how leadership of a infectious diseases society can lead change in combating healthcare inequities. The President of IDSA, Carlos Del Rio, and the ESCMID President, Annelies Zinkernagel, will discuss how advocacy locally, nationally and globally with the backing of a strong society can inform the public, debunk \"fake news,\" lead to changes in legislation, lead to increased allocations of resources, and more. Additionally, how societies can develop and enhance the success of pipelines of historically underrepresented peoples into science and medicine.\n",
      "sess auth :- Annelies ZINKERNAGEL\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "3143-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 291\n",
      "=====**=====S291=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall B\n",
      "sess type :- Meet-the-ExpertHall B\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3362 - New drugs for respiratory viruses in the immunosuppressed: not only SARS-CoV-2 please...\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Infections in Compromised Hosts (ESGICH) As the COVID-19 pandemic abates, a population at risk for community-acquired respiratory viruses (CARV) remains. Immunocompromised hosts, including transplant recipients, are at increased risk for morbidity and mortality from the CARV, and long-term consequences can include chronic lung dysfunction and graft loss. Progress has been made in assessing the risk for progression to lower respiratory tract infection and long-term sequelae. At the same time, several new antiviral agents show promise for treatments of CARV. Risk assessment and new antiviral treatment options will be discussed in the context of both solid organ and haematological malignancy/stem cell transplantation.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3362-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3362-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 292\n",
      "=====**=====S292=====**======= 2\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour Oral SessionHall C\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP01 - Rapid phenotypic AST for Gram-negative rod\n",
      "abs text :-  \n",
      "sess auth :- Erika MATUSCHEK ; Alasdair P. MACGOWAN\n",
      "sess aff :- Sweden; United Kingdom\n",
      "========================================================================================================================\n",
      "ALP0101 === 14:45 - 15:45\n",
      "abs title :- Performance evaluation of the UMIC cefiderocol to determine MIC in Gram-negative bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0102 === 14:45 - 15:45\n",
      "abs title :- Validation of a fully automated rapid antimicrobial susceptibility testing system directly from blood culture bottles for Gram-negative bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0103 === 14:45 - 15:45\n",
      "abs title :- Lateral flow immunoassay for the detection of blaOXA carbapenemases and blaNDM from Gram-negatives\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0104 === 14:45 - 15:45\n",
      "abs title :- New blaKPC variants conferring ceftazidime-avibactam resistance and performance of the NG-Test CARBA-5 in its detection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0105 === 14:45 - 15:45\n",
      "abs title :- A multi-centre evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 293\n",
      "=====**=====S293=====**======= 9\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour SymposiumHall J\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3333 - AMR impact initiatives and research: WHO 2022 Bacterial Priority Pathogens List (BPPL), and list of Critically Important Antimicrobials (CIAs)\n",
      "abs text :- Co-organised with                    \n",
      "World Health Organisation (WHO) During this symposium the resulty of the \"2022 WHO Bacterial Priority Pathogens List (BPPL)\" will be presented. WHO BPPL ranks bacterial pathogens for R&D according to their public health importance in the context of AMR. The session will also present for the first time the results of the \"List of Critically Important Antimicrobials (CIA)\", which ranks antibacterial agents according to their importance in human medicine. Speakers will also cover the implementation aspects of this research and the impact these lists have in informing R&D, and public health decision-making, for AMR. Finally, the audience will also hear about the methodologies used in developing these global lists, their limitations and the main lesson learned.\n",
      "sess auth :- Valeria GIGANTE ; Elena CARRARA\n",
      "sess aff :- Switzerland; Italy\n",
      "========================================================================================================================\n",
      "3333-1 === \n",
      "abs title :- Development of 2022 WHO Bacterial Priority Pathogens list\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3333-2 === \n",
      "abs title :- Implementation considerations for WHO lists of AMR Priority Bacterial and Fungal Pathogen\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 294\n",
      "=====**=====S294=====**======= 10\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3439 - Hot topics in hepatitis B and D infections\n",
      "abs text :- Co-organised with                    \n",
      "European Association for the study of the liver (EASL), Norwegian Society of Infectious Diseases (NFIM) Chronic viral hepatitis remains a significant threat to global health. While chronic hepatitis B infection is the most prevalent form of chronic viral hepatitis, co-infection with hepatitis D (or delta) is the most aggressive form with fast progression to liver-related complications. In recent years, great progress has been made in understanding the viral life cycles and the antiviral immune responses, resulting in novel therapeutic approaches. This symposium will focus on the current therapy of HBV mono-infection and HBV/HDV co-infection, including a discussion on the recently approved entry inhibitor bulevirtide and promising candidates in clinical development. Moreover, the importance of antiviral immunity in clearing the infection and viral strategies to avoid immune pressure will be presented.\n",
      "sess auth :- Aylin YILMAZ ; Maria BUTI\n",
      "sess aff :- Sweden; Spain\n",
      "========================================================================================================================\n",
      "3439-1 === \n",
      "abs title :- Therapeutic landscape for HBV and HDV\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3439-2 === \n",
      "abs title :- Lessons from antiviral immunity for curative therapies in HBV\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 295\n",
      "=====**=====S295=====**======= 11\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall L\n",
      "sess type :- 1-hour Oral SessionHall L\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD07 - Take home antimicrobial stewardship interventions\n",
      "abs text :-  \n",
      "sess auth :- Rita MURRI\n",
      "sess aff :- Italy\n",
      "========================================================================================================================\n",
      "MYD0701 === 14:45 - 15:45\n",
      "abs title :- Evaluating the impact of antimicrobial stewardship program on antibiotic use in resource-limited hospital settings in Vietnam using autoregressive integrated moving average models\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0702 === 14:45 - 15:45\n",
      "abs title :- Implementation of an antimicrobial stewardship programme targeting residents with urinary tract infections in long-term care facilities\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0703 === 14:45 - 15:45\n",
      "abs title :- Challenging antibiotic allergy status (CATALYST): developing a transferable model for non-allergist direct oral penicillin allergy challenge\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0704 === 14:45 - 15:45\n",
      "abs title :- Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0705 === 14:45 - 15:45\n",
      "abs title :- The impact of multidisciplinary team (MDT) antimicrobial stewardship (AMS) round\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 296\n",
      "=====**=====S296=====**======= 12\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour Oral SessionHall M\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD09 - Non-canonical approaches to treatment of infections\n",
      "abs text :-  \n",
      "sess auth :- Ran NIR\n",
      "sess aff :- Israel\n",
      "========================================================================================================================\n",
      "MYD0901 === 14:45 - 15:45\n",
      "abs title :- Nanostructured lipid carriers (NLC): effective against Helicobacter pylori, safe for gut bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0902 === 14:45 - 15:45\n",
      "abs title :- Antibody-drug conjugate therapy of S. aureus implant-associated osteomyelitis in a murine model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0903 === 14:45 - 15:45\n",
      "abs title :- Combined antibacterial photodynamic and photothermal activity of 5-ALA coated SPIONs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0904 === 14:45 - 15:45\n",
      "abs title :- In vivo validation of cold plasma technology in a bioluminescent mouse scald burn wound infection model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0905 === 14:45 - 15:45\n",
      "abs title :- Targeted and non-targeted ultrasound-activated microbubbles for treating cardiovascular biofilms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 297\n",
      "=====**=====S297=====**======= 13\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall N\n",
      "sess type :- 1-hour SymposiumHall N\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3394 - Sex matters for infection outcomes\n",
      "abs text :-  Sex differences are increasingly appreciated as important contributors to microbial infection susceptibility, response, and outcomes. Historically, biomedical research was largely conducted in male organisms for reasons that have been largely disproven. To diversify our understanding of the influence of biological sex, funding bodies now increasingly require that sex as a biological variable be factored into research design, analysis, and reporting in vertebrate animal and human studies. This session will highlight how sex shapes pathogen interactions and host responses in the context of the urinary tract and lung infections.\n",
      "sess auth :- Jose Ramon PANO\n",
      "sess aff :- Spain\n",
      "========================================================================================================================\n",
      "3394-1 === \n",
      "abs title :- The influence of sex on UTI and immunity\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3394-2 === \n",
      "abs title :- Influence of sex on viral infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 298\n",
      "=====**=====S298=====**======= 14\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall O\n",
      "sess type :- Meet-the-ExpertHall O\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3404 - Secondary haemophagocytic lymphohistiocytosis and infectious diseases\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Education Subcommittee Haemophagocytic lymphohistiocytosis (HLH) is a rare syndrome that is often fatal despite treatment. It is caused by a dysregulation in natural killer T cell function, resulting in activation and proliferation of histiocytes with uncontrolled hemophagocytosis and cytokines overproduction. The syndrome is characterised by fever, haepatosplenomegaly, cytopaenias, liver dysfunction, and hyperferritinaemia. HLH can be secondary to many infections or other conditions. This syndrome is often overlooked and deserves to be well-known by ID physician as it presents with the picture of severe sepsis.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3404-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3404-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 299\n",
      "=====**=====S299=====**======= 15\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour Case SessionHall P\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES04 - Bewildering bacteria\n",
      "abs text :-  \n",
      "sess auth :- Nuria FERNANDEZ\n",
      "sess aff :- Spain\n",
      "========================================================================================================================\n",
      "BES0401 === 14:45 - 15:45\n",
      "abs title :- Emergence of Vibrio infection as a sea-water associated pathogen in Ireland: a new geographic distribution associated with increasing ocean temperatures?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0402 === 14:45 - 15:45\n",
      "abs title :- Diagnosis of meningoradiculitis from Borrelia miyamotoi in an immunocompromised adult by metatranscriptomics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0403 === 14:45 - 15:45\n",
      "abs title :- Burkholderia vietnamiensis outbreak in ICU from contaminated shaving cream\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0404 === 14:45 - 15:45\n",
      "abs title :- Fatal case caused by a new genus of the Pasteurellaceae family\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0405 === 14:45 - 15:45\n",
      "abs title :- Two approaches, one entity: Coxiella burnetii aortitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 300\n",
      "=====**=====S300=====**======= 17\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM02 - Epidemiology of fungal infections: a changing scenario\n",
      "abs text :-  \n",
      "sess auth :- Maurizio SANGUINETTI\n",
      "sess aff :- Italy\n",
      "========================================================================================================================\n",
      "MEM0201 === 14:45 - 15:45\n",
      "abs title :- Myriodontium keratinophilum, a rare keratinophilic fungi as an emerging agent of dermatophytosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0202 === 14:45 - 15:45\n",
      "abs title :- Spectrum of fungal keratitis (FK) in a tertiary eye care centre in Nepal\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0203 === 14:45 - 15:45\n",
      "abs title :- Cryptococcosis in immunocompromised and immunocompetent patients: data from a national multi-centre cohort study in Brazil\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0204 === 14:45 - 15:45\n",
      "abs title :- Blastomycosis in eastern Ontario: is there a changing epidemiology?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0205 === 14:45 - 15:45\n",
      "abs title :- Features and evaluation of mucormycosis in patients with COVID-19 from two Iranian hospitals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0206 === 14:45 - 15:45\n",
      "abs title :- Urine may act as a reservoir for azole-resistant Candida tropicalis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0207 === 14:45 - 15:45\n",
      "abs title :- Epidemiology and disease burden of mucormycosis in Canada: CANMUS registry\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0208 === 14:45 - 15:45\n",
      "abs title :- Antifungal susceptibility profiles and azole resistance mechanisms of Candida auris clinical isolates from South Korea\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0209 === 14:45 - 15:45\n",
      "abs title :- The trend of reducing the number of cryptic species: examples in Aspergillus and consequences for diagnostics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 301\n",
      "=====**=====S301=====**======= 19\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 14:45 - 15:45\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW01 - Novel and possible future diagnostic markers for SARS-CoV-2 infection\n",
      "abs text :-  \n",
      "sess auth :- Jake DUNNING\n",
      "sess aff :- United Kingdom\n",
      "========================================================================================================================\n",
      "EW0101 === 14:45 - 15:45\n",
      "abs title :- Variant-specific antibody binding following SARS-CoV-2 infection enables VOC-specific sero-surveillance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0102 === 14:45 - 15:45\n",
      "abs title :- Retrospective analysis of SARS-CoV-2 subgenomic RT-PCR clinical utility in a paediatric quaternary care setting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0103 === 14:45 - 15:45\n",
      "abs title :- Analysis of cellular and humoral responses after SARS-CoV-2 infection and vaccination using a new interferon-gamma release assay\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0104 === 14:45 - 15:45\n",
      "abs title :- Comparison of saliva collected by a commercial sponge method and nasopharyngeal swabs for detection of SARS-CoV-2 by the PCR method\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0105 === 14:45 - 15:45\n",
      "abs title :- Detection of SARS CoV-2 RNA and infectious virus in faeces and rectal swabs: implications for screening faecal microbiota transplant (FMT) samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0106 === 14:45 - 15:45\n",
      "abs title :- Point-of-care testing for antiviral host response using fingerprick MxA continues to be an accurate and useful emergency department triage tool in the context of co-circulation of SARS-CoV-2, influenza and RSV\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0107 === 14:45 - 15:45\n",
      "abs title :- Leptin signaling in macrophage defense against SARS-CoV-2\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0108 === 14:45 - 15:45\n",
      "abs title :- Characterisation of respiratory transcriptomics signatures induced by several SARS CoV-2 variants including Omicron in patients with severe COVID-19 pneumonia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0109 === 14:45 - 15:45\n",
      "abs title :- Cytokine dynamics in the acute and post-acute phase of hospitalized COVID-19 patients and their link to disease severity, mortality, and long COVID\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 302\n",
      "=====**=====S302=====**======= 0\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Hall A\n",
      "sess type :- 1-hour SymposiumHall A\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3169 - Expanding genomic sequencing capacity globally to enhance epidemic surveillance and response\n",
      "abs text :-  \n",
      "sess auth :- Marc J. STRUELENS\n",
      "sess aff :- Sweden\n",
      "========================================================================================================================\n",
      "3169-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3169-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 303\n",
      "=====**=====S303=====**======= 1\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour SymposiumHall B\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3136 - Expanding global access to diagnostics\n",
      "abs text :- Co-organised with                    \n",
      "Lancet Commission on Diagnostics, ESCMID Study Group for Clinical Parasitology (ESGCP), Trainee Association of ESCMID (TAE) Steering Committee Most of the world's population lacks access to diagnostics. Without improved availability and access to diagnostics, countries will be unable to meet the goal of universal health coverage, mitigate the worsening problem of antimicrobial resistance, or prepare for future pandemics and work towards Global Health Security. This symposium will address the current state of availability and access to diagnostics, barriers facing countries that want to provide this availability and access, solutions to these barriers, and an update on the Lancet Commission for Diagnostics, as well as progress made on the Commission recommendations.\n",
      "sess auth :- Francesca TAMAROZZI ; Michael L. WILSON\n",
      "sess aff :- Italy; United States\n",
      "========================================================================================================================\n",
      "3136-1 === \n",
      "abs title :- Updates from the Lancet Commission on Diagnostics: progress and next steps\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3136-2 === \n",
      "abs title :- Current status of availability and barriers to access to diagnostics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3136-3 === \n",
      "abs title :- Access to diagnostics in LMICs: solutions and pathways forward\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3136-4 === \n",
      "abs title :- Rapid diagnostic methods for parasitic diseases: current status and future challenges\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 304\n",
      "=====**=====S304=====**======= 2\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour Educational WorkshopHall C\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3160 - Communication, team dynamics, and patient involvement in antimicrobial stewardship\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Antimicrobial stewardship (ESGAP), World Health Organization (WHO) This workshop will cover state-of-the-art evidence on how we communicate in antimicrobial stewardship and infection prevention and control. The presenters will use examples of existing practices and work from high, low- and middle-income settings to illustrate how we can more effectively communicate within working teams, with stakeholders involved in infection-related practices in hospital settings, patients, and caregivers, showing also why social science and ethnographic research matter.\n",
      "sess auth :- Karin THURSKY ; Aurelien DINH\n",
      "sess aff :- Australia; France\n",
      "========================================================================================================================\n",
      "3160-1 === \n",
      "abs title :- Growing and sustaining teams in antimicrobial stewardship\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3160-2 === \n",
      "abs title :- Coomunication is key in infection prevention and control and antimicrobial stewardship programmes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3160-3 === \n",
      "abs title :- Patient-centred care on AMR for better patient outcomes in infectious diseases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 305\n",
      "=====**=====S305=====**======= 3\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S58 - Spanning the diagnostics portfolio: an in depth look at outcomes and use cases benefitting different patient populations\n",
      "abs text :- Organized by                    \n",
      "Roche In this symposium, there will be an engaging divergence of diagnostics and how they are utilised in different patient populations. During the first session, the speaker will focus on all comers with bloodstream infections and the results of a randomised control trial in France. Medical and economic outcomes were generated comparing rapid molecular blood culture identification testing to traditional microbiological techniques in order to assess how a rapid syndromic result can help to improve mortality and decrease both time to appropriate therapy and length of stay, while reducing costs.\n",
      "\n",
      "In the second half, the speakers will discuss humoral and cellular immune responses against SARS-CoV-2 upon infection or vaccination. Particularly, this session will unveil the value of T cell response monitoring using interferon gamma release assays (IGRAs) to assess immune protection among at-risk patient groups including people living with HIV and transplant recipients.\n",
      "sess auth :- Gilbert GREUB\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "inr 306\n",
      "=====**=====S306=====**======= 4\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall E\n",
      "sess type :- Integrated SymposiumHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- S50 - Facing a new era in infectious disease control: unlocking complexity with molecular syndromic multiplex testing\n",
      "abs text :- Organized by                    \n",
      "QIAGEN From COVID-19 to Mpox, emerging global outbreaks are a continuous challenge and represent important public health threats. Rapid and accurate diagnostic tests are important for clinical microbiology laboratories and infectious diseases clinicians to improve patient treatment and to understand current epidemiological trends and public health management. Join us at QIAGEN´s integrated symposium to listen to experts who will review testing solutions from Mpox to more established infectious diseases such as meningitis/encephalitis or gastroenteritis. The session will bring together expert laboratorians and clinicians to explore the various impacts of syndromic testing and gain new perspective into the post pandemic world.\n",
      "sess auth :- Heiman WERTHEIM\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "inr 307\n",
      "=====**=====S307=====**======= 5\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S49 - Success in managing CA-RTIs and reducing antimicrobial resistance: can both be achieved?\n",
      "abs text :- Organized by                    \n",
      "GSK .\tAntibiotic resistance is an increasingly serious threat. In line with the WHO Global action plan against antimicrobial resistance, it is necessary to optimise the use of antibiotics by antibiotic stewardship and propagating appropriate antibiotic prescribing.  \n",
      ".\tResistance rates have been increasing for key community pathogens i.e. S pneumoniae<\\em> to antibiotics such as beta lactams, macrolides and quinolones.\n",
      ".\tMisuse of antibiotics, not guided by surveillance data or guidelines, further increase the problem of antibiotic resistance. The aim is to emphasise the importance of application of local surveillance data to guide empirical antibiotic prescribing.  It is likely that indiscriminate use of antibiotics to manage patients with respiratory tract infections during COVID has probably increased problem of antibiotic resistance, and it would be good to discuss emerging trends in this area.\n",
      ".\tTo enhance the longevity of antibiotics, it is also important to integrate principles of PK/PD and optimise dosing to improve patient outcomes.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 308\n",
      "=====**=====S308=====**======= 6\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall G\n",
      "sess type :- Integrated SymposiumHall G\n",
      "sess cate :- 11. Other\n",
      "sess title :- S48 - Disruptive innovations in the sepsis patient pathway and the impact on antibiotic stewardship\n",
      "abs text :- Organized by                    \n",
      "Beckman Coulter In this session we will discuss the sepsis patient pathway and the impact of new technology on improving antibiotic stewardship and patient outcomes. Current practices in the microbiology laboratory, including antimicrobial-susceptibility testing biomarkers and molecular testing, will be discussed along with opportunities that exist in the workflow. There is an increasing pressure in laboratories to improve antibiotic stewardship use and associated patient outcomes. Our key experts will discuss current practices today and innovations needed to improve antibiotic use.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "inr 309\n",
      "=====**=====S309=====**======= 7\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall H\n",
      "sess type :- Integrated SymposiumHall H\n",
      "sess cate :- 11. Other\n",
      "sess title :- S47 - Past and future of RSV: where are we now?\n",
      "abs text :- Organized by                    \n",
      "Sanofi Raise awareness of RSV and need to reduce the burden associated with RSV infection, specifically:\n",
      ".\tKnowns and unknowns in RSV and the risk of severe disease in infants\n",
      ".\tContextualising the clinical and economic burden of RSV\n",
      ".\tStrategies for the prevention of RSV in all infants\n",
      "\n",
      "RSV is a highly transmissible seasonal virus responsible for unpredictable and severe outcomes in infants and one of the few remaining paediatric infectious diseases which, as yet, has no preventative option for all infants. RSV is the most frequent cause of respiratory disease in infants and, including bronchiolitis and pneumonia, is the leading cause of hospitalisations, most of which are in otherwise healthy infants born at term. RSV also causes substantial burdens across settings and perspectives. Efforts to prevent RSV have been ongoing for decades. This symposium will present an interactive roundtable discussion regarding the issues that impact RSV, from which all infants need protection.\n",
      "sess auth :- Laurent KAISER\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "inr 310\n",
      "=====**=====S310=====**======= 9\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour SymposiumHall J\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3405 - New and old staphylococci\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) Staphylococci are responsible for many mild to severe infections involving various organs. Although they alone can cause such infections, numerous situations involve other microorganisms (bacteria, yeast, viruses), either sequentially or concomitantly, the role and contribution of which are frequently overlooked. This session will address the pathophysiology of Staphylococcus aureus from the perspective of co-infections, but also provide the audience with cutting edge clinical, epidemiological and evolutionary insights into non- aureus staphylococci\n",
      "sess auth :- Alicia LACOMA ; Gerard LINA\n",
      "sess aff :- Spain; France\n",
      "========================================================================================================================\n",
      "3405-1 === \n",
      "abs title :- AMR of veterinary staphylococci\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3405-2 === \n",
      "abs title :- Molecular interactions between S. aureus and co-infecting microorganisms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3405-3 === \n",
      "abs title :- Clinical significance of coagulase negative staphylococci in hip and knee surgery\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3405-4 === \n",
      "abs title :- Emerging staphylococci (S.schweitzeri, S.roterodami/S.singaborensis): what to expect with such species?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 311\n",
      "=====**=====S311=====**======= 10\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall K\n",
      "sess type :- 2-hour SymposiumHall K\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3202 - Pending challenges in contemporary HIV care\n",
      "abs text :-  Over the past decades, access to effective antiretroviral treatment has led to significant shifts in paradigm in HIV management, from frequent visits focusing on obtaining viral suppression and managing opportunist diseases to infrequent visits in an aging population with comorbidities. This 2-hour symposium will focus on the most pertinent clinical issues in contemporary HIV management, such as choosing the most optimal antiretroviral regimen and insights into most recently licensed antiretrovirals, identification and management of polypharmacy and drug-drug interactions, implementation of a rational and personalised diagnostic strategy for dealing with co- and multimorbidity and discussions of the particular challenges encountered in women and minority groups living with HIV. The session will not only bring the audience up to date with state-of-the-art clinical management considerations but will also provide an understanding of the most important pending questions in contemporary HIV care.\n",
      "sess auth :- Lene RYOM ; Siri GOEPEL\n",
      "sess aff :- Denmark; Germany\n",
      "========================================================================================================================\n",
      "3202-1 === \n",
      "abs title :- New antiviral agents and role of injectables\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3202-2 === \n",
      "abs title :- Polypharmacy and pitfalls of drug-drug interactions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3202-3 === \n",
      "abs title :- Role of ageing and comorbidity\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3202-4 === \n",
      "abs title :- Minority populations in Europe\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 312\n",
      "=====**=====S312=====**======= 11\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall L\n",
      "sess type :- 2-hour Oral SessionHall L\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK11 - Metagenomic testing to improve laboratory diagnostics for infectious diseases\n",
      "abs text :-  \n",
      "sess auth :- Vitali SINTCHENKO ; Mario RAMIREZ\n",
      "sess aff :- Australia; Portugal\n",
      "========================================================================================================================\n",
      "PAK1101 === 16:15 - 18:15\n",
      "abs title :- The development, integration, and evaluation of an automated bioinformatics pipeline for the analysis of bacterial metagenomic sequenced data\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1102 === 16:15 - 18:15\n",
      "abs title :- A rapid metagenomics protocol for the combined detection of RNA viruses, DNA viruses, bacteria and fungi\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1103 === 16:15 - 18:15\n",
      "abs title :- Concordance between upper and lower respiratory tracts microbiota in children with cystic fibrosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1104 === 16:15 - 18:15\n",
      "abs title :- Evaluation of shotgun metagenomics in mycology and parasitology diagnosis: about 200 clinical samples and 17 matrices\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1105 === 16:15 - 18:15\n",
      "abs title :- Beyond monkeypox virus: clinical metagenomics searching for mucocutaneous infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1106 === 16:15 - 18:15\n",
      "abs title :- Diagnosis of meningitis by host transcriptomic approach based on metagenomic data\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1107 === 16:15 - 18:15\n",
      "abs title :- The circulating phageome reflects bacterial infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1108 === 16:15 - 18:15\n",
      "abs title :- Direct-from-blood culture metagenomic sequencing provides accurate antimicrobial resistance predictions faster than routine methods\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1109 === 16:15 - 18:15\n",
      "abs title :- Detection of bacterial pathogens causing acute febrile illness using Nanopore sequencing: a feasibility and efficacy study from North India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1110 === 16:15 - 18:15\n",
      "abs title :- Metagenomic detection of Microsporidium as the causative pathogen of an ongoing keratoconjunctivitis outbreak in Israel\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 313\n",
      "=====**=====S313=====**======= 12\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall M\n",
      "sess type :- 2-hour SymposiumHall M\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- 3451 - Post-infective fatigue syndromes and long COVID: similarities and differences\n",
      "abs text :- Co-organised with                    \n",
      "The Collaborative on Fatigue Following Infection (COFFI) Ongoing fatigue is a feature of long COVID, with up to 46% of patients reporting symptoms lasting months. The session will review the prevalence, natural history, and potential pathophysiology of post-infective fatigue syndromes (PIFS) and long COVID, with advice on future directions by international experts. Clinicians and researchers will gain a better understanding of PIFS and long COVID.\n",
      "sess auth :- Diane GRIFFIN ; Chiara IARIA\n",
      "sess aff :- United States; Italy\n",
      "========================================================================================================================\n",
      "3451-1 === \n",
      "abs title :- Prevalence and natural history of post-infective fatigue in adults and children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3451-2 === \n",
      "abs title :- Prevalence and natural history of long-COVID in adults and children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3451-3 === \n",
      "abs title :- Pathophysiology of post-infective fatigue states\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3451-4 === \n",
      "abs title :- Physiological and patient-reported outcomes over two years after COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 314\n",
      "=====**=====S314=====**======= 13\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall N\n",
      "sess type :- 2-hour Educational WorkshopHall N\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3366 - Are we having any impact? Monitoring guidelines implementation and impact in practice\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Guideline Subcommittee Great resources are devoted to developing guidelines and recommendations, but implementation of guidelines is still a neglected area for both research and practice. Which characteristics of guidelines are associated to greater uptake and impact? Which are more useful and used? The infectious diseases field is peculiar because considerations beyond the individual patients (transmission and infectiousness, antimicrobial resistance, vaccines) need to be taken into account. This session aims at reviewing which tools are available to guidelines developers and guidelines users, to track, monitoring and improve the uptake of guidelines and recommendations in clinical practice, with a special focus on infectious diseases, clinical microbiology and infection control.\n",
      "sess auth :- Effrossyni GKRANIA; Luigia SCUDELLER\n",
      "sess aff :- United Kingdom; Italy\n",
      "========================================================================================================================\n",
      "3366-1 === \n",
      "abs title :- Interpretation of levels of evidence and level of recommendation for the individual patient\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3366-2 === \n",
      "abs title :- Planning guidelines implementation, uptake and monitoring at the time of developing recommendations: is it really done?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3366-3 === \n",
      "abs title :- Monitoring the uptake and implementation of guidelines: challenges and solutions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 315\n",
      "=====**=====S315=====**======= 14\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour Educational WorkshopHall O\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3215 - Scaling up AMR interventions with stakeholders: diversity, equity and inclusion\n",
      "abs text :- Co-organised with                    \n",
      "International Centre for Antimicrobial Resistance Solutions (ICARS) Antimicrobial resistance (AMR) mitigation occurs across the intervention-implementation research (IIR) continuum. This begins with the proof-of-concept that an AMR intervention works within a controlled setting, followed by proof-of-implementation in the real-life setting. The process should be adapted to specific local contexts and early engagement and ownership by all stakeholders is critical to systems wide scale-up. Following the IIR continuum can substantially advance the implementation of National Action Plans on AMR in resource-constrained settings. This workshop focuses on the targeted integration and scale-up of AMR interventions with a focus on stakeholder engagement. Using a case study approach, panelists will debate and provide experiential learning to enable participants to identify and facilitate conversations towards a common AMR mitigation goal amongst diverse stakeholders with different mandates.\n",
      "sess auth :- Philip MATHEW ; Martha GYANSA\n",
      "sess aff :- Denmark; Ghana\n",
      "========================================================================================================================\n",
      "3215-1 === \n",
      "abs title :- Scalable AMR interventions: what we know and what we need to know\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3215-2 === \n",
      "abs title :- Making all stakeholders work together to move where it matters the most\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3215-3 === \n",
      "abs title :- Public-private alliances to implement One Health in the fight against the antimicrobial resistance in Colombia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 316\n",
      "=====**=====S316=====**======= 15\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 18:15\n",
      "sess loca :- Hall P\n",
      "sess type :- 2-hour Oral SessionHall P\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- PAK09 - Do we trust the results of new diagnostic technologies for the treatment of respiratory infections?\n",
      "abs text :-  \n",
      "sess auth :- Pavel DREVINEK ; Agnes Maria SONNEVEND\n",
      "sess aff :- Czech Republic; Hungary\n",
      "========================================================================================================================\n",
      "PAK0901 === 16:15 - 18:15\n",
      "abs title :- INHALE WP3: Clinical outcomes and antimicrobial stewardship analyses from of a multi-centre RCT (INHALE) testing the utility of rapid multiplex PCR for hospital-acquired and ventilator-associated pneumonia in critical care\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0902 === 16:15 - 18:15\n",
      "abs title :- Impact of a multiplex pulmonary PCR on antibiotic prescription in a real-life cohort of critically ill patients with suspected ventilated pneumonia during the SARS-CoV-2 pandemic : a retrospective monocentric observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0903 === 16:15 - 18:15\n",
      "abs title :- Multiplex PCR pneumonia panel for microbiological diagnosis and the clinicians' perspective on the utilisation of the results in the management of patients with LRTI: a one-year experience in a private tertiary care centre\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0904 === 16:15 - 18:15\n",
      "abs title :- Impact of the Biofire Filmarray Pneumonia Panel to guide exacerbations diagnostic and treatment in bronchiectasis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0905 === 16:15 - 18:15\n",
      "abs title :- Impact of rapid multiplex PCR on the antimicrobial therapy management in VA-LTRI patients: an observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0906 === 16:15 - 18:15\n",
      "abs title :- The diagnostic utility of microscopic quality assessment of lower respiratory tract samples in the era of rapid syndromic PCR testing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0907 === 16:15 - 18:15\n",
      "abs title :- The diagnostic utility of concomitant testing with a commercial protein-based host response test and rapid microbial multiplex PCR panels in patients with suspected lower respiratory tract infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0908 === 16:15 - 18:15\n",
      "abs title :- Next-generation sequencing of microbial cell-free DNA for identification of patients with suspected  Pneumocystis jirovecii pneumonia: a case series\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0909 === 16:15 - 18:15\n",
      "abs title :- Breath analysis of COVID-19 patients in a tertiary UK hospital by optical spectrometry: the E-Nose CoVal Study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK0910 === 16:15 - 18:15\n",
      "abs title :- Changes ongoing? The impact of new modulator therapy on microbiological isolates in cystic fibrosis patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 317\n",
      "=====**=====S317=====**======= 16\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP06 - Non-tuberculous mycobacteria: from epidemiology to new drugs\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "CSP0601 === 16:15 - 17:15\n",
      "abs title :- Outpatient parenteral antimicrobial therapy (OPAT) for mycobacterial infections in the Republic of Ireland, 2013–2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0602 === 16:15 - 17:15\n",
      "abs title :- Towards clinical breakpoints for non-tuberculous mycobacteria: determination of epidemiological cut-offs for the Mycobacterium avium complex (MAC) and Mycobacterium abscessus (MAB) using broth microdilution\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0603 === 16:15 - 17:15\n",
      "abs title :- Spectinomycin analogeus for the treatment of Mycobacterium abscessus infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0604 === 16:15 - 17:15\n",
      "abs title :- Nontuberculous mycobacteria in immigrants in Denmark\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0605 === 16:15 - 17:15\n",
      "abs title :- A multi-centre evaluation of treatment durability and safety of omadacycline for Mycobacterium abscessus infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0606 === 16:15 - 17:15\n",
      "abs title :- A novel broad-spectrum antibiotic with in vivo bactericidal activity against the important cystic fibrosis pathogen Mycobacteroides abscessus\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0607 === 16:15 - 17:15\n",
      "abs title :- Evolution of Mycobacterium abscessus in the human lung: cumulative mutations and genomic rearrangement of porin genes in patient isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0608 === 16:15 - 17:15\n",
      "abs title :- Genomic analysis of microevolution and reinfection in patients with Mycobacterium abscessus sequential isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0609 === 16:15 - 17:15\n",
      "abs title :- A retrospective review of disseminated Mycobacterium bovis infections following intravesical BCG installation in Western Australia over a 20-year period\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 318\n",
      "=====**=====S318=====**======= 18\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK09 - Antimicrobial resistant organisms: surveillance and epidemiology\n",
      "abs text :-  \n",
      "sess auth :- Andreas VOSS\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "PJK0901 === 16:15 - 17:15\n",
      "abs title :- What is the burden of carbapenem-resistant Enterobacterales (CRE) colonisation acquisition on patients' health outcomes?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0902 === 16:15 - 17:15\n",
      "abs title :- Innovative approaches to surveillance and quantifying the burden of bacterial infections and antibiotic resistance in northern Australia, a resource-limited setting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0903 === 16:15 - 17:15\n",
      "abs title :- Impact of the Pseudomonas aeruginosa high risk clones ST111 and ST654 in the prevalence of the carbapenemase genes (blaVIM-2; blaKPC-2; blaIMP-16) among clinical isolates recovered from 2018 to 2021 in Chilean hospitals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0904 === 16:15 - 17:15\n",
      "abs title :- The prevalence of carriage of multi-drug resistant organisms (MDROs) in Israeli post-acute care facilities (PACFs)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0905 === 16:15 - 17:15\n",
      "abs title :- Long-read sequencing to support outbreak investigations in the healthcare setting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0906 === 16:15 - 17:15\n",
      "abs title :- Which anatomic sites should be sampled to screening Candida auris?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0907 === 16:15 - 17:15\n",
      "abs title :- Influences of initial empiric antibiotics with ampicillin plus cefotaxime on the outcomes of neonates with respiratory failure: a propensity score matched analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0908 === 16:15 - 17:15\n",
      "abs title :- The global point prevalence survey of antimicrobial consumption and resistance (Global-PPS) results from public and private hospitals in Kenya and Tanzania in 2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK0909 === 16:15 - 17:15\n",
      "abs title :- Is universal contact isolation effective in reducing pathogen acquisition in a tertiary care setting medical intensive care unit?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 319\n",
      "=====**=====S319=====**======= 22\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 17/04/2023\n",
      "sess time :- 16:15 - 17:15\n",
      "sess loca :- 179 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting179 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET26 - Non-traditional Antibacterial Therapy Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGNTA The official open business meeting for the ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Tristan FERRY ; Ran NIR; Jean; Shawna MCCALLIN ; Zuzanna DRULIS\n",
      "sess aff :- France; Israel; Belgium; Switzerland; Poland\n",
      "========================================================================================================================\n",
      "inr 320\n",
      "=====**=====S320=====**======= 17\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP15 - Enterococcus spp.: still an important pathogen\n",
      "abs text :-  \n",
      "sess auth :- Luisa Maria Vieira PEIXE\n",
      "sess aff :- Portugal\n",
      "========================================================================================================================\n",
      "ALP1501 === 17:15 - 18:15\n",
      "abs title :- Collateral damage: rifaximin use and the emergence of daptomycin-resistant Enterococcus faecium\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1502 === 17:15 - 18:15\n",
      "abs title :- In-patient diversity of intestinal vancomycin-resistant enterococci in haematological and oncological patients: results from a prospective multicentre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1503 === 17:15 - 18:15\n",
      "abs title :- An update on faecal carriage of Enterococcus species by healthy humans unveils E. lactis as a predominant highly bacteriocinogenic species that can harbor optrA\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1504 === 17:15 - 18:15\n",
      "abs title :- Vancomycin-resistant vanB- and vanA/vanB-type Enterococcus faecium causing invasive infections in adult patients in Chile (2018-2022)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1505 === 17:15 - 18:15\n",
      "abs title :- Antibiotic resistance patterns of Enterococcus spp. during COVID-19 pandemic\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1506 === 17:15 - 18:15\n",
      "abs title :- Characterisation of vancomycin-resistant Enterococcus faecium from a central hospital over the last decade: fluctuating clones, plasmids and bacteriocins challenge classical infection control\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1507 === 17:15 - 18:15\n",
      "abs title :- Different growth conditions occurring in the environment affect Enterococcus spp. susceptibility to quaternary ammonium compounds\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1508 === 17:15 - 18:15\n",
      "abs title :- A multi-centre study comparing the molecular epidemiology of vancomycin-resistant and vancomycin-susceptible Enterococcus faecium bloodstream isolates in Germany\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1509 === 17:15 - 18:15\n",
      "abs title :- Emergence of optrA-mediated linezolid resistance in Enterococcus faecalis clinical isolates from Argentina\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 321\n",
      "=====**=====S321=====**======= 21\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- 178 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting178 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET21 - Legionella Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGLI The official open business meeting for the ESCMID Study Group for Legionella Infections (ESGLI). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Markus PETZOLD ; Sophie JARRAUD ; Diane LINDSAY ; Anastasia FLOUNTZI ; Maria Luisa RICCI\n",
      "sess aff :- Germany; France; United Kingdom; Greece; Italy\n",
      "========================================================================================================================\n",
      "inr 322\n",
      "=====**=====S322=====**======= 24\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 17:15 - 18:15\n",
      "sess loca :- 181 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting181 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET20 - Travel and Migration Infection Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGITM The official open business meeting for the ESCMID Study Group for Infections in Travellers and Migrants (ESGITM). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Christian WEJSE ; Corneliu Petru POPESCU ; Ana REQUENA\n",
      "sess aff :- Denmark; Romania; Sweden\n",
      "========================================================================================================================\n",
      "inr 323\n",
      "=====**=====S323=====**======= 25\n",
      "sess date :- 17/04/2023\n",
      "sess time :- 18:30 - 20:00\n",
      "sess loca :- Moche Room\n",
      "sess type :- Special SessionMoche Room\n",
      "sess cate :- 11. Other\n",
      "sess title :- S73 - General assembly of members\n",
      "abs text :-  \n",
      "sess auth :- Murat AKOVA ; Emmanuelle CAMBAU ; Alexander W. FRIEDRICH ; Christian GISKE ; Leonard LEIBOVICI ; Evelina TACCONELLI ; Annelies ZINKERNAGEL ; Anu KANTELE ; Jose Ramon PANO; Maurizio SANGUINETTI ; Luigia SCUDELLER ; Jacob MORAN; Robert Leo SKOV ; Jon S. FRIEDLAND\n",
      "sess aff :- Turkey; France; Germany; Sweden; Israel; Italy; Switzerland; Finland; Spain; Italy; Italy; Israel; Denmark; United Kingdom\n",
      "========================================================================================================================\n",
      "inr 324\n",
      "=====**=====S324=====**======= 0\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall A\n",
      "sess type :- Special SessionHall A\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3480 - Clinical Grand Round\n",
      "abs text :- Co-organised with                    \n",
      "Infectious Diseases Society of America (IDSA) The very popular Clinical Grand Round pits the wits of six internationally renowned physicians against seven difficult clinical cases involving patients with infectious diseases. It is co-sponsored by the Infectious Disease Society of America. In a 2-hour session, cases are presented by trainee ID physicians from Europe and USA and discussed with the senior professors. The presenting trainees and their cases are selected in a competitive process in the months leading up to the congress.\n",
      "sess auth :- Jacob STRAHILEVITZ ; David L. PATERSON ; Dimitrios P. KONTOYIANNIS ; Souha S. KANJ ; Nina KHANNA ; Robert C. READ ; Priscilla RUPALI\n",
      "sess aff :- Israel; Australia; United States; Lebanon; Switzerland; United Kingdom; India\n",
      "========================================================================================================================\n",
      "3480-1 === \n",
      "abs title :- Case 1\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3480-2 === \n",
      "abs title :- Case 2\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3480-3 === \n",
      "abs title :- Case 3\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3480-4 === \n",
      "abs title :- Case 4\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3480-5 === \n",
      "abs title :- Case 5\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3480-6 === \n",
      "abs title :- Case 6\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3480-7 === \n",
      "abs title :- Case 7\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 325\n",
      "=====**=====S325=====**======= 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour SymposiumHall B\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3168 - The role of the microbiota in development and progression of cancer\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for host and microbiota interaction (ESGHAMI), American Society of Microbiology (ASM), European Helicobacter & Microbiota Study Group (EHMSG), ESCMID Study Group for Biofilms (ESGB) The microbiota and its metabolites influence intestinal and systemic immunity against various forms of cancer. Modulating the microbiome by live biotherapeutic or microbiota transplantations potentially improves the response to cancer treatment and quality of life. This symposium will introduce the audience to recent technical developments to study complex host-microbiota interactions with various omics techniques to better understand the new cancer therapeutic approaches. It also aims to present current data concerning the gastric microbiota besides Helicobacter pylori and gastric cancer, intestinal microbiota, and colorectal cancer, areas that have been neglected in the past.\n",
      "sess auth :- Ed J. KUIJPER ; Sofia FORSLUND\n",
      "sess aff :- Netherlands; Germany\n",
      "========================================================================================================================\n",
      "3168-1 === \n",
      "abs title :- Colorectal cancer and biofilms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3168-2 === \n",
      "abs title :- Gut microbiota and gastric cancer\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3168-3 === \n",
      "abs title :- Microbiome and immune checkpoint inhibitors in cancer\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3168-4 === \n",
      "abs title :- What has brought metagenomics to understand cancer disease?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 326\n",
      "=====**=====S326=====**======= 2\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour Oral SessionHall C\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK14 - Diagnosis and prevention of antimicrobial-resistant infections\n",
      "abs text :-  \n",
      "sess auth :- Jaroslav HRABAK\n",
      "sess aff :- Czech Republic\n",
      "========================================================================================================================\n",
      "PJK1401 === 08:30 - 10:30\n",
      "abs title :- Mupirocin-based decolonisation for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients: a longitudinal study over 2 decades\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1402 === 08:30 - 10:30\n",
      "abs title :- Role of differential time to positivity for the diagnosis of catheter-related bloodstream infections due to staphylococci or Candida spp\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1403 === 08:30 - 10:30\n",
      "abs title :- Persistence of blaOXA-48-producing ST-22 Citrobacter freundii in patients and the hospital environment between 2016 and 2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1404 === 08:30 - 10:30\n",
      "abs title :- Mortality in patients with intestinal colonisation by blaKPC and blaOXA producing bacteria: a cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1405 === 08:30 - 10:30\n",
      "abs title :- An evaluation to determine if adding lactoferrin testing increases the sensitivity of rapid test algorithms for detecting C. difficile infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1406 === 08:30 - 10:30\n",
      "abs title :- The value of aligning diagnostic approaches with multi-disciplinary review to inform the treatment of Clostridioides difficile infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1407 === 08:30 - 10:30\n",
      "abs title :- Long-term ICU outbreak of blaNDM-producing Enterobacterales involving interspecies plasmid diffusion and a persisting environmental reservoir\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1408 === 08:30 - 10:30\n",
      "abs title :- How to avoid multidrug resistance (MDR)?  Successful experience with the application of a hospital bundle (HB)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1409 === 08:30 - 10:30\n",
      "abs title :- Bacterial culture and ATP measurements of disinfected patient rooms following admission of patients colonized with multi-drug resistant organisms (MDRO)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1410 === 08:30 - 10:30\n",
      "abs title :- Active follow-up of patients identified with highly resistant microorganisms to discontinue contact precautions\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 327\n",
      "=====**=====S327=====**======= 5\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S19 - Challenging the status quo: examining the treatment landscape for resistant or refractory CMV in transplant recipients\n",
      "abs text :- Organized by                    \n",
      "RMEI Medical Education, LLC Cytomegalovirus (CMV) is a common and potentially life-threatening viral infection after solid organ transplant or haematopoietic cell transplant. Strategies to prevent or treat CMV infection are limited by toxicities and cross-resistance to multiple agents. Long-term administration of antivirals for treatment or dose reduction for toxicities increase the risk of drug resistance.  \n",
      "During this symposium, a panel of CMV experts will discuss guideline-based recommendations for CMV prevention and treatment after transplantation. Interesting real-world clinical cases in CMV post-transplant provide an opportunity for you to consider how you would treat these patients, and expert opinion for optimal management. The panel will provide guidance on how to use a new antiviral maribavir in clinical practice for refractory or resistant CMV after transplantation.\n",
      "sess auth :- Roy CHEMALY\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "inr 328\n",
      "=====**=====S328=====**======= 8\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall I\n",
      "sess type :- 2-hour SymposiumHall I\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3308 - Unusual resistance and new antimicrobials for difficult to treat anaerobic infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Anaerobic Infections (ESGAI) Resistance in anaerobic bacteria is well documented in Bacteroides fragilis, for which multidrug-resistant isolates are regularly described. However, anaerobic bacteria are a heterogeneous group with many different genera and species, therefore many different resistance phenotypes exist. Unfortunately, it is not always possible to document antimicrobial susceptibility typing for each isolate. This symposium aims to review the resistance pattern in multiple groups of anaerobic bacteria, both expected and acquired. We will focus on resistance to Gram-positive anaerobic bacteria, Clostridia and former Clostridia genre and other Gram-positive anaerobic rods and discuss the use of new antibiotics in the treatment of difficult to treat infections.\n",
      "sess auth :- Trefor MORRIS ; Agnes Maria SONNEVEND\n",
      "sess aff :- United Kingdom; Hungary\n",
      "========================================================================================================================\n",
      "3308-1 === \n",
      "abs title :- Gram-positive cocci and other less commonly isolated anaerobes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3308-2 === \n",
      "abs title :- Clostridia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3308-3 === \n",
      "abs title :- Other anaerobic Gram-positive rods\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3308-4 === \n",
      "abs title :- Alternative antibiotics to treat anaerobic infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 329\n",
      "=====**=====S329=====**======= 9\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour Oral SessionHall J\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW11 - Novel strategies for anti-COVID treatment: still a challenge\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "EW1101 === 08:30 - 10:30\n",
      "abs title :- Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1102 === 08:30 - 10:30\n",
      "abs title :- Efficacy and safety of a single dose of AZD7442 (tixagevimab/cilgavimab) for prevention of COVID-19: 12-month analysis of the PROVENT phase 3 study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1103 === 08:30 - 10:30\n",
      "abs title :- Neutralisation capacity of clinically relevant monoclonal antibodies against currently circulating SARS-CoV-2 variants\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1104 === 08:30 - 10:30\n",
      "abs title :- Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): findings from the United Kingdom randomised, controlled open-label, platform adaptive trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1105 === 08:30 - 10:30\n",
      "abs title :- Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1106 === 08:30 - 10:30\n",
      "abs title :- Remdesivir is associated with decreased mortality in hospitalised COVID-19 patients requiring high-flow oxygen in the United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1107 === 08:30 - 10:30\n",
      "abs title :- Dexamethasone suppresses endotheliopathy and endothelial-induced coagulopathy in COVID-19\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1108 === 08:30 - 10:30\n",
      "abs title :- AXA1125, an endogenous metabolic modulator composition, improves long COVID fatigue, vascular biology and mitochondrial energetics: findings from a Phase 2a placebo-controlled clinical trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1109 === 08:30 - 10:30\n",
      "abs title :- Adoptive cell therapy with memory T lymphocytes to treat infectious diseases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW1110 === 08:30 - 10:30\n",
      "abs title :- ABO isoagglutinins inhibit coronavirus infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 330\n",
      "=====**=====S330=====**======= 10\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall K\n",
      "sess type :- 2-hour SymposiumHall K\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3156 - Individualised antimicrobial therapy: the future is now!\n",
      "abs text :-  The symposium will focus on the overall topic of dose individualisation as an integral component of clinical practice. First, it will focus on the evidence behind dose individualisation, therapeutic drug monitoring of anti-infectives, and novel approaches to dose individualisation, such as minimally-invasive sampling, microneedles, biosensors, and dosing software. Speakers will also describe how to implement dose individualisation techniques in different settings (resource-limited or 'first-world').\n",
      "sess auth :- Sonia LUQUE ; Sebastian WICHA\n",
      "sess aff :- Spain; Germany\n",
      "========================================================================================================================\n",
      "3156-1 === \n",
      "abs title :- Evidence for dose individualisation: where are we in 2023?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3156-2 === \n",
      "abs title :- New technologies for dose optimisation: a five-year outlook\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3156-3 === \n",
      "abs title :- Dose optimisation in resource-limited settings\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3156-4 === \n",
      "abs title :- Dose optimisation within antibiotic stewardship programmes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 331\n",
      "=====**=====S331=====**======= 11\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall L\n",
      "sess type :- 2-hour Oral SessionHall L\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK03 - Respiratory viruses are back!\n",
      "abs text :-  \n",
      "sess auth :- Siran KESKE\n",
      "sess aff :- Turkey\n",
      "========================================================================================================================\n",
      "MAK0301 === 08:30 - 10:30\n",
      "abs title :- Population diversity and spatio-temporal patterns of seasonal human coronaviruses\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0302 === 08:30 - 10:30\n",
      "abs title :- Common cold coronavirus disease among children and adults: re-examining their role in respiratory disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0303 === 08:30 - 10:30\n",
      "abs title :- Influenza virus infection and acute myocardial infarction: a replication study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0304 === 08:30 - 10:30\n",
      "abs title :- Out-of-season epidemic of respiratory syncytial virus (RSV) in Denmark in the summer/fall of 2021 with more cases and admissions than seen in previous winter seasons and a shift in affected age groups towards older children aged two-five years\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0305 === 08:30 - 10:30\n",
      "abs title :- An ongoing challenge in choosing the correct clinical samples for the diagnosis of respiratory viral infections in patients with severe respiratory syndromes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0306 === 08:30 - 10:30\n",
      "abs title :- Retrospective analysis of viral diagnostics data of patients referred to the Policlinico San Martino Hospital in Genoa with acute respiratory infection during eight sequential seasons (2014-2022)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0307 === 08:30 - 10:30\n",
      "abs title :- Estimation of hospitalisations and deaths attributable to influenza and RSV infections in adults 65 years and older in France using a model-based approach\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0308 === 08:30 - 10:30\n",
      "abs title :- Significance of nasopharyngeal virus detection in immunocompromised patients with acute respiratory failure\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0309 === 08:30 - 10:30\n",
      "abs title :- Preventing the winter quadruple threat: the value of hospital bed capacity freed up by vaccination\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0310 === 08:30 - 10:30\n",
      "abs title :- The influenza activity is fully recovered and even higher than before during Omicron pandemic in Beijing, China: a retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 332\n",
      "=====**=====S332=====**======= 12\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall M\n",
      "sess type :- 2-hour Educational WorkshopHall M\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3243 - Post-infectious neurological complications\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Infectious Diseases of the Brain (ESGIB), Trainee Association of ESCMID (TAE) Steering Committee Following common respiratory or gastrointestinal infections, an overactivated immune system can attack the nervous system. It can damage the peripheral nervous system, such as in Guillain-Barre syndrome, but also cause demyelination of the central nervous system, such as in acute disseminated encephalomyelitis or transverse myelitis. In children, cerebellitis is a frequently observed post-infectious nervous system complication, mainly after mycoplasma infections. In this session, speakers will discuss the different clinical presentations of central and peripheral nervous system complications following infections, including a separate presentation on paediatric complications.\n",
      "sess auth :- Willeke WESTENDORP ; Matthias KLEIN\n",
      "sess aff :- Netherlands; Germany\n",
      "========================================================================================================================\n",
      "3243-1 === \n",
      "abs title :- Post-infectious central nervous system complications: from demyelination to antibody-mediated encephalitis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3243-2 === \n",
      "abs title :- Post-infectious peripheral nervous system complications: Guillain-Barre and more...\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3243-3 === \n",
      "abs title :- Update on CNS shunt infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 333\n",
      "=====**=====S333=====**======= 13\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall N\n",
      "sess type :- 2-hour Educational WorkshopHall N\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- 3237 - Eosinophilia in migrants and travellers: challenging cases and common pitfalls\n",
      "abs text :- Co-organised with                    \n",
      "British Infection Association (BIA) This session will launch the 2023 UK Guidelines for the investigation and management of eosinophilia in migrants and travellers, to be published in May 2023. In this interactive session, a range of cases will be used to explore challenges and pitfalls in the management of eosinophilia. We use this international panel to draw out lively discussions around clinical management and laboratory diagnosis. Covered areas include: How to manage asymptomatic eosinophilia? Urinary schistosomiasis: who to investigate and follow up? Recent laboratory developments: diagnosis and test of cure.\n",
      "sess auth :- Anna CHECKLEY ; Nicola PETROSILLO\n",
      "sess aff :- United Kingdom; Italy\n",
      "========================================================================================================================\n",
      "3237-1 === \n",
      "abs title :- 2023 UK guidelines for the investigation and management of eosinophilia in migrants and travellers: the new, the challenging and the controversial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3237-2 === \n",
      "abs title :- Diagnosis and test of cure in schistosomiasis: challenges and changes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3237-3 === \n",
      "abs title :- Interactive cases: when to test, when to treat\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 334\n",
      "=====**=====S334=====**======= 14\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 10:30\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour Oral SessionHall O\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM08 - New weapons against fungi: from clinical trials to innovative therapies\n",
      "abs text :-  \n",
      "sess auth :- Ana ALASTRUEY\n",
      "sess aff :- Spain\n",
      "========================================================================================================================\n",
      "MEM0801 === 08:30 - 10:30\n",
      "abs title :- Outcomes of invasive fungal infections (IFI) due to Lomentospora prolificans infections treated with olorofim\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0802 === 08:30 - 10:30\n",
      "abs title :- All-cause and attributable mortality in invasive candidiasis and/or candidaemia with rezafungin and caspofungin treatment: outcomes from the ReSTORE trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0803 === 08:30 - 10:30\n",
      "abs title :- All oral lipid nanocrystal amphotericin B for cryptococcal meningitis: a phase II randomized trial\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0804 === 08:30 - 10:30\n",
      "abs title :- Focus on effectiveness, tolerability, and safety among different amphotericin B formulations in Brazilian patients' intended-to-treat invasive fungal infections: a real-life multi-centre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0805 === 08:30 - 10:30\n",
      "abs title :- Nebulised liposomal amphotericin B (NLAB) therapy in invasive pulmonary aspergillosis (IPA), safety and monitorisation of response with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET-TC): a pilot clinical trial (NAIFI)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0806 === 08:30 - 10:30\n",
      "abs title :- Enhancement of amphotericin B activity against Cryptococcus neoformans using lipid nanoparticles\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0807 === 08:30 - 10:30\n",
      "abs title :- CAR-T cells as a promising cellular therapy for fungal infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0808 === 08:30 - 10:30\n",
      "abs title :- Nanobody-based immunotherapy for the treatment of invasive fungal infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0809 === 08:30 - 10:30\n",
      "abs title :- SF001: a third-generation broad-spectrum, renal sparing polyene antifungal\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0810 === 08:30 - 10:30\n",
      "abs title :- European EFISG study of cerebral aspergillosis treated with isavuconazole\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 335\n",
      "=====**=====S335=====**======= 16\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP12 - Emerging and re-emerging bacterial infections\n",
      "abs text :-  \n",
      "sess auth :- Volker FINGERLE\n",
      "sess aff :- Germany\n",
      "========================================================================================================================\n",
      "CSP1201 === 08:30 - 09:30\n",
      "abs title :- Using source-associated mobile genetic elements to identify extraintestinal infections caused by zoonotic Escherichia coli strains\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1202 === 08:30 - 09:30\n",
      "abs title :- Culture-proven actinomyces infection  an increasingly recognised emerging implicated pathogen, an observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1203 === 08:30 - 09:30\n",
      "abs title :- The complex genomic diversity of Yersinia pestis on the long-term plague foci in Qinghai-Tibet Plateau\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1204 === 08:30 - 09:30\n",
      "abs title :- Evaluation of a duplex lateral flow assay for the diagnosis of plague\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1205 === 08:30 - 09:30\n",
      "abs title :- Risk of Lyme carditis in individuals with positive Borrelia burgdorferi serum antibodies, a matched nationwide cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1206 === 08:30 - 09:30\n",
      "abs title :- Antimicrobial mechanisms employed by macrophages exposed to pathogenic spirochaetes responsible to Lyme borreliosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1207 === 08:30 - 09:30\n",
      "abs title :- Delayed tetracycline initiation increases mortality risk in patients with Japanese spotted fever: a retrospective analysis using a national inpatient database\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1208 === 08:30 - 09:30\n",
      "abs title :- Probable airborne transmission of Burkholderia pseudomallei causing an urban outbreak of melioidosis during typhoon season in Hong Kong, China\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1209 === 08:30 - 09:30\n",
      "abs title :- A climate change associated outbreak of melioidosis in Queensland, Australia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 336\n",
      "=====**=====S336=====**======= 18\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 08:30 - 09:30\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- MAK08 - HIV from pathogenesis to diagnosis\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "MAK0801 === 08:30 - 09:30\n",
      "abs title :- Incidence of childbirth, pregnancy, spontaneous abortion, and induced abortion among women living with HIV, a nationwide matched cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0802 === 08:30 - 09:30\n",
      "abs title :- Risk of depression in people living with HIV, a nationwide population-based matched cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0803 === 08:30 - 09:30\n",
      "abs title :- Stabilisation of gp120 outer domain of HIV-1 Env using saturation suppressor mutagenesis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0804 === 08:30 - 09:30\n",
      "abs title :- HIV reservoir evaluation in GALT and PBMCs of virologically suppressed patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0805 === 08:30 - 09:30\n",
      "abs title :- Potential of emergency departments to uncover new HIV diagnosis: a before/after trial evaluating effects of national implementation of a protocol for targeted screening\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0806 === 08:30 - 09:30\n",
      "abs title :- Impact of cancers on clinical presentation, treatment limitation decisions and outcomes in critically ill HIV-infected patients: a multi-centre cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0807 === 08:30 - 09:30\n",
      "abs title :- Baseline HIV drug resistance profile three years after pre-exposure prophylaxis introduction: time to look back\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0808 === 08:30 - 09:30\n",
      "abs title :- Gut resistome linked to sexual preference and HIV infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MAK0809 === 08:30 - 09:30\n",
      "abs title :- Evaluation of lipid profile and intima media thickness in HIV experienced patients treated with PI-based regimens vs PI-sparing regimens\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 337\n",
      "=====**=====S337=====**======= 17\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP16 - Changing epidemiology of Acinetobacter spp. and Pseudomonas spp.\n",
      "abs text :-  \n",
      "sess auth :- Laurent POIREL\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "ALP1601 === 09:30 - 10:30\n",
      "abs title :- Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2012–2019\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1602 === 09:30 - 10:30\n",
      "abs title :- Recovery of carbapenem-resistant Enterobacterales and Acinetobacter by active surveillance in a tertiary university hospital: analysis of a coupled molecular and cultural approach over a six-year time span\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1603 === 09:30 - 10:30\n",
      "abs title :- Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) infections in critically ill patients with previous CRAB colonisation\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1604 === 09:30 - 10:30\n",
      "abs title :- Evolution of multidrug-resistant Acinetobacter baumannii pneumonia in years in terms of tigecycline treatment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1605 === 09:30 - 10:30\n",
      "abs title :- Knockout of the plasmid-borne tigecycline resistance gene tet(Y) results in the up-regulation of pilus-related proteins in Acinetobacter baumanni\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1606 === 09:30 - 10:30\n",
      "abs title :- Real-time monitoring of Pseudomonas aeruginosa mutational resistome using an enrichment panel for direct sequencing of clinical samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1607 === 09:30 - 10:30\n",
      "abs title :- Prediction of Pseudomonas aeruginosa antibiotic resistance levels using machine learning and protein quantification from blood cultures\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1608 === 09:30 - 10:30\n",
      "abs title :- An 18-month genomic investigation of Pseudomonas aeruginosa epidemiology and nosocomial spread at a large US hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1609 === 09:30 - 10:30\n",
      "abs title :- The emergence of blaGES-type extended-spectrum β-lactamases among Pseudomonas aeruginosa clinical isolates in Switzerland and characterisation of the novel variant GES-57\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 338\n",
      "=====**=====S338=====**======= 19\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 09:30 - 10:30\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- PJK10 - Surgical site, device infections and more\n",
      "abs text :-  \n",
      "sess auth :- Luis Eduardo LOPEZ\n",
      "sess aff :- Spain\n",
      "========================================================================================================================\n",
      "PJK1001 === 09:30 - 10:30\n",
      "abs title :- External validation of semi-automated surveillance algorithms for deep surgical site infections after colorectal surgery in an independent country\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1002 === 09:30 - 10:30\n",
      "abs title :- Deciphering a vancomycin-resistant E.faecium (VRE) outbreak at a cardiothoracic surgery department by whole genome sequencing (WGS)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1003 === 09:30 - 10:30\n",
      "abs title :- Combination of high-dose daptomycin and ceftriaxone for cardiac implantable electronic devices: a 10-year single-centre experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1004 === 09:30 - 10:30\n",
      "abs title :- Pseudomonas aeruginosa (PA) in urine as a risk factor for acquisition of PA bacteraemia in a hospital setting: a case control study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1005 === 09:30 - 10:30\n",
      "abs title :- Deep brain stimulators-related infections: incidence, characteristics and risk factors – a retrospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1006 === 09:30 - 10:30\n",
      "abs title :- Team dynamics and communication in the surgical operating room to identify infection and patient safety related roles, stressors and practices: an ethnographic study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1007 === 09:30 - 10:30\n",
      "abs title :- Surgical site infection detection: contribution of datamining models and data extract from hospital information system\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1008 === 09:30 - 10:30\n",
      "abs title :- Factors associated with septic thrombophlebitis among patients with catheter-related bloodstream infections due to staphylococci or Candida spp\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PJK1009 === 09:30 - 10:30\n",
      "abs title :- Ventilator-associated event (VAE) epidemiology and prognosis: preliminary results of VAE-Turkey\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 339\n",
      "=====**=====S339=====**======= 0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall A\n",
      "sess type :- Keynote LectureHall A\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3473 - Pneumococcal epidemiology, pathogenesis and intervention\n",
      "abs text :-  Birgitta Henriques-Normark is a Head Physician and Professor of Clinical Microbiology at the Karolinska Institutet, Stockholm, Sweden. She has extensive research and clinical expertise in host-bacterial interactions, ranging from bacterial regulatory systems to the immune response of the host, especially in the field of respiratory pathogens, mainly Streptococcus pneumoniae. Since 1st of July 2022, she is officially President of the Royal Swedish Academy.\n",
      "sess auth :- Ron DAGAN ; Mario RAMIREZ\n",
      "sess aff :- Israel; Portugal\n",
      "========================================================================================================================\n",
      "3473-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 340\n",
      "=====**=====S340=====**======= 1\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall B\n",
      "sess type :- Meet-the-ExpertHall B\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3424 - How to best use serology and molecular methods for surveillance of emerging infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Emerging Infections Task Force (EITaF) This session will discuss the best strategies and innovations for prompt clinical and laboratory diagnosis of emerging pathogens for the new and unforeseen challenges. Most microbiology labs have a repertoire of tests suited for routine testing in the local environment and do not have the capacity of workforce and supplies for a novel methodology such as metagenomics and sequencing. Should local labs be able to perform broader diagnostics, especially metagenomics and sequencing? When and how to decide to go outside the normal diagnostic repertoire? How could surveillance studies be implemented?\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3424-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3424-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 341\n",
      "=====**=====S341=====**======= 2\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall C\n",
      "sess type :- 1-hour Oral SessionHall C\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW08 - Clinical phenotypes in the era of evolving SARS-CoV-2 variants\n",
      "abs text :-  \n",
      "sess auth :- Surbhi MALHOTRA; Jean Paul STAHL\n",
      "sess aff :- Belgium; France\n",
      "========================================================================================================================\n",
      "EW0801 === 11:00 - 12:00\n",
      "abs title :- A new score to predict disease progression in SARS-CoV-2 infected people in the vaccines and early treatment era\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0802 === 11:00 - 12:00\n",
      "abs title :- COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, severity and viral kinetics, irrespective of vaccination history\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0803 === 11:00 - 12:00\n",
      "abs title :- SARS-CoV-2 Delta clades are associated with higher hospitalisation rates in unvaccinated but not in the vaccinated population\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0804 === 11:00 - 12:00\n",
      "abs title :- Clinical phenotypes in patients admitted with COVID-19 and their association with anti-coagulant and corticosteroid treatment on mortality in two hospitals in Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0805 === 11:00 - 12:00\n",
      "abs title :- Clinical phenotypes and cluster of symptoms predicting long COVID: the European ORCHESTRA cohort experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 342\n",
      "=====**=====S342=====**======= 3\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall D\n",
      "sess type :- 1-hour Oral SessionHall D\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP18 - Clostridioides and other bacterial gastro-intestinal infections:whats new?\n",
      "abs text :-  \n",
      "sess auth :- Philippe MONTRAVERS ; Fidelma FITZPATRICK\n",
      "sess aff :- France; Ireland\n",
      "========================================================================================================================\n",
      "CSP1801 === 11:00 - 12:00\n",
      "abs title :- Investigating the transmission of Clostridioides difficile from asymptomatic patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1802 === 11:00 - 12:00\n",
      "abs title :- Microbiota resilience after Clostridioides difficile infection treatments\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1803 === 11:00 - 12:00\n",
      "abs title :- Using machine learning for probabilistic assignment of the source of clinical campylobacteriosis cases in the United States\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1804 === 11:00 - 12:00\n",
      "abs title :- A decade of Vibrio and Shewanella infections in Denmark show correlation with high seawater temperature and genome-wide association with environmental isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1805 === 11:00 - 12:00\n",
      "abs title :- Genomic analysis of non-typhoidal Salmonella infections in the UK associated with travel to Africa\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 343\n",
      "=====**=====S343=====**======= 4\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall E\n",
      "sess type :- Meet-the-ExpertHall E\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3125 - Complex infections in critically ill children\n",
      "abs text :- Co-organised with                    \n",
      "European Society of Paedriatic and Neonatal Intensive Care (ESPNIC) The session aims to highlight and discuss some of the most complex clinical scenarios related to infectious diseases in PICU. Speakers will discuss challenging clinical pictures of the microbiological agents (MDR, invasive fungal infections) and complexities related to the fragility of critically ill children (the immune-compromised paediatric patient). Furthermore, they will present key innovation elements impacting extracorporeal circuits in PICU on antimicrobial drugs. They will finally discuss \"hot topics in PICU\" to help attendees take home the educational value of real practice and these highly complex clinical conditions.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3125-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3125-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 344\n",
      "=====**=====S344=====**======= 5\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall F\n",
      "sess type :- 1-hour SymposiumHall F\n",
      "sess cate :- 9. Experimental microbiology, microbial pathogenesis & biofilm\n",
      "sess title :- 3427 - Hidden intracellular lifestyle of bacterial pathogens\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) Staphylococcus aureus is a commensal pathogen that can colonise and infect different anatomical sites causing a wide range of infections in terms of severity. In addition, S. aureus can lead to chronic infections, representing a reservoir for re-infection. This capacity of adaptation may hinder the activity of some antimicrobials. This symposium will highlight the molecular mechanisms employed by S. aureus to persist intracellularly. A better understanding of such strategies can reveal potential targets for novel therapies.\n",
      "sess auth :- Nikolai SIEMENS ; Christine MOISSL\n",
      "sess aff :- Germany; Austria\n",
      "========================================================================================================================\n",
      "3427-1 === \n",
      "abs title :- Enterococcus faecalis hijacks host trafficking pathways to replicate intracellularly\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3427-2 === \n",
      "abs title :- Intracellular multiplication niche among Acinetobacter baumannii clinical isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 345\n",
      "=====**=====S345=====**======= 6\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall G\n",
      "sess type :- 1-hour SymposiumHall G\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3260 - Infectious disease diagnostics in the light of new regulations on in vitro diagnostics (IVDR)\n",
      "abs text :- Co-organised with                    \n",
      "Danish Society of Clinical Microbiology, Swedish society of Clinical Microbiology, ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD) The EU regulation 2017/746 (IVDR) affects the use of established microbiological analyses and the introduction of new techniques like metagenomics. The regulation is implemented stepwise from May 26th 2022 until the beginning of 2028. This session will discuss the consequences for present and future diagnostics in the field of clinical microbiology.\n",
      "sess auth :- Gilbert GREUB ; Helle ERIKSEN\n",
      "sess aff :- Switzerland; Denmark\n",
      "========================================================================================================================\n",
      "3260-1 === \n",
      "abs title :- Implications of the IVDR for a routine diagnostic lab\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3260-2 === \n",
      "abs title :- Pandemic preparedness within the IVDR framework\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 346\n",
      "=====**=====S346=====**======= 7\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall H\n",
      "sess type :- 1-hour Oral SessionHall H\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP03 - Co-evolution of antibiotic resistance and virulence\n",
      "abs text :-  \n",
      "sess auth :- Kai ZHOU\n",
      "sess aff :- China\n",
      "========================================================================================================================\n",
      "ALP0301 === 11:00 - 12:00\n",
      "abs title :- Convergence of hypervirulence and carbapenemase-mediated resistance in Klebsiella pneumoniae in Switzerland\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0302 === 11:00 - 12:00\n",
      "abs title :- Gp05, a prophage-encoded virulence factor, contributes to persistent methicillin-resistant Staphylococcus aureus endovascular infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0303 === 11:00 - 12:00\n",
      "abs title :- Longitudinal genomic surveillance of combined hyper-virulent and antimicrobial-resistant Klebsiella spp. from Irish hospitals, 2016-2021\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0304 === 11:00 - 12:00\n",
      "abs title :- Widespread and ongoing convergence of antibiotic resistance and virulence traits in Klebsiella pneumoniae though plasmid hybridisation in One Health settings\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 347\n",
      "=====**=====S347=====**======= 8\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall I\n",
      "sess type :- 1-hour SymposiumHall I\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3197 - New insights into influenza and COVID-19 associated pulmonary aspergillosis: when Aspergillus goes viral\n",
      "abs text :-  Influenza and COVID-19 associated pulmonary aspergillosis (IAPA/CAPA) are fungal super-infections in critically ill patients with severe influenza and COVID-19. They are associated with high morbidity and mortality despite the use of antifungals. A deep understanding of the disease is urgently needed to develop novel diagnostic biomarkers and targets for immunomodulatory therapy. This symposium will give a state-of-the-art update on the immunological mechanisms underlying IAPA/CAPA in critically ill patients. Novel insights from relevant animal models will also be discussed.\n",
      "sess auth :- Fanny LANTERNIER ; Agostinho CARVALHO\n",
      "sess aff :- France; Portugal\n",
      "========================================================================================================================\n",
      "3197-1 === \n",
      "abs title :- Understanding and treating IAPA/CAPA in critically ill patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3197-2 === \n",
      "abs title :- Translating IAPA/CAPA disease mechanisms from animal models\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 348\n",
      "=====**=====S348=====**======= 9\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall J\n",
      "sess type :- 1-hour SymposiumHall J\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3271 - Antibiotic drug shortages: causes and consequences\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Antimicrobial stewardship (ESGAP) This symposium will explore the increasingly common problem of antibiotic drug shortages and how this shapes the efforts to address the problem of antimicrobial resistance. The topics discussed will include the weaknesses in existing strategies for access to antibiotics and supply chain and demand considerations. Using examples from current challenges and solutions, we will explore the global gaps and opportunities in antibiotic manufacturing and supply chains and the implications for antimicrobial resistance and stewardship.\n",
      "sess auth :- Paul Otieno YONGA ; Katja DE WITH\n",
      "sess aff :- Kenya; Germany\n",
      "========================================================================================================================\n",
      "3271-1 === \n",
      "abs title :- Antibiotic supply chain disruptions: where and why?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3271-2 === \n",
      "abs title :- Antibiotic shortages: can we learn from our fate?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 349\n",
      "=====**=====S349=====**======= 10\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall K\n",
      "sess type :- 1-hour SymposiumHall K\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3254 - What is new in transplant infectious diseases?\n",
      "abs text :-  Tremendous progress has been made in transplantation in recent decades. Nevertheless, success is compromised by infectious complications. Prevention strategies have reduced the morbidity and mortality associated with post-transplant infections and may have influenced the timing and relative frequency of infections. In addition, transplant recipients are particularly vulnerable to difficult-to-treat bacterial, viral, fungal, or multidrug-resistant infections because of prolonged immunosuppression. This symposium will discuss current challenges related to infectious diseases in transplantation.\n",
      "sess auth :- Michael G ISON ; Carla WALTI\n",
      "sess aff :- United States; Switzerland\n",
      "========================================================================================================================\n",
      "3254-1 === \n",
      "abs title :- How do current approaches affect the occurence of post-transplant infections?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3254-2 === \n",
      "abs title :- What is the impact of bacterial, viral, and fungal multidrug resistance on the outcome of haematopoietic cell transplant recipients?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 350\n",
      "=====**=====S350=====**======= 11\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall L\n",
      "sess type :- Meet-the-ExpertHall L\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3117 - EUCAST frequently asked questions in AST\n",
      "abs text :- Co-organised with                    \n",
      "EUCAST Steering Committee During this Meet-the-Expert, EUCAST frequently asked questions will be answered in detail. This includes questions relating to the full range of activities of EUCAST, which can include new and revised testing, screening and breakpoint methods. As well as issues regarding modifications to supporting dosage information and new species added to the testing list.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3117-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3117-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 351\n",
      "=====**=====S351=====**======= 12\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall M\n",
      "sess type :- 1-hour SymposiumHall M\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3460 - Innate and adaptive immunity to viral infections\n",
      "abs text :-  The COVID-19 pandemic demonstrated many gaps in our understanding of immunity against viruses and how to measure and modulate immunity. During this symposium, speakers will review the recent findings in the fields of innate and adaptive immunity to respiratory viruses and discuss what should be the next steps in research, diagnostics, and therapeutics to fight viral infections.\n",
      "sess auth :- Florian KRAMMER ; Dana WOLF\n",
      "sess aff :- United States; Israel\n",
      "========================================================================================================================\n",
      "3460-1 === \n",
      "abs title :- Effects of trained immunity against viral infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3460-2 === \n",
      "abs title :- B and T cell responses to viral antigens\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 352\n",
      "=====**=====S352=====**======= 13\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall N\n",
      "sess type :- Meet-the-ExpertHall N\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3119 - How do I prevent and manage vascular device and graft infections\n",
      "abs text :-  Vascular graft infections are complex to manage, both from the diagnostic and the therapeutical perspective. Frequently require a multidisciplinary approach involving microbiologists, radiologists, surgeons, and infectious diseases physicians. This session aims to summarise some of the most relevant aspects of diagnosis (clinical, radiological, and microbiological) and treatment (antibiotic therapy and surgical options) of the different types of vascular graft infection (acute vs chronic, groin vs intrabdominal).\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3119-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3119-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 353\n",
      "=====**=====S353=====**======= 14\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall O\n",
      "sess type :- 1-hour Case SessionHall O\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES01 - Using new antifungals for complex infections\n",
      "abs text :-  \n",
      "sess auth :- Joshua NOSANCHUK\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "BES0101 === 11:00 - 12:00\n",
      "abs title :- Successful treatment of azole-resistant disseminated aspergillosis with olorofim in an 8-year old girl\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0102 === 11:00 - 12:00\n",
      "abs title :- Olorofim successful treatment for resistant Microascus sp treatment: a mini series of three cases\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0103 === 11:00 - 12:00\n",
      "abs title :- Succesful rezafungin treatment for an azole-resistant chronic mucocutaneous candidiasis in a STAT1 gain-of-function patient\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0104 === 11:00 - 12:00\n",
      "abs title :- Successful treatment of Candida endocarditis with rezafungin: a case series\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0105 === 11:00 - 12:00\n",
      "abs title :- Calcaneal Rhodotorula mucilaginosa osteomyelitis treated with oral amphotericin B (MAT2203)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 354\n",
      "=====**=====S354=====**======= 15\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Hall P\n",
      "sess type :- 1-hour Case SessionHall P\n",
      "sess cate :- 13. Case reports and case series\n",
      "sess title :- BES06 - Intriguing clinical cases across the One Health spectrum\n",
      "abs text :-  \n",
      "sess auth :- Ana VALE\n",
      "sess aff :- Ireland\n",
      "========================================================================================================================\n",
      "BES0601 === 11:00 - 12:00\n",
      "abs title :- Never get between an iguana and his cake: a cautionary tale of a subcutaneous mass following an iguana bite\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0602 === 11:00 - 12:00\n",
      "abs title :- Capnocytophaga canimorsus bactereamia, diagnostic key to a case of chronic lymphocytic leukaemia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0603 === 11:00 - 12:00\n",
      "abs title :- Next-generation sequencing techniques to detect rare guests in the ICU: Morbus Weil\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0604 === 11:00 - 12:00\n",
      "abs title :- The Farmer's Fertile Feet\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "BES0605 === 11:00 - 12:00\n",
      "abs title :- An Eosinophillic end to a Stag-Party in Thailand\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 355\n",
      "=====**=====S355=====**======= 16\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP08 - Current topics in Gram-positive cocci\n",
      "abs text :-  \n",
      "sess auth :- Richard KUEHL\n",
      "sess aff :- Switzerland\n",
      "========================================================================================================================\n",
      "CSP0801 === 11:00 - 12:00\n",
      "abs title :- Geospatial factors preeminently shape the global genome profiles of Staphylococcus aureus ST398\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0802 === 11:00 - 12:00\n",
      "abs title :- mleS in Staphylococcus aureus contributes to microaerobic metabolic activity, abscess formation, and survival in macrophages\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0803 === 11:00 - 12:00\n",
      "abs title :- Increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008-2021)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0804 === 11:00 - 12:00\n",
      "abs title :- Correlation of persisting bacteraemia and complicated Staphylococcus aureus infection: a retrospective cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0805 === 11:00 - 12:00\n",
      "abs title :- Efficacy of a new multidomain peptide D5L37D5L37 to prevent methicillin-resistant Staphylococcus epidermidis (MRSE) in vivo catheter-related infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0806 === 11:00 - 12:00\n",
      "abs title :- Translation of Raman-based characterisation of cefazolin: Staphylococcus aureus interaction from extracellular bacteria to an intracellular S. aureus infection model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0807 === 11:00 - 12:00\n",
      "abs title :- Characteristics of major lineages causing invasive disease due to Streptococcus dysgalactiae subsp. equisimilis in adults in Spain\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0808 === 11:00 - 12:00\n",
      "abs title :- Longer-term mortality and kidney outcomes of participants in the combination antibiotics for methicillin-resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0809 === 11:00 - 12:00\n",
      "abs title :- Increasing incidence of community-acquired adult group A streptococcal meningitis in the Netherlands\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 356\n",
      "=====**=====S356=====**======= 18\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 11:00 - 12:00\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP17 - Evolving epidemiology of drug-resistant enteric pathogens\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "ALP1701 === 11:00 - 12:00\n",
      "abs title :- Impact of a typhoid conjugate vaccine campaign on Salmonella Typhi population structure and antibiotic resistance in Harare, Zimbabwe\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1702 === 11:00 - 12:00\n",
      "abs title :- Epidemiological study of antimicrobial susceptibility of enteric Salmonella spp. at Vall d'Hebron University Hospital (2016-2021)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1703 === 11:00 - 12:00\n",
      "abs title :- Comparison of genetic and phenotypic characteristics of Salmonella enterica serovar Choleraesuis isolated in humans and animals from 2006 to 2021: a One Health approach for antimicrobial resistance surveillance\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1704 === 11:00 - 12:00\n",
      "abs title :- Multidrug-resistant Salmonella enterica serotype Kentucky ST198 is widely distributed across poultry farms in Nigeria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1705 === 11:00 - 12:00\n",
      "abs title :- blaKPC-producing Salmonella enterica subspecies enterica serovar Brandenburg causing bloodstream infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1706 === 11:00 - 12:00\n",
      "abs title :- Occurrence and distribution of antimicrobial resistant non-typhoidal Salmonella species in slaughtered animals in Pakistan\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1707 === 11:00 - 12:00\n",
      "abs title :- Antibiotic resistance profile of multidrug-resistant Shigella sonnei and Shigella flexneri in Portugal, 2015-2022\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1708 === 11:00 - 12:00\n",
      "abs title :- Circulation of fluoroquinolone resistant strains of Shigella sonnei and S. flexneri in Spain from 2015 to 2022: a retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP1709 === 11:00 - 12:00\n",
      "abs title :- Antimicrobial susceptibility profile of Campylobacter jejuni and Campylobacter coli isolates during a 10-year period: characterisation of multi-drug resistant isolates using whole genome sequencing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 357\n",
      "=====**=====S357=====**======= 3\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall D\n",
      "sess type :- Integrated SymposiumHall D\n",
      "sess cate :- 11. Other\n",
      "sess title :- S14 - Rapid AST on positive blood culture: efficient use in clinical routine laboratories\n",
      "abs text :- Organized by                    \n",
      "QUANTAMATRIX The aim of our Integrated Symposium will be to focus on different topics related to medico-economical aspects of rapid AST solutions and how it can bring added value for different laboratory workflow: How rapid AST solutions can be economically valuable for a clinical laboratory. Medico-economical contrast between public and private laboratory environment for rapid AST solutions. Use of rapid AST solutions in different laboratory workflow schedules\n",
      "sess auth :- Gérald ULRICH ; Paul Christoffer LINDEMANN\n",
      "sess aff :- France; Norway\n",
      "========================================================================================================================\n",
      "S1401 === 12:15 - 13:15\n",
      "abs title :- Welcome and introduction\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1402 === 12:15 - 13:15\n",
      "abs title :- How rapid AST solutions can be economically valuable for a clinical laboratory\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1403 === 12:15 - 13:15\n",
      "abs title :- Use of rapid AST solutions in different laboratory workflow schedules\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1404 === 12:15 - 13:15\n",
      "abs title :- Laboratory Workflow Innovation for Rapid AST\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "S1405 === 12:15 - 13:15\n",
      "abs title :- Panel discussion and Q&A\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 358\n",
      "=====**=====S358=====**======= 5\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Hall F\n",
      "sess type :- Integrated SymposiumHall F\n",
      "sess cate :- 11. Other\n",
      "sess title :- S53 - Role of first-line screening stool tests for gastrointestinal infectious diseases\n",
      "abs text :- Organized by                    \n",
      "SD Biosensor - Epidemiology and morphology of G.I. pathogens  \n",
      "- Introducing various laboratory approaches and methodologies for G.I infections  0\n",
      "- Emphasising the role of screening test for G.I. infections \n",
      "- Adequate approaches of using screening test for G.I. infections  \n",
      "- Sharing clinical study results: comparison between commercially available screening tests and microbiological confirmatory methods\n",
      "sess auth :- Eric CLAAS\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "inr 359\n",
      "=====**=====S359=====**======= 18\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 12:15 - 13:15\n",
      "sess loca :- Arena 3\n",
      "sess type :- Open ForumArena 3\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3453 - Online educational resources for antimicrobial stewardship\n",
      "abs text :- Co-organised with                    \n",
      "British Society for Antimicrobial Chemotherapy (BSAC), ESCMID Fungal Infection Study Group (EFISG), European Confederation of Medical Mycology (ECMM) Education is a critical element of successful antimicrobial stewardship (AMS) programmes but can be difficult to access and time consuming to deliver in person. Online resources can bring global experience directly to the screen of health professionals enabling instant access to up-to-date knowledge and speedy dissemination of innovative stewardship opportunities. While free to access on-line AMS resources are attractive as learners can choose their own topics and access learning at times convenient to them, identifying quality content that is relevant and worth investing time in can be challenging. This session will focus on high quality educational resources that can benefit busy healthcare professionals in key focus areas for antimicrobial stewardship. Attendees will learn where to access educational resources that can support learning and enable effective stewardship programmes, with a more detailed look at educational resources in four key subject areas.\n",
      "sess auth :- Jeroen SCHOUTEN\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "3453-1 === \n",
      "abs title :- Online educational resources for antibiotic allergy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3453-2 === \n",
      "abs title :- Online educational resources for stewardship in LMICs\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3453-3 === \n",
      "abs title :- Online educational resources for stewardship in the hospital\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3453-4 === \n",
      "abs title :- Online educational resources for stewardship in mycology\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 360\n",
      "=====**=====S360=====**======= 20\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 12:00 - 13:30\n",
      "sess loca :- Poster Area\n",
      "sess type :- Poster SessionPoster Area\n",
      "sess cate :- 11. Other\n",
      "sess title :- PS076 - 11a. Professional affairs and career development\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PS07601 === 12:00 - 13:30\n",
      "abs title :- Disproportionate deployment of infectious disease specialists at designated medical institutions in Japan\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS07602 === 12:00 - 13:30\n",
      "abs title :- Complexity of patients with or without infectious disease consultation in tertiary care hospitals in Germany\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS07603 === 12:00 - 13:30\n",
      "abs title :- The first European Exam in Medical Microbiology (EEMM): the the role of exam candidate feedback in improving the trainees' experience\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS07604 === 12:00 - 13:30\n",
      "abs title :- Does orphan legislation provide the same protection of patient safety when developing anti-Pseudomonas drugs as non-orphan legislation?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS07605 === 12:00 - 13:30\n",
      "abs title :- Effect of video training on improving physicians' knowledge of invasive fungal disease: a multi-center, cluster randomized controlled study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PS07606 === 12:00 - 13:30\n",
      "abs title :- Strengthening capacity of early career researchers in South Africa and India: lessons learnt in delivering to antimicrobial resistance research needs in the context of global health\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 361\n",
      "=====**=====S361=====**======= 21\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 12:00 - 13:00\n",
      "sess loca :- 180 (Hotel, 1st Floor)\n",
      "sess type :- ESCMID open meeting180 (Hotel, 1st Floor)\n",
      "sess cate :- \n",
      "sess title :- MEET25 - Nosocomial Infections Study Group open meeting\n",
      "abs text :- Co-organised with                    \n",
      "ESGNI The official open business meeting for the ESCMID Study Group for Nosocomial Infections (ESGNI). Open to all ECCMID registrants who are interested in learning more about the topic or joining the Study Group.\n",
      "sess auth :- Elisabeth PRESTERL ; Margreet C. VOS ; Walter ZINGG ; Hilary HUMPHREYS\n",
      "sess aff :- Austria; Netherlands; Switzerland; Ireland\n",
      "========================================================================================================================\n",
      "inr 362\n",
      "=====**=====S362=====**======= 1\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall B\n",
      "sess type :- 2-hour Educational WorkshopHall B\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3228 - Applying metagenomics in diagnostics: three different perspectives\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD) Metagenomic sequencing is a powerful and emerging tool in infection diagnostics. The many possibilities and challenges for optimal use in diagnostics and targeted treatment will be discussed. How and when to use, how to interpret and communicate results to ensure rapid diagnostics and targeted treatment will be presented and discussed through the eyes of the technology expert, the medical microbiologist and the end user. Do they agree? Examples of sample and infection types where this tool is especially useful will be presented.\n",
      "sess auth :- Cecile BEBEAR ; John W. A. ROSSEN\n",
      "sess aff :- France; Netherlands\n",
      "========================================================================================================================\n",
      "3228-1 === \n",
      "abs title :- The \"technology expert\"'s perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3228-2 === \n",
      "abs title :- The microbiologist's perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3228-3 === \n",
      "abs title :- The clinician's perspective\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 363\n",
      "=====**=====S363=====**======= 2\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall C\n",
      "sess type :- 2-hour SymposiumHall C\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- 3116 - Surveillance of carbapenemase-producing and colistin-resistant Enterobacterales in European countries\n",
      "abs text :-  Emerging of carbapenemase-producing and colistin-resistant Enterobacterales represent a global threat to global health. The symposium will discuss the molecular epidemiology of those bacteria with a special focus on horizontal gene transfer. In addition, will highlight current approaches in molecular epidemiology. Based on epidemiological features, it is crucial to map a complete genome, including mobile genetic elements' characterisation. Within the presentation, important bioinformatic tools will be also discussed. As an important part of surveillance is an action in the site of outbreak, possible epidemiological measures will be discussed as well. In Europe, molecular surveillance of carbapenemase-producing and colistin-resistant bacteria has been implemented within EuSCAPE project followed by EURGen-Net. Important activities of the project will be disused in the closing presentation.\n",
      "sess auth :- Ana GALES ; Spyros POURNARAS\n",
      "sess aff :- Brazil; Greece\n",
      "========================================================================================================================\n",
      "3116-1 === \n",
      "abs title :- Molecular epidemiology of carbapenemase-producing Enterobacterales in Europe: from clonal spread to plasmid epidemics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3116-2 === \n",
      "abs title :- WGS for the epidemiology of MDR Gram-negative bacteria: is it necessary to use long-read sequencing?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3116-3 === \n",
      "abs title :- How to combat carbapenemase-producing and colistin-resistant Enterobacterales\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3116-4 === \n",
      "abs title :- Capacity building for European laboratories to perform surveillance of carbapenemase-producing and colistin-resistant Enterobacterales\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 364\n",
      "=====**=====S364=====**======= 3\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall D\n",
      "sess type :- 2-hour Oral SessionHall D\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- CSP13 - Trending topics in tuberculosis\n",
      "abs text :-  \n",
      "sess auth :- Roxana FILIP ; Lorenzo GUGLIELMETTI\n",
      "sess aff :- Romania; France\n",
      "========================================================================================================================\n",
      "CSP1301 === 13:30 - 15:30\n",
      "abs title :- Network-based analysis reveals a plasma protein signature associated with active tuberculosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1302 === 13:30 - 15:30\n",
      "abs title :- Resolution of blood transcriptional biomarker signatures fails to discriminate contemporaneous sputum culture status at 8 weeks of TB treatment\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1303 === 13:30 - 15:30\n",
      "abs title :- A machine learning approach to identify latent tuberculosis infection with higher risk to develop active infection from whole blood transcriptomics\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1304 === 13:30 - 15:30\n",
      "abs title :- Tuberculosis recurrence and long-term mortality in TB/HIV co-infected persons from Eastern Europe: a cohort study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1305 === 13:30 - 15:30\n",
      "abs title :- Pregnancy outcomes in women screened for tuberculosis infection in Swedish antenatal care\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1306 === 13:30 - 15:30\n",
      "abs title :- Comparison of chest radiograph interpretations by artificial intelligence vs radiologists in the diagnosis of pulmonary TB\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1307 === 13:30 - 15:30\n",
      "abs title :- Spatial transcriptomics uncovers neutrophil and matrix metalloproteinase-driven inflammation in central nervous system tuberculomas of human and mice with adjunctive matrix metalloproteinase inhibition improving survival\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1308 === 13:30 - 15:30\n",
      "abs title :- The association of meropenem with ethambutol enhances the exposure of Mycobacterium tuberculosis peptidoglycan and promotes its synergistic killing\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1309 === 13:30 - 15:30\n",
      "abs title :- Clinical improvement among 18 patients with severe central nervous system tuberculosis by TNF-α inhibitor treatment adjunction: a retrospective observational study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP1310 === 13:30 - 15:30\n",
      "abs title :- A phase 2a, randomised, active-control, open-label trial evaluating the safety/efficacy of OPC-167832 combined with delamanid and/or bedaquiline for drug-susceptible pulmonary tuberculosis for fourteen days\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 365\n",
      "=====**=====S365=====**======= 4\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall E\n",
      "sess type :- 2-hour Oral SessionHall E\n",
      "sess cate :- 7. Parasitic diseases & global health\n",
      "sess title :- PAK15 - Malaria: challenges in LMICs and HICs\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "PAK1501 === 13:30 - 15:30\n",
      "abs title :- Side effects and factors influencing non-adherence to mass drug administration for malaria control in the context of a cluster randomised clinical trial (MATAMAL) on the Bijagós Archipelago, Guinea-Bissau\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1502 === 13:30 - 15:30\n",
      "abs title :- Non-typhoidal Salmonella co-infect children with malaria and impair outcome of hospital-admitted children under five in DR Congo\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1503 === 13:30 - 15:30\n",
      "abs title :- Impact of the COVID-19 pandemic on maternal and malaria services in thirty health facilities in northern Uganda: an interrupted time series analysis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1504 === 13:30 - 15:30\n",
      "abs title :- Factors associated with post-artesunate delayed haemolysis in severe imported Plasmodium falciparum malaria: a national prospective multicentre study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1505 === 13:30 - 15:30\n",
      "abs title :- Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry as a diagnostic tool for Plasmodium falciparum malaria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1506 === 13:30 - 15:30\n",
      "abs title :- Screening for malaria parasites in migrants from Sub-Saharan Africa arriving in Sweden\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1507 === 13:30 - 15:30\n",
      "abs title :- Health itinerary related survival of children under five with severe malaria or bloodstream infection, DR Congo\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1508 === 13:30 - 15:30\n",
      "abs title :- Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1509 === 13:30 - 15:30\n",
      "abs title :- Population pharmacokinetic model of artesunate and its metabolite dihydroartemisinin from infants to adults: are current dosing regimens giving equivalent exposure across weight groups\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "PAK1510 === 13:30 - 15:30\n",
      "abs title :- Sub-microscopic malaria in a low transmission setting: two-year observational, prospective hospital-based study, a first hospital-based study from India\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 366\n",
      "=====**=====S366=====**======= 5\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall F\n",
      "sess type :- 2-hour SymposiumHall F\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3381 - Abdominal sepsis in the elderly population\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Infections in Critically Ill Patients (ESGCIP), ESCMID Study Group for Infections in the Elderly (ESGIE) Sepsis of abdominal origin is the second most frequent reason for a septic shock in interdisciplinary ICU and is associated with significant morbidity and mortality. Elderly patients are due to polypharmacy at particularly high risk for altered pharmacokinetics and drug-related toxicity associated with the administration of antibiotics. Moreover, the patients frequently suffer from infections due to multidrug-resistant bacteria including carbapenem-resistant Enterobacterales (CRE). This symposium will address the challenges associated with abdominal sepsis in the elderly. The epidemiology of this subgroup of patients and pathophysiological alterations and their impact on the PK of drugs will be discussed. This symposium will also highlight the importance of surgical source control including the peculiarities in the elderly population and application of antibiotic stewardship principles.\n",
      "sess auth :- Marco FALCONE ; Rossitza VATCHEVA\n",
      "sess aff :- Italy; Bulgaria\n",
      "========================================================================================================================\n",
      "3381-1 === \n",
      "abs title :- Epidemiology and outcome of abdominal sepsis in the elderly\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3381-2 === \n",
      "abs title :- CRE in abdominal sepsis: from genomics to clinical impact\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3381-3 === \n",
      "abs title :- Source control in abdominal sepsis: peculiarities of the elderly\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3381-4 === \n",
      "abs title :- Antimicrobial stewardship in elderly patients with abdominal sepsis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 367\n",
      "=====**=====S367=====**======= 6\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall G\n",
      "sess type :- 2-hour SymposiumHall G\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- 3146 - Why the fuss about fungi: emerging mycoses\n",
      "abs text :-  A remarkable number of fungal diseases are rapidly emerging. Some are within specific regions, whereas others have exploded across the globe. Certain pathogens, such as C. auris, are highly resistant to our current antifungal armamentarium. In addition, emerging pathogens are linked to increasingly immunosuppressed populations, the expansion of humans into different environments, climate change, etc. This symposium will explore specific fungal pathogens and provide a guide to addressing rare fungal infections.\n",
      "sess auth :- Thuy LE\n",
      "sess aff :- United States\n",
      "========================================================================================================================\n",
      "3146-1 === \n",
      "abs title :- Candida auris, an expanding global threat\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3146-2 === \n",
      "abs title :- Emergomyces species: emerging on multiple continents\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3146-3 === \n",
      "abs title :- The story of Sporothrix brasilensis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3146-4 === \n",
      "abs title :- Emerging rare yeast and dimorphic fungal infections: approaches to diagnosis and management\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 368\n",
      "=====**=====S368=====**======= 7\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall H\n",
      "sess type :- 2-hour Educational WorkshopHall H\n",
      "sess cate :- 8. Healthcare-associated infections, infection prevention & control\n",
      "sess title :- 3391 - A primer on infection prevention and control\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Nosocomial Infections (ESGNI) In this Educational Workshop, the main tasks of infection prevention and control for all professionals interested in the routine clinical work of infection control will be described. Furthermore, changes and development in recent years will be addressed, and the principles and rationales of IPC will be shared. The main discussed issues will include: the epidemiology of healthcare-associated infections (implementation, consequences and future aspects), the IPC requirements for \"systems\", in particular water or ventilation systems and for the design of wards, the practical IPC skills, e.g., clean care and their impact, and last no least, the implementation of the IPC programme in the hospital and the links to public health.\n",
      "sess auth :- Preeti MALANI ; Ermira TARTARI\n",
      "sess aff :- United States; Malta\n",
      "========================================================================================================================\n",
      "3391-1 === \n",
      "abs title :- Epidemiology of healthcare-associated infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3391-2 === \n",
      "abs title :- IPC implementation and infrastructure\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3391-3 === \n",
      "abs title :- Infection prevention and control practical skills\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 369\n",
      "=====**=====S369=====**======= 9\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall J\n",
      "sess type :- 2-hour SymposiumHall J\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- 3190 - Changing the paradigm of neutropaenic fever prevention and management\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Antimicrobial Stewardship (ESGAP), ESCMID Study Group for Infections in Compromised Hosts (ESGICH) There is emerging evidence that antimicrobial use in cancer patients can impact treatment response. With novel drugs and therapies, including immunotherapeutics and CAR-T cells, the clinical epidemiology of neutropenic fever has changed. Therefore, treatment pathways should reflect optimal care of these patients, minimising their antimicrobial exposures and the associated unintended consequences, including dysbiosis, antimicrobial resistance, and prolonged hospital stays. This session will bring experts from the field to discuss novel approaches to management of the most common infection complications in cancer.\n",
      "sess auth :- Malgorzata MIKULSKA ; Nicolas MUELLER\n",
      "sess aff :- Italy; Switzerland\n",
      "========================================================================================================================\n",
      "3190-1 === \n",
      "abs title :- Machine learning for prediction of febrile neutropaenia\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3190-2 === \n",
      "abs title :- The pros and cons of neutropaenic fever prophylaxis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3190-3 === \n",
      "abs title :- Short course antimicrobials for neutropaenic fever\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3190-4 === \n",
      "abs title :- Implementation of ambulatory programmes for neutropaenic fever in adults and children\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 370\n",
      "=====**=====S370=====**======= 13\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall N\n",
      "sess type :- 2-hour SymposiumHall N\n",
      "sess cate :- 11. Other\n",
      "sess title :- 3281 - The future of CM/ID training\n",
      "abs text :- Co-organised with                    \n",
      "Trainee Association of ESCMID (TAE) Steering Committee, ESCMID Professional Affairs Subcommittee, International Federation of Medical Students Associations, Young Leaders Circle of American Society fo Medical education is at a crossroads. Although unique features exist at the undergraduate, graduate, and continuing education levels, shared aspects of all three levels form the basis for informed decision-making about the future of medical education. However, training curricula in clinical microbiology and infectious diseases vary widely across European countries, which hampers mobility of trainees and equal standards of training. The first part of this symposium will discuss the challenges faced by early career scientists, especially in gaining scientific independence. The second part will focus on the need of a reference standard in Europe by outlining specifically the skills and theoretical background which are essential in CM and ID training and how ESCMID can contribute to harmonized training conditions in providing tailored educational tools and courses aiming at bridging different national training standards.\n",
      "sess auth :- Maria João LOPES ; Anu KANTELE\n",
      "sess aff :- Portugal; Finland\n",
      "========================================================================================================================\n",
      "3281-1 === \n",
      "abs title :- Challenges for early career scientists in 2023\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3281-2 === \n",
      "abs title :- Addressing specific challenges: road towards gaining scientific independence\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3281-3 === \n",
      "abs title :- European standards of post-graduate medical specialist training and Europe-wide standardised board exams: dream or nightmare?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3281-4 === \n",
      "abs title :- ESCMID vision on educational training tools to facilitate harmonised training in CM and ID\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 371\n",
      "=====**=====S371=====**======= 14\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall O\n",
      "sess type :- 2-hour SymposiumHall O\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3126 - Neonatal congenital infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Nosocomial Infections (ESGNI), ESCMID Study Group for Clinical Parasitology (ESGCP), European Society of Paediatric Infectious Diseases (ESPID) Congenital infections acquired before or during birth are challenging for the neonatologist, the obstetrician, the infectious diseases and the infection control specialists. Viral infections, primarily rubella, herpes viridae infections, herpes simplex and CMV have a major impact on the future life of the infants and its family. In addition, congenital toxoplasmosis is still existing and a multidrug-resistant bacteria are emerging, posing a threat the newborns due to the lack of a new readily available therapies. In the hospital, IPC precautions must be taken while the infected infants often are shedding the virus. The experts will focus on challenges of congenital infection diagnostics and therapy.\n",
      "sess auth :- Angelika BERGER\n",
      "sess aff :- Austria\n",
      "========================================================================================================================\n",
      "3126-1 === \n",
      "abs title :- Toxoplasmosis in pregnancy and neonates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3126-2 === \n",
      "abs title :- Cytomegalovirus in pregnancy and neonates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3126-3 === \n",
      "abs title :- Herpes virus infections in pregnancy and neonates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3126-4 === \n",
      "abs title :- Infection control at the neonatal unit\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 372\n",
      "=====**=====S372=====**======= 15\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 15:30\n",
      "sess loca :- Hall P\n",
      "sess type :- 2-hour Oral SessionHall P\n",
      "sess cate :- 3. Bacterial susceptibility & resistance\n",
      "sess title :- ALP06 - Plasmids: shuffling and dealing major drivers of increasing AMR\n",
      "abs text :-  \n",
      "sess auth :- Edward FEIL ; Angela NOVAIS\n",
      "sess aff :- United Kingdom; Portugal\n",
      "========================================================================================================================\n",
      "ALP0601 === 13:30 - 15:30\n",
      "abs title :- Genetic determinants of plasmid persistence in a comprehensive five-year, multi-centred population analysis of 1,071 closed carbapenemase-producing Enterobacterales genomes\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0602 === 13:30 - 15:30\n",
      "abs title :- Global transmission of blaNDM-producing Escherichia coli is mediated by three major clades and geographically diverse mobile genetic elements\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0603 === 13:30 - 15:30\n",
      "abs title :- Does drug consumption has an influence on plasmids diffusion in CZA-resistant Klebsiella pneumoniae isolates?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0604 === 13:30 - 15:30\n",
      "abs title :- Generation of a database to study the spread of resistance plasmids of highly resistant microorganisms between One Health domains in the Netherlands\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0605 === 13:30 - 15:30\n",
      "abs title :- “Non-transmissible” plasmids as major spreaders of antimicrobial resistance. E pur si muove!\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0606 === 13:30 - 15:30\n",
      "abs title :- Genetic background of neomycin resistance in clinical Escherichia coli isolated from Danish pig farms\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0607 === 13:30 - 15:30\n",
      "abs title :- Genomic investigation of emerging multi-species and multi-variant blaNDM outbreak reveals role of interspecies IncN and IncX3 plasmid transfer\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0608 === 13:30 - 15:30\n",
      "abs title :- Characterisation of broad host range IncC plasmid bearing multiple carbapenemases: blaKPC-2, blaNDM-1, and blaVIM-24\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0609 === 13:30 - 15:30\n",
      "abs title :- Phytobacter, a novel reservoir of ESBL encoding plasmids in hospital water systems\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "ALP0610 === 13:30 - 15:30\n",
      "abs title :- A global evolution pathway for the generation of carbapenem-resistant hypervirulent Klebsiella pneumoniae\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 373\n",
      "=====**=====S373=====**======= 16\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 1\n",
      "sess type :- 1-hour ePoster Flash SessionArena 1\n",
      "sess cate :- 6. Fungal infection & disease\n",
      "sess title :- MEM03 - What's new in the fungal diagnostic field\n",
      "abs text :-  \n",
      "sess auth :- Jon SALMANTON\n",
      "sess aff :- Germany\n",
      "========================================================================================================================\n",
      "MEM0301 === 13:30 - 14:30\n",
      "abs title :- The current state of laboratory mycology in Asia/Pacific: a survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0302 === 13:30 - 14:30\n",
      "abs title :- Development and performance of MycoMEIA – Aspergillus: a new urine diagnostic for aspergillosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0303 === 13:30 - 14:30\n",
      "abs title :- Does (1,3)-β-d-glucan predict the degree of pulmonary involvement in Pneumocystis jirovecii pneumonia?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0304 === 13:30 - 14:30\n",
      "abs title :- 1,3-β-d-glucan as a treatment response biomarker in invasive candidiasis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0305 === 13:30 - 14:30\n",
      "abs title :- On-time typing is possible: Fourier transform infrared spectroscopy vs microsatellite-based typing of azole-resistant bloodstream infection Candida parapsilosis isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0306 === 13:30 - 14:30\n",
      "abs title :- Multicentre evaluation of the galactomannan antigen assay on bronchoalveolar lavage of patients with haematological disease\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0307 === 13:30 - 14:30\n",
      "abs title :- Rapid identification of filamentous fungi by an optimised sample preparation method for MALDI-ToF MS\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0308 === 13:30 - 14:30\n",
      "abs title :- Testing multiple isolates is needed to spot antifungal resistance in Candida spp. from intra-abdominal samples\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MEM0309 === 13:30 - 14:30\n",
      "abs title :- The first established microsatellite markers able to distinguish Candida orthopsilosis isolates\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 374\n",
      "=====**=====S374=====**======= 18\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 13:30 - 14:30\n",
      "sess loca :- Arena 3\n",
      "sess type :- 1-hour ePoster Flash SessionArena 3\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- MYD03 - PK/PD: from bench to bedside and back\n",
      "abs text :-  \n",
      "sess auth :- Birgit KOCH\n",
      "sess aff :- Netherlands\n",
      "========================================================================================================================\n",
      "MYD0301 === 13:30 - 14:30\n",
      "abs title :- Investigating the impact of a humanised vancomycin infusion on kidney function and kidney injury in a translational rat model\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0302 === 13:30 - 14:30\n",
      "abs title :- In vitro evaluation of the interaction between meropenem/fosfomycin and meropenem/vaborbactam/fosfomycin in a clinical multi-drug resistant K. pneumoniae strain expressing blaKPC-2\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0303 === 13:30 - 14:30\n",
      "abs title :- Quantification of antibiotic-induced changes in bacterial counts and morphology using time-lapse microscopy, image analysis, machine learning and pharmacokinetic-pharmacodynamic modelling\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0304 === 13:30 - 14:30\n",
      "abs title :- Development and implementation of a model-informed precision dosing instrument for meropenem in critically ill: the TIAS study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0305 === 13:30 - 14:30\n",
      "abs title :- Evaluation of CSF penetration of vancomycin in patients with ventriculitis based on a physiologically-based pharmacokinetic approach\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0306 === 13:30 - 14:30\n",
      "abs title :- Population pharmacokinetics and dosing simulation of the β-lactam temocillin in liver-transplanted paediatric patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0307 === 13:30 - 14:30\n",
      "abs title :- Clustering-based model selection to improve the predictive performance of individualised vancomycin dosing in neonates and infants\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0308 === 13:30 - 14:30\n",
      "abs title :- A photo finish of machine learning models for predicting beta-lactam target non-attainment in critically ill patients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "MYD0309 === 13:30 - 14:30\n",
      "abs title :- Evaluating the area under the curve (AUC) of piperacillin and vancomycin: is elevated serum creatinine a marker of nephrotoxicity associated combination treatment?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 375\n",
      "=====**=====S375=====**======= 17\n",
      "sess date :- 18/04/2023\n",
      "sess time :- 14:30 - 15:30\n",
      "sess loca :- Arena 2\n",
      "sess type :- 1-hour ePoster Flash SessionArena 2\n",
      "sess cate :- 12. COVID-19\n",
      "sess title :- EW02 - License to SARS-CoV-2 immunity\n",
      "abs text :-  \n",
      "sess auth :- Zitta Barrella HARBOE\n",
      "sess aff :- Denmark\n",
      "========================================================================================================================\n",
      "EW0201 === 14:30 - 15:30\n",
      "abs title :- Hybrid immunity and COVID-19 re-infection with different vaccines schedules\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0202 === 14:30 - 15:30\n",
      "abs title :- Deciphering T cell receptor signatures of SARS-CoV-2 natural infection, vaccination and hybrid immunity\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0203 === 14:30 - 15:30\n",
      "abs title :- Long-term COVID-19 immunity: is naturally acquired infection better than vaccination?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0204 === 14:30 - 15:30\n",
      "abs title :- Persistence of anti-SARS-CoV-2 cellular immune response developed post-infection or post-vaccination\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0205 === 14:30 - 15:30\n",
      "abs title :- Evaluation of SARS-CoV-2-specific T cell responses in vaccinated elderly\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0206 === 14:30 - 15:30\n",
      "abs title :- SARS-CoV-2-specific B- and T-cell immune memory beyond one year after infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0207 === 14:30 - 15:30\n",
      "abs title :- Antibody response following COVID-19 boosters during the US Omicron wave: a decentralised, digital health, real-world study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0208 === 14:30 - 15:30\n",
      "abs title :- The humoral and cellular immunity against Omicron variant BA.4/5 is comparable between once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "EW0209 === 14:30 - 15:30\n",
      "abs title :- Nucleocapsid antibody response to SARS-CoV-2 infection by vaccination status and variant in England\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 376\n",
      "=====**=====S376=====**======= 19\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 18/04/2023\n",
      "sess time :- 14:30 - 15:30\n",
      "sess loca :- Arena 4\n",
      "sess type :- 1-hour ePoster Flash SessionArena 4\n",
      "sess cate :- 10. Immunology & vaccinology\n",
      "sess title :- CSP01 - Immune response in vaccine preventable diseases\n",
      "abs text :-  \n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "CSP0101 === 14:30 - 15:30\n",
      "abs title :- Estimating the Health and Economic Burden of Pneumococcal diseases Attributable to V116 Vs. PCV20 Serotypes Among Adults in Italy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0102 === 14:30 - 15:30\n",
      "abs title :- Adaptive immune responses to aerosolised bacillus Calmette-Guérin (BCG) as a surrogate controlled human infection model for Mycobacterium tuberculosis\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0103 === 14:30 - 15:30\n",
      "abs title :- Use of MVA-BN vaccine in the context of the current mpox outbreak: early experience of an infectious and tropical diseases unit in Florence, Italy\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0104 === 14:30 - 15:30\n",
      "abs title :- Establishing a pig model for preclinical evaluation of vaccines against urinary tract infection\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0105 === 14:30 - 15:30\n",
      "abs title :- A novel peptide-based vaccine targeting bacterial glyceraldehyde-3-phosphate dehydrogenase to prevent neonatal infections\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0106 === 14:30 - 15:30\n",
      "abs title :- Phage-specific antibodies improve adaptive immunity against recognisable bacteria\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0107 === 14:30 - 15:30\n",
      "abs title :- Utility of BKV-ELISPOT to predict the risk of BK infection and nephropathy in kidney recipients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0108 === 14:30 - 15:30\n",
      "abs title :- Cellular immune response to pneumococcal polysaccharide vaccine (PPV23) after conjugated vaccine (PCV13) in haematopoietic stem cell transplant (HSCT) recipients\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "CSP0109 === 14:30 - 15:30\n",
      "abs title :- SARS-CoV-2 antibody response in solid organ transplant recipients after mRNA BNT162b2: data from an observational retrospective study\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 377\n",
      "=====**=====S377=====**======= 0\n",
      "sess date :- 24/05/2023\n",
      "sess time :- 16:00 - 17:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3361 - Tropical diseases: what's new in this post-pandemic time?\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Veterinary Microbiology (ESGVM), ESCMID Study Group for Infections in Travellers and Migrants (ESGITM), Pan-Aamerican Association Infectious Diseases (API) Several highly pathogenic viral infections are difficult to control as they have a zoonotic reservoir and are further challenging as they spread in highly mobile populations as migrants and other travelers. There are important One Health aspects to consider in order to identify the animal reservoir, the risk factors for zoonotic and human-to-human transmission, and the ecological conditions favorable to its emergence needs to be described. There are current outbreaks of some of these infections and a need to describe the implications of these outbreaks for animal contact and screening of mobile populations. The aim of this session is to discuss updates on highly pathogenic viral infections and what is the effect on mobile populations on the epidemiology of these infections.\n",
      "sess auth :- Gustavo Daniel LOPARDO ; Christian WEJSE\n",
      "sess aff :- Argentina; Denmark\n",
      "========================================================================================================================\n",
      "3361-1 === \n",
      "abs title :- Back to the stage: Dengue and its complications\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3361-2 === \n",
      "abs title :- Yellow fever: what's new?\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 378\n",
      "=====**=====S378=====**======= 0\n",
      "sess date :- 24/05/2023\n",
      "sess time :- 17:00 - 18:00\n",
      "sess loca :- Science track\n",
      "sess type :- Meet-the-ExpertScience track\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3305 - PrEP implementation in Europe: achievements and challenges\n",
      "abs text :- Co-organised with                    \n",
      "European AIDS Clinical Society (EACS) Pre-exposure prophylaxis (PrEP) against HIV, being a well-established and effective prevention tool, is far from reaching the set European target of three million people. Key implementation challenges include information gaps both among medical personnel and PrEP users, stigma and inadequate legislative support. Furthermore, as new PrEP options are being delivered to the clinical practice, it is of primary importance to inform on the novel efficacy data and practical implementation issues, as well as risks related to sexually transmitted infections (STI). This session aims to provide novel data on the challenges of PrEP implementation across various European healthcare settings, inform on the risks and strategies related to STI among PrEP users, and provide insight on the future PrEP strategies, including long-acting options. The session is timely not only from the perspective of advances in HIV prevention but also from observed war-related migration from higher HIV prevalence countries.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3305-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3305-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 379\n",
      "=====**=====S379=====**======= 0\n",
      "sess date :- 24/05/2023\n",
      "sess time :- 18:00 - 19:00\n",
      "sess loca :- Science track\n",
      "sess type :- Meet-the-ExpertScience track\n",
      "sess cate :- 1. Viral infection & disease\n",
      "sess title :- 3161 - Challenges and opportunities in respiratory syncytial virus research\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Respiratory Viruses (ESGREV) The aim of the session is to discuss updates and next steps in RSV research. Our goal is to share knowledge on the latest developments and to connect leading worldwide scientists. The two speakers will focus on burden of disease and mortality (including LMIC perspectives), molecular epidemiology and evolution, diagnostics, and clinical interventions.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3161-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3161-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 380\n",
      "=====**=====S380=====**======= 0\n",
      "sess date :- 25/05/2023\n",
      "sess time :- 16:00 - 17:00\n",
      "sess loca :- Science track\n",
      "sess type :- Meet-the-ExpertScience track\n",
      "sess cate :- 4. Diagnostic microbiology\n",
      "sess title :- 3226 - Taking genomic pathogen surveillance to the next level\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Epidemiological Markers (ESGEM), ESCMID Study Group for Public Health Microbiology (ESGPHM), ESCMID Food- and Water-borne Infections Study Group (EFWISG) Recently, we have seen tremendous advances in establishing genome-based methods as frontline tool for pathogen and antimicrobial resistance surveillance, on the local, regional, national and international level. In this Meet-the-Expert, speakers will focus on the. The target audience are public health officials, national and international stakeholders and all ID/CM specialists dealing with genome-based analyses for diagnostics and strain typing on a routine basis.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3226-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3226-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 381\n",
      "=====**=====S381=====**======= 0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sess date :- 25/05/2023\n",
      "sess time :- 17:00 - 18:00\n",
      "sess loca :- Science track\n",
      "sess type :- 1-hour SymposiumScience track\n",
      "sess cate :- 5. New antibacterial agents, PK/PD & Stewardship\n",
      "sess title :- 3440 - Rapid diagnostics to inform the management of acute respiratory\n",
      "abs text :- Co-organised with                    \n",
      "Value-Dx Acute respiratory tract infections are among the most frequently encountered infectious diseases problems in both community and hospital settings. These infections are also the leading cause of unnecessary use of empirical antimicrobials and one of main drivers of the emergence of antibiotic resistance. Availability and rationale use of reliable point-of-care tests and various rapid diagnostic tools in this setting may improve antimicrobial usage for these infections. VALUE-Dx is an IMI project and partnered by ESCMID and European Respiratory Society (ERS) for studying this issue and a consensus report in underway by experts involved from both Societies and by those involved in different work packages in the project. This session will summarise the main outcomes of the report that will be issued in 2023 and discuss its implementations in daily practice.\n",
      "sess auth :- Surbhi MALHOTRA; Chris C. BUTLER\n",
      "sess aff :- Belgium; United Kingdom\n",
      "========================================================================================================================\n",
      "3440-1 === \n",
      "abs title :- Use of rapid diagnostics in ARTIs: a consensus report from ESCMID and ERS\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3440-2 === \n",
      "abs title :- Implementation of the consensus report in the clinical setting\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 382\n",
      "=====**=====S382=====**======= 0\n",
      "sess date :- 25/05/2023\n",
      "sess time :- 18:00 - 19:00\n",
      "sess loca :- Science track\n",
      "sess type :- Meet-the-ExpertScience track\n",
      "sess cate :- 2. Bacterial infection & disease\n",
      "sess title :- 3314 - New developments in clinical radiology for infections\n",
      "abs text :- Co-organised with                    \n",
      "ESCMID Study Group for Infectious Diseases of the Brain (ESGIB), ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) The radiological diagnosis of central nervous system infections can be quite difficult: is it a brain abscesses or a tumor, cerebral toxoplasmosis or metastasis? In this session experts in the field of radiological diagnoses of central nervous system infections will guide us through the steps the radiologist takes to interpret CT and MRI of the brain. These ground rules of interpretation will aid the ID physician in understanding the images of the brain in the evaluation of brain abscess and opportunistic infections of the brain.\n",
      "sess auth :- \n",
      "sess aff :- \n",
      "========================================================================================================================\n",
      "3314-1 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "3314-2 === \n",
      "abs title :- TBD\n",
      "abs auth :- \n",
      "abs aff :- \n",
      "-*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+--*-+-\n",
      "inr 383\n"
     ]
    }
   ],
   "source": [
    "se_no = 1\n",
    "for dat in dates:\n",
    "    \n",
    "    reqout = requests.get(f'https://eccmid2023.key4.live/programme-live-1?coday=2023-{dat}&embed=1')\n",
    "    soup = BS(reqout.content, 'lxml')\n",
    "    \n",
    "    outer_row = soup.find_all(class_='row live-program-card-row-grid')\n",
    "    locations = soup.find_all(class_='d-flex-block text-center roomsName py-2')\n",
    "    \n",
    "    for ou in outer_row:\n",
    "\n",
    "        col_div = 0\n",
    "        \n",
    "        for i_id in ou.find_all(class_='border text-center program-grid-calandar'):\n",
    "            \n",
    "            if i_id.find(class_='programme-session-card programme-session-display border'):\n",
    "                \n",
    "                session_number = f'S{se_no}'\n",
    "                print(f'=====**====={session_number}=====**=======', col_div)\n",
    "                i_id = i_id.find(class_='programme-session-card programme-session-display border')\n",
    "\n",
    "                data['sessionRef'] = i_id.get('data-session-reference')\n",
    "                \n",
    "                req = requests.post(\n",
    "                    'https://eccmid2023.key4.live/fo-user-display-session-details.php',\n",
    "                    cookies=cookies,\n",
    "                    headers=headers,\n",
    "                    data=data,)\n",
    "\n",
    "                soupin = BS(req.content, 'lxml')\n",
    "                sess_data = soupin.find(id='modal-session-content')\n",
    "\n",
    "                # -------------------------------------    date time location ya type     ------------------------------------\n",
    "                sess_date = ''\n",
    "                sess_time = ''\n",
    "                sess_loc = ''\n",
    "                sess_type = ''\n",
    "                sess_loc = ''\n",
    "                sess_loc = locations[col_div].text.strip()\n",
    "                date_time_type = edit.text_cleaner(sess_data.find(class_='modal-session-header').text)\n",
    "\n",
    "                sess_date = date_time_type.split(',')[0].strip()\n",
    "                sess_time = date_time_type.split(',')[1].split('CET')[0].strip()\n",
    "                sess_type = date_time_type.split('CET')[-1].strip()\n",
    "\n",
    "                # --------------------------------------  category or type and title -----------------------------------------------------\n",
    "                sess_cate = ''\n",
    "                sess_cate = sess_data.find(class_='modal-title-cat mt-2 mb-2').text.strip()\n",
    "                sess_title = sess_data.find(class_='modal-session-name mb-2').text.strip()\n",
    "                sess_title = i_id.get('data-session-reference') + ' - ' + sess_title\n",
    "\n",
    "                # --------------------------------------- abstract text OR co organised ---------------------------------------------\n",
    "                co_org = ''\n",
    "                sess_text = ''\n",
    "                if sess_data.find(class_='modal-session-organized-by mt-2'):\n",
    "                    co_org = sess_data.find(class_='modal-session-organized-by mt-2').text.strip()\n",
    "                if sess_data.find(class_='modal-session-desc mt-2'):\n",
    "                    sess_text = sess_data.find(class_='modal-session-desc mt-2').text.strip()\n",
    "                    \n",
    "                sess_text = co_org + ' ' + sess_text\n",
    "\n",
    "                # ------------------------------------------- session ka authors aff --------------------------------------------------\n",
    "                sess_author = ''\n",
    "                sess_aff = ''\n",
    "\n",
    "                if sess_data.find(class_='modal-session-moderators'):\n",
    "                    for i in sess_data.find(class_='modal-session-moderators').find_all(class_='row'):\n",
    "\n",
    "                        aff = i.find(class_='modal-session-moderator-country').text.strip()\n",
    "                        auth = i.text.strip()\n",
    "                        auth = auth.replace(aff, '').split('-')[0]\n",
    "                        aff = aff.replace(',', '').strip()\n",
    "\n",
    "                        sess_author += auth + '; '\n",
    "                        sess_aff += aff + '; '\n",
    "\n",
    "                sess_author = clean_semicolon(sess_author)\n",
    "                sess_aff = clean_semicolon(sess_aff)\n",
    "                sess_date = sess_date + '/2023'\n",
    "                sess_type = re.sub(sess_loc, '', sess_type)\n",
    "\n",
    "                print(f'sess date :- {sess_date}')\n",
    "                print(f'sess time :- {sess_time}')\n",
    "                print(f'sess loca :- {sess_loc}')\n",
    "                print(f'sess type :- {sess_type}')\n",
    "                print(f'sess cate :- {sess_cate}')\n",
    "                print(f'sess title :- {sess_title}')\n",
    "                print(f'abs text :- {sess_text}')\n",
    "                print(f'sess auth :- {sess_author}')\n",
    "                print(f'sess aff :- {sess_aff}')\n",
    "\n",
    "                dic['session_number'].append(session_number)\n",
    "                dic['name'].append('Session')\n",
    "                dic['source_id'].append('')\n",
    "                dic['manual_id'].append('')\n",
    "                dic['article_title'].append(sess_title)\n",
    "                dic['url'].append(f'https://eccmid2023.key4.live/programme-live-1?coday=2023-{dat}&embed=1')\n",
    "                dic['authors'].append(sess_author)\n",
    "                dic['author_affiliation'].append(sess_aff)\n",
    "                dic['abstract_text'].append(sess_text)\n",
    "                dic['date'].append(sess_date)\n",
    "                dic['start_time'].append(sess_time.split('-')[0].strip())\n",
    "                dic['end_time'].append(sess_time.split('-')[-1].strip())\n",
    "                dic['location'].append(sess_loc)\n",
    "                dic['session_title'].append(sess_title)\n",
    "                dic['session_type'].append(sess_type)\n",
    "                dic['category'].append(sess_cate)\n",
    "                dic['sub_category'].append('')\n",
    "                dic['disclosure'].append('')\n",
    "                print('======'*20)\n",
    "                \n",
    "                # *+*+*+*+*+*+*+*+*+*+*+*+*  ------------------- ABSTRACT DATA ----------------- *+*+*+*+*+*+**+**+*+*+*\n",
    "                \n",
    "                abs_data = sess_data.find(class_='modal-sessions-interventions')\n",
    "                if abs_data:\n",
    "                    \n",
    "                    pno = 1\n",
    "                    for ab in abs_data.find_all(class_='modal-sessions-interventions-group clearfix'):\n",
    "\n",
    "                        abs_title = ab.find(style='font-weight: bold').text.strip()\n",
    "\n",
    "                        # abs author\n",
    "                        abs_author = ''\n",
    "                        abs_aff = ''\n",
    "                        if ab.find(class_='modal-session-faculties mb-1'):\n",
    "                            ab_authaff = ab.find(class_='modal-session-faculties mb-1').text.strip()\n",
    "                            abs_author = ', '.join(ab_authaff.split(',')[:-1])\n",
    "                            abs_aff = ab_authaff.split(',')[-1]\n",
    "\n",
    "                        if abs_title == '':\n",
    "                            abs_title = 'TBD'\n",
    "                            \n",
    "                        # source id...... time shit\n",
    "                        \n",
    "                        ar_id = ''\n",
    "                        art_time = ''\n",
    "                        \n",
    "                        if re.search('^[A-Z]{1,5}\\d{1,10}|^\\d{1,5}', sess_title):\n",
    "                            src_code = re.search('^[A-Z]{1,5}\\d{1,10}|^\\d{1,5}', sess_title).group()\n",
    "\n",
    "                            if src_code:\n",
    "\n",
    "                                if re.search('^\\d{1,6}', src_code):\n",
    "                                    ar_id = src_code + '-' + str(pno)\n",
    "                                    art_time = ''\n",
    "                                elif re.search('^[A-Z]{1,5}\\d{1,10}', src_code):\n",
    "\n",
    "                                    str_pno = str(pno)\n",
    "                                    if len(str_pno) == 1:\n",
    "                                        str_pno = '0' + str_pno\n",
    "                                    ar_id = src_code + str_pno\n",
    "                                    art_time = sess_time\n",
    "                        else:\n",
    "                            ar_id = 'QC'\n",
    "                        \n",
    "                            \n",
    "                        print(ar_id, '===', art_time)\n",
    "                        print(f'abs title :- {abs_title}')\n",
    "                        print(f'abs auth :- {abs_author}')\n",
    "                        print(f'abs aff :- {abs_aff}')\n",
    "\n",
    "                        dic['session_number'].append(session_number)\n",
    "                        dic['name'].append('Abstract')\n",
    "                        dic['source_id'].append(ar_id)\n",
    "                        dic['manual_id'].append('')\n",
    "                        dic['article_title'].append(abs_title)\n",
    "                        dic['url'].append(f'https://eccmid2023.key4.live/programme-live-1?coday=2023-{dat}&embed=1')\n",
    "                        dic['authors'].append(abs_author)\n",
    "                        dic['author_affiliation'].append(abs_aff)\n",
    "                        dic['abstract_text'].append('')\n",
    "                        dic['date'].append(sess_date)\n",
    "                        dic['start_time'].append('')\n",
    "                        dic['end_time'].append('')\n",
    "                        dic['location'].append(sess_loc)\n",
    "                        dic['session_title'].append(sess_title)\n",
    "                        dic['session_type'].append(sess_type)\n",
    "                        dic['category'].append(sess_cate)\n",
    "                        dic['sub_category'].append('')\n",
    "                        dic['disclosure'].append('')\n",
    "                        print('-*-+-'* 17)\n",
    "                        pno += 1\n",
    "                        \n",
    "                se_no += 1\n",
    "                print('inr', se_no)\n",
    "                \n",
    "            col_div += 1\n",
    "            "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "882bf967",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>source_id</th>\n",
       "      <th>manual_id</th>\n",
       "      <th>article_title</th>\n",
       "      <th>url</th>\n",
       "      <th>authors</th>\n",
       "      <th>author_affiliation</th>\n",
       "      <th>abstract_text</th>\n",
       "      <th>date</th>\n",
       "      <th>start_time</th>\n",
       "      <th>end_time</th>\n",
       "      <th>location</th>\n",
       "      <th>session_title</th>\n",
       "      <th>session_number</th>\n",
       "      <th>name</th>\n",
       "      <th>session_type</th>\n",
       "      <th>category</th>\n",
       "      <th>sub_category</th>\n",
       "      <th>disclosure</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>3437 - Multi-country outbreaks: from signal to...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td>Jacob MORAN; Ines STEFFENS</td>\n",
       "      <td>Israel; Sweden</td>\n",
       "      <td>Co-organised with                    \\nEurosur...</td>\n",
       "      <td>15/02/2023</td>\n",
       "      <td>16:00</td>\n",
       "      <td>17:00</td>\n",
       "      <td>Science track</td>\n",
       "      <td>3437 - Multi-country outbreaks: from signal to...</td>\n",
       "      <td>S1</td>\n",
       "      <td>Session</td>\n",
       "      <td>1-hour SymposiumScience track</td>\n",
       "      <td>7. Parasitic diseases &amp; global health</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>3437-1</td>\n",
       "      <td></td>\n",
       "      <td>A dangerous pre-Easter surprise: multi-country...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>15/02/2023</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Science track</td>\n",
       "      <td>3437 - Multi-country outbreaks: from signal to...</td>\n",
       "      <td>S1</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>1-hour SymposiumScience track</td>\n",
       "      <td>7. Parasitic diseases &amp; global health</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3437-2</td>\n",
       "      <td></td>\n",
       "      <td>Multi-country detections of diphtheria in migr...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>15/02/2023</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Science track</td>\n",
       "      <td>3437 - Multi-country outbreaks: from signal to...</td>\n",
       "      <td>S1</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>1-hour SymposiumScience track</td>\n",
       "      <td>7. Parasitic diseases &amp; global health</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>3268 - Tick-borne diseases in Europe: new, eme...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td>Nanna Skaarup ANDERSEN ; Olli VAPALAHTI</td>\n",
       "      <td>Denmark; Finland</td>\n",
       "      <td>Co-organised with                    \\nDanish ...</td>\n",
       "      <td>15/02/2023</td>\n",
       "      <td>17:00</td>\n",
       "      <td>18:00</td>\n",
       "      <td>Science track</td>\n",
       "      <td>3268 - Tick-borne diseases in Europe: new, eme...</td>\n",
       "      <td>S2</td>\n",
       "      <td>Session</td>\n",
       "      <td>1-hour SymposiumScience track</td>\n",
       "      <td>2. Bacterial infection &amp; disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>3268-1</td>\n",
       "      <td></td>\n",
       "      <td>Lyme borreliosis: recent progress and remainin...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>15/02/2023</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Science track</td>\n",
       "      <td>3268 - Tick-borne diseases in Europe: new, eme...</td>\n",
       "      <td>S2</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>1-hour SymposiumScience track</td>\n",
       "      <td>2. Bacterial infection &amp; disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1870</th>\n",
       "      <td>3440-1</td>\n",
       "      <td></td>\n",
       "      <td>Use of rapid diagnostics in ARTIs: a consensus...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>25/05/2023</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Science track</td>\n",
       "      <td>3440 - Rapid diagnostics to inform the managem...</td>\n",
       "      <td>S381</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>1-hour SymposiumScience track</td>\n",
       "      <td>5. New antibacterial agents, PK/PD &amp; Stewardship</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1871</th>\n",
       "      <td>3440-2</td>\n",
       "      <td></td>\n",
       "      <td>Implementation of the consensus report in the ...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>25/05/2023</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Science track</td>\n",
       "      <td>3440 - Rapid diagnostics to inform the managem...</td>\n",
       "      <td>S381</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>1-hour SymposiumScience track</td>\n",
       "      <td>5. New antibacterial agents, PK/PD &amp; Stewardship</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1872</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>3314 - New developments in clinical radiology ...</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Co-organised with                    \\nESCMID ...</td>\n",
       "      <td>25/05/2023</td>\n",
       "      <td>18:00</td>\n",
       "      <td>19:00</td>\n",
       "      <td>Science track</td>\n",
       "      <td>3314 - New developments in clinical radiology ...</td>\n",
       "      <td>S382</td>\n",
       "      <td>Session</td>\n",
       "      <td>Meet-the-ExpertScience track</td>\n",
       "      <td>2. Bacterial infection &amp; disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1873</th>\n",
       "      <td>3314-1</td>\n",
       "      <td></td>\n",
       "      <td>TBD</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>25/05/2023</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Science track</td>\n",
       "      <td>3314 - New developments in clinical radiology ...</td>\n",
       "      <td>S382</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>Meet-the-ExpertScience track</td>\n",
       "      <td>2. Bacterial infection &amp; disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1874</th>\n",
       "      <td>3314-2</td>\n",
       "      <td></td>\n",
       "      <td>TBD</td>\n",
       "      <td>https://eccmid2023.key4.live/programme-live-1?...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>25/05/2023</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Science track</td>\n",
       "      <td>3314 - New developments in clinical radiology ...</td>\n",
       "      <td>S382</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>Meet-the-ExpertScience track</td>\n",
       "      <td>2. Bacterial infection &amp; disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1875 rows × 18 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     source_id manual_id                                      article_title  \\\n",
       "0                         3437 - Multi-country outbreaks: from signal to...   \n",
       "1       3437-1            A dangerous pre-Easter surprise: multi-country...   \n",
       "2       3437-2            Multi-country detections of diphtheria in migr...   \n",
       "3                         3268 - Tick-borne diseases in Europe: new, eme...   \n",
       "4       3268-1            Lyme borreliosis: recent progress and remainin...   \n",
       "...        ...       ...                                                ...   \n",
       "1870    3440-1            Use of rapid diagnostics in ARTIs: a consensus...   \n",
       "1871    3440-2            Implementation of the consensus report in the ...   \n",
       "1872                      3314 - New developments in clinical radiology ...   \n",
       "1873    3314-1                                                          TBD   \n",
       "1874    3314-2                                                          TBD   \n",
       "\n",
       "                                                    url  \\\n",
       "0     https://eccmid2023.key4.live/programme-live-1?...   \n",
       "1     https://eccmid2023.key4.live/programme-live-1?...   \n",
       "2     https://eccmid2023.key4.live/programme-live-1?...   \n",
       "3     https://eccmid2023.key4.live/programme-live-1?...   \n",
       "4     https://eccmid2023.key4.live/programme-live-1?...   \n",
       "...                                                 ...   \n",
       "1870  https://eccmid2023.key4.live/programme-live-1?...   \n",
       "1871  https://eccmid2023.key4.live/programme-live-1?...   \n",
       "1872  https://eccmid2023.key4.live/programme-live-1?...   \n",
       "1873  https://eccmid2023.key4.live/programme-live-1?...   \n",
       "1874  https://eccmid2023.key4.live/programme-live-1?...   \n",
       "\n",
       "                                      authors author_affiliation  \\\n",
       "0                  Jacob MORAN; Ines STEFFENS     Israel; Sweden   \n",
       "1                                                                  \n",
       "2                                                                  \n",
       "3     Nanna Skaarup ANDERSEN ; Olli VAPALAHTI   Denmark; Finland   \n",
       "4                                                                  \n",
       "...                                       ...                ...   \n",
       "1870                                                               \n",
       "1871                                                               \n",
       "1872                                                               \n",
       "1873                                                               \n",
       "1874                                                               \n",
       "\n",
       "                                          abstract_text        date  \\\n",
       "0     Co-organised with                    \\nEurosur...  15/02/2023   \n",
       "1                                                        15/02/2023   \n",
       "2                                                        15/02/2023   \n",
       "3     Co-organised with                    \\nDanish ...  15/02/2023   \n",
       "4                                                        15/02/2023   \n",
       "...                                                 ...         ...   \n",
       "1870                                                     25/05/2023   \n",
       "1871                                                     25/05/2023   \n",
       "1872  Co-organised with                    \\nESCMID ...  25/05/2023   \n",
       "1873                                                     25/05/2023   \n",
       "1874                                                     25/05/2023   \n",
       "\n",
       "     start_time end_time       location  \\\n",
       "0         16:00    17:00  Science track   \n",
       "1                         Science track   \n",
       "2                         Science track   \n",
       "3         17:00    18:00  Science track   \n",
       "4                         Science track   \n",
       "...         ...      ...            ...   \n",
       "1870                      Science track   \n",
       "1871                      Science track   \n",
       "1872      18:00    19:00  Science track   \n",
       "1873                      Science track   \n",
       "1874                      Science track   \n",
       "\n",
       "                                          session_title session_number  \\\n",
       "0     3437 - Multi-country outbreaks: from signal to...             S1   \n",
       "1     3437 - Multi-country outbreaks: from signal to...             S1   \n",
       "2     3437 - Multi-country outbreaks: from signal to...             S1   \n",
       "3     3268 - Tick-borne diseases in Europe: new, eme...             S2   \n",
       "4     3268 - Tick-borne diseases in Europe: new, eme...             S2   \n",
       "...                                                 ...            ...   \n",
       "1870  3440 - Rapid diagnostics to inform the managem...           S381   \n",
       "1871  3440 - Rapid diagnostics to inform the managem...           S381   \n",
       "1872  3314 - New developments in clinical radiology ...           S382   \n",
       "1873  3314 - New developments in clinical radiology ...           S382   \n",
       "1874  3314 - New developments in clinical radiology ...           S382   \n",
       "\n",
       "              name                   session_type  \\\n",
       "0          Session  1-hour SymposiumScience track   \n",
       "1     Presentation  1-hour SymposiumScience track   \n",
       "2     Presentation  1-hour SymposiumScience track   \n",
       "3          Session  1-hour SymposiumScience track   \n",
       "4     Presentation  1-hour SymposiumScience track   \n",
       "...            ...                            ...   \n",
       "1870  Presentation  1-hour SymposiumScience track   \n",
       "1871  Presentation  1-hour SymposiumScience track   \n",
       "1872       Session   Meet-the-ExpertScience track   \n",
       "1873  Presentation   Meet-the-ExpertScience track   \n",
       "1874  Presentation   Meet-the-ExpertScience track   \n",
       "\n",
       "                                              category sub_category disclosure  \n",
       "0                7. Parasitic diseases & global health                          \n",
       "1                7. Parasitic diseases & global health                          \n",
       "2                7. Parasitic diseases & global health                          \n",
       "3                     2. Bacterial infection & disease                          \n",
       "4                     2. Bacterial infection & disease                          \n",
       "...                                                ...          ...        ...  \n",
       "1870  5. New antibacterial agents, PK/PD & Stewardship                          \n",
       "1871  5. New antibacterial agents, PK/PD & Stewardship                          \n",
       "1872                  2. Bacterial infection & disease                          \n",
       "1873                  2. Bacterial infection & disease                          \n",
       "1874                  2. Bacterial infection & disease                          \n",
       "\n",
       "[1875 rows x 18 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.DataFrame(dic)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "6aeac088",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_excel('binaFilter_all.xlsx', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "da6d0e5b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7f0fbd86",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "28f48148",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
